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of this work. The resulting publications of these date are cited where relevant and attached in 
the appendix. The tissues from the one year confetti mice lineage tracing into adulthood were 






The mammary gland is a dynamic organ that undergoes many cycles of proliferation and death 
throughout both oestrus cycling and the gestation/lactation/involution cycle. Moreover, it is a 
unique tissue in that the majority of its development occurs postnatally coincident with the 
production of ovarian hormones in puberty. This capacity of the mammary gland for rapid 
growth and regeneration has been attributed to mammary stem cells (MaSCs). However, 
despite extensive efforts over the past 60 years, definitive characterisation of the stem and 
progenitor cells of the mammary gland has yet to be achieved. A number of recent conflicting, 
lineage tracing studies have served only to fuel the fires of controversy, with previous 
characterisation of the mammary gland largely carried out using two-dimensional tissue 
sections. However, in order to fully appreciate the capacity of MaSCs and to maintain spatial 
information of the complex topological structure, the mammary gland must be investigated in 
its intact form. Accordingly, there is still much disagreement regarding the potency, capacity 
and location of MaSCs.  
 
Consequently, in order to unequivocally elucidate the MaSC hierarchy, a variety of novel 
techniques have been combined in this thesis. The first involves development and optimisation 
of optical tissue clearing techniques to allow the visualisation of the native mammary gland, in 
situ, and in three dimensions. To do so, a number of different optical tissue clearing methods 
have been assessed and combined with a variety of microscopy techniques to allow the 
multiple focal planes of the ductal network to be examined. These imaging techniques were 
then combined with two neutral lineage tracing models; the first, the Rosa26[CA]30 model, 
utilises stochastic continuous clonal labelling to allow for the fate tracking of the progeny from 
single functional stem and progenitor cells. The second unbiased lineage tracing approach, the 
Rosa26-Confetti model, allows for the mammary stem and progenitor progeny to be traced 
with precise timing, with the additional benefit of a multicolour reporter. Next, proliferation 
was examined in wholemount tissues to investigate the functional requirements for MaSCs, 
and their potential locations. Finally, these techniques have been combined with an ex vivo 3D 
organoid culture system to investigate the use of culture methods in examining mammary 
epithelial cell dynamics.  
 
By combination of these techniques, clonally marked regions can be investigated throughout 
the development of the mammary gland, from the formation of the embryonic mammary 
 
 iv 
rudiment, to expansion of the ductal tree in puberty, and ultimately their fate in lactation and 
involution, where the mammary gland fulfils its evolutionary purpose. The mammary gland 
provides a unique opportunity to investigate epithelial development extra-embryonically that 
is not available in other tissues. Moreover, study of maintenance and turnover of this organ 
has important implications for other epithelial systems. Finally, elucidation of the normal MaSC 
hierarchy also has important implications for understanding the complex heterogeneity of 
breast cancer and the cell(s) of origin of breast cancer. Given the proposed longevity and 
suggested ability of MaSCs to survive multiple waves of cell death in involution, they represent 
a logical candidate for a potential cell of origin of breast cancer. 
 
The work presented in this thesis provides novel insights into MaSCs and progenitors and 
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Chapter 1   
Introduction 
  
Chapter 1 - Introduction to the mammary gland 
2 
 
1.1. Introduction to the mammary gland 
The mammary gland is a complex organ, which undergoes multiple cycles of expansion and 
regression throughout life. Unlike most organs, the majority of mammary gland development 
occurs postnatally. During puberty there is a large expansion of the epithelial compartment, 
with elongation and branching of the ductal tree throughout the mammary fat pad. The 
mammary gland also undergoes significant growth and tertiary branching during pregnancy to 
form milk-producing alveoli that are removed during post-lactational regression by rapid cell 
death coupled with tissue remodelling. As such, the mammary gland represents a unique organ 
to study adult stem cells and their contribution to tissue development, maintenance and 
remodelling.  
 
Moreover, as one of the defining features of mammalian biology, study of the mammary gland 
has important evolutionary interest. Indeed, although several aspects of mammary gland 
biology vary between mammals – for example number and positioning – development of the 
mammary gland amongst mammals broadly follows the same stages (Oftedal and Dhouailly, 
2013). Consequently, the mouse is widely used to model mammary developmental 
mechanisms due to the functional similarities between the mammary tissue of both human and 
mouse, in addition to its amenability to complex genetic manipulations. 
 
Embryonic mammary development of the mouse 
During mouse embryonic development, mammary placode formation is initiated at 
approximately embryonic day (E) 10.5, with the formation of two so-called milk lines from 
the overlying ectoderm (Propper et al., 2013). These mammary lines, which can be detected 
by expression of a number of Wnt proteins including Wnt10b (Veltmaat et al., 2004) and 
Wnt5a (Yamaguchi et al., 1999), form bilaterally along the rostral/caudal axis between the fore 
and hind limb buds (Sakakura et al., 1982). This is followed a day later on E11.5 with the 
development of five pairs of placodes along these lines (Figure 1.2,i), formed of aggregates of 
epithelial cells which can be detected histologically by the thickening of the surface ectoderm. 
Interestingly, these placodes develop asynchronously in a defined order, but with each 
individual pair of placodes developing symmetrically (Veltmaat et al., 2004, 2006). By E12.5, 
the cells of the placode expand then begin to pile up and arrange themselves into a concentric 
formation, meaning they can be detected as small bulges on the ventral surface of the embryo 
(Howard, 2012) (Figure 1.1,ii). 




By E13.5, each placode expands and invaginates into the underlying dermal mesenchyme 
(Figure 1.1,iii), to result in the formation of a mammary bud which continues to expand until 
E14.5 (Watson and Khaled, 2008). At this point, the underlying mesenchyme also begins to 
change as the surrounding cells elongate and condense around the expanding mammary bud 
(Figure 1.1,iv). In male mice, this time coincides with the production of androgens leading to 
the expansion of the underlying mesenchyme, which eventually severs the connection of the 
mammary bud to the skin (Heuberger et al., 1982; Veltmaat et al., 2003) and is followed by 
apoptosis of the mammary mesenchyme and the majority of the mammary bud (Dunbar et al., 
1999). This process is in contrast to male human development, whereby this severing event 
does not occur. Instead, the bud goes on to form a small ductal outgrowth that remains 
connected to the nipple (Howard and Gusterson, 2000). For this reason, although rare, male 
humans can be susceptible to breast cancer, in addition to other benign aberrations of the 
breast.  
 
In female mice, by E15.5 distinct cell types form within the neck of the mammary bud which 
subsequently push the distal end of the mammary bud deeper (Figure 1.1,v). Consequently, 
E16.5 marks the commencement of the first phase of branching morphogenesis in the 
mammary gland. Here, the mammary bud invaginates further from the primary mammary 
mesenchyme and into a third stromal compartment (Figure 1.1,vi). Termed the mammary fat 
pad pre-cursor, this consists of an assemblage of preadipocytes which mediate a number of 
paracrine signalling pathways (Hens and Wysolmerski, 2005). The invasion into the mammary 
fat pad initiates the expansion and branching of the epithelial tubular sprout, culminating in the 
development of the primordial ductal tree by E18.5 (Figure 1.1,vii) (Howard, 2012). From this 
point onwards, the embryonic mammary gland is unusual in that it remains relatively quiescent, 
expanding only isometrically with the rest of the body, even after birth. At the termination of 
embryonic mammary development, the epithelium of the gland consists of a primary duct 
consisting of approximately 10 – 15 initial branches surrounded by a number of stromal cells, 
altogether which forms the scaffold upon which further mammary development will be built. 




Figure 1.1 Schematic overview of murine embryonic mammary gland 
development  
(i) Mammary placodes form at E11.5 along the milk lines, visible as a slight 
thickening of the endoderm. (ii) At E12.5, the mammary placode can be detected 
as visible elevation as the mammary bud forms. (iii) At E13.5 the mammary 
mesenchyme expands as the placode invaginates into the underlying dermal 
mesenchyme. (iv) At E14.5, further expansion can be seen as the mammary 
mesenchyme thickens further and the fat pad precursor is formed. (v) At E15.5 the 
mammary bud elongates further and reaches the fat pad precursor which initiates 
a round of branching morphogenesis (iv) at E16.5. By E18.5 (vii) a primordial 
ductal tree is present which expands isometrically until puberty. Based upon figure 
from Veltmaat et al., 2003. 
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Pubertal development of the mouse mammary gland  
Interestingly, despite being just a rudimentary ductal system, the gland at birth is equipped 
with the capability to produce milk, colloquially referred to as witch’s milk in humans. This is 
due to foetal exposure to maternal hormones, either from the placenta during the latter stages 
of gestation or via the breast milk from the mother herself after birth. However, the hormones 
responsible for this process do not cause significant further expansion of the ductal network, 
and once this aberrant endocrine influence has subsided the gland returns to a period of 
isometric growth, expanding only at a rate proportionate with the overall growth of the rest 
of the body.  
 
In the mouse, the symphony of hormone and growth factor signalling that initiates puberty 
begins at approximately 4 weeks of age (Elo et al., 2017), where the growth of the gland 
switches to allometric growth. Here, the gland returns to a highly dynamic state, largely as a 
response to the increase in serum levels of oestrogen, a membrane-soluble ligand produced 
by the ovaries, which acts on its two nuclear receptors, ERα and ERβ, to generate the burst 
of proliferation needed to re-enter another stage of branching morphogenesis. In concert with 
this, proliferation is also mediated through paracrine and endocrine insulin-like growth factor 
1 (IGF1) signalling in the mammary stroma, which is produced both locally in the mammary 
gland and systemically in the liver via pituitary growth hormone action (Ruan and Kleinberg, 
1999; Richards et al., 2004). The establishment of the requirement for oestrogen in pubertal 
morphogenesis has been shown by a variety of knockout mouse models, which also 
demonstrated that it is ERα that is the most important for development, with complete 
knockout of the receptor resulting in the inability of ducts to invade the fat pad (Mallepell et 
al., 2006; Feng et al., 2007). 
 
This proliferation and invasion of the fat pad is driven by the formation of terminal end buds 
(TEBs) at the tip of ducts (Figure 1.2, iv). These club-shaped structures are comprised of an 
outer compartment formed of a single layer of cap cells and a multi-layered inner core of body 
cells, which are found 4 – 6 cells thick (Williams and Daniel, 1983). As the TEBs continue to 
penetrate the fat pad, clefting in the highly proliferative tip of the structure occurs which 
results in the subsequent bifurcation (and even trifurcation) to generate the branches that 
form the ductal tree (Figure 1.2,ii). This is thought to be primarily lead by the cap cells, which 
have been shown to have a superior ability to regenerate the ductal tree in in transplantation 
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studies (Bai and Rohrschneider, 2010) and so have historically been considered as a reservoir 
of regenerative mammary stem cells (MaSCs). 
 
The cells of these invading TEBs subsequently give rise to the expanding mammary epithelium, 
with the more differentiated and least proliferative cells found in the neck and subtending duct. 
As the duct elongates the TEB cells differentiate into the two main cell lineages of the 
mammary epithelium: luminal epithelial cells, marked by keratin (K)6, 8 and 18, are presumed 
to form from body cells and line the central lumen of the ductal structures. It is a subset of 
the luminal cell compartment which subsequently differentiates into secretory cells to produce 
milk during pregnancy and lactation, and as such express oestrogen and progesterone 
receptors to allow them to respond to hormonal signals (Ismail et al., 2002; Grimm et al., 
2006). The cap cell layer is thought to differentiate into the other epithelial cell type of the 
mammary gland that makes up the outer layer of the duct, the myoepithelial cells (herein 
referred to as basal cells) (Tiede and Kang, 2011). These are the cells that are in contact with 
the surrounding basement membrane.  
 
The interaction between cap and body cells of the TEB is a subject of dynamic research in and 
of itself: initially, it was hypothesised that the outer layer of cap cells are able to enter the 
lumen of the TEB to contribute to the body cells, and thus the subsequent luminal cell lineage. 
This was supported by later work, which demonstrated that body cells within the TEB undergo 
apoptosis (Humphreys et al., 1996), potentially to support lumen formation in the duct. 
However, more recent work utilising mathematical modelling has demonstrated that cap cells 
do not contribute to the body and luminal cell lineage (Paine et al., 2016). Nevertheless, recent 
innovative in vivo imaging of the TEB has shown for the first time, that the TEB is a highly 
dynamic structure within itself, with cell migration and movement occurring constantly 
(Scheele et al., 2017). Altogether, this shows the unique nature of TEBs – given 
their heterogeneous cellular composition, high proliferation rates (60–90%) at the same time 
as high apoptosis rates (5–15%), level of invasive ability, and the ability to recruit stromal 
cells (Daniel and Smith, 1999). 
 
However, ductal elongation is not only an epithelial intrinsic mechanism. Multiple studies have 
demonstrated the instructive role of the mammary stroma for ductal morphogenesis, and its 
fundamental role in dictating proper ductal development. Accordingly, the mammary stroma 
is comprised of several cell types: the first and most abundant is the adipocytes, which form 
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the mammary fat pad that develops in concert with the epithelia during embryonic 
development. Adipogenic signalling in the mammary gland has been shown to be important 
(Couldrey et al., 2002); indeed, this is emphasised by the effect of the mammary bud reaching 
the pre-adipocytes in the fat pad pre-cursor during embryonic development, highlighting the 
tight association between adipocytes and mammary epithelial cells throughout development.  
  
Several different immune cells are also a vital component of the mammary stroma. In 
particular, macrophages have been found to be in tight association with the mammary 
epithelium during pubertal development, even being detected within the body cell layer where 
they have been shown to support the formation of the lumen in the subtending duct by 
clearance of apoptotic cells via phagocytosis (Gouon-Evans et al., 2000). Macrophages also 
function within the stroma surrounding the TEBs, where they are recruited by colony 
stimulating factor-1 (CSF-1) which also regulates their survival and proliferation (Van Nguyen 
and Pollard, 2002). Here, they are found within the collagen fibres of the basement membrane 
where they are presumed to help guide the direction of the developing TEB. This function is 
thought to be due to their role in remodelling collagen I into long fibrillar bundles that project 
laterally from the sides of the TEB (Ingman et al., 2006). Recent work has developed this 
further, demonstrating that macrophage function in the mammary gland is STAT5 dependent 
(Brady et al., 2017).  
 
In addition to contributing to the structural morphology and organisation of the gland, 
macrophages also function as one of the many paracrine signalling mediators in the mammary 
gland. Furthermore, macrophages have been shown to influence stem cell activity and number 
in the mammary gland, demonstrated by the reduction in mammary repopulating units in 
transplantation studies (Gyorki et al., 2009). Until recently the exact mechanism was not fully 
understood. However, recent work has suggested that this may be mediated via a feedback 
loop involving Notch and Wnt signalling pathways, which are well known to be involved in 
adult stem cell maintenance, including in the mammary gland (Chu et al., 2004; Plaks et al., 
2013; Lilja et al., 2018). It is proposed that interaction occurs within a “macrophageal niche”, 
which is identified exclusively in the mammary gland. Here, a subpopulation of MaSCs express 
the Notch ligand Delta-like 1 (Dll1), which activates Notch2/3 receptors on macrophages 
within the mammary stroma to cause downstream Notch signalling. This subsequently induces 
expression of Wnt ligands which initiates a feedback loop, whereby the Wnt ligands further 
promote the function of these Dll1+ MaSCs (Chakrabarti et al., 2018). 




Other more surprising immune cell populations contribute to the milieu of factors that make 
up the mammary stroma. Granulocytes, which are traditionally considered to be primarily 
involved in allergic responses, pathogen defence and wound healing can be found within the 
pubertal mammary stroma. Recruitment of eosinophils is mediated by secretion of the 
chemokines eotaxin and amphiregulin, with the latter being induced by oestrogen and 
progesterone production (Aupperlee et al., 2014). These cells can be found surrounding the 
leading tip of the TEB where they are thought to be involved in branch patterning – indeed, 
the absence of eosinophils leads to a reduction in branch number and TEB formation, although 
this does not affect ductal elongation (Gouon-Evans et al., 2000). The precise mechanism for 
this is not fully understood, but eosinophils themselves have been shown in other systems to 
produce several cytokines and growth factors which have been shown to be important for 
ductal morphogenesis, such as vascular endothelial growth factor (VEGF) (Horiuchi and 
Weller, 1997). Moreover, eosinophils also appear to secrete chemokines in order to mediate 
the recruitment and growth of other immune cells, including macrophages via the 
chemoattractant C10 (Gouon-Evans et al., 2002), and mast cells via eosinophil-derived stem 
cell factor and nerve growth factor (NGF), which is crucial for mast cell survival and activation 
(Rothenberg and Hogan, 2006). 
 
Mast cells themselves, another type of granulocyte, have also been shown to be important in 
the regulation of proliferation in TEBs and subsequent ductal elongation, with aberrations in 
both number and function of mast cells affecting pubertal mammary development (Reed and 
Schwertfeger, 2010). In particular, full degranulation of mast cells has been highlighted as an 
essential aspect. The release of active intracellular factors has been shown to be crucial for 
mast cells mediating their effects, such as serine proteases, which may act on the extracellular 
matrix to remodel the stroma. The actual amount of mast cells in the gland is also critical: in 
the W-sash genetic mouse model for mast cell ablation, ductal tree development was more 
affected in mice homozygous for W-sash relative to their heterozygote and wildtype 
littermates (Lilla and Werb, 2010).  
 
The vital significance of the mammary stroma throughout mammary development and beyond 
has been elegantly highlighted by the transplantation of mammary epithelium into the 
mesenchyme of various other tissues, including that of the salivary gland (Kratochwil, 1969; 
Sakakura et al., 1976), prostate (Taylor et al., 2009) and epidermal lineages (Cunha et al., 1995), 
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whereby mammary epithelium is able to contribute to, and form the morphology inherent to 
the transplanted environment. However, memory of mammary cell identity can still be 
maintained, as shown by the production of milk proteins following stimulation with pregnancy 
hormones after mammary cells have been transplanted into the salivary mesenchyme 
(Sakakura et al., 1976). 
 
Conversely, non-mammary cells can be transplanted into the mammary stroma and will adopt 
a mammary cell fate – as has been demonstrated for several cell types including normal, 
stem/progenitor (Booth et al., 2008; Boulanger et al., 2012), and cancer cells (Booth et al., 
2011). Indeed, even testicular cells can alter their cell fate and contribute towards the 
regeneration of the ductal tree (Boulanger et al., 2007). Of note, there is a requirement for 
co-transplantation of mammary epithelial cells, suggesting a potential role for paracrine 
signalling of mammary cells in the transdifferentiation of cell fate – however whether this is 
mediated via direct signalling to the foreign cells or rather indirectly, for example by activating 
the naive stroma, remains to be determined (Howard and Lu, 2014). Together, these 
transplantation studies establish that mammary epithelial cell identity appears to be dictated 
by a combination of both local cues from the mammary stroma and cell-intrinsic signals.  
 
In the mouse, TEBs regress at approximately 10 weeks of age when the ductal network has 
reached the extremities of the fat pad, leaving behind blunt ended ductal termini (Paine and 
Lewis, 2017). Thus, pubertal development and ductal morphogenesis of the mammary gland is 
ceased.  
  




Figure 1.2 Schematic overview of murine mammary gland development  
i) A rudimentary ductal tree develops during embryogenesis of the mammary 
gland, which expands during puberty with the onset of ovarian hormone production 
(ii). During this time, terminal end buds (TEB) form (iv), composed of cap and body 
cells. After the fat pad is filled at the end of puberty, the gland is also able to 
undergo further expansion with lactation (iii), whereby lateral side branching 
occurs with the formation of lobuloalveolar structures (v), formed again of luminal 
and basal cells. Figure based on Gjorevski and Nelson, 2011.  
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Post-pubertal mammary gland homeostasis 
After pubertal branching morphogenesis is complete the post-pubescent mammary gland is 
often said to remain relatively dormant until pregnancy. However, we are gaining increasing 
understanding in both humans and rodents, that this may be in fact a misnomer. Indeed, in 
mice morphological and cellular changes occur over the short 4-5 day oestrous cycle, with the 
mammary gland exhibiting a pattern of mild proliferation, differentiation and involution (Cole, 
1933). During this period, lateral expansion results in the formation of tertiary branches, and 
brief pulses of alveolar budding occurs cyclically in response to ovarian hormones, with the 
gland preparing for pregnancy, which then collapse in response to hormonal cues if pregnancy 
does not occur at the end of the oestrous cycle.  
 
The mouse oestrous cycle can be split into four parts, largely defined by ovarian hormone 
levels: ovulation occurs during the oestrous stage of the cycle, which can be characterised by 
maximum serum oestrogen levels (Zeps et al., 1999). Conversely, a substantial drop in 
progesterone levels occurs due to the regression of the corpus luteum if implantation does 
not occur (Fata et al., 2007). Accordingly, the mammary epithelium is largely of ductal 
morphology and it is during this stage that that gland is relatively quiescent, with minimal levels 
of both proliferation and apoptosis detected. 
 
Following this, metoestrous occurs, as serum levels of progesterone begin to rise, with 
oestrogen levels dropping. This is also associated with increases in expression of matrix 
metalloproteinases (MMPs) within the mammary gland, including MMP-9 and MMP-13 (Fata et 
al., 2003) which are presumed to mediate oestrous-cycle related remodelling ready for 
expansion of the ducts (Khokha and Werb, 2011). Accordingly, macrophages also begin to 
increase in both abundance and association with the mammary epithelium where they 
presumably aid in this remodelling (Hodson et al., 2013). 
 
Dioestrous, characterised by peak serum levels of progesterone and reduction in oestrogen, 
is associated with the process of tertiary branching and lobuloalveologenesis. The resulting 
increase in mammary epithelial volume is accompanied by peak cell proliferation and followed 
by cell death at the end (Giraddi et al., 2015). As such, dioestrous has sometimes been divided 
into two, which has been recently described further whereby two dioestrous states exist, with 
either low or high proliferative activity, as shown by Ki67 labelling (Shehata et al., 2018). This 
parallels the luteal stage in the human menstrual cycle (Navarrete et al., 2005), where 
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increased density in mammograms has been demonstrated (Ursin et al., 1998). These 
lobuloalveolar buds formed in the mouse are rudimentary alveolar structures which are only 
capable of milk production when pregnancy-induced growth, mediated by prolactin and 
progesterone, fully differentiates them into their full grown secretory lobuloalveolar 
structures.  
 
The final stage is pro-oestrous, whereby collapsing of the alveolar epithelium takes place if 
pregnancy does not occur. This process is mediated by the sharp decline in serum levels of 
progesterone, as oestrogen levels begin to return (Fata et al., 2001). Macrophages again play 
a role, where they are thought to help mediate this remodelling and cell death (Chua et al., 
2010).  
 
Pregnancy and lactational development of the mouse mammary gland  
In the event of pregnancy, the mammary gland completely changes form once again, whereby 
multiple signalling pathways are activated to orchestrate an unprecedented amount of 
proliferation resulting in alveologenesis. Specifically, increases in the levels of progesterone 
stimulate the proliferation and initiate the formation of tertiary side branches and the 
secretory alveoli responsible for the production of milk in response to prolactin (Gjorevski 
and Nelson, 2011). The mammary stroma is also remodelled, with a reduction in volume of 
the adipocyte compartment to accommodate for the vast expansion of the epithelium. 
Furthermore, the vasculature is remodelled such that capillaries can be found in close contact 
with each individual alveolus. Subsequent cleavage and differentiation of the alveolar buds 
occurs in the second stage of pregnancy resulting in the formation of individual alveoli.  
 
Following birth, oxytocin is induced by suckling during lactation, which stimulates the 
contraction of alveolar basal cells to expel milk from the lumen of the alveoli. This dynamic 
process continues throughout lactation until weaning, when prolactin levels decline and milk 
production ceases (Hynes and Watson, 2010). Post-lactational regression of the mammary 
gland, known as involution, then occurs, marked by extensive  programmed cell death of 
secretory alveoli and the re-emergence of adipocytes (Kreuzaler et al., 2011). Interestingly, 
this first phase of involution is reversible, with the gland able to re-initiate lactation upon 
further suckling. However, the second phase is irreversible - whereby degradation of the 
basement membrane occurs by MMP2 and MMP3 expressed by the mesenchyme (Fata et al., 
2007). Consequently, the mammary gland is returned to a structure akin to the nulliparous 
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state formed of a network of ductal branches (Sargeant et al., 2014). As such, this cycle of 
alveologenesis will occur anew with each successive pregnancy. 
 
1.2. The case for mammary stem cells  
This remarkable capacity of the mammary gland for rapid growth and regeneration through 
multiple cycles of both oestrus and pregnancy has been attributed to the existence of adult 
mammary stem cells (MaSCs). Although the identification and characterisation of these 
putative stem cells is a highly dynamic area of research that has extended over 60 years, there 
remains significant controversy and disparity regarding the number, molecular identity, 
anatomical location and differentiation hierarchy of these elusive MaSCs. 
 
The presence of adult stem cells has long been known in a variety of different epithelial tissues, 
such as the intestine, skin, liver and stomach (Tumbar et al., 2004; Lopez-Garcia et al., 2010; 
Stange et al., 2013; Huch et al., 2014). However, in these organs the key role of adult stem 
cells in to maintain homeostasis of the tissue – namely the replacement of cells which are lost 
due to attrition or injury. In contrast, the majority of mammary gland development occurs 
postnatally, as outlined previously. Consequently, the adult stem cells within the mammary 
gland are required to serve both developmental and homeostatic purposes, in addition to 
allowing the gland to completely change form in pregnancy. To study these important cells, 
two main approaches have been historically applied, which will be discussed below. 
 
Historical perspective on mammary stem cell research: transplantation assays 
Transplantation studies carried out in the 1950’s was the first methodology used that provided 
evidence of the existence of MaSCs. This seminal work described the use of de-epithelialised 
(‘cleared’) mouse mammary fat pads, whereby endogenous epithelium is surgically removed, 
as transplantation sites for normal, pre-neoplastic or malignant mammary tissue fragments 
(DeOme et al., 1959). Portions of normal mammary epithelium could be successfully engrafted 
into cleared fat pads of recipient mice, resulting in the regeneration of an entirely new ductal 
epithelial tree in vivo. This was the first suggestion of the existence of repopulating cells in the 
mammary gland, inferred to be MaSCs (also called mammary repopulating units, MRUs) 
(Hoshino, 1962; Smith and Medina, 1988). Subsequently, studies showed successful 
engraftment from any segment of the mammary epithelial tree, indicating the widespread 
distribution of MaSCs (Smith and Medina, 1988). Notably, these outgrowths could in turn 
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produce secondary outgrowths when serially transplanted, confirming that mammary 
epithelium contained cells that displayed characteristics of stem cells, such as self-renewing 
potential and multipotency (Oakes et al., 2014).  
 
Subsequently, using fluorescence-activated cell sorting (FACS) it was shown that that a single 
cell had the capacity to reconstitute the entire mammary epithelium. The first study to suggest 
this relied on experiments using retrovirally marked mammary epithelial cells as endogenous 
clonal markers (Kordon and Smith, 1998). Subsequent work relied on the differential 
expression of cell surface markers to identify and isolate heterogeneous mammary epithelial 
cell subpopulations in order to provide functional evidence that a single multipotent cell could 
regenerate the entire mammary epithelium upon transplantation (Shackleton et al., 2006; 
Sleeman et al., 2006; Stingl et al., 2006). This was in turn further refined, showing that specific 
subpopulations of cells could be purified which had superior repopulating capacities.  
 
As such, transplanting single cells and assessing their ability to clonally expand to form a 
functional mammary gland comprised of both cellular lineages, in addition to their ability to 
self-renew in serial transplants, has been traditionally considered the “Gold Standard” assay 
for the detection of MaSCs (Visvader and Stingl, 2014). In addition to suggesting that MaSCs 
were sporadically located throughout the gland, transplantation studies also inferred that they 
were present at various stages throughout development, and that they were long lived 
(Kordon and Smith, 1998). Moreover, together these analyses supported the notion that adult 
MaSCs are bi- or multipotent in nature, in that they are able to produce cells of both the 
luminal and basal lineage, in addition to the secretory luminal lineage during lactation. 
 
However, recent lineage tracing studies have raised concerns regarding the reliability of 
transplantation assays for investigating the cell fate of normal mammary epithelial cells. Indeed, 
it has been subsequently demonstrated that lineage-restricted cells can be forced to adopt a 
multipotent fate under “regenerative conditions”, which has challenged the previous dogma 
(Van Keymeulen et al., 2011; de Visser et al., 2012; van Amerongen et al., 2012). It is postulated 
that the process of tissue dissociation and transplantation into a cleared fat pad may reveal 
properties of cells that do not reflect their true behaviour in intact tissue in vivo. 
Transplantation assays are therefore increasingly considered more akin to an injury model, 
where cells may de-differentiate to reacquire stem-like properties, rather than a way of 
assaying for a native stem cell population (Visvader and Stingl, 2014).  




Consequently, it is now largely accepted that the mammary repopulating cells that are 
identified by transplantation are distinct from the stem cells that exist under physiological 
conditions. Nevertheless, this technique has provided some important insights into the 
qualities of self-renewal and regeneration, with enduring relevance. Moreover, the notion that 
fate decisions within the hierarchy are not strictly unidirectional, and in some conditions can 
be reversed, has wide-reaching implications for both oncology and regenerative medicine. 
 
New techniques for studying mammary stem cells: fate mapping in lineage tracing 
While transplantation assays are useful for assessing the repopulating capacity of defined 
subpopulations, the advent of mouse models engineered to express reporter proteins that are 
driven by pre-specified, lineage-specific promoters has enabled the tracking and fate mapping 
of putative MaSCs in vivo under physiological conditions. These studies utilise tamoxifen- or 
doxycycline-responsive transgenic mouse models to induce the expression of reporter genes 
in predefined populations of cells (Van Keymeulen et al., 2011; de Visser et al., 2012; van 
Amerongen et al., 2012; Rios et al., 2014; Wang et al., 2015; Davis et al., 2016; Wuidart et al., 
2016). The genetic label, which is typically either a fluorescent or histochemical reporter, is 
then permanently expressed by the original cell and can be subsequently transmitted to all of 
its progeny. An analysis of reporter expression through time can then be used to determine 
whether the original labelled population contained lineage-restricted stem cells or cells with 
multi-lineage differentiation potential.  
 
As such, studies have employed various gene promoters in the mammary gland to trace the 
fate of different cell populations, including Elf5, a proposed marker of luminal progenitor cells 
(Oettgen et al., 1999; Oakes et al., 2008), and various cytokeratin’s reported to be differentially 
expressed in the various cell lineages. The first inducible cell fate mapping study to use this 
system in the mammary gland challenged prevailing work on the contribution of multipotent 
MaSCs to postnatal gland development. This study used a transgenic inducible Cre 
recombinase driven by K14/K5 or K8/K18 promoters for labelling basal and luminal cells and 
their progeny, respectively. Inducing labelling of K14-expressing cells in embryos resulted in 
the labelling of both luminal and basal cells at puberty, implying that embryonic basal cells are 
multipotent.  
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However, when labelling was induced after birth unipotent cells were traced throughout the 
different stages of development, suggesting that lineage-restricted MaSCs, rather than bipotent 
stem cells, drive development and homeostasis in the postnatal mammary gland (Van 
Keymeulen et al., 2011). Moreover, when the differentiation potential of both epithelial 
lineages was determined using transplantation assays it was demonstrated that label-positive 
basal cells, but not luminal cells, were capable of reconstituting a mammary gland, in line with 
previous findings that originally identified multipotent basal MaSCs. In turn, this strongly 
supports that the experimental context of transplantation forces differentiation of basal MaSCs 
into both epithelial lineages, while in the intact gland in vivo only lineage-restricted unipotent 
stem cells exist. 
 
Controversially, other studies using similar fate mapping methodologies then provided further 
evidence in support of the original paradigm for the existence of bipotent stem cells in the 
adult mammary gland. Here, bipotent MaSCs traced at a clonal level in situ demonstrated that 
basal-labelled cells generated both cellular lineages, were long lived, and contributed not only 
to the major stages of morphogenesis in the postnatal gland but also in ductal tree maintenance 
during adult homeostasis (Rios et al., 2014). Since this work, another study has also provided 
evidence for the existence of unique, multipotent MaSCs that are marked by the expression 
of protein C receptor (Procr), a novel Wnt signalling target in the mammary gland (Wang et 
al., 2015).  
 
Subsequent lineage-tracing studies have provided evidence in support of both unipotent (Davis 
et al., 2016; Wuidart et al., 2016; Scheele et al., 2017) and bi/multipotent adult MaSCs (van 
Amerongen et al., 2012). Furthermore, lineage-restricted cell populations have been shown to 
possess the capacity to convert to multipotency in vivo by oncogenic PI3KCA signalling (Koren 
et al., 2015; Van Keymeulen et al., 2015) - suggesting that there is scope for plastic 
transformation and thereby adding further complexity to this system.  
 
Consequently, these inconsistencies in the results gained from lineage tracing in the normal 
mammary gland have therefore raised questions regarding the accuracy of some of these 
methods and brought to light some of their drawbacks. Firstly, a key limitation of many of the 
fate mapping approaches is the reliance on promoter driven reporter expression. This leads 
to assumptions regarding the molecular identity of MaSCs and progenitors, which therefore 
lends itself to bias and limitations in the cells that can be traced. Moreover, the temporal 
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expression of pathway-specific promoters or the fidelity of pan-lineage promoters means 
previous models are now being re-examined (de Visser et al., 2012; van Amerongen et al., 
2012). Accordingly, given that a single mammary stem/progenitor cell is capable of producing 
many hundred progeny (Davis et al., 2016) the promiscuous labelling of even a small number 
of cells of the opposing lineage could significantly confound downstream lineage analysis in this 
model (Wuidart et al., 2016). Secondly, criticisms have also arisen when high doses of 
tamoxifen are used to induce promoter driven reporter expression, given its effect on 
oestrogen signalling (Asselin-Labat et al., 2010; Shehata et al., 2014). 
 
A third limitation relates to the power of population-based labelling approaches to accurately 
detect the expansion of a single clone, which is a function of both the method of detection 
and the initial labelling density. To overcome this problem, as well as potential tracing artefacts 
associated with the preferential labelling of specific (and potentially non-representative) cell 
subpopulations, a recent study has mapped the fate of all basal cells (a technique termed 
saturation lineage-tracing) (Wuidart et al., 2016). If rare bipotent MaSCs do reside in the basal 
compartment and contribute even minimally to mammary gland morphogenesis and 
homeostasis (Visvader and Clevers, 2016), this could be detected by an increase in the number 
of fluorescently labelled luminal cells observed using either FACS or 3D image quantification. 
However, no population flux was detected using either method of analysis in these studies, 
suggesting that basal MaSCs are indeed lineage-restricted.  
 
In the developing gland, stem cells have been proposed to reside in the proliferating TEBs, 
particularly cap cells. These data raise important questions - do stem or long-lived progenitor 
cells remain in the mature mammary gland after ductal morphogenesis is complete? And, if so, 
where do these stem/progenitor cells reside after the TEBs collapse at the end of puberty? 
One possible explanation is that MaSCs may be deposited along the length of the ducts by the 
travelling TEBs during ductal elongation. Moreover, it may be that these proliferating MaSCs 
seen during puberty then become quiescent in adulthood when the requirement for extensive 
proliferation in the virgin gland ceases. Additionally, although these preliminary observations 
require further characterisation, elucidation of how these presumptive MaSCs are deposited 
along the length of the ductal tree (e.g., whether this occurs in a random fashion or during 
bifurcation of a TEB or upon side branching) is an important question, and may shed new light 
on the likelihood of a mammary stem cell niche.  
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Mammary stem cells: current perspectives 
As a result of the work spanning 60 years, there are now two main schools of thought 
regarding the identity of MaSCs. The first, largely brought about through lineage tracing 
experiments, suggest that each of the main cell types is derived from their own unipotent, 
lineage-restricted stem cell (Van Keymeulen et al., 2011; Davis et al., 2016; Wuidart et al., 
2016; Lloyd-Lewis et al., 2017; Scheele et al., 2017). The second hypothesis suggests that 
bipotent MaSCs exist that are able to give rise to both luminal and basal cell lineages 
(Shackleton et al., 2006; Rios et al., 2014; Wang et al., 2015); as supported by the ability of 
single cells to repopulate both lineages in a cleared mammary gland. While both transplantation 
and lineage tracing approaches have suggested potential MaSC populations, they have also 
revealed a number of conflicting results and conclusions.  
 
Multiplicity of mammary stem cells  
Development of the mammary gland requires proliferative stem cells that are responsible for 
the genesis and expansion of the mammary epithelium that drive ductal elongation in puberty 
and lobuloalveogenesis in pregnancy (known as professional, functional, or bona fide stem 
cells).  However, there may also exist a population of cells in the adult mammary gland with 
the capacity to behave as stem cells under particular conditions (termed facultative 
or potential stem cells) (Potten and Loeffler, 1990; Visvader and Clevers, 2016). Populations 
akin to this have been shown in other epithelial systems, but they are less well understood in 
the mammary gland. These may include either a subset of cells that remain quiescent during 
normal tissue development, and cells that are recruited under regenerative 
conditions (Shackleton et al., 2006; Van Keymeulen et al., 2011; Aloia et al., 2016) or in cancer 
(Koren et al., 2015; Van Keymeulen et al., 2015). 
 
Support for this hierarchal arrangement in the breast that departs from a unidirectional, top-
down model is given by transplantation studies. As discussed above, although it is now 
generally accepted that this method is not suitable for identification of homeostatic stem 
cells, the underlying experimental observation - that only a certain population of cells is 
capable of regeneration of the ductal tree - points to the existence of a population of cells that 
have an intermediate or plastic nature. However, the fact remains that the physiological and 
pathological role of these cells and their relationship to putative populations of quiescent 
MaSCs is not immediately apparent.  
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A pool of quiescent stem cells, which have temporarily and reversibly exited the cell cycle, has 
been observed in several self-renewing epithelial tissues, including the skin (Cotsarelis et al., 
1990) and intestine (Buczacki et al., 2013). These cells may be able to re-enter the cell cycle 
when required, for example upon injury (Ito et al., 2005) or homeostasis (Boras-Granic et al., 
2014) to regenerate the tissue. Of note, these quiescent stem cells are unlikely to be detected 
by conventional lineage tracing approaches, which require proliferation in order to be able to 
identify clones (Li and Clevers, 2010).  
 
As such, label-retention assays have been developed for the analysis of slow-cycling and 
quiescent cells, based on the idea that proliferating cells will dilute out the label. Consequently, 
any cells that remain labelled after a predetermined chase, known as label-retaining cells, are 
presumed to be slow-cycling/quiescent stem cells - although they may also be long-lived 
terminally-differentiated cells. Alternatively, label retention will also occur if the proposed 
stem cell has retained its template strand of DNA and undergone asymmetric cell division – a 
theory based on the Cairns/Immortal Strand Hypothesis (Potten et al., 1978). This proposed 
method of DNA replication allows for long-lived stem cells to retain the mother strand and 
thus protect against DNA replication-related mutagenesis, with any mutations occurring in 
the daughter strand passed on to terminally differentiated daughter cells (Cairns, 1975). 
 
A number of different methods have been developed to investigate label retention. Firstly, 
DNA nucleoside analogues (such as bromodeoxyuridine (BrdU), 5-ethynyl-2′-deoxyuridine 
(EdU), and [3H]-thymidine) become incorporated into DNA during the synthesis (S) phase of 
the cell cycle, and as such can be used to label cells that are in cycle at the time of the pulse 
(Salic and Mitchison, 2008). Indeed, this method has been applied in the mammary gland, which 
revealed evidence of asymmetric cell division in putative MaSCs using sequential administration 
of [3H]-thymidine and BrdU labelling (Smith, 2005). This method of cell division would be 
beneficial for putative MaSCs due to the potential number of cell cycles required to maintain 
long term regeneration potential with pregnancy and oestrous cycling, without increasing 
mutagenic load.  
 
Alternatively, genetically modified models can be used to label specific populations of cells, 
without the requirement for cells being in cycle at the time of labelling. For example, the GFP-
labelled histone H2B model allows the expression of H2B–GFP to be temporally moderated 
by administration of doxycycline (Tumbar et al., 2004; dos Santos et al., 2013). Indeed, the 
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application of the H2B–GFP model to the mammary gland identified a novel population of cells 
with an enhanced repopulating ability upon transplantation, marked by the cell surface 
receptor CD1d (dos Santos et al., 2013). Interestingly, CD1d+ mammary repopulating cells 
were also enriched for Bcl11b expression, a C2H2 zinc finger transcription factor that has 
recently been independently shown to be associated with physiological quiescence and 
superior repopulating activity under transplantation conditions (Cai et al., 2017).   
 
However, neither Cd1d nor Bcl11b mRNAs were found to be enriched in a recently identified 
quiescent population of basal cells defined by Lgr5 and Tspan8 expression (Fu et al., 2017). 
These Lgr5+Tspan8hi basal cells, located within the proximal ductal tree, were also 
demonstrated to have enhanced repopulating activity in limiting dilution transplantation assays. 
Taken together, these data suggest there may be significant multiplicity within the stem and 
progenitor population of the mammary gland, even within the putative subset of quiescent 
mammary repopulating cells. 
 
In light of the ongoing debate regarding the identity and potency of MaSCs, it is reasonable to 
suggest that there may be a residual population of quiescent bi/multipotent MaSCs that remain 
in the postnatal mammary gland after embryonic development (Boras-Granic et al., 
2014). Given the fundamental necessity for cell proliferation for clone detection in lineage 
tracing studies, combined with the idea that quiescent stem cells may reside at the apex of 
tissue hierarchies, this cannot be ruled out (dos Santos et al., 2013). 
 
Indeed, in utero DNA labelling has provided some support for this hypothesis, identifying long-
lived label-retaining cells that are able to reversibly re-enter the cell cycle and contribute to 
tissue development and maintenance (Boras-Granic et al., 2014). However, more recent 
saturation lineage tracing, which labels at least 95% of all cells within a single lineage, has 
indicated that quiescent MaSCs are lineage-restricted (if they exist and participate in any way 
to tissue development or homeostasis) (Wuidart et al., 2016). Moreover, analysis of cell 
division kinetics and telomere lengths in different mammary epithelial populations also suggests 
that that each lineage is maintained by its own precursors throughout reproductive life 
(Giraddi et al., 2015). 
 
Given the multiple cycles of regeneration in the mammary gland, as outlined above, the 
proliferative requirement of mammary stem and progenitor cells throughout reproductive life 
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is substantial. As such, the relative importance of these putative quiescent MaSCs in normal 
development and homeostasis remains unclear. However, several important aspects are still 
to be deciphered: the mechanism by which these quiescent and potential stem cells may be 
recruited, and by which specific signals in the microenvironment, and their relationship, if any, 
to the functional stem cells responsible for ductal and alveolar morphogenesis. However, given 
the complex cellular heterogeneity in breast cancer (Cassidy and Bruna, 2017), a long-lived 
and highly plastic stem cell could serve as a potential cell of origin for this disease (Blanpain, 
2013; Zomer et al., 2013). This highlights the importance of determining the full landscape of 
MaSC populations and the factors regulating their recruitment. 
 
A potential mammary stem cell niche 
It may be the case that potential or quiescent MaSC are not necessarily a separate population 
of cells but in fact a function of their environment – for example cells may be able to re-enter 
the cell cycle in response to niche signals, such as hormonal cues. The ability of MaSCs to 
rapidly and faithfully respond to developmental and homeostatic demands throughout 
reproductive life may be attributable to their intimate association with a specific cellular 
microenvironment, known as the mammary stem cell niche. Stem cell niches have been shown 
to embody discrete and highly specialized sites in particular tissues, for example the crypt base 
of the small intestine and the hair follicle (O’Brien and Bilder, 2013).  
 
However, other tissues, including the post-pubescent mammary gland, prostate, and lung, 
seem to lack an easily discernible niche. It has therefore been suggested that stem cells in 
these organs may instead respond to more ubiquitous tissue signals, and the niche may 
represent a much more dynamic, less physically defined area. Nevertheless, reciprocal 
interactions between putative MaSCs and their mature epithelial progeny, neighbouring 
stromal cells, and the supporting extracellular matrix would undoubtedly provide a 
combination of autocrine, juxtracrine, and paracrine signals that will direct and adjust cell fate 
(Sreekumar et al., 2015). Extrinsic regulatory cues may include diffusible molecules (e.g., 
growth factors and cytokines) as well as mechanical forces (e.g., cell–cell and cell–matrix 
interactions) (Howard and Lu, 2014).  
 
The absence of conclusive markers, or a molecular portrait of MaSCs, combined with 
uncertainties regarding their exact location within the post-pubescent mammary epithelium, 
has greatly impeded the analysis of potential MaSC niches. Cell-surface signatures utilised in 
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FACS, which have facilitated the isolation of mammary repopulating cells, have provided little 
insight into the tissue-positional cues that may direct cell behaviour due to the dissociation of 
the tissue required for cell sorting. However, early transplantation and ultrastructural studies 
did imply that these mammary repopulating cells were distributed throughout the ductal 
epithelium (Hoshino, 1962; Daniel et al., 1968; Young et al., 1971), positing that MaSC niches 
may reside in a ‘suprabasal' location in the epithelial bilayer (Smith and Medina, 1988; Chepko 
and Smith, 1997; Chepko and Dickson, 2003). 
 
Within the pubertal mammary gland, it is generally accepted that the TEBs of elongating ducts 
likely serve as a transient niche during puberty (Sreekumar et al., 2015; Paine et al., 2016). 
Therefore, examining the signalling events involved in regulating TEB-resident stem cells is a 
significant step that may yield important insights into the pathways directing MaSC activity and 
fate, which may also provide relevant suggestions for the nature of the niche in a post-
pubescent gland. Within the TEB, cap and body cells are generally considered to be the 
precursors of mature basal and luminal epithelial lineages, respectively. Furthermore, cap cells 
have been long hypothesised to represent an enriched population of bi/multipotent MaSCs 
(Williams and Daniel, 1983; Smith and Medina, 1988; Srinivasan et al., 2003).  
 
Supporting this, recent work has demonstrated that the alternative promoter of the stem cell-
associated phosphatase gene Ship1/INPP5D (s-Ship) is exclusively expressed in cap cells during 
puberty. Furthermore, its expression has been shown to correlate with enhanced mammary 
repopulating capacity in limiting dilution transplantation assays (Bai and Rohrschneider, 2010). 
In addition, s-Ship-expressing cap cells are strongly associated with the expression of Par3L, a 
protein related to the cell polarity regulator Par3 which has been shown to be required for 
MaSC maintenance and ductal morphogenesis during puberty (Huo and Macara, 2014).  
 
However, the bipotency of cap cells has been brought into question by recent work using 
mathematical modelling of mammary ductal elongation, suggesting that inwardly migrating cap 
cells in fact do not contribute to the luminal epithelial lineage as previously hypothesised (Paine 
et al., 2016). Consequently, the precise contribution of these anatomically distinct cells to 
ductal morphogenesis requires further investigation. Moreover, the relationship between cap 
cells in the TEB and the unipotent MaSCs that have been identified by genetic lineage-tracing is 
also unclear. An answer to these important questions, and a potential unifying definition of 
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physiological MaSC potency, may be obtained by future inducible fate-mapping studies using 
transgenic s-Ship and/or Par3L reporter models. 
 
In the post-pubescent mammary gland, where TEBs have fully regressed, the location of MaSCs 
and their niche constituents is even more ambiguous. One hypothesis is that MaSCs are left 
behind by elongating TEBs during pubertal growth and consequently are dispersed throughout 
the adult epithelial network. Here, hormonal cues can then stimulate further branching and 
the formation of alveolar-like buds and lobuloalveoli during oestrous cycling and in pregnancy, 
respectively (Brisken and O’Malley, 2010). The notable absence of hormone receptors in 
mammary repopulating cells (Sleeman et al., 2007) and in MaSC-enriched basal cell populations 
(Asselin-Labat et al., 2006) implies that paracrine interactions between hormone receptor-
expressing cells and stem cells guide tissue development and homeostasis (Asselin-Labat et al., 
2010; Joshi et al., 2010; Cai et al., 2014; Rajaram et al., 2015).  
 
Indeed, multiple paracrine signalling pathways are reported to regulate MaSC function 
downstream of hormone action, including Wnt, EGFR, IGFR, and RANK signalling (Cowin and 
Wysolmerski, 2010). In addition, FGF, Hedgehog and Notch signalling pathways have also been 
implicated in modulating MaSC fate during different stages of mammary gland development. 
However, how the local activities of these pathways are controlled by systemic changes in 
hormone levels remains unknown (Brisken and Ataca, 2015). Nonetheless, the widespread 
distribution of hormone receptor-positive cells throughout the adult mammary epithelial 
tree suggests that MaSCs would be able to receive and integrate these paracrine signals at 
most architectural locations within the ductal epithelium. Moreover, alterations in the 
abundance and distribution of hormone receptor-positive cells with age (Ismail et al., 
2002) may reflect lifetime-dependent variations in a putative MaSC niche. 
 
MaSCs are thought to survive tissue remodelling during post-lactational involution, enabling 
further cycles of expansion with each subsequent pregnancy. As such, it may be that MaSCs 
could reside in the vicinity of epithelial branch points, poised to generate the lateral branches 
and lobuloalveolar structures required for lactation. Fate-mapping studies using an alveolar-
specific whey acidic protein (WAP)-driven Cre have also identified a population of long-lived 
parity-identified mammary epithelial cells (PI-MECs) that are sustained through multiple 
reproductive cycles (Wagner et al., 2002). These cells reside at the ductal extremities in the 
post-parous mammary gland and contribute exclusively to the hormone receptor-negative 
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luminal lineage in subsequent pregnancies (Chang et al., 2014). Thus, these observations may 
also support a model wherein an alveolar stem cell niche is positioned near bifurcation sites 
in the mature ductal epithelium. Interestingly, increased MaSC activity during pregnancy 
correlates with the re-expression of s-Ship specifically in basal cells at the tips of alveolar buds, 
suggesting the emergence of a transient stem cell niche during lobuloalveologenesis (Bai and 
Rohrschneider, 2010). 
 
As outlined earlier in this chapter, distinct adult MaSCs are postulated to fulfil the proliferative 
and homeostatic demands of the mammary gland. The degree to which this heterogeneity in 
the MaSC compartment is intrinsic or instead a result of microenvironmental cues, however, 
is not known. A recent single-cell lineage-tracing study, which employed quantitative 
volumetric analysis to determine the contribution of a single labelled MaSC to ductal 
morphogenesis, estimated that at least 35 lineage-restricted MaSCs actively and stochastically 
contribute to the development of each major duct during puberty (Wuidart et al., 2016). A 
subsequent study, also using quantitative lineage-tracing at clonal density, put this number at 
260 lineage-restricted MaSCs per TEB, leading to the suggestion that most TEB cells can 
function as lineage-committed MaSCs (Scheele et al., 2017).  
 
Discrepancies between these two studies may reflect differing functional definitions of MaSCs 
as well as the quantitative and mathematical platforms and assumptions for analysis. 
Quantitative lineage-tracing studies also suggest that molecularly heterogeneous populations 
of TEB-resident MaSCs function as single equipotent pools, colonising ductal branches through 
stochastic neutral drift dynamics (Scheele et al., 2017). Random segregation during successive 
rounds of TEB bifurcation mediates the unequal distribution of MaSC progeny between 
adjacent ductal structures, leading to clonal enrichment or extinction over time, supporting 
previous observations of clonal labelling patterns. These early applications of quantitative and 
single-cell lineage-tracing approaches in the mammary gland have provided unprecedented 
insights into clonal dynamics and stem/progenitor heterogeneity and multiplicity, heralding a 
new era in our investigation and understanding of normal and malignant stem cells in the 
breast. 
 
A novel approach for lineage tracing in the mammary gland 
Previous lineage tracing studies in the mammary gland have facilitated in situ examination of 
MaSC properties under conditions of minimal interference. However, unlike transplantation 
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assays, a limitation of these studies is that they have traditionally been unable to map the fate 
of a single labelled cell (Shackleton et al., 2006). As such, due to the inherent biases of these 
two approaches discussed above, a neutral way to assess stem cell dynamics in a physiological 
context, that makes fewer prior assumptions and can be interpreted at various stages of 
development, is required to resolve the long running debate on the MaSC hierarchy. 
 
Consequently, for a novel lineage tracing approach, independent of pre-defined, promoter 
driven reporters, the work presented in this thesis utilises two transgenic mouse strains to 
neutrally trace single stem/progenitor cells. The first, the R26[CA]30, exploits the inherent 
instability of microsatellite repeats to cause spontaneous, random frame shift mutations during 
DNA replication. For this, a [CA]30 dinucleotide repeat tract is placed upstream of an out-of-
frame reporter cassette (either enhanced yellow fluorescent protein (YFP) or a modified, 
thermophillic beta-glucosidase (SYNbglA) (McCutcheon et al., 2010; Kozar et al., 2013). 
During DNA replication, a mismatch repair (or “slippage”) of the reading frame can randomly 
occur, potentially moving the reporter in-frame and thus triggering constitutive reporter 
expression in the “slipped cell” from the constitutively expressed Rosa26 locus. Accordingly, 
this leaves an indelible mark on the cell and, if this is a stem/progenitor cell, all of its progeny 
will also be marked. Importantly, this slippage event is exceedingly rare, and thus it can be 
used to track the fate of a single labelled cell with confidence  
 
Because terminally differentiated cells are unable to divide, subsequent analysis of the clone 
size, structural organisation and cellular composition of clonally-marked regions in the 
mammary gland can provide useful insights regarding the nature of mammary stem/progenitor 
cells - including potency, location and capacity. Moreover, because strand slippage is more 
likely to occur in proliferating cells, this model will be used to look at the active contribution 
of the proliferative, functional stem cells that primarily contribute to the development of the 
gland during puberty, and during the highly proliferative pregnant phase resulting in a lactating 
mammary gland. 
 
However, for the ability to time tracing and to enable marking of quiescent cells another model 
must be used. For this, R26R-Confetti mice will be employed (Livet et al., 2007; Snippert et 
al., 2010). Using a similarly neutral approach to the R26[CA]30 model, mice that express inducible 
Cre recombinase in all cells (R26CreERT2) are crossed with R26Confetti animals to achieve low-
density, multicolour and unbiased labelling. 




In this latter model, the constructs contain two tandem invertible DNA segments; with 
administration of tamoxifen, Cre recombinase is translocated to the nucleus and removes the 
loxP flanked “STOP” roadblocks. Subsequent stochastic inversion and excision recombination 
events create four random expression possibilities (nuclear green fluorescent protein (GFP), 
cytoplasmic YFP, cytoplasmic red fluorescent protein (RFP), or membrane-bound cyan 
fluorescent protein (CFP)). Cells will thus be marked at random in one of four colours. 
Importantly, any cell can be labelled with this model because cells are traced under the 
ubiquitous Rosa26 promoter. Furthermore, labelling density can be titrated, with sparse 
reporter induction attained using low doses of tamoxifen. It also provides the benefit of a 
multicolour reporter, which aids with the distinction of individual clones. 
 
1.3. Imaging the murine mammary gland 
The location of the stem/progenitor cells in the mammary gland is another important aspect 
that requires clarification. Previously, proposed identities of MaSCs have been derived from 
FACS sorted cells, which removes important spatial information, or lineage-traced cells, which 
are visualised from 2D sections and may not accurately reflect the true nature of the 
heterogeneous gland, and fail to provide information about spatial distribution of clones (Sale 
and Pavelic, 2015). Moreover, this becomes especially relevant in the context of single cell 
genetic lineage tracing, whereby labelling is rare and as such requires analysis of the whole 
tissue which would not be readily achievable using thin 2D tissue sections. 
 
Historical approaches  
Given this, 3D imaging in the mammary gland has been previously demonstrated by utilising a 
number of different methods. Indeed, fluorescent imaging using confocal microscopy has 
shown success in imaging the mammary primordia during embryonic development (Kogata 
and Howard, 2013). However, the inherent smaller sample size associated with embryos mean 
they do not face the same challenges as the postnatal mammary gland, such as deeper imaging 
depths and a higher proportion of adipose tissue, and as such this technique is not compatible 
with the study of the gland after embryonic development.  
 
Within the pubertal gland, protocols for colourimetric wholemount imaging - such as X-gal 
labelling for LacZ - are often not compatible with high resolution imagining. This means that 
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imaging is usually carried out using  stereomicroscopy which renders the visualisation of 
individual single cells not possible (Sale and Pavelic, 2015). To combat this, an improved X-gal 
labelling protocol has been developed for better imaging of single cells within wholemount 
mammary glands, which allows for high magnification imaging at different focal depths (Šale et 
al., 2013). Using this method combined with a Notch2 paralogue as a genetic marker, the 
authors were able to identify two previously unknown subpopulations of luminal cells with 
novel topological locations which would not have been detected in 2D using traditional serial 
sections. However, this method can still not be combined with in situ co-staining, meaning it 
had to be supplemented with an additional fluorescent model which allowed for definitive 
identification of cell types.  
 
Consequently, another method that utilises fluorescent multiphoton imaging has been used, 
that even demonstrated live imaging of mammary glands by taking advantage of the glands 
inherent autofluorescence (Johnson and Mueller, 2013). Furthermore, use of multiphoton 
imaging provided the additional benefit of using second harmonic generation (SHG). This 
process allows for imaging of collagen fibres based on their structural signal, without the need 
for additional staining. Interestingly, the authors also combined this with imaging wholemount 
glands from HAI-1 transgenic mice, which overexpresses the Kunitz-type protease inhibitor 
HAI-1 in their mammary glands, that had been previously stained with Carmine Alum. The 
wholemount glands were able to be retrospectively imaged, with SHG used to image collagen 
fibres and the fluorescent signal from the Carmine Alum stain utilised to detect the epithelial 
ductal tree. This identified abnormal TEB and collagen fibre development which could not be 
fully appreciated in H&E stained paraffin sections, thus highlighting the utility of analysing tissues 
in multiple focal planes in the context of disease. However, this protocol faces similar issues 
in that the light refractive adipose tissue impeded successful high-resolution imaging, and only 
structures relatively close to the surface of the tissue were able to be imaged. Moreover, this 
protocol was still restricted in the options for staining, limiting its utility.   
 
A number of more recent protocols have therefore been developed to allow labelling of 
multiple aspects, given the necessity to be able to differentiate between at least the luminal 
and basal epithelial compartments. The first involves the use of microdissection, whereby 
portions of the epithelial ductal tree are removed from its native stroma (Rios et al., 2014). 
This therefore negates the need to image through the large volumes of adipocytes and other 
stromal cells that are present in the gland and are especially light refractive and as such limit 
Chapter 1 - Imaging the murine mammary gland 
28 
 
the imaging depth, before even reaching the epithelial compartment of the gland (Rios et al., 
2014). The use of this technique was combined with lineage tracing which allowed imaging of 
large clonal regions in the ductal network (Rios et al., 2014; Wang et al., 2015; Fu et al., 2017). 
However, this method comes with a number of drawbacks. Firstly, it limits the extent of 
epithelium that can be imaged, with often only small sections of the ductal network being able 
to be dissected. Along with this, there is a requirement for a high degree of technical skill to 
carry out dissection on such a small area. Moreover, it rules out the use of 3D imaging to 
study the native stromal compartment of the mammary gland. Together, this means that the 
use of microdissection for 3D imaging in the mammary gland may miss out important aspects.  
 
Another method previously used for 3D imaging of the mammary gland involves a combination 
of enzymes, such as collagenase and hyaluronidase, to dissolve the extracellular matrix – and 
in the case of the mammary gland – the surrounding adipocytes (Wuidart et al., 2016). 
Consequently, the mammary gland can then be imaged in toto. However, achieving specific 
digestion of the stroma whilst also leaving the epithelium intact is a delicate balance. 
Consequently, recent work has shown that the use of this proteolytic digestion in the 
mammary gland has a detrimental effect on the structure of the epithelium (Rios et al., 2016). 
Specifically, the basal cell layer was shown to be particularly affected, presumed to be due to 
the destruction of the basal lamina on which basal cells rely on for cell contact. Using even 
low concentrations of proteolytic enzymes resulted in depletion of cells in the outermost layer 
of the ductal tree, leading to gaps in the usually continuous morphology. Furthermore, the 
basal cells which remained, displayed an altered morphology, losing their traditional elongated 
shape and becoming more rounded (Rios et al., 2016). This may have important implications 
when using this technique to assess the results from fate mapping studies – indeed, it has been 
postulated that rare, bi-lineage clones may be missed under these conditions if certain cell 
types are preferential affected by the protocol (Rios et al., 2016)






Figure 1.3 Limitations of 2D imaging in the mammary gland 
The complex topological architecture associated with a high branched structure such 
as the mammary gland presents issues when imaging in two focal planes. Schematic 
shows representative labelled cells from lineage tracing studies and their associated 
2D tissue sections. (A) Shows cells arising from presumably the same mother cell, with 
a common branch of origin. (B) Shows labelling from two unrelated branches and thus 
potentially unrelated progeny. However, both 2D sections would reveal the same 
result, thus confounding interpretation of lineage tracing data, especially in the case of 
rare or clonal labelling. The 2D sections would also not reveal the differential labelling 
patterns. Figure adapted from (Sale and Pavelic, 2015).  
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A new technique for imaging the mammary gland 
Altogether, this highlights the importance of imagining the mammary gland in multiple focal 
planes, and as such the development of methods to achieve this that are without the limitations 
of those previously used. Consequently, this thesis will describe the development and 
optimisation of optical tissue clearing methods for use in the mammary gland. This process 
involves treatments to strip away lipids and/or match the refractive index of tissues and thus 
minimise the scattering of light at the oil-water interface. This is particularly important in the 
virgin mammary gland, which is difficult to image at depth due to the high proportion of fat, 
which is especially light-refractive (Susaki et al., 2014). As a result, optical clearing permits the 
visualisation of mammary tissue to a single cell level, while allowing for staining and retaining 
the fluorescence (or colourimetric) signal, tissue integrity and important spatial information.  
 
Optical clearing involves use of strong detergents and matching of refractive indices in order 
to enable imaging of whole mount organs and tissues. First established for use in the brain, a 
number of different methods have now been developed that have allowed novel insights into 
the 3D architecture of tissues. For the mammary gland, the ability to image the tissue in its 
entirety is particularly important due to its unpredictable ductal architecture, which presents 
unique challenges in terms of interpretation of lineage tracing data. Traditional tissue sections 
can be insufficient for accurate quantitative analysis and do not reveal complex spatial patterns 
(summarised in Figure 1.3). As such, methods to provide the ability to image the gland in 3D 
are vital. Indeed, traditional use of the wholemount stain, carmine alum, has been utilised 
extensively in mammary gland research despite its incompatibility with other antibody co-
staining - demonstrating the importance for researchers to be able to visualise the entire 
ductal tree in the mammary gland. 
 
As such, optical tissue clearing provides a method to yield the benefits of imaging the entire 
mammary gland in 3D, without detrimental effects on either the stroma or the epithelium. 
Imaging the ductal network, in situ and without alteration, removes potential complications or 
anomalies that arise and that may contribute to disparities in the interpretation of data in the 
field of mammary gland research. 
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1.4. Aims of this thesis 
Despite research in mammary gland biology spanning over 60 years, definitive elucidation of a 
number of  the aforementioned key aspects of mammary gland biology remain. The techniques 
and associated limitations previously used have unfortunately hampered conclusive definitions 
in these important areas. Consequently, the work described in this thesis aims to develop and 
optimise methods for use in the murine mammary gland to allow study of its tissue 
development and stem cells. This will be done while avoiding the shortcomings associated with 
the techniques which have been traditionally applied to mammary gland research. As such, the 
primary objective of this work is to further characterise the requirements for MaSCs during 
normal tissue morphogenesis, and maintenance in the mature gland. To achieve this, this thesis 
has the following overall aims:  
 
Aim 1 : Develop 3D imaging methods for the mammary gland  
The utility of analysing the mammary gland in multiple focal planes has been well demonstrated. 
Consequently, the use of optical tissue clearing in the mammary gland will be assessed by 
testing multiple protocols and optimising them accordingly. Moreover, the imaging techniques 
to visualise the tissue in 3D will be developed. These methods will then be applied to the work 
in the following chapters.  
 
Aim 2 : Lineage tracing in the mammary to further understand MaSC 
characteristics 
The use of neutral lineage tracing models to study cell fate in the multiple stages of mammary 
gland development will be established and assessed. These will be used to identify clonally-
marked regions in the embryonic, pubertal, adult and lactating mammary gland to elucidate 
the nature of MaSCs, in terms of their potential, capacity and location. Based upon previous 
work, the hypothesis is that multiple unipotent adult MaSCs contribute to ductal 
morphogenesis in pubertal development and alveolar development in pregnancy. It is further 
hypothesised that these are present throughout the postnatal mammary gland in 
architecturally-restricted sites. This will be examined by analysing the mammary gland in 3D 
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Aim 3 : Identify the proliferative capacity of the mammary gland  
Next, the proliferative capacity of the mammary gland during different stages will be assessed. 
This will be done in pre-pubertal, pubertal, young adult and finally older adult mammary glands. 
Combining this knowledge with the results from Aim 2 will provide insights into the functional 
requirements and potential locations of MaSCs. 
 
Aim 4 : Assess the use of an ex vivo system of mammary gland development  
Finally, the work carried out in the previous three chapters will be combined to assess the use 
of ex vivo 3D organoid models of the mammary gland to study development. Specifically, fate 
mapping of the cells will be carried out using cells from the lineage tracing models, and 
proliferation assessed and compared with these results. Furthermore, use of optical clearing 
will be tested for imaging the organoids in three dimensions.  
 
1.5. Importance and implications 
The mammary gland provides a unique opportunity to investigate epithelial development 
extra-embryonically that is not available in other tissues. Moreover, study of maintenance and 
turnover of this organ has important implications for other epithelial systems. As such, 
combining methods for non-proteolytic 3D imaging, together with quantitative platforms for 
image analysis which consider tissue architecture, cell morphology, chimerism, and Cre-
specificity will aid the study of mammary gland development and the contribution of stem cells, 
in addition to potentially providing new insights for epithelial tissue development.  
 
Elucidation of the normal MaSC hierarchy also has important implications for understanding 
the biology of the mammary gland in relation to neoplastic development. The heterogeneity 
of breast cancer is complex and although there is now an increased understanding of molecular 
and pathological subtypes, there is still much work required to get closer to understanding 
the cell(s) of origin of breast cancer. Given the proposed longevity and suggested ability of 
MaSCs to survive multiple waves of cell death in involution, they represent a logical candidate 
for a potential cell of origin of breast cancer. Reponses to treatment are still highly 
unpredictable and the hope is that better stratification of breast cancer can improve response 
to therapy and may lead to the development of more targeted therapies. By increasing our 
understanding of the potential cell(s) of origin, this work could enhance current methods of 
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Materials and methods 
  





2.1.1 Husbandry  
Experiments using animals were conducted under a United Kingdom Home Office license in 
accordance with the United Kingdom Animals (Scientific Procedures) Act 1986 and in accordance 
with European Union Directive EU 86/609. Specific experimental studies were approved by the 
University of Cambridge Department of Pathology animal unit and animals were housed in 
individually ventilated cages under a 12:12 hour light–dark cycle, with water and food available 
ad libitum.  
 
All non-pregnant/lactating animals were assessed for oestrus cycle staging based on a non-
invasive protocol in order to prevent unnecessary stress and complications with pseudo-
pregnancies as previously described (McLean et al., 2012). Briefly, after visual assessment, 
approximately 100 L of sterile phosphate buffered saline (PBS) was used to carry out a vaginal 
lavage, which was then smeared onto a glass slide and left to air dry. This was stained with 
toluidine blue and the oestrus stage was assessed based on cytological assessment as visualised 
under a light microscope, with the stage categorised depending on the presence and/or 
proportion of nucleated epithelial cells, cornified epithelial cells and lymphocytes. For studies 
during lactation, mice were mated with studs, allowed to litter and tissue was harvested 
between lactation days 2 to 10.  
 
For tissues, female mice were sacrificed by dislocation of the neck or terminal anaesthesia. 
Eight mammary glands (excluding the first (cervical) pair) were dissected and immediately 
spread and fixed on card (Tetra Pak) in 10% neutral buffered formalin (NBF) for 9 hours at 
room temperature for all experiments, with the exception of EdU incorporation studies where 
tissues were fixed overnight at 4oC. All animals were assessed also for oestrous cycle staging 
posthumously, as previously described. Fixed tissue was then stored at 4°C in PBS containing 
sodium azide (0.05% (w/v)) for up to 8 weeks.  
 
2.1.2 Mouse models 
The R26[CA]30 SYNbglA and R26[CA]30 YFP strains were a gift from Doug Winton and have been 
previously described (Kozar et al., 2013). Briefly, [CA30]-SYNBglA and [CA30]-YFP reporter 
cassettes were synthesized by Yorkshire Bioscience. These were subsequently subcloned by 
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Nhe1 digestion into the pROSA-MCS13-puro targeting construct, carried out by the 
transgenic facility at the Cancer Research UK London Research Institute in an embryonic stem 
cell line of C57BL/6J genetic background (cell line: B6 1.1). R26[CA]30 SYNbglA and R26[CA]30 YFP 
mice were then maintained as hemizygotes on a C57BL/6J genetic background. Animals were 
examined at 7 weeks of age for all studies in pubertal mice. All quantitative analysis was 
performed on mice that were hemizygous for R26[CA]30SYNbglA or R26[CA]30YFP. For 
genotyping primers and conditions see appendix. R26R-Confetti mice have been previously 
described (Livet et al., 2007; Ventura et al., 2007) and were a gift from Jenny Nichols. Mice 
that were hemizygous for both R26-Confetti and R26-CreERT2 were generated by mating 
homozygous mice. For genotyping primers and conditions see appendix.  
 
2.1.3 Initiation of lineage tracing 
Cre-mediated recombination was achieved through a single intraperitoneal injection of 0.5 mg 
tamoxifen in virgin mice, or oral gavage of 33.3 mg/kg in pregnant mice unless otherwise stated. 
Lineage tracing was induced at 4 weeks for studies in pubertal R26-Confetti;R26-CreERT2 
mice, unless otherwise stated. Tissues were collected after a 2-day chase to determine initial 
labelling or after 3 weeks for pubertal lineage-tracing studies. Tamoxifen was made up in sterile 
corn oil. 
 
2.1.4 Tumours  
Syngeneic mammary tumours were established by orthotopically implanting 5 × 103 TUBO 
cells, into the abdominal (fourth) mammary gland. This cloned cell line was established from a 
mammary carcinoma that spontaneously arose in a BALB-neuT mouse and therefore carries 
the Her-2/neu oncogene driven by the MMTV promoter, as previously described (Rovero et 
al., 2000). Mice were monitored regularly, and tumours were harvested before exceeding 
humane endpoints (approx. 4–5 weeks from implantation).  
 
2.1.5 EdU incorporation studies 
EdU powder (life technologies, catalogue number C10339) was reconstituted in sterile saline 
at a final concentration of 10 mM, according to manufacturer’s guidelines. Female mice (aged 
4, 7, 12 and 24 weeks, n=10 for each) were oestrous staged at the same time each morning 
for one week prior to injection (described above), and when in dioestrous were administered 
25mg/kg via I.P. injection. A non-injected saline-control mouse was included in each cohort. 4 
hours after injection the mice were sacrificed by a Schedule 1 approved methods (typically 
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cervical dislocation), and upper and lower mammary glands were dissected, along with the 
first 5 cm of the small intestine as proliferative positive controls, in addition to vaginal lavage 
samples taken for oestrus staging confirmation.  
 
2.2 Histology 
2.2.1 SeeDB optical clearing 
See deep brain (SeeDB) optical clearing was adapted for the mammary gland from the protocol 
outlined by Fujimoto et al (Ke et al., 2013). Samples were permeabilised and blocked in 10% 
BSA with 1% Triton-X in PBS, overnight at 4C on a shaker. The following day primary 
antibodies were added, diluted in blocking solution, and samples incubated for 4 days at 4C 
on a shaker. Samples were then washed 3 times for 1 hour on a shaking platform at room 
temperature with PBS, before appropriate secondary antibodies added and samples again 
incubated at 4C on a shaker for 2 days. They were then washed again in PBS at room 
temperature and stained with 10uM 4’,6-diamidino-2-phenylindole (DAPI) diluted in PBS for 
up 3 hours at room temperature. Following this, the samples were put through increasing 
concentrations of fructose with 0.5% -thioglycerol every 12 hours (20, 40, 60 then 80%), at 
room temperature on a rocking platform. Finally, the samples were left in 100% fructose for 
24 hours followed by SeeDB solution (115% w/v) for another 24 hours and then finally imaged 
using confocal microscopy.  
 
2.2.2 CUBIC optical clearing 
CUBIC clearing in the mammary gland was adapted from method outlined by (Susaki et al., 
2014). Tissues were immersed in reagent 1a for 24 hours at 37C (a less harsh adaptation of 
the original reagent 1, unpublished with protocol available at http://cubic.riken.jp/), urea (10% 
w/w), N,N,N’,N’-tetrakis (2-hydroxypropyl) ethylenediamine (5% w/w) and Triton X-100 
(10% w/w) with 5M NaCl in distilled water). The next day samples were permeabilised and 
blocked with incubation in 10% normal goat serum (NGS) with 0.5% Triton-X in PBS, 
overnight at 4C on a shaker. The following day appropriate primary antibodies were added 
and samples incubated for a further 4 days at 4C on a shaker. Following this, samples were 
washed 3 times for 1 hour on a shaking platform with PBS + 0.1% Triton-X at room 
temperature, before appropriate secondary antibodies added and samples again incubated at 
4C for 2 days on a shaker. Samples were then again washed and incubated for up to 60 
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minutes with 10uM DAPI then finally left in reagent 2 (sucrose (44% w/w), urea (22% w/w), 
2,2’,2”-nitrilotriethanol (9% w/w), Triton X-100 (0.1% w/w) in distilled water) for 24 hours at 
37C on a shaker before being imaged. For full CUBIC regent recipes see appendix. 
 
2.2.3 PACT-sRIMS optical clearing 
The A4P0 hydrogel formulation was selected for PACT- based clearing of the mouse 
mammary gland. A4P0 was prepared to contain acrylamide (4% (v/v)), 2,2′-Azo- bis[2-(2-
imidazolin-2-yl)propane] dihydrochloride (0.25% (w/v)) in PBS. PACT-clearing solution 
consisted of SDS (8% (w/v)) in distilled water, pH 7.5. Mammary tissue pieces (approx. 10 × 
10 × 1 mm) were incubated in A4P0 hydrogel monomer for 4 days at 4°C and heated to 37°C 
in a water bath for 4–6 h. Excess gel was carefully re- moved from the tissue and samples 
were immersed in PACT clearing solution for 24 hours at room temperature. Samples were 
immersed in fresh clearing solution, incubated at 37°C for 4 days (with replenishment every 
second day), and finally washed with PBS containing triton- X100 (0.1% (w/v)) for 24 h. For 
immunostaining, samples were blocked in PBS containing triton-X100 (0.5% (w/v)) with goat 
serum (10% (v/v)) overnight at 4 °C. Primary antibodies were diluted in blocking buffer at 4°C 
for 4 days with agitation. The tissue was washed 3 times for >1 hour in PBS then incubated 
with Alexa Fluor conjugated secondary antibodies for 2 days at 4oC with agitation. Samples 
were then again washed in PBS and incubated with DAPI (10 μM) for 2–3 h.  samples were 
incubated in sRIMS for 4 days or until imaging. sRIMS was prepared by combining sorbitol 
(70% (w/v)) in 0.02 M phosphate buffer (Marx, 2014; Yang et al., 2014).  
 
2.2.4 Optical clearing and measurement of sample size changes  
Mammary tissue pieces were processed using 3DISCO, PACT-RC, PACT-sRIMS, CUBIC or 
SeeDB-based tissue clearing protocols, and images were acquired on a dissecting microscope 
(Leica MZ75) with constant exposure, gain and magnification. For quantification of sample size 
changes, image thresholding was performed using ImageJ (v1.49p, National Institutes of Health) 
and the pixel area was measured. Volume changes were calculated as the ratio of the pixel 
area before and after tissue clearing.  
 
2.2.5 Human tumour optical clearing  
Optical clearing of human tumour samples and collagen scaffolds was carried out by Dr Robert 
Hume (Hume et al., 2018a). The human breast biopsy material was provided by the Breast 
Cancer Now Tissue Bank held at Barts Cancer Institute, Queen Mary University of London, 
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United Kingdom. This tissue bank is licensed by the Human Tissue Authority, according to 
United Kingdom ethical guidelines and approval, and biopsy material is obtained following 
informed consent. Anonymized data linked to each sample are provided. 
 
Human ER+ breast tumour biopsies were fixed overnight in 4% paraformaldehyde (PFA) at 
4C followed by immersion in Reagent 1a (modified from Reagent 1, unpublished, available at 
http://cubic.riken.jp) at 37oC for 3 days changing into fresh Reagent 1a each day. Samples were 
blocked overnight in 0.5% Triton-X 10% normal goat serum–phosphate buffered saline (NGS-
PBS) (blocking solution). Primary antibodies were diluted in blocking solution and agitated on 
a rocker for 5 days at 4oC. Samples were washed in PBS briefly followed by 3 x 1 hour washes 
in fresh PBS. Secondary antibodies were diluted in blocking solution and agitated on a rocker 
for 2 days at 4oC. Samples were washed in PBS briefly followed by a 1 hour wash in fresh PBS. 
Nuclei were marked with a 2 hour wash in 10 mM DAPI. Samples were washed in PBS briefly 
followed by a 1 hour wash in fresh PBS and immersed in Reagent 2 at 37oC in a dry incubator 
for 24 hours before imaging. Two-photon microscopy techniques were carried out on a 
LaVision BioTec TriM Scope II upright two-photon scanning fluorescence microscope. 
 
2.2.6 Antibodies  
The following primary antibodies were used for immunostaining: rabbit anti-K5 (Covance, 
PRB160P, 1:100), rat anti-K8 (Developmental Studies Hybridoma Bank, TROMA-I, 1:50), 
rabbit anti-SMA (Abcam, ab5694, 1:300), mouse anti-SMA (Abcam, ab7817, 1;200), rabbit anti-
E-cadherin (Cell Signalling, 3195, 1:50), rabbit anti-PR (DAKO, A0098, 1:50) and chicken anti-
GFP (Abcam, ab13970, 1:2000), anti-laminin (1:500; Abcam, ab11575), anti-collagen IV (1:500; 
Abcam, ab6586),  anti-Ki67 (1:100; Abcam, ab15580), anti-ER (1:50; Leica, NCL-L-ER-6F11). 
 
The following Alexa Fluor-conjugated secondary antibodies were purchased from Life 
Technologies and used 1:500: goat anti-mouse 488 (A11001), goat anti-mouse 647 (A21237), 
goat anti-rat Cy3 (A10522), goat anti-rat 488 (A11006), goat anti-rabbit 488 (A11008), goat 
anti-rabbit 647 (A21245), goat anti-chicken 488 (A11039) and goat anti- chicken 568 (A11041). 
 
2.2.7 EdU detection 
EdU incorporation was detected using Click-iT EdU Alexa Fluor 594 or 488 Imaging Kit (Life 
Technologies, catalogue number C10339), using the manufactures protocol but adapted and 
optimised for whole mount staining. Briefly, samples were fixed overnight in 10% NBF, 
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followed by block and permeabilisation overnight in 10% BSA in 1% PBS-Triton-X. Following 
this, samples were washed in 3% BSA then the Click-iT reaction cocktail was made up 
according to manufactures protocol and samples incubated with the solution for 2 days at 4C 
on a rocking platform. After this, samples were washed then usual steps for primary and 
secondary antibody staining carried out, as detailed above.  
 
2.2.8 Methyl green staining 
Due to the colour of the SYNbglA lineage tracing being similar to traditional carmine whole 
mount staining, an alternative with different colouring was required. After assessment of 
several histological stains Methyl green was chosen. Tissues were initially cleared using CUBIC, 
as outlined above. They were then incubated in 0.5% methyl green solution for 1.5 hours at 
room temperature, before being briefly rinsed 3 times in H2O. Tissues were then de-stained 
for 15-30 minutes in 50 mL of 50% ethanol plus 122.5 L of 32% hydrogen chloride (HCl), 
with level of destaining checked regularly, before finally being rinsed in PBS.  
 
2.2.9 Wholemount DAB staining  
A similar CUBIC protocol as outlined above was utilised for whole mount diaminobenzidine 
(DAB) staining with some alterations. Samples were left in reagent 1 for 2 days then reagent 
2 for 1 day (both at 37C), then washed in PBS briefly before being incubated overnight in 3% 
hydrogen peroxide with 20% DMSO in methanol on order to quench endogenous peroxidase 
activity. The following day the samples were blocked with 10% NGS in 0.5% Triton-X in PBS, 
overnight at 4C, followed by incubation with primary antibodies for 4 days at 4C. Following 
this samples were washed then incubated with appropriate species- specific conjugated 
horseradish peroxidase (HRP, all Dako), for 2 days at 4C. For DAB staining, samples were 
washed then DAB (Sigma, catalogue number D5905) added for 30-60 minutes. After being 
briefly washed, samples were stained with 0.5% methyl green for 1.5 hours. After this, samples 
were briefly rinsed in distilled H2O then de-stained for up to 30 minutes in ethanol and HCl. 
Samples were then put back in reagent 2 for 24 hours before being imaged. Alternatively, 
quenching, blocking and antibody steps can be performed after immersion in reagent 1 with a 
similar outcome.  
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2.2.10 Organoid wholemount imaging  
For whole-culture imaging of organoids, media was first removed and wells washed with cold 
PBS three times. Using widened P1000 pipette tips pre-coated in FBS, the Matrigel was gently 
dissolved in ice cold PBS and organoids transferred to 15mL falcon tubes. The organoids were 
left to settle to the bottom, supernatant removed and then fixed in 4% PFA at room 
temperature for 30 minutes. After this, they were washed three times with PBS for 10 minutes 
before the blocking / permeabilisation step, using PBS + 5% FBS + 2% BSA + 0.2% Triton for 
2 hours at room temperature on a shaking platform. Primary antibody staining was then 
carried out, with antibodies diluted in blocking buffer, overnight at 4 C. The following day, 
after three washes in PBS, secondary antibody staining was carried out (again diluted in 
blocking buffer), for 2 hours at room temperature. After a further three washes in PBS, DAPI 
staining was carried out for 1 hour. Following a final wash, organoids were then imaged.  
 
2.3 Mammary organoids  
Mouse mammary organoids were developed based on the protocol by Jarde et al. Female mice 
were culled by cervical dislocation and 4th and 5th mammary glands dissected, with lymph nodes 
removed. Glands were placed on ice in L-15 + 10% foetal bovine serum + penicillin / 
streptomycin + 10% glutamax until use. Following this, tissues were dissociated based on 
previously described protocols. Tissues were dipped in 70% ethanol and transferred to fresh 
L-15/FPSG for mincing. To do this, tissues were placed in sterile petri dishes and minced using 
two scalpel blades until a fine, semi-liquid slurry was formed. Minced tissue (up to 6 mice per 
35ml) was then incubated with sterile-filtered trypsin (Sigma, T5266) / collagenase A (Roche, 
11088793001) mixture in L-15/PSG media at 37oC for 1 hour with agitation.  
 
Following digestion, tissue was spun (all centrifugations carried out at 1500 rpm for 5 minutes 
at 4°C unless otherwise stated) and the resulting fat layer was removed and transferred to a 
fresh falcon tube to be centrifuged again. The original pellet was then resuspended in 1mL of 
L-15/ FPSG and washed with 9mL of media, then combined with any remaining pelleted cells 
from the fat layer. The combined pellet was then re-suspended in red blood cell lysis buffer 
and incubated for 5 minutes at room temperature. The sample was then washed and 
centrifuged, and the resulting pellet was resuspended thoroughly in 1mL DMEM + 10% FBS + 
PSG with a P1000 pipette and transferred to a T75 tissue culture flask and incubated for 1 
hour at 37oC and 5% CO2 for depletion of fibroblasts. 




Following this, the majority of fibroblasts should have attached and with moderate shaking the 
epithelial cells were removed. After rinsing off any remaining un-attached cells, the cell 
suspension was centrifuged and washed in order to remove any remaining serum. The 
resulting pellet was then gently resuspended in the required volume of growth factor reduced 
Matrigel (BD, 356231) with pre-cooled pipette tips. 50µL drops were then placed in the centre 
of wells on pre-warmed 24-well plates and placed in an incubator to set. After 10 minutes, 
500µL of defined medium was added to each well (see appendix for composition).  
 
Media was changed three times per week, and organoids were passaged approximately every 
14 days, or on an as-needed basis. To do this, media was removed from wells and 500µL of 
ice cold DMEM/F12 added to each well. Using pre-cooled P1000 pipette tips, the Matrigel was 
broken up and mixed approximately 15 times. Well contents were then transferred to a 15mL 
falcon and each well was washed with a further 1mL which was combined with the previous 
contents. The contents were washed with DMEM/F12 and centrifuged, supernatant removed 
and washed and centrifuged again to remove any remaining Matrigel.  
 
Following this, the supernatant was removed and dissociation was carried out by resuspending 
the pellet with 500µL of trypsin-EDTA 0.05% (Invitrogen, 25300054) and mixing with a P1000 
pipette 5 times (pre-coated with FBS to ensure organoid structures did not stick to tips). The 
sample was incubated at 37oC for 5 minutes, then an equal volume of trypsin inhibitor was 
added and mixed thoroughly 20 times with a P1000 pipette. After waiting 2 minutes for the 
larger, un-trypsinised structures to sink to the bottom, the supernatant was strained through 
a 70µM cell strainer (BD, 352350). The trypsinisation and straining process was then repeated 
until all larger organoid structures were broken down and the cell suspension was centrifuged. 
After removal of supernatant, the pellet was thoroughly resuspended in the required volume 
of Matrigel and re-plated onto pre-warmed plates as previously described.  
 
2.4 Microscopy  
2.4.1 Confocal 
Images of wholemount mammary glands were acquired using a Leica TCS SP8 inverted 
confocal microscope with 10×/0.4 or 20×/0.75 HC PL APO objective lenses. Laser power, line 
averaging and step increment were adjusted manually to give optimal fluorescence intensity 
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for structure depth for each fluorophore with minimal photobleaching. For confetti data, all 
channels (RFP, GFP, YFP) were acquired regardless of labelling (with exclusion of CFP due to 
use of DAPI as a nuclear marker). Images were acquired with a pixel intensity range of 12 or 
16 bits to obtain the maximum possible illumination information for subsequent data analysis 
and quantification. 
 
2.4.2 Light sheet 
Samples were immunostained and cleared according to the CUBIC protocol. After clearing, 
samples were embedded within an agarose (1% (w/v) in H2O) tube, prepared by aspirating 
agarose (37–38°C) into a pre-warmed 1-mL syringe in which the syringe neck had been cut 
off. Mammary tissue strips were quickly placed within the agarose tube using forceps and 
centred by rolling the syringe between the palms. After setting, the plunger was removed, and 
the entire syringe was submerged in CUBIC reagent 2 for 24 hours. Samples were imaged in 
reagent 2 or glycerol in H2O (34% (w/w)).  
 
The light sheet system was a home-built modified version of the OpenSPIM system (Pitrone 
et al., 2013). The microscope was built and operated in the T-SPIM layout, whereby 
illumination happens from two sides simultaneously by overlapping two individual sheets to 
allow a more even illumination and to reduce artefacts, such as striping. We used two Olympus 
5×/0.15 air lenses to generate the light sheet. The higher refractive indices, long working 
distance (20 mm) and the fact that the lenses were on threaded mounts allowed us to adjust 
the point of focus accordingly. The imaging light path was equipped with a Nikon 16×/0.8 
water dipping lens.  
 
We imaged onto an Andor Neo 5.5 (ANDOR) or a Hamamatsu ORCA- Flash4 V2 
(Hamamatsu) with 6.5 µm pixels. For excitation a home-built laser combiner was used, 
bundling 405 nm, 488 nm, 561 nm and 640 (Coherent Cube 405 and 640, Coherent Sapphire 
488 and 561) into a single- mode fibre. Channels were acquired sequentially, and emission was 
filtered by suitable band-pass or long-pass filters (DAPI: 447/60; AF647: 705/72; both AHF 
Analysentechnik). The sample was mounted in a 4D (xyzθ) stage (Picard Industries) allowing 
optimal positioning of the sample in the light sheet. During imaging the sample was moved 
through the light sheet with a step size of 1.5 μm and the light sheet thickness was adjusted 
to be 6 μm to warrant an even thickness of the sheet across the entire sample width. Exposure 
times were between 15 and 150 ms.  




2.4.3 Stereoscope  
For wholemount bright field transmission imaging of mammary glands, images were acquired 
using a Leica MZ75 dissecting microscope with Leica Acquisition Software (LAS).  
 
2.5 Imaging analysis 
2.5.1 Imaris  
Images were processed and 3D image reconstructions were generated using Imaris image 
management software (v8.0, Bitplane) or Image J Fiji (version 2.0, National Institutes of Health) 
using 3D and / or maximum intensity projections. Denoising of 3D image sequences was 
performed in MATLAB (version R2014a, The MathWorks Inc., Natick, Massachusetts).  
 
2.5.2 Computational analysis 
Computational analyses were developed with and carried out by Dr Leila Muresan (Cambridge 
Advanced Imaging Centre). Analyses of 3D image stacks, selected on the basis of their 
resolution and compatibility with 3D image analysis, aimed to identify ducts within the intact 
mammary stroma and to subsequently recognize all ductal YFP+ cells. Ductal YFP+ cells were 
classified as luminal or basal based on the proportion of K8 versus SMA fluorescence signal.  
 
For a volumetric analysis, the volume ratio of YFP+ cells within each duct was computed with 
respect to the entire ductal (cellular) volume, and the intensity of K8 in YFP+ cells was also 
compared with the overall K8 intensity level within the duct. For computational efficiency, a 
multi-resolution transform was used for the K8 channel; a coarse scale was used to detect the 
duct and the full detail scale was used to identify voxels significantly different from the 
background. The coarse scale was segmented with a robust threshold, obtained as the median 
of the intensity values in the transformed stack plus three times the median absolute deviation 
of these values. The up-sampled structure represents an approximation of the duct and the 
sum of all its voxels was a measure of the volume of the duct.  
 
Within the duct, significant voxels (excluding intercellular spaces and nuclei) were detected 
plane-wise from the fine detail levels of the wavelet coefficients of the two-dimensional wavelet 
transformed image by applying a false discovery rate-based thresholding. Independently, YFP+ 
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cells were identified after a difference of Gaussian filtering suited to the noise level of the 
image; as the filter was applied on the full-resolution 3D stack, a recursive filter implementation 
in CImg (Deriche, CImg) was used for time efficiency. The threshold was computed as above, 
as the robustly estimated 99% quantile of the Gaussian distribution of filtered intensity values: 
the median plus three times the median absolute deviation of these intensities. Subsequently, 
only YFP+ cells inside the detected duct were taken into account. These cells were classified 
as luminal or basal based on the comparison of intensity values in the K8 and SMA channels of 
the voxels belonging to each segmented cell; for a chosen threshold, the voxels exceeding this 
threshold in the K8 and SMA channels, respectively, were counted. If the number of K8 voxels 
exceeded the SMA, the cell was classified as luminal, otherwise it was classified as basal. Note 
that a perfect exclusion of one colour cannot be expected due to the resolution limits of the 
optical system.  
 
To provide robustness with respect to the choice of the intensity threshold, the classification 
was performed using a multi-threshold approach, with levels 100, 300, 500, up to 1,500 and 
the majority vote for all thresholds gave the final classification of the cell. Finally, a 
Kolmogorov–Smirnov test was performed to determine if the significant voxels of the duct in 
K8 channel were differentially distributed compared with the significant voxels inside the 
segmented YFP+ cell. 
 
Some particularities of the basal YFP+ co-localization images (such as the poorer signal-to-
noise ratio of these images due to the depth of this clone within the mammary fat pad and 
the elongated shape of the YFP+ cells) meant modifications of the described analysis was 
necessary. To improve the quality of the images, a denoising step was applied followed by a 
fast deblurring step (Dr Jerome Boulanger, Medical Research Council Laboratory of Molecular 
Biology, private communication). The segmentations are performed in 3D for all channels, 
however, to separate elongated and overlapping YFP+ cells, a seeded watershed was used (the 
seeds are thresholded distance images of the inverted segmented YFP+ image, where the 
threshold is manually selected).  
 
The classification of the YFP+ cells was performed as before: if the number of K8 voxels 
exceeded the SMA, the cell was classified as luminal, otherwise it was classified as basal. Using 
this analysis, two cells were excluded from the classification due to their localization in regions 
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where the SMA signal was undetectable and thus the double/nested tubular structure could 
not be observed.  
 
2.5.3 PR / K8 association analysis 
Quantification of PR+ and K8hi cells was performed on maximum intensity projections of 3D 
image stacks using the Cell Counter plugin in Image J (v1.50a, National Institutes of Health). 
Maximum intensity projections of PR and K8 channels were scored independently. At least 
200 cells were counted per image, with six images analysed from three independent mice 
(total cells counted: 1,831). Manual counting of YFP+ cells was performed on 10 histological 
sections cut 425 mm apart, spanning 300 mm. K8 was used to mark the luminal lineage and 
SMA was used to mark basal cells. The number of alveoli that were fully or partially populated 
by YFP cells of a single lineage were manually counted in Image J.  
 
2.5.4 Nearest neighbour clonal analysis  
A cell neighbour analysis was used to analyse labelling outcomes in the R26R-Confetti model 
in both embryonic and pubertal labelling. Quantification method was based off previous 
pair/patch-based analysis (Wuidart et al., 2018), with manual scoring (Van Keymeulen et al., 
2011; van Amerongen et al., 2012; Rios et al., 2014). 3D image stacks of label positive regions 
were randomly selected based on image quality (and therefore ability to accurately record cell 
lineage via cell morphology, topology and SMA positivity). For all cells within a region, the 
lineage of its closest same-colour neighbour was recorded in one of two bins: “same” or 
“different”. For example, if a luminal YFP+ cell was observed and its closest YFP+ neighbour 
(in x-y-z dimensions) was also luminal, this cell would be counted as “same”, and thus 
potentially supporting unipotency of the clone. On the other hand, if its closest YFP+ 
neighbour was basal, this would be counted as “different” and thus potentially supporting 
bipotency of the clone.  
 
Hundreds of cells were counted over different clones in different mice to obtain a cell 
neighbour lineage analysis. Based on the relatively low level of labelling and the multi-colour 
reporter system, this method of analysis assumes that two proximal cells of the same colour 
within a specific region were derived from a common labelled ancestor. Thus, two luminal 
YFP+ cells counted as “same” may be distinct labelling events derived from different precursor 
cells – as such, this model may over-represent the percentage of possible unipotent clones. 
Similarly, a luminal and basal YFP+ cell counted as “different” may also be from distinct labelling 
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events and thus this model may also overrepresent the proportion of possible bipotent clones, 
which was extremely small in this study. 
 
2.6 Statistics.  
To determine if a single labelled mammary stem/progenitor cell contributed equally to both 
the K8hi/PR+ and K8lo/PR luminal populations, the Kolmogorov–Smirnov test was performed 
on custom 3D imaging algorithms in MATLAB (R2014a, The MathWorks Inc., Natick, 
Massachusetts). Briefly, this test was performed in order to determine if the significant voxels 
of the segmented total ductal luminal cells were differently distributed to the significant voxels 
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Development of optical clearing and 
3D imaging techniques for use in the 
mammary gland 
  




3.1.1 Imaging requirements in the mammary gland 
As described previously, the mammary gland is a complex, branched organ embedded in a 
fatty stroma. Numerous primary and secondary ducts occupy multiple focal planes which are 
remodelled during oestrous cycling and with gestation/lactation/involution cycles (Watson and 
Khaled, 2008). As such, this can present issues when visualising the mammary gland. Like other 
tissues, traditionally the gland has been imaged using 2D sections of either paraffin-embedded 
or frozen tissue. Taking multiple slices, usually only approximately 10M thick, allows 
antibody-based immunohistochemical staining which can result in excellent cellular resolution. 
However, cells and tissues are inherently 3D, and thus analysing tissues in 2D can present 
issues when placing the section in the context of both other branches, as well as the entire 
gland.   
 
This becomes particularly relevant when interpreting lineage tracing data, whereby the 
progeny of labelled stem or progenitor cells are analysed in order to deduce characteristics 
of the parent cells – such as lineage, location and proliferation capacity. Traditional tissue 
sections can be insufficient for accurate quantitative analysis and do not reveal complex spatial 
patterns that may be present. As such, visualising the mammary gland in 3D, with the entire 
ductal tree intact, is an important step in correctly describing mammary gland development, 
and its stem and progenitor cells and their progeny. 
 
3.1.2 Optical clearing: theory and development  
Other tissues with branching characteristics have presented similar difficulties. This, combined 
with advancing imaging techniques which have allowed increased imaging depth, has 
necessitated the development of methods that allow for imaging whole tissues in three 
dimensions. As such, tissue optical clearing techniques have been developed, which render 
tissue transparent to allow for imaging entire tissues in one piece.  
 
The general theory of optical clearing involves using different techniques to homogenise the 
refractive indices of tissues. Different cellular and intracellular components have differing 
refractive indices depending on the contents and density of its constituents, such as proteins 
and lipids (Johnsen and Widder, 1999; Tuchin, 2015). When light travels through structures 
with differing refractive indices it is bent, or refracted, causing spherical aberrations, resulting 
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in the inability to image any deeper. Moreover, this scattering of light results in the loss of 
excitation and emission efficiency, resulting in a lower resolution and imaging depth when using 
fluorescence microscopy. 
 
Optical clearing techniques have been largely spearheaded by the neuroscience field, with the 
development of CLARITY for whole brain imaging in 2013(Chung et al., 2013). Protocols can 
be generally divided into active or passive: active optical clearing involves the use of 
electrophoresis chambers that, over time, perfuse the tissue with the clearing solution. Passive 
clearing, on the other hand, simply involves immersion of tissues into clearing solutions, and 
as such less equipment and set up is required, meaning they are generally more economical.  
 
Despite the peak in the development of optical clearing techniques within the last decade, 
tissue clearing is not a new concept. German anatomist Werner Spalteholz first described the 
use of “aufhellungspräparate”, or brightening preparations, in the 19th century, whereby the 
coronary arteries of the heart were imaged following impregnation with methyl salicylate, 
benzyl benzoate and wintergreen oil by immersion in a solution of these reagents in order to 
obtain matched refractive indices (Spalteholz, 1911), in a similar manner to modern-day 
protocols. Recent optical clearing methods are based on the same concept of refractive index 
homogenisation, but with a shift towards more sophisticated approaches that utilise more 
current techniques, which allows tissue integrity to be maintained whilst also requiring much 
shorter protocol times.  
 
The recent renaissance of optical clearing has also been brought about by advancement in 
imaging methods that are able to image whole tissues. There have been significant advances in 
the microscope since the development of the modern day model by Antonie van 
Leeuwenhoek in the 17th century (Azaripour et al., 2016), with the introduction of the ability 
for optical sectioning. Confocal microscopy is now a standard tool for scientists, allowing 
imaging of multiple colours sequentially. Moreover, recent developments have led to light 
sheet microscopy also gaining popularity.   
 
Although 3D imaging of the mammary gland has been done previously, the protocols used 
result in a number of limitations. This has been achieved largely using either microdissection 
or proteolytic digestion, although both have a number of caveats. Microdissection involves 
removing parts of the epithelial ductal tree from its native stroma (Rios et al., 2014), therefore 
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negating the need to image through the large volumes of adipocytes that are present in the 
gland, and are especially light refractive (Rios et al., 2014). However, this presents a number 
of issues. Firstly, this often means that only small sections of the ductal network can be imaged, 
in addition for the need of a high degree of technical skill. Secondly, it rules out using 3D 
imaging in the study of the native stromal compartment of the mammary gland.  
 
The other method previously used for 3D imaging of the mammary gland involves a 
combination of enzymes, such as collagenase and hyaluronidase, to dissolve the extracellular 
matrix – and in the case of the mammary gland – the surrounding adipocytes (Wuidart et al., 
2016). However, achieving specific digestion of the stroma whilst also leaving the epithelium 
intact is a delicate balance. Consequently, recent work has shown that the use of proteolytic 
digestion for 3D imaging in the mammary gland has a detrimental effect on the epithelium 
(Rios et al., 2016). The basal cell layer was shown to be particularly affected, presumably due 
to the destruction of the basal lamina, which basal cells rely on for cell contact. Using even 
low concentrations of proteolytic enzymes resulted in depletion of cells in the outermost layer 
of the ductal tree, leading to gaps. The remaining cells displayed altered morphology, losing 
their traditional elongated striated shape and becoming more rounded (Rios et al., 2016).  
 
As such, optical tissue clearing provides a method to yield the benefits of imaging the entire 
mammary gland in 3D, without detrimental effects on either the stroma or the epithelium. 
Imaging the ductal network, in situ and without alteration, removes potential complications or 
anomalies that arise and that may contribute to disparities in the interpretation of data in the 
field of mammary gland research. 
 
3.1.3 Aims 
The current imaging methods in the mammary gland may lead to the inability to properly 
interpret the data, and as such may be contributing to many of the disparities that are currently 
affecting mammary gland research. As such, we aimed to develop and optimise optical tissue 
clearing methods for use in the mammary gland, based on the adaptation of published 
protocols, to allow wholemount imaging. Moreover, we aimed to assess multiple imaging 
methods in order to determine microscopy techniques that can be combined with optical 
tissue clearing for different uses. 
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To assess the clearing methods in the mammary gland, in the first instance, methods were 
evaluated based on the ability to render the gland macroscopically transparent. However, the 
compatibility with immunohistochemical staining, including wholemount colourimetric and 
antibody-based immunofluorescence, were also considered as of primary importance, as well 
as maintenance of tissue integrity. 




3.2.1 Assessment and selection of optical clearing protocols 
There are multiple optical clearing protocols that have been developed, and as such this 
required a strategy to narrow down options. To begin, we decided to focus on passive optical 
clearing due to both the relatively gentler treatment of the tissue (in comparison to active 
optical clearing, involving often harsh electrophoresis). Additionally, generally passive optical 
clearing protocols provide a more economical option – requiring both less cost and time – as 
well as being more user-friendly due to not requiring specialist equipment. Due to the fact 
that a number of tissues would be analysed in future projects, these criteria were considered 
to be important.  
 
The mammary gland is a relatively delicate epithelial organ, but with a high level of fat content. 
Consequently, a fine balance would need to be considered in order to achieve an adequate 
level of clearing, whilst still maintaining tissue integrity, such as morphology - both on the 
larger scale in terms of the ductal network, and on the cellular scale in terms of cell-cell 
contact. For imaging of optically cleared tissue, we assessed the protocols in the first instance 
for compatibility with confocal microscopy. The majority of laboratories have access to a 
confocal microscope, and is the most available method in our laboratory. Moreover, with its 
ability to optically section, it is reasonably easy to adapt to imaging of wholemount tissues.  
 
3.2.1.1 SeeDB optical clearing 
The first clearing protocol we elected to examine was the water-based “See Deep Brain” 
(SeeDB). Developed to allow reconstruction of neuronal circuits, SeeDB clearing utilises 
increasing concentrations of fructose to match the refractive indices of tissues, combined with 
-thioglycerol to prevent Maillard reaction-based tissue browning (Dills, 1993; Ke et al., 2013), 
resulting in a total protocol length of 15 days, including antibody staining (Figure 3.2.1.1a). This 
protocol aims to overcome the limitations of previously published protocols - namely long 
incubation times and tissue deformation. The gentle nature, with the absence of harsh 
detergents and other chemicals, also means that theoretically tissue integrity is highly 
preserved – for example in terms of epitopes for antibody binding or fine tissue structures. 
This makes SeeDB particularly amenable for multicolour fluorescent-based 
immunohistochemistry, particularly when combined with endogenous fluorescent protein 
expression.  




When tested on the mammary gland, SeeDB optical clearing lead to adequate optical 
transparency in the virgin mammary gland (Figure 3.2.1.1b, left). An increase in optical 
transparency was also achieved in the lactating mammary (Figure 3.2.1.1b, right), but to a lesser 
degree than in the virgin – presumably due to the increase in epithelial density associated with 
lactation.  
 
Although SeeDB did not provide the highest degree of optical transparency compared to other 
protocols (judged by the degree of visibility of the reference grid), it was however adequate 
enough for use with confocal imaging (Figure 3.2.1.1c), with both luminal and basal cells 
visualised using K8, E-cad, K5 and SMA antibodies. Importantly, due to the inert nature of 
fructose, most antibodies tested were highly compatible with this method.  
 
The longer incubation times required in the SeeDB protocol have the potential to cause 
browning of the tissue via the Maillard reaction, due to the interaction between the amino 
acids and proteins in the tissue and the fructose in SeeDB (Dills, 1993). The result of this is 
the formation of both brown and fluorescent by-products, which can lead to high levels of 
background fluorescence accumulation. Moreover, the loss of amino acid residues as a result 
of the reaction results in a reduction in protein quality, which could lead to a decrease in 
antibody binding due to changes in epitope structure (Dills, 1993). However, in the mammary 
gland, there was a very low level of autofluorescence background (Figure 3.2.1.1d), and the 
protocol was found to be compatible with a number of antibodies, presumably due to the 
inclusion of -thioglycerol in the fructose solutions which inhibits the Maillard reaction. 
Consequently, SeeDB was assessed as a compatible method for use with immunofluorescence-
based confocal imaging, especially in situations whereby new or sensitive antibodies are to be 
used.  
  




Figure 3.2.1.1 SeeDB-based optical tissue clearing in the mammary gland 
(A) Schematic outline of the SeeDB optical clearing protocol, including primary and secondary 
antibody staining, resulting in a total protocol time of 13 days. (B) Use of SeeDB in both virgin 
and lactating tissue resulted in adequate transparency, without any decolourisation (shown by 
the presence of blood vessels, arrow heads, after optical clearing. (C) Fluorescent antibody-
based staining using K8 and E-CAD for luminal cells, and K5 and SMA for basal cells was used on 
virgin and lactating mammary gland tissues (top and bottom panels, respectively). (D) No-
primary control tissue, with only secondary antibodies used, showed a very low level of 
background and autofluorescence on mammary tissue with this SeeDB protocol. 




3.2.1.2 CUBIC optical clearing 
The second immersion-based method that was tested is known as CUBIC (Clear, 
Unobstructed Brain Imaging Cocktails) (Susaki et al., 2014). CUBIC clearing is composed of 
sequential incubations in the two reagents, reagent 1 (R1) and regent 2 (R2). R1 is designed 
to dissolve fat and remove pigment, being composed of high concentrations of detergents, 
such as urea and Triton-X100. R2 also contains triton X-100 and urea but at lower 
concentrations that R1. The inclusion of a high level of sucrose in R2 lends to its primary utility 
in matching the refractive index of tissues. 
 
In this clearing protocol, we found incubation in R1 and R2 for 72 and 48 hours respectively, 
was optimal for the mammary gland, resulting in a total protocol time of 15 days when 
including antibody staining (Figure 3.2.1.2a). The higher concentration of detergents in this 
protocol lead to a higher degree of transparency in comparison to SeeDB, with the additional 
benefit of removal of pigment - which is seen by the disappearance of blood vessels, due to 
the discolouration of haem (Figure 3.2.1.2b, arrowheads). Strong immunostaining of basal cells 
was observed using antibodies such as K5 and SMA (Figure 3.2.1.2c, right). However, in some 
cases, the use of stronger detergents also came with an associated decrease in antibody 
viability: immunostaining with antibodies such as K8 and E-cad resulted in non-uniform 
expression, presumably due to changes in epitope structure induced by the detergents 
themselves (Figure 3.2.1.2c, left).  
 
  




Figure 3.2.1.2 CUBIC-based optical tissue clearing in the mammary gland 
(A) Schematic outline of the CUBIC optical clearing protocol, including primary and 
secondary antibody staining, resulting in a total protocol time of 15 days. (B) Use of CUBIC 
in both virgin and lactating tissue resulted in excellent transparency, with the additional 
benefit of decolourisation (shown by the absence of blood vessels after optical clearing 
(arrow head). (C) Fluorescent antibody-based staining was used in both virgin and lactating 
mammary gland tissues (top and bottom panels, respectively). Using K8 and E-Cad, for 
luminal cells, showed immunostaining was not as compatible with CUBIC clearing as other 
protocols. However, K5 and SMA staining for basal cells worked well. BV, blood vessels. 
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However, a recent modification of the CUBIC protocol, termed CUBIC R1a (Susaki and Ueda, 
2016), has been developed as a more gentle alternative. CUBIC R1a uses lower concentrations 
of detergents, with a third less triton-X and a two-thirds reduction in urea. Using this modified 
formulation, we were able to observe improved immunostaining of both K8 and E-cad (Figure 
3.2.1.3a) - suggesting that the higher concentration of detergents in the original CUBIC R1 
formulation does indeed affect the preservation of epitope availability. However, in both the 
new and original protocols, levels of autofluorescence were observed within some ducts and 
blood vessels, which could be seen on both confocal (Figure 3.2.1.3b) and stereo microscopy 
(Figure 3.2.1.3c). Significant background was also seen on the no primary control (Figure 
3.2.1.3d). This could be due to the accumulation of the clearing solution within closed off 
structures, such as blunt-ended ducts, and as such, we decided to increase washing times to 
try and prevent this from occurring. 
 
Due to the excellent level of transparency achieved and relative ease of the protocol, we also 
opted to assess the use with wholemount colourimetric stains, which require high 
transparency for the ability the see through the entirety of the tissue. CUBIC-based clearing 
was compatible with the enzymatic reaction used to detect β-glucosidase (SYNbglA), a 
magenta coloured reporter similar to LacZ (McCutcheon et al., 2010; Kozar et al., 2013) 
(Figure 3.2.1.4a). Due to the magenta colour of the SYNbglA reporter being too similar to the 
traditional carmine stain used in the mammary gland (Figure 3.2.1.4b), we also needed to use 
a different coloured epithelial co-stain. For this, we opted to test methyl green, a traditional 
DNA counterstain used in IHC (Høyer et al.). This worked well to show the epithelial 
compartment of the mammary gland, with the entire ductal network easily visualised along 
with a low background (Figure 3.2.1.4c).  
 
We also utilised diaminobenzidine (DAB) staining with CUBIC clearing, an often-used enzyme-
based chromogenic stain in 2D immunohistochemical analysis (Singer, 1959). We found using 
the original CUBIC R1 protocol and DAB staining combined with SMA, either after R1a or 
R2, lead to good signal, especially at high resolution (Figure 3.2.1.4d). This suggests that CUBIC 
clearing does not disrupt the ability to use a number of enzymatic-based counterstains. We 
therefore adopted use of CUBIC for colourimetric staining, where the importance of 
visualising the whole tissue in transmission imaging outweighs the need for specific antibody 
binding. 
 




Figure 3.2.1.1 CUBIC R1a-based optical tissue clearing in the mammary 
gland 
(A) CUBIC R1a clearing was more compatible than the original CUBIC clearing cocktail for 
subsequent fluorescent antibody-based staining. Images show examples of staining for luminal 
cells using K8 and E-Cad and for basal cells using SMA in virgin mammary gland. (B) However, 
both CUBIC protocols resulted in high levels of non-specific background fluorescence within 
ductal structures when visualised using confocal microscopy (arrow heads). (C) This could also 
be detected when visualised using stereo microscopy (example image shows 4 week mammary 
gland) (D) A background autofluorescent signal could also be seen in the no primary control, 
with secondary antibody staining using Cy3 and AlexaFluor647. BV, blood vessels 





Figure 3.2.1.2 CUBIC-based optical tissue clearing combined with colourimetric 
staining in the mammary gland 
(A) CUBIC clearing was compatible with the enzymatic reaction required to stain for the SYNbglA 
reporter (B) CUBIC clearing was also compatible with carmine staining, in addition to methyl 
green counterstain, as shown in (C). (D) CUBIC clearing could also be combined with DAB 
immunohistochemistry, with example images showing SMA staining in both virgin (top) and 
lactating tissue (bottom).  
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3.2.1.3 PACT optical clearing  
We next assessed a hydrogel-embedding based clearing protocol, which is designed to provide 
extra sub-cellular stabilisation of tissue integrity due to the protein cross-linking (Chung et al., 
2013). PAssive CLARITY Technique (PACT)-based tissue clearing involves three main steps: 
first, stabilisation of biomacromolecules is achieved using hydrogel embedding to facilitate 
crosslinking and hybridization to hydrogel monomers (Yang et al., 2014). Next, ionic 
detergents are used to extract lipids from the issue, before a final third step of embedding in 
a refractive index matching solution (RIMS) for refractive index homogenisation for either 
imaging or long-term storage (summarised in Figure 3.2.1.5a).  
 
PACT-RapiClear uses a commercially available RIMS as the final step. When used in both virgin 
and lactating tissue, excellent transparency was achieved (Figure 3.2.1.5b). However, when we 
imaged using confocal microscopy after immunostaining with SMA, the signal was patchy and 
had a high background level, especially in virgin tissue (Figure 3.2.1.5c, top panels). Moreover, 
RapiClear is used with specialised imaging chambers for final embedding to allow for longer 
term storage.  
 
However, when used with both virgin and lactating mammary gland samples, imaging was 
restricted due to the limited working distance of most commercial confocal microscope 
objectives. We found that using the imaging chambers meant the tissues could not be properly 
orientated against the cover glass, meaning optimal sample illumination and imaging was 
difficult to achieve, especially with thicker samples, such as those in the lactating mammary 
gland (Figure 3.2.1.5c, bottom panel). This, combined with the commercial aspect of RapiClear, 
which makes it much less economical than other clearing agents, meant we sought to find an 
alternative RIMS to use with PACT clearing. 
 
As such, we opted to test PACT with the non-commercial refractive index-matching solutions. 
The first, RIMS, uses a high concentration of a solution of Histodenz, a chemical often used as 
a radiocontrast agent (Ye et al., 2014). The concentration can be adjusted depending on the 
RI of the tissue in question, up to an 88% w/v solution which corresponds to a refractive index 
of 1.48 (Yang et al., 2014). The refractive index of the murine mammary gland has not been 
tested, and as such estimations based on similar tissues were  
made. The refractive index of adipose is generally one of the highest of all tissue types (Susaki 
et al., 2014), with bovine adipose tissue samples being previously measured at 1.455 (Bolin et 
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al., 1989). One study in rat mammary tissue has corroborated this – with rat mammary adipose 
and stroma being measured at 1.467 and 1.388 respectively (Zysk et al., 2006). As such, we 
decided to test 20 – 88% w/v histodenz, which encompasses refractive indices from 1.38 – 
1.48 and thus encompasses the ranges likely to be found in murine mammary tissue.  
 
After PACT hydrogel embedding in A4P0 and clearing in sodium dodecyl sulfate (SDS), virgin 
mammary gland tissue fragments were incubated in increasing concentrations of histodenz 
(20-88% w/v), and the transparency levels over the next few hours observed. PACT clearing 
resulted in pigment removal (as shown by the absence of blood vessels) but no significant 
changes in transparency or change in tissue volume (Figure 3.2.1.6a). Significant changes in the 
tissue transparency were not apparent until concentrations above 60%, presumably due to the 
high RI of the fat in the mammary gland - suggesting that the RI of the murine mammary gland 
is above 1.44. Supporting this, incubation in 88% histodenz resulted in noticeable transparency 
changes after only 2 hours, with a maximum level seen after 48 hours. However, we found 
RIMS to be both difficult to dissolve, and associated with a high cost. We therefore decided 
to asses next the alternative, sorbitol refractive index matching (sRIMS), which utilises a 
sorbitol-based solution for RI matching. 
 
Following PACT clearing, transparency was seen after two hours, similar to RIMS. After 48 
hours, maximum transparency was achieved, but to a slightly lesser extent than with RIMS. 
Due to sorbitol being a common laboratory reagent, sRIMS has the benefit over both 
histodenz-based RIMS and RapiClear in that it is both inexpensive and easier to source (at 
approximately £0.11 per millilitre it is over 40 times more economical than RIMS).  
 
We therefore decided to combine PACT-sRIMS and immunofluorescent staining with confocal 
imaging. In both the virgin and lactating tissue, we were able to image the mammary gland 
using the standard antibody panel (Figure 3.2.1.6b). However, in some cases, there appeared 
a high degree of background, which can complicate downstream computational image analysis. 
However, this was improved with the application of 3D de-noising algorithms (Boulanger et 
al., 2010), which although not overtly affecting the outward appearance of the image stacks, 
would be beneficial for any subsequent computer-assisted analyses. This, combined with the 
longest total protocol time of 20 days, meant PACT-sRIMS did not provide any benefit over 
other protocols for day to day optical tissue clearing in the mammary gland when combined 
with confocal microscopy.  




Figure 3.2.1.3 PACT-RapiClear optical tissue clearing in the mammary 
gland 
(A) Schematic outline of PACT-RapiClear optical clearing protocol, including primary and 
secondary antibody staining, resulting in a total protocol time of 20 days. (B) Fragments of 
virgin mammary tissue were cleared with the PACT protocol. Tissue was then incubated in 
RapiClear for refractive index matching. (C) PACT clearing and RapiClear refractive index 
matching were used in both virgin and lactating mammary gland (top and bottom panels, 
respectively). This was combined with fluorescent antibody-based staining for SMA and 
imaged using confocal microscopy.  





Figure 3.2.1.4 PACT-RIMS and sRIMS optical tissue clearing in the 
mammary gland 
(A) Fragments of virgin mammary tissue were cleared with the PACT protocol (second 
panel). Tissue was then incubated in increasing concentrations of histodenz (20-80%), or 70% 
sorbitol (bottom row) for refractive index matching. (B) PACT clearing and sRIMS refractive 
index matching were used in both virgin and lactating mammary gland (top and bottom 
panels, respectively). This was combined with fluorescent antibody-based staining. Using K8 
and E-Cad, for luminal cells, and K5 and SMA for basal, cells allowed for good visualisation 
at single cell resolution using confocal microscopy.  
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3.2.1.4 3DISCO optical clearing  
Solvent-based tissue clearing of the mammary gland using “3D imaging of solvent-cleared 
organs” (3DISCO) was previously described in the original protocol (Ertürk et al., 2012). This 
protocol consists of three steps: initial dehydration with increasing concentrations of the 
solvent tetrahydrofuran (THF), lipid extraction with incubation in dichloromethane (DCM) 
and RI matching with immersion in dibenzyl ether (DBE) (summarised in Figure 3.2.1.7a). 
3DISCO is well suited to lipid-rich tissues due to the de-lipidation steps, and so in theory 
should be well-matched for use in the mammary gland.  
 
We used 3DISCO clearing in both virgin and lactating mammary tissue, which resulted in very 
good transparency in comparison to other immersion-based clearing methods (Figure 
3.2.1.7b). Moreover, it involved fewer steps, and as such less time, with a total protocol length 
of only 12 days (Figure 7a). Despite this, we found its utility in the mammary gland to be limited 
for a number of reasons. Despite the shorter incubation times, the mammary gland was left 
brittle and showed a significant level of damage. On the macro level, this resulted in significant 
shrinkage in both virgin and lactating tissues (Figure 3.2.1.7c). This was also reflected on the 
microscopic level, with reduced staining of SMA, in addition to the virgin ducts and lactational 
alveoli displaying structural deformations when imaged using confocal microscopy (Figure 
3.2.1.7d) 
 
Additionally, on a practical level, the solvents utilised in 3DISCO pose a number of safety risks 
and as such require specialist imaging chambers, equipment and disposal of imaging solutions 
(for example, THF negates the use of any plastic). This also means that 3DISCO is incompatible 
with most immersion objectives. Moreover, the use of these strong solvents negates the ability 
to store tissue for prolonged periods of time, particularly in samples with endogenous 
fluorescence. The authors of the original manuscript also stated that less stable fluorescent 
proteins, such as YFP, are particularly affected. For these combined reasons, although 3DISCO 
may have utility in other tissues and organs, it was not pursued further for use in the mammary 
gland. 
  




Figure 3.2.1.5 3DISCO-based optical tissue clearing in the mammary gland 
(A) Schematic outline of 3DISCO optical clearing protocol, including primary and secondary 
antibody staining, resulting in a total protocol time of 10 days. (B) Use of 3DISCO in both virgin 
(left) and lactating (right) tissue resulted in excellent transparency. (C) Quantification of size 
changes after 3DISCO clearing in both virgin and lactating mammary gland tissue fragments (n=3 
for each time point). (D) Fluorescent antibody-based staining with SMA was used in virgin 
mammary gland tissue. Tissues were imaged using confocal microscopy, and resulted in 
suboptimal and inconsistent staining at both time points.  
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3.2.2 Use of optical tissue clearing in cancer research 
3.2.2.1 Optical clearing in mouse syngeneic tumour models  
The performance of the clearing protocols was tested on ex vivo mammary gland tumours to 
determine whether the techniques described herein could be adopted for use in cancer 
research. TUBO tumours are derived from a cloned, HER2 overexpressing syngeneic tumour 
cell line originating from a spontaneous a BALB-neuT mouse mammary carcinoma (Rovero et 
al., 2000). Tumours were dissected out after reaching maximum growth limits permitted on 
the project licence, and then divided into small fragments (approximately 1cm3). We then 
compared staining of HER2, K8 and DAPI when using the three optical clearing protocols that 
worked best in the normal mammary gland - PACT-sRIMS, CUBIC and SeeDB. With all three 
protocols, we were able to image HER2-expressing cells at an enhanced depth and in high 
resolution (Figure 3.2.2.1a,b,c). K8 expression was also seen by fluorescence co-staining, but 
in a similar manner to that seen in the normal tissue, K8 was lower using the original CUBIC 
protocol compared to the other clearing methods (Figure 3.2.2.1b) - but this may be improved 
with the use of the second generation CUBIC R1a (Kubota et al., 2017).  
 
We therefore opted to use SeeDB to examine the use of other antibodies in tumour imaging, 
due to its higher amenability to antibody staining (Figure 3.2.2.1c). In larger tumour fragments, 
we were able to see cells expressing the normal luminal marker K8, which appeared to be 
concentrated on the outer edges (Figure 3.2.2.2a), in addition to Her2 expressing tumour cells 
(Figure 3.2.2.2b). We also opted to co-stain for cleaved-caspase 3 (CC3), a marker of cell 
death, which has also been implicated in increased recurrence and death rates in breast cancer 
(Huang et al., 2011). This showed positive staining that was concentrated in the centre of 
lobules, as well as in between lobules (Figure 3.2.2.2a,b).  
  




Figure 3.2.2.1 Assessment of optical tissue clearing protocols in mammary 
tumours 
TUBO tumour fragments were cleared using PACT-sRIMS (A), CUBIC (B) and SeeDB (C) 
optical clearing protocols. Tumours were stained for DAPI, HER2 and K8 and imaged using 
confocal microscopy. Images show maximum intensity projections with corresponding optical 
slices and their z-value for each protocol. 
  




Figure 3.2.2.2 SeeDB optical clearing to examine apoptotic cell death in 
TUBO mammary tumours 
TUBO tumour fragments were cleared using SeeDB optical clearing protocols and stained 
for DAPI, K8 and cleaved caspase 3 (CC3) (A) and DAPI, HER2 and CC3 (B) and imaged 
using confocal microscopy to examine apoptotic cell death. Images show maximum intensity 
projections with corresponding single colour images.  





However, we observed reducing intensity of DAPI, HER2 and K8 staining with increasing 
imaging depth when looking through z-stacks of images. Initially, this was thought to be due to 
technical artefacts – i.e. suboptimal fixation or inadequate antibody penetration leading to edge 
effects, or reduction in signal intensity when imaging deeper. To investigate if this was a 
phenomenon of the wholemount staining and imaging, we opted to carry out traditional 2D 
immunohistochemistry on formalin-fixed paraffin-embedded (FFPE) tumour sections. Sections 
from both the edge (Figure 3.2.2.3a) and middle (Figure 3.2.2.3b) of the tumour mirrored the 
pattern that was seen in the wholemount images, showing reduced staining intensity of both 
K8 and HER2 in the centre of lobules. This similar pattern displayed in tumours stained and 
imaged in both 2D and 3D rules out inadequate antibody penetration or signal reduction due 
to wholemount imaging. However, inadequate fixation could still play a part.  
 
As such, to explore this further and discern if there could be a biological reason for this, we 
next carried out CC3 staining in FFPE tumour sections to examine if this could be due to an 
increase in cell death in the centre of tumours due to necrosis. In doing so, we saw multiple 
zones of CC3 positivity, especially in the centre of tumour lobules within areas of low E-cad 
expression, in both sections from the edge (Figure 3.2.2.4a) and middle of the tumour (Figure 
3.2.2.4b) - again, mirroring the pattern seen in wholemount SeeDB cleared tumours. Together, 
this suggests that the reduction in fluorescence intensity may also be, in part, attributable to 
the inherent biology of tumours, whereby centres of the tumour mass are often found to have 
high levels of cell death and necrosis, for example due to insufficient blood supply and the 
resulting hypoxic environment. This also highlighted the usefulness of carrying out 2D analyses 
in parallel to 3D imaging, especially in the case of characterising large, complex and/or 
heterogeneous tissues, such as tumours. 
 
We next assessed the proliferation in the tumours by examining Ki67 staining – a marker of 
proliferative cells in the G1, S, G2 and mitosis phase of cell cycle, but not in quiescent or 
resting cells in G0 (Gerdes et al., 1984). This marker is often used in prognostic settings in 
breast cancer using tissue sections (Inwald et al., 2013; Li et al., 2014), and as such the utility 
in wholemount tissues could be important. We observed high levels of proliferation 
throughout the tumour fragment, but especially on the leading edges and boundaries of the 
lobules (Figure 3.2.2.5, arrows). Co-staining with CC3 in the tumours showed a concentration 
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of apoptotic cell death in different areas to Ki67-marked proliferation – again, at the centre of 
the tumours (Figure 3.2.2.5, arrowheads). 
  




Figure 3.2.2.3 Staining pattern in FFPE TUBO tumour sections 
TUBO fragments from the edge (A) and centre (B) of the tumour were formalin fixed and 
paraffin embedded, then sectioned and stained for K8 and HER2.  
  




Figure 3.2.2.4 Apoptotic cell death in FFPE TUBO tumour sections  
TUBO fragments from the edge (A) and centre (B) of the tumour were formalin fixed and 
paraffin embedded, then sectioned and stained for E-cad and CC3.  
  




Figure 3.2.2.5 SeeDB optical clearing to examine cell proliferation and 
death in TUBO mammary tumours  
TUBO tumour fragments were cleared with the SeeDB optical clearing protocol and 
stained for DAPI, Ki67 and CC3. Proliferation (marked by Ki67) appeared to be 
concentrated on leading edges of tumour lobules (arrows), whereas apoptosis (marked 
by CC3) was concentrated in the centre of tumour lobules (arrow heads). Images show 
maximum intensity projections, along with individual channels.  
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Since the TUBO tumour cells are a syngeneic line, and as such grow in an immunocompetent 
environment, we also wanted to investigate whether optical clearing could be utilised to 
examine the immune infiltrate in the tumours. This is a particularly important aspect of tumour 
research given the increasing understanding of the importance of the immune system in 
tumour development and maintenance, in addition to the number of immunotherapies in the 
clinic. Using 3D imaging in multiple focal planes, as opposed to 2D sections, allows a better 
appreciation of immune cell location in the context of an entire tumour. Additionally, as larger 
areas are imaged, it allows for patterns to be more easily seen, that may not be appreciated 
when surveying a single focal plane. 
 
Therefore, we opted to stain for the markers CD3 and CD11b, which are pan-T and pan-
myeloid cell markers, respectively (Reinherz et al., 1980; Arnaout et al., 1983). We were able 
to see zones of both CD3 and CD11b staining (Figure 3.2.2.6). Interestingly, these were often 
in between lobules of the tumour, and in different locations to one another. When examining 
at a higher resolution, CD3 cells with differing morphology were seen – with some exhibiting 
rounder (arrows) while others displaying more elongated shapes (arrowheads). This is 
potentially indicative of the different T cell subsets and activation status (Negulescu et al., 








Figure 3.2.2.6 SeeDB optical clearing to examine immune infiltrate in 
TUBO mammary tumours  
TUBO tumour fragments were cleared with the SeeDB optical clearing protocol and 
stained for DAPI, CD11b for myeloid cells, HER2 for tumour cells and CD3 for T cells. 
Images show maximum intensity projections, with individual channels, merge and 
magnified views (inset). Staining for CD3 reveals T cells with differing morphology, with 
some displaying an elongated shape (arrowhead) whereas others have a more rounded 
shape (arrows). 
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3.2.2.2 Optical clearing in human tumour samples and ex-vivo models 
Whether CUBIC-based optical clearing could be used in human tumours – specifically, to 
investigate collagen involvement in carcinogenesis – was also tested (Hume et al., 2018a). In 
order to see if optical clearing could be used in the context of human tumours whilst also 
preserving the collagen architecture, a biopsy from an ER+ breast tumour was cleared using 
CUBIC R1a. This resulted in substantial optical transparency, with no noticeable differences 
in size (Figure 3.2.2.7a) (Hume et al., 2018a). The tumour fragment was then stained for K8 
and ER and imaged using 2-photon (2P) excitation microscopy, with the non-linear imaging 
method second harmonic generation (SHG) used to specifically detect collagen without the 
need for staining (Chen et al., 2012). In doing so, anisotropic collagen fibres could be observed 
running horizontally between ER+/K8+ epithelial cells (Figure 3.2.2.7b), mirroring what has 
been seen in traditional 2D FFPE sections (Hume et al., 2018a).  
 
An anisotropic collagen I-based 3D scaffold co-culture method had been previously developed 
in the laboratory for culturing both human breast cancer cell lines and ex vivo tumours 
(Campbell et al., 2017). This was expanded to more accurately recapitulate the human breast 
microenvironment, by using immortalised human mesenchymal stem cells (hMSC) isolated 
from breast reduction mammoplasties to provide an adipogenic environment (Hume et al., 
2018a). Scaffolds seeded with the immortalised hMSC were differentiated into adipocytes and 
after fixation and immunostaining CUBIC optical clearing used. Samples were imaged again 
using 2P fluorescence microscopy with SHG for collagen I detection, in addition to coherent 
anti-stokes Raman spectroscopy (CARS), with the input signal adjusted for lipid detection (Le 
et al., 2009). This showed attachment of the hMSC’s to collagen I pores, with a CARS signal 
on the perilipin+ vesicles (Figure 3.2.2.7c). Together, this shows that CUBIC-based optical 
clearing preserves collagen architecture in human tumour samples, as well as the relatively 
more delicate architecture of the scaffolds, in addition to maintaining the lipid vesicles (Hume 
et al., 2018a).  
 
  




Figure 3.2.2.7 CUBIC optical clearing in human tumours and collagen co-
culture models 
(A) Use of CUBIC optical clearing in a human ER+ tumour biopsy resulted in excellent 
transparency. (B) Following CUBIC clearing, tissues were stained with fluorescent 
antibody-based staining using K8, ER and DAPI then imaged using 2-photon microscopy, 
combined with second harmonic generation to image collagen fibres. Images show optical 
sections throughout the tumour, with z values listed. (C) A collagen and immortalised 
human mesenchymal stem cell model for adipogenesis was tested. After using CUBIC 
clearing, scaffolds were stained for DAPI and perilipin, with second harmonic generation 
to image collagen and coherent anti-stokes Raman spectroscopy (CARS) to image lipid 
vesicles. 




3.2.3 Combing optical clearing with other microscopy methods 
Recent optical and computational advances have bought about an increase in microscopy 
options. Many of these are applicable to imaging of wholemount tissues due to the ability to 
optically section tissues. Although the use of confocal microscopy worked well with the 
aforementioned optically cleared samples and is often an accessible microscopy method, we 
wished to also investigate the utility of other microscopy techniques, and the compatibility of 
the clearing protocols was tested with these. 
 
3.2.3.1 Two-photon excitation microscopy 
The first alternative imaging method assessed was 2P excitation microscopy. This allows for 
deeper imaging penetration due to the longer wavelengths used in comparison to confocal – 
a useful utility when imaging wholemount tissue. This also results in other benefits such as less 
light scattering, leading to reduced out-of-focus photobleaching as well as faster imaging 
speeds. To asses 2P microscopy, we imaged a SeeDB-cleared tumour stained with Her2 and 
DAPI. We achieved imaging depths of approximately 1.2 × 1.2 × 0.1 mm of tissue in less than 
15 minutes per individual channel (Figure 3.2.3.1). Both the speed and imaging depth was 
superior compared to confocal microscopy. However, when imaging multiple channels, 2P 
microscopy presented issues with spectral bleed through and as such resulted in less utility 
compared with the ease of imaging up to 4 channels on confocal, as standard.  
 
  




Figure 3.2.3.1 SeeDB optical clearing and 2-Photon excitation microscopy in 
murine TUBO tumours  
TUBO tumours were immunostained with HER2 (green, left) DAPI nuclear staining (blue) 
and imaged using 2-Photon excitation microscopy. Example images show maximum 
intensity projections, with magnified views (inset) and optical slices (2 μm) and their 
corresponding depth (z value) relative to the first image in the image sequence (bottom 
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3.2.3.2 Light sheet fluorescence microscopy 
The second alternative imaging technique assessed was light sheet fluorescence microscopy 
(LSFM). Here, a laser light sheet is used to illuminate only a thin slice of the sample, which 
reduces both photobleaching and background signal due to the increased optical sectioning 
capabilities. Additionally, due to the fact that samples are scanned using a plane of light (as 
opposed to a point, or pinhole, in confocal), image acquisition speeds can theoretically be up 
to 100-1000 times faster than point-scanning methods (Pitrone et al., 2013).  
 
One important aspect of LSFM, where it differs from confocal, is the requirement for sample 
mounting. Unlike confocal, where the objectives are either above or below the sample, in the 
OpenSpim LSFM system used, the objectives and illumination comes from the side (Pitrone et 
al., 2013). As such, the samples require mounting in order to be suspended in the imaging 
chamber. One way to do this is to embed the tissue in agarose gel within a syringe, that can 
be suspended into the imaging chamber, surrounded by the objective media (schematic shown 
in Figure 3.2.3.2). This therefore requires optimisation and adaptation for use with the optical 
clearing protocols to ensure that the matched refractive index is maintained between the 
sample, agarose, objective media and objective.  
 
The first optical clearing protocol we tried with LSFM was SeeDB, due to its compatibility 
with fluorescent antibody staining. Tissue was put through the usual SeeDB clearing process 
and then suspended in a 1% w/v agarose solution in the syringe tube. However, the 
transparency of the tissue was lost due to the exchange of fructose into the agarose, and the 
water content returning to the tissue. Therefore, the agarose roll containing the tissue then 
required incubation with the fructose solutions again, which resulted in a lengthy process. 
 
To combat this, we decided to combine the fructose solutions with the agarose to maintain a 
fructose concentration and limit the exchange of water and fructose. However, even at low 
fructose and agarose concentrations, the resulting gel became more solid and brittle. This lack 
of mailability presented technical issues when mounting in the small syringe system. Moreover, 
when imaging the tissue on the LSFM, the fructose/agarose gel appeared to reflect the light, 
thus preventing the tissue from being imaged. The reason for this could be due to the chemical 
structures of fructose and agarose monomers. When combined, these are able to form 
hydrogen bonds and produce a polymer, with a reduced elastic modulus (Nishinari et al., 1994; 
Maurer et al., 2012).  




Therefore, we opted to try the combination with PACT-sRIMS, due to the fact that this also 
involves clearing with detergents, and as such does not only rely upon RI homogenisation to 
optically clear. Moreover, the sRIMS solution is very economical and can be used in the large 
quantities that are required for the imaging chamber. When combining agarose with sorbitol, 
the resulting gel both maintained the transparency of the tissue and was more amenable to 
tissue mounting than the stiff fructose/agarose gel.  
 
We also combined CUBIC tissue clearing with LSFM. For this, tissue was cleared using the 
standard CUBIC protocol, staining with SMA and then mounted in agarose. Unlike SeeDB 
clearing, the tissue remained transparent, presumably due to CUBIC using detergents to 
optically clear and not relying only on RI matching. Using CUBIC R2 in the imaging chamber 
for a consistent refractive index allowed imaging of early gestation mammary gland tissue 
(Figure 3.2.3.3a) with a total depth of 800m. Moreover, 0.8 x 0.8 x 1.5 mm of CUBIC-cleared 
normal virgin mammary tissue was imaged (Figure 3.2.3.3b), at acquisition times of less than 5 
minutes per individual channel. Together, this highlights the importance of sample preparation 
in LSFM. However, although both imaging speeds and depths were superior to both confocal 
and 2P fluorescence microscopy, the time involved in sample preparation and optimisation 
meant that LSFM did not provide any benefits over confocal microscopy for routine imaging 
of the virgin mammary gland. 
  




Figure 3.2.3.2 Schematic diagram of light sheet microscopy imaging set up 
The optically cleared tissue is embedded in a low concentration agarose solution and 
placed in an adapted syringe. When ready to image, the agarose/tissue is then expelled 
into the imaging chamber which contains RI-matched solution (such as CUBIC R2). This 








Figure 3.2.3.3 CUBIC optical clearing and light sheet fluorescence 
microscopy in the mammary gland 
Early gestation (approximately day 5) (A) and virgin mammary gland (B) tissues were 
immunostained with SMA and cleared using CUBIC optical clearing. Using CUBIC R2 
solution in the imaging chamber, tissues were imaged using light sheet fluorescence 
microscopy. Example images show maximum intensity projections of early gestation 
mammary gland (A), and virgin tissue (B), with “BV” and arrows denoting SMA-
expressing blood vessels. 




3.2.4 Other applications of optical clearing methodologies  
 
3.2.4.1 Liver 
We decided to investigate the utility of optical tissue clearing in other systems. One tissue 
selected was the liver. Here, CUBIC, sRIMS and seeDB based clearing were compared. Due 
to the increased thickness of liver tissue compared to the mammary gland, liver tissue was 
sectioned using a vibratome into 400µm and 1000µm slices. Out of the protocols, CUBIC 
clearing was found to be the most beneficial, presumably due to the high haem content in the 
liver, and the pigment removal that CUBIC provides. The original CUBIC protocol was tested 
(Figure 3.2.4.1a )in addition to a recent addition, termed CUBIC L/R (Figure 3.2.4.1b) (see 
discussion). Both resulted in significant pigment removal and optical clarity, which allowed 
wholemount imaging using confocal microscopy with co-staining using antibodies for the 
structural protein osteopontin which marks ductal cells (Figure 3.2.4.1c) 
  




Figure 3.2.4.1 CUBIC-based optical clearing in murine liver tissue 
Liver samples were sectioned to 400µm and 1000µm and cleared with either (A) 
CUBIC R1/2 or (B) CUBIC L/R. (C) CUBIC R1/2 samples were then stained for 
oestopontin and Hoechst and imaged using confocal microscopy. Images show 
representative maximum intensity z-projections with magnified region of interest.  
 
  




Altogether, the data presented in this chapter shows that optical tissue clearing can be 
successfully applied to study the mammary gland, both in homeostasis, during periods of 
development and lactation, in addition to in tumours of both the moue and human mammary 
gland. By assessing the leading protocols for use in the mammary gland, we have highlighted 
that not all optical clearing methods will work in every tissue. Moreover, these studies 
emphasise that some clearing protocols may be best suited to specific tissue types, with 
adaptation based on both the tissue in question and the microscopy technique used. For use 
in the mammary gland, this work concludes that SeeDB and CUBIC (specifically, the later 
published R1a protocol) are most suited for use in the mammary gland. An overview of the 
methods tested in the mammary gland is summarised in Table 1.  
 
3.3.1 SeeDB optical clearing  
Sucrose solutions have been previously used to reduce light scattering (Tsai et al., 2009). 
However, the authors of the original SeeDB protocol found fructose to be beneficial over 
other sugar solutions or water-based clearing agents – being both highly soluble in water, 
having a higher refractive index and causing less tissue shrinkage (Ke et al., 2013). One of the 
stated benefits of SeeDB is the preservation of fragile tissue architecture, such as dendrites in 
the brain. This also appears to be the case in the mammary gland, with preservation of fine 
features such as the striations of SMA in the basal cells remaining highly visible. Moreover, 
most antibodies tested worked with SeeDB clearing, suggesting that the protocol does not 
affect protein quality and epitope structure. 
 
However, the downside to this gentle nature of SeeDB means that often the imaging depth is 
relatively limited compared to other protocols. This is especially true in the virgin gland, 
whereby the high proportion of adipocytes to epithelial components requires imaging through 
up to approximately 300m of fat before reaching the ductal network. This is compounded 
by the fact that most commercially available and inbuilt imaging objectives have both short 
working distances, in addition to being built with the RI of air, water or oil in mind, which can 
result in spherical aberrations. However, the availability of specially manufactured objectives, 
as was developed and used in the original research protocol, which is matched to the RI of 
SeeDB, will allow for better compatibility with SeeDB optical clearing in the future. 
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3.3.2 CUBIC optical clearing  
This work has shown that optical clearing using the CUBIC protocol is also highly compatible 
with the mammary gland. Despite being a reasonably simple, immersion-based protocol, we 
found excellent results in terms of both transparency and adaptability with microscopy 
techniques. However, one of the downsides found is the high level of background fluorescence 
seen, in addition to the reduced compatibility with some antibodies. Given that R2 contains 
50% w/v sucrose, it may be that the Maillard reaction has a role to play in this, due to the 
interaction between the high level of sugar and proteins in the tissue. This could cause the 
formation of fluorescent by-products and reduction in protein quality (Dills, 1993) – both 
factors seen in CUBIC cleared tissue. As such, the inclusion of -thioglycerol, as in used in 
SeeDB, may be beneficial in inhibiting the Maillard reaction and therefore reducing these 
subsequent issues.  
 
We also used CUBIC and SeeDB for analysis of tumour infiltrate in 3D using optical clearing 
methods. This showed that these are viable methods for assessing tumours, which may be 
particularly important with the increase in immunotherapies for breast cancer. Recent 
optimisations and advancements of the CUBIC protocols may also provide even better optical 
tissue clearing solutions, for both normal tissues and other aspects of cancer research (Kubota 
et al., 2017; Tainaka et al., 2018). Using a similar chemical screen as was done in the original 
work, the authors have recently described the addition of CUBIC-L, which has been specially 
designed for de-lipidation. When combined with CUBIC-R, for refractive index matching, 
entire adult mice were able to be imaged to study cancer metastasis (Kubota et al., 2017) – 
providing further utility for optical clearing in cancer research.  
 
Recently, further work has helped better understand the chemical properties required for 
successful optical tissue clearing. Consequently, an additional 5 CUBIC protocols have been 
presented, which are adaptable depending on required use. By combining 6 different CUBIC 
cocktails, users can develop a method based on the tissue used and required role – for 
example, de-lipidation, decolourisation, decalcification and refractive index matching (Tainaka 
et al., 2018). This highlights the possibility for combining different protocols and the 
importance of adapting methods based on the tissue type and research question. 
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3.3.3 Other clearing methods not tested 
We also wanted to test an optical clearing protocol that utilises hydrogel embedding. Despite 
the relatively harsh treatment used in the PACT protocol, with high SDS concentrations used, 
most antibodies worked quite well. This could suggest that using hydrogel embedding is 
beneficial in stabilising tissue when applying optical clearing in the mammary gland. Although 
not tested here, it may be that applying a hydrogel embedding step prior to optical clearing 
methods which were not compatible, such as 3DISCO, would stabilise the tissue and result in 
a better outcome. Moreover, given that it is not feasible to carry out antigen retrieval methods 
on wholemount tissues, as is done on FFPE tissues, this makes it more susceptible to under- 
or over- fixation issues and subsequent reduction in protein and epitope quality. The addition 
of hydrogel embedding as the first step in other optical clearing protocols may be a useful 
addition to solving this issue.  
 
The use of an organic solvent-based clearing protocol was also tested. Optical clearing with 
the 3DISCO protocol resulted in the excellent transparency of the tissue, and in less time in 
comparison with the other protocols. However, the quenching of endogenous fluorescence 
limited its future use in the mammary gland. Moreover, the significant shrinkage of the tissue 
and subsequent effects on the tissue integrity meant it was not compatible with the mammary 
gland.  
 
However, a recent amendment of the 3DISCO protocol, “ultimate DISCO” (uDISCO), has 
been published, which utilises a different combination of solvents for better preservation of 
fluorescent signal (Pan et al., 2016). Moreover, uDISCO actually takes advantage of the tissue 
shrinkage caused by the 3DISCO protocol, allowing for imaging of larger volumes in a single 
scan - thus avoiding issues with sectioning and mosaic imaging. Use of uDISCO in an adult 
mouse brain resulted in a 55% reduction in tissue size, whilst preserving individual cell and 
vascular morphologies. Importantly, the new solvents included the addition of an antioxidant 
(α-tocopherol, or vitamin E), resulting in endogenous fluorescence being preserved over many 
weeks. If the use of uDISCO allowed for better preservation of tissue integrity than 3DISCO, 
the shrinkage of tissue and subsequent ability to image larger regions of the ductal network 
would be very beneficial. If the gland was reduced in size at the same proportions seen in the 
brain, it would also likely allow for imaging through the entire gland, from top to bottom.  
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Conversely, other recent protocols have utilised the increases in tissue size seen in optical 
clearing, resulting in the development of expansion microscopy (Chen et al., 2015; Murakami 
et al., 2018). Traditional optical microscopy is limited in its resolution to approximately 200 
nanometers (nm), meaning that objects separated by less than half the wavelength of visible 
light cannot be separated (Simpson, 2006). As such, it is not possible to resolve anything below 
this diffraction barrier limit. In expansion microscopy, the expansion of the tissue is taken 
advantage of, by introducing a polymer network which can be subsequently swollen, increasing 
the tissue size with it (Chen et al., 2015). This allows for the capture of small nanostructures 
in the tissue that are not otherwise possible to image. This technique has enabled the imaging 
of objects at 70nm in both cultured cells and brain tissue, and even single molecules of RNA 
using fluorescent in situ hybridization (Chen et al., 2016).  
 
In a similar manner, the CUBIC-X expansion microscopy and tissue clearing protocol utilised 
a combination of hyperhydration and subsequent gel embedding for the expansion of cleared 
adult mouse brain by 10-fold. This allowed subcellular imaging throughout the entire brain and 
lead to the development of the CUBIC-atlas – a mouse brain map with single cell annotation 
(Murakami et al., 2018). Although this was beyond the scope of the current work, the use of 
expansion microscopy in the mammary gland could be useful in providing new insights into 
the smaller details of the gland, such as investigating cell shapes and junctions. However, given 
the current limits brought about by imaging whole tissues, this would also require both more 
microscopy adaptation and data storage solutions to be developed. 
 
3.3.4 Other microscopy methods not tested 
The recent advances in microscopy have also bought about the opportunity to use optical 
clearing to enable imaging of whole organs. Here, we combined confocal, 2P and light sheet -
fluorescence microscopy with optical clearing methods. However, all of these microscope set-
ups have a certain level of adaptable configuration and as such, may result in different outcomes 
when tested in different settings or on different systems. 
 
A key example of this is LSFM, with the open source system used, OpenSPIM, which allows 
for a high degree of adaptability depending on the required results (Pitrone et al., 2013). The 
set up tested here uses an immersion-based imaging chamber, and as such, some of the issues 
with compatibility with LSFM was due to the more complicated mounting methods required 
when compared to confocal. Moreover, the nature of the system also presents issues 
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regarding data storage due to the large file sizes that are the result of imaging such large tissues. 
There are a number of other microscopy systems that were outside the scope of this work, 
that would be compatible with optical clearing, including optical projection tomography. 
 
3.3.5 Conclusions  
This work has highlighted the compatibility of using optical tissue clearing for imaging the 
mammary gland, in situ and in 3D. These protocols can be utilised in future work in order to 
provide new insights into mammary gland development and were used for further work in this 
thesis. 
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Table 1 Comparison of optical tissue clearing methods in the mammary gland. 
 
Method Overview RI Clearing 
capability 






Uncleared No clearing  − − 1 day Preserved Preserved Compatible No Possible − 





1.45 Weak 10 days 
Preserved, mild 
expansion 




















1.49 Moderate 5 days 
Preserved, mild 
shrinkage 
Preserved Compatible Nof Confirmed Ke et al. 2013 
 
aDuration from the time of tissue harvest (includes fixation time typically 6–16 hours for mammary tissue, but not antibody staining). bThe fluorescence signal is rapidly quenched 
using benzyl alcohol benzyl benzoate (BABB) and a specialised imaging chamber is required for dibenzyl ether (DBE). cLikely to be compatible, but not tested in this study. dThis is 
improved by using the second-generation protocol using Reagent 1A.  eSome antibodies (i.e. E-cad, K8 and HER2) do not perform as well using the R1 protocol. This can be improved 





Chapter 4   
Neutral lineage tracing in the mammary 
gland for studying development, 
homeostasis and stem cells.





Unlike most organs, development of the mammary gland is a multistage process that occurs 
over several developmental stages, with the majority of development occurring postnatally. 
Once fully formed, it does not remain quiescent as both oestrous and pregnancy induce 
multiple cycles of expansion and regression throughout the reproductive life of female 
mammals. As such, the mammary gland represents a unique organ to study adult stem cells 
and their contribution to tissue development, maintenance and remodelling. The mouse is 
widely used to model mammary developmental mechanisms due to the functional similarities 
between the mammary tissue of both human and mouse, in addition to its amenability to 
complex genetic manipulations. 
 
4.1.1 Mammary gland development  
During mouse embryonic development, mammary placode formation is initiated at 
approximately embryonic day (E) 10.5, with the formation of two so-called milk lines from the 
overlying ectoderm (Propper et al., 2013). This is followed a day later with the asynchronous 
appearance of five pairs of placodes at specific and symmetric locations between the fore- and 
hindlimbs by E11.5 (Lloyd-Lewis et al., 2017). These develop asynchronously and invaginate to 
result in the formation of the mammary bud by E13.5, which evolves in to an epithelial tubular 
sprout by E15.5-16.5. The tubular sprout then invades the underlying mammary fat pad 
precursor which initiates the first phase of branching morphogenesis, culminating in the 
development of the primordial ductal tree by E18.5 (Howard, 2012).  
 
From this point and during the weeks immediately after birth, growth of the ductal tree is 
isometric with body growth. However, the emergence of ovarian hormones during puberty 
then causes the second stage of ductal morphogenesis in the mammary gland. This ovarian 
hormone signalling combined with local growth factors in the microenvironment returns the 
gland to a highly dynamic state, whereby the rudimentary ductal structure expands to fill the 
fat pad, driven by cell proliferation in the TEBs (Watson and Khaled, 2008). These structures 
are present at the tip of ducts and comprise an outer layer of cap cells and a multi-layered 
inner core of body cells which form the two main cell lineages of the mammary epithelium, 
basal and luminal epithelial cells, respectively (Tiede and Kang, 2011). After branching 
morphogenesis is complete, the virgin mammary gland is thought to remain largely dormant, 
Chapter 4 - Introduction 
94 
 
with brief pulses of branching and alveolar budding and collapse in response to hormonal cues 
with each oestrous cycle. 
 
The mammary gland undergoes another stage of branching morphogenesis, when it completely 
changes form again during pregnancy. Here, multiple signalling pathways are activated to 
orchestrate an unprecedented amount of proliferation during the process of alveologenesis. 
During lactation oxytocin is induced by suckling which stimulates the contraction of alveolar 
basal cells to expel milk from the lumen. When this ceases and the young are weaned, post-
lactational regression of the mammary gland, known as involution, occurs, marked by 
extensive cell death of secretory alveoli (Kreuzaler et al., 2011), which returns the mammary 
gland to a structure akin to the nulliparous state (Watson, 2006). 
 
4.1.2 Lineage tracing in the mammary gland 
Use of lineage tracing to define stem cells is an oft-used technique with the advent of mouse 
genetic modification. Mouse models are engineered to express reporter proteins, often 
fluorescent or colourimetric, that are driven by pre-specified promoters for specific, pre-
defined lineages. Once the reporter protein is induced in a cell, that cell and all of its daughters 
will harbour the genetic mark. If the cell marked is a stem or progenitor cell then this allows 
for the tracking and fate mapping of its progeny. The use of lineage tracing in many other 
tissues has allowed for a conclusive description and identification of adult stem and progenitor 
cell populations involved in tissue development, homeostasis, and even carcinogenesis.  
 
In the mammary gland, the first inducible lineage tracing study challenged prevailing work on 
the contribution of multipotent MaSCs to postnatal gland development (Van Keymeulen et al., 
2011). Using an inducible Cre recombinase driven by K14/K5 or K8/K18 promoters, basal and 
luminal cells and their progeny could be labelled, respectively. When inducing tracing 
postnatally, unipotent cells were traced throughout the different stages of development, 
suggesting that unipotent, rather than bipotent, stem cells drive development and homeostasis 
in the postnatal mammary gland (Van Keymeulen et al., 2011). Moreover, when the 
differentiation potential of both epithelial lineages was determined using transplantation assays 
it was demonstrated that label-positive basal cells, but not luminal cells, were capable of 
reconstituting a mammary gland, in line with previous findings that originally identified 
multipotent basal MaSCs. In turn, this strongly supports the notion that the experimental 
context of transplantation forces de-differentiation and reprogramming of basal MaSCs into 
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both epithelial lineages due to the non-homeostatic regenerative conditions. Conversely, in 
the intact gland in vivo only lineage-restricted unipotent stem cells appear to exist. 
 
Controversially, more recent studies using similar methodologies have once again disputed 
the unipotent hypothesis and instead provided further evidence in favour of the original 
paradigm for the existence of bipotent stem cells in the adult mammary gland (Rios et al., 
2014; Wang et al., 2015). Bipotent MaSCs were traced at a clonal level in situ and this study 
demonstrated that basal-labelled cells generated both cellular lineages, were long lived, and 
contributed not only to the major stages of morphogenesis in the postnatal gland but also in 
ductal tree maintenance during adult homeostasis(Rios et al., 2014). Since, another study has 
also provided evidence for the existence of unique, multipotent MaSCs that are marked by 
the expression of protein C receptor (Procr), a novel Wnt signalling target in the mammary 
gland (Wang et al., 2015). However, a key limitation of this approach is the reliance on 
promoter driven reporter expression, leading to assumptions regarding the molecular identity 
of MaSCs and progenitors, which therefore lends itself to bias and limitations in the cells that 
can be traced. Criticisms have also arisen when tamoxifen is used to induce promoter driven 
reporter expression (Asselin-Labat et al., 2010). 
 
4.1.3 Role of mammary stem cells  
Consequently, the remarkable capacity of the mammary gland for rapid growth and 
regeneration through multiple cycles of oestrus and pregnancy has been attributed to the 
existence of adult mammary stem cells (MaSCs). Although the identification and 
characterisation of these putative stem cells is a highly dynamic area of research that has 
extended over 60 years, there remains significant controversy and dispute regarding the 
number, molecular identity, anatomical location and hierarchy of these elusive adult MaSCs. 
 
As a result, there are now two main schools of thought regarding the identity of MaSCs. The 
first, largely brought about through lineage tracing experiments, suggests that each of the main 
cell types is derived from their own unipotent, lineage-restricted stem cell (Van Keymeulen et 
al., 2011; Wuidart et al., 2016; Scheele et al., 2017). The second hypothesis suggests that 
bipotent MaSCs do exist, and are able to give rise to both luminal and basal cell lineages (Rios 
et al., 2014); as supported by the ability of single cells to repopulate both lineages in a cleared 
mammary gland. While both transplantation and lineage tracing approaches have suggested 
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potential MaSC populations, they have also revealed a number of conflicting results and 
conclusions.  
 
4.1.4 Aims of this chapter 
The main aims of this chapter are to characterise the requirements for adult MaSCs during 
normal tissue development of the mammary gland; during embryogenesis, at puberty and 
during maintenance of the mature gland, and finally during lactation. This information will be 
used to elucidate the identity, number, lineage potential and location of adult stem cells in the 
mammary gland. This will first be investigated during pubertal development, when MaSCs are 
functionally active, and this information will be used to inform subsequent investigations in the 
developed adult gland. 
 
Due to the inherent biases of these two approaches discussed above, a neutral way to assess 
stem cell dynamics in a physiological context, that makes fewer prior assumptions and can be 
interpreted at various stages of development, is required to resolve the long running debate 
on the MaSC hierarchy. Consequently, we will combine two novel neutral lineage tracing 
models to unequivocally define the mammary stem and progenitor cells throughout the stages 
of mammary gland morphogenesis and homeostasis – embryogenic, pubertal, gestation and 
adult homeostasis.  
 
Unlike many other adult organs, there are no definitive markers for MaSCs that can be utilised 
for lineage tracing. As such, and to avoid any bias, a combination of neutral approaches was 
employed to trace single cells using two mouse models. In the first, utilisation of a [CA]30 
cassette allows for stochastic labelling of single cells to reveal the active contribution of single 
stem/progenitor cells to the developing gland. This approach relies on the inherent instability 
of microsatellite repeats, resulting in “slippage” during replication to label rare cells. 
Accordingly, this leaves an indelible mark on the cell and, if this is a stem/progenitor cell, all of 
its progeny will also be marked. Importantly, genetic labelling in this model is exceedingly rare, 
thereby allowing the fate of a single-labelled cell to be traced with a high degree of confidence. 
This “slippage” event has previously been reported to occur at a rate of 1/17,000 cell divisions 
within the intestine and murine embryonic fibroblasts (Kozar et al., 2013). 
 
However, the ability to time the initiation of tracing and to enable marking of quiescent cells 
necessitates the use of a second model. For this, R26R-Confetti mice will be employed (Livet 
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et al., 2007; Snippert et al., 2010). In a similarly neutral approach to the R26[CA]30 model, the 
confetti model traces cells expressing a reporter from the ubiquitous Rosa26 promoter, with 
the benefit of a multicolour reporter that aids with the distinction of individual clones. The 
construct contains two tandem invertible DNA segments; upon administration of tamoxifen, 
Cre recombinase (also expressed from the Rosa26 promoter) is translocated to the nucleus 
and removes the loxP flanked ‘STOP’ roadblock. Subsequent stochastic inversion and excision 
recombination events create four random expression possibilities (nuclear green fluorescent 
protein (GFP), cytoplasmic yellow fluorescent protein (YFP), cytoplasmic red fluorescent 
protein (RFP), or membrane-bound cyan fluorescent protein (CFP)). Cells will thus be marked 
at random in one of four colours. 
 
Proposed MaSC identities are often derived from FACS sorted cells, which removes important 
spatial information and has been shown to be affected by the dissociation process (Shehata et 
al., 2012). Alternatively, identity is sourced from lineage tracing data visualised using 2D 
sections and may not accurately reflect the true nature of the heterogeneous gland. To resolve 
this, optical tissue clearing methods developed in the previous chapter will be utilised. Thus, 
optical clearing permits the visualisation of mammary tissue to a level that has not been 
previously achievable, while retaining the fluorescence (or colourimetric) signal and important 
spatial information.  
 
4.1.5 Importance  
The mammary gland provides a unique opportunity to investigate epithelial development 
extra-embryonically that is not available in other tissues. Moreover, study of maintenance and 
turnover of this organ has important implications for other epithelial systems. 
 
Elucidation of the normal MaSC hierarchy also has important implications for understanding 
the biology of the mammary gland in pathological conditions. The heterogeneity of breast 
cancer is complex and although there is now an increased understanding of molecular and 
pathological subtypes (Visvader, 2009; Pece et al., 2010), there is still much work required to 
get closer to understanding the cell(s) of origin of breast cancer. Given the proposed longevity 
and suggested ability of MaSCs to survive multiple waves of cell death in involution, they 
represent a logical candidate for a potential cell of origin of breast cancer (Howard and 
Veltmaat, 2013). Reponses to treatment are still highly unpredictable and the hope is that 
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better stratification of breast cancer can improve response to therapy and may lead to the 
development of more targeted therapies (Pfefferle et al., 2015).




4.2.1 Tracing embryonic mammary stem cells 
 
4.2.1.1 R26[CA]30 SYNbglA 
Previous work investigating development of the mammary gland has suggested that the stem 
cells involved in the formation of the embryonic mammary rudiment are multipotent (Van 
Keymeulen et al., 2011; Spike et al., 2012; Boras-Granic et al., 2014; Rodilla et al., 2015; Wang 
et al., 2015). This has been shown using both transplantation assays, in addition to more recent 
work using genetic lineage tracing models. However, despite the volume of work there is still 
much disparity regarding both the molecular identity and differentiation potential of embryonic 
mammary stem and progenitor cells (Wansbury et al., 2011). The first model we used to 
investigate embryonic MaSCs was the R26[CA]30 beta-glucosidase (SYNbglA) model. 
 
The R26[CA]30 model exploits the inherent instability of microsatellite repeats to cause 
spontaneous, random frame shift mutations during DNA replication. For this, a [CA]30 
dinucleotide repeat tract is placed upstream of an out-of-frame reporter cassette (a modified, 
thermophillic SYNbglA) (McCutcheon et al., 2010; Kozar et al., 2013). During DNA 
replication, a mismatch repair (or “slippage”) of the reading frame can randomly occur, 
potentially moving the reporter in-frame and thus triggering constitutive reporter expression 
in the “slipped cell” from the R26 locus (Figure 4.2.1.1a).  
 
Accordingly, this leaves an indelible mark on the cell and, if this is a stem/progenitor cell, all of 
its progeny will also be marked. Importantly, genetic labelling in this model is exceedingly rare, 
thereby allowing the fate of a single-labelled cell to be traced with a high degree of confidence. 
If the slippage occurs during embryonic development, then this allows for tracing of stem or 
progenitor cells from this point onwards. The SYNbglA reporter, combined with CUBIC 
optical clearing and co-staining with methyl green (outlined in chapter 2), allows wholemount 
imaging and identification of clonal structures at a macroscopic scale, in relation to the entire 
gland.  
 
Hence, we sought to investigate labelling events at 7 weeks of age, at the end of pubertal 
development of the mouse. The approximate timing of the slippage event can be inferred from 
the location of the labelled cells relative to the nipple, since the exact timing cannot be 
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determined in the R26[CA]30 model. At the start of puberty, the ductal tree develops 
approximately 1mm proximal from the nipple region, expanding outwards into the fat pad. 
Therefore, using this predictable developmental process it was assumed that slippage had 
occurred in a stem or progenitor cell postnatally if clones were observed proximally from this 
point (Paine et al., 2016). 
 
Using this model, a number of SYNbglA positive regions were seen, with variable clone size. 
Interestingly, labelled cells were often intermixed with unlabelled cells (Figure 4.2.1.1b), 
presumably from the progeny of an unlabelled stem or progenitor cell, suggesting the presence 
of multiple cells that contribute to ductal expansion. Some of these labelled regions contained 
large clones of cells, occupying multiple ducts in the developing gland - likely having arisen 
from a highly proliferative MaSC. In one particularly rare situation, uniform labelling occurred 
in all cells, which was seen in multiple tissues examined, including both the mammary gland 
and the intestine (Figure 4.2.1.1c), presumably due to slippage occurring in very early on in 
embryogenesis or even in a germ cell. Nonetheless, the majority of labelled regions seen were 
relatively small, presumably developing from a recent frame-shift mutation or from strand 
slippage in a restricted progenitor or differentiated cell.  
 
However, in one case a large clone was observed encompassing more than 10 mm of the 
ductal tree, and appearing to begin at the nipple (Figure 4.2.1.2a, asterisk denoting nipple). 
Interestingly, this appeared to be comprised of labelled basal regions in close proximity to 
ducts with luminal clones. In order to more accurately identify the lineage of labelled cells we 
therefore carried out traditional 2D immunohistochemistry using DAB co-staining for lineage 
markers, which allows for accurate single cell resolution for lineage determination. This 
confirmed what was seen on the wholemounts, with both basal (Figure 4.2.1.2b) and luminal 
clones (Figure 4.2.1.2c) detected in the two regions. The expansive size of this clone combined 
with the starting location at the nipple region of the mammary gland may suggest that a 
bipotent MaSC was labelled at some point during embryogenesis. Although definitive 
confirmation is problematic, one hypothesis is that this bipotent embryonic MaSC could have 
then given rise to both a luminal and basal daughter cell that was deposited along the expanding 
ductal tree to later generate the lineage-restricted progeny during postnatal development. 
 
On another occasion, we detected a fourth mammary gland that was comprised of a high 
proportion of SYNbglA labelled cells (Figure 4.2.1.3a). The vast density of labelling (Figure 
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4.2.1.3bi,ii,ii) meant lineage was difficult to distinguish and so again DAB lineage staining was 
carried out using 2D immunohistochemistry. Markedly, in contrast the other large clone the 
majority of labelled cells observed were of the luminal lineage (Figure 4.2.1.4). This suggests 
that even during very early embryogenesis of the mammary gland, MaSCs can display a degree 
of lineage bias and as such are not all bipotent.  
 
  




Figure 4.2.1.1 R26[CA]30 SYNbglA tracing in the embryonic mammary gland 
Diagram of the transcript of the R26[CA]30 SYNbglA model. Random indels during DNA 
replication result in expression of the SYNbglA reporter, driven by the ubiquitous 
Rosa26 promoter. B) Multiple clones, marked by SYNbglA, can be seen when observing 
pubertal mammary glands. C) in one rare case, labelling of an embryonic germ cell 
resulted in uniform SYNbglA labelling in all cells, shown in the mammary gland and 
intestine (left and right, respectively)  
 
  




Figure 4.2.1.2 Clonal embryonic labelling in the R26[CA]30 SYNbglA model 
(A) A large clonal region visualised using stereomicroscopy, encompassing more than 10 mm of 
the ductal tree, labelled with SYNbglA and methyl green counter stain. Nipple denoted with 
asterisk. Labelled luminal and basal cells were observed in close proximity (arrowheads and 
arrows, respectively). Confirmation of lineage was carried out using immunohistochemistry with 
DAB staining for SMA, marking basal cells (B) and E-cad for luminal cells (C). 





Figure 4.2.1.3. Clonal embryonic labelling in the R26 [CA]30 SYNbglA model 
A) A large clone encompassing the majority of the fourth mammary gland, visualised 
using stereomicroscopy. B) Magnification of labelled regions shown throughout the gland, 
from the nipple region (ii) to the outer reaches of the fat pad (i and iii).  





Figure 4.2.1.4 Immunohistochemistry of R26[CA]30 SYNbglA clone shown in 
Figure 4.2.1.3. 
Sections were co-stained for lineage analysis of the clone, with E-cad or SMA (for luminal 
and basal cells, respectively). Labelled cells (purple) all expressed K8.  
  
Chapter 4 - Results 
106 
 
4.2.1.2 R26-Confetti  
The R26[CA]30 SYNbglA model allowed for unbiased investigation of proliferative MaSCs that 
arise in embryogenesis and contribute to ductal development in puberty, without the need for 
tamoxifen. Furthermore, the extremely rare mutation rate provides assurance that clones are 
the progeny of a single stem or progenitor cell. However, the stochastic nature of the model 
also means that the exact timing at which tracing began cannot be accurately known. 
Moreover, it is not possible to precisely discern lineage in situ using the SYNbglA colourimetric 
stain, and consequently requires subsequent 2D immunohistochemistry.  
 
We therefore sought to use a second unbiased approach for these reasons and to provide 
additional validation of the findings. Hence, the R26R-Confetti model was adopted. Similar to 
the R26[CA]30 model, the R26R-Confetti model traces cells with reporters expressed under the 
control of the ubiquitous R26 promoter (Figure 4.2.1.5a). With administration of tamoxifen, 
Cre is translocated to the nucleus and removes the loxP flanked roadblock resulting in the 
random expression of one of four reporters (Snippert et al., 2010) (Figure 4.2.1.5b). This 
model can also be combined with the 3D imaging developed in the previous chapter, which is 
devoid of proteolytic digestion, and fluorescent immunohistochemistry which allows for in situ 
co-staining with lineage markers. 
 
Accordingly, mice that were homozygous for R26Cre-ERT2 were bred with mice that were 
homozygous for R26R-Confetti (Figure 4.2.1.5a). The resulting progeny would therefore be 
hemizygous for R26CreERT2;R26R-Confetti, allowing lineage tracing following the 
administration of tamoxifen. Due to tamoxifen-mediated effects on oestrogen signalling, which 
can affect successful labour and result in pup mortality (Lizen et al., 2015), tamoxifen was 
delivered via oral gavage. Although tamoxifen is then is subject to the first-pass effect, resulting 
in reduced systemic bioavailability due to absorption by the liver (Rowland, 1972), this route 
of administration is reported to result in more uniform Cre-recombination due to systemic 
diffusion rather than a bolus dose given with intraperitoneal (I.P) injections  (Park et al., 2008), 
in addition to reduced pup fatalities (Lizen et al., 2015). As such, a single low-dose of tamoxifen 
(equivalent to 33μg per g of maternal body weight) was administered by oral gavage to 
pregnant mice on approximately E16.5-E17.5 to induce neutral labelling of the embryos in utero 
(Figure 4.2.1.5c).  
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To investigate the involvement of the progeny of stem or progenitor cells labelled during 
embryonic mammary development in pubertal mammary morphogenesis, labelling events in 
the mammary gland were investigated at 6 weeks post birth. In order to analyse the entire 
focal plane without enzymatic tissue digestion, CUBIC optical tissue clearing (outlined in 
chapter 2) was used to image wholemount glands using fluorescent immunohistochemistry 
and confocal microscopy. Glands were stained for the basal cell marker SMA and confocal 
microscopy used to image endogenous fluorescence (YFP, GFP, RFP and CFP). Importantly, 
ductal morphology was similar when compared to non-injected animals not exposed to low-
dose tamoxifen in utero (as seen in wholemounts in Figure 4.2.1.6). 
 
Using this approach, we were able to observe large regions of labelled cells, with some 
spanning from the nipple to the outer reaches of the fat pad (Figure 4.2.1.6,a-c). So as to 
investigate the labelling efficiency, we analysed the patterns of labelling events in regions either 
proximal or distal to the nipple. Labelled regions proximal to the nipple were always 
comprised of at least two colours (Figure 4.2.1.7.a). However, distal regions were more 
commonly comprised of single colours (Figure 4.2.1.8a,b). To quantify this, the number of 
single- and multicoloured branches in the regions proximal or distal to the nipple were 
counted. 100% of nipple regions observed were multicolour (Figure 4.2.1.8c,i), whereas only 
approximately 40% of distal branches contained more than one colour (Figure 4.2.1.8c,ii). This 
supports the notion that as the gland develops, progeny of MaSCs become diluted out in distal 
branches. However, this also highlights the potential of clone convergence, whereby the 
progeny from separate stem / progenitor cells are labelled in the same colour and thus are 
unable to be distinguished as separate clonal populations.  
 
Next, the lineage of labelled cells was investigated by observing labelled cell morphology and 
co-localisation with the basal cell marker, SMA. Mixed lineage, same-colour clones were 
occasionally observed in regions proximal to the nipple (Figure 4.2.1.7a, arrows), and to a 
lesser extent in distal regions (Figure 4.2.1.9a, arrows). These data support the previous 
hypothesis that embryonic MaSCs are multipotent and can contribute to both basal and luminal 
lineages. However, despite the high risk of clone convergence, single lineage clones were often 
observed in both distal and proximal regions of the ductal network.  
 
A nearest-neighbour analysis was therefore carried out to quantify this, whereby the lineage 
of the nearest cell was counted. Again, the location of labelling events was analysed in relation 
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to the nipple (proximal or distal) in order to determine when labelling occurred.  During 
expansion of the mammary gland during puberty, ductal elongation and side branching occur 
due to stem/progenitor cell proliferation within TEBs. As TEBs elongate, the progeny of these 
cells are dropped along the length of the developing ducts, with mixing of clonal progeny. 
Consequently, clones arising from labelling in both the embryonic and pubertal epithelium are 
thus not contiguous. Previously, proliferation was thought to exclusively occur in the TEBs 
(Wang et al., 2015; Scheele et al., 2017). However, work discussed in Chapter 5 of this thesis 
indicates that significant proliferation can also occur in the ductal region during pubertal 
development. Therefore, a method of clone analysis was carried out that did not exclude the 
possibility of ductal proliferation and took into account the bona fide 3D nature of the 
mammary epithelium.  
 
Briefly, z-projections of randomly selected 3D image stacks containing label-positive cells were 
created. For all cells within each region, the lineage of the closest same-colour neighbour was 
recorded as either ‘same’ or ‘different’ by manual scoring. GFP, YFP, RFP and far red channels 
were imaged for each image sequence. However, it is also important to consider that using 
this method, two luminal labelled cells counted as “same” may in fact be distinct labelling 
events derived from different precursor cells; as such, this model may over-represent the 
percentage of possible unipotent clones. Similarly, a luminal and basal labelled clone counted 
as “different” may also be from distinct labelling events and thus this model may also 
overrepresent the proportion of possible bipotent clones; however, this was extremely small 
in this study. 
 
This analysis showed that the majority of same-colour neighbours were in fact cells of the 
same lineage in both nipple regions and distal branches (Figure 4.2.1.9b,i and ii, respectively). 
This expands the finding seen with the R26[CA]30 SYNbglA model - namely that embryonic 
MaSCs may not all be bipotent at E16.5-17.5. Indeed, this is supported by recent work that 
suggests that even as early as E14.5, embryonic MaSCs can display lineage restriction (Lilja et 
al., 2018; Wuidart et al., 2018). 
 
  




Figure 4.2.1.5 Overview of the R26-Confetti model for embryonic tracing 
of mammary stem cells 
(A) Schematic outline of the construct for the R26CreERT2;R26-Confetti model. 
R26CreERT2 mice (expressing inducible Cre-recombinase in all cells) were crossed to 
R26-Confetti mice (expressing a conditional multicolour reporter in all cells) to generate 
double hemizygous mice. (B) Administration of low-dose tamoxifen produces stochastic 
genetic labelling of cells at low density. Labelling outcomes include membranous CFP, 
nuclear GFP, cytosolic YFP or cytosolic RFP. (C) Outline of lineage tracing using the 
R26-Confetti model for embryonic lineage tracing. Tamoxifen (equivalent to 33 μg/g of 
maternal weight) was administered by oral gavage on day E16.5-E17.5 (approximately 4-
5 days prior to birth - mice on C57Bl/6 background with total gestation time of 
approximately 21 days). Tissue was harvested from R26CreERT2;R26-Confetti offspring 
at 6 weeks of age. 
 




Figure 4.2.1.6 Wholemount fluorescence stereomicroscopy images of the 
mammary ductal network observed in 6 week old R26R-Confetti mice 
labelled in utero.  
Pregnant dams were induced with tamoxifen via oral gavage at approximately E16.5-E17.5. 
Labelling was observed in the resulting hemizygous R26-Confetti offspring at 6 weeks of 
age. Representative examples of GFP. YFP and RFP labelling in mammary glands co-stained 
with DAPI nuclear dye are shown with zooms from different mice in (A), (B), and (C), 
showing the extent of labelling, from the nipple region to outer edges of the fat pad. 





Figure 4.2.1.7 Examples of multi-colour regions in R26R-Confetti mice in 
mammary glands of 6 week old mice labelled in labelled in utero.  
(A) Example of a multicoloured nipple region. Magnified regions (inset) show 
distinct clonal regions, in addition to presumed bipotent clones (arrow and 
arrowhead indicate adjacent RFP+ basal and luminal cells, respectively). (B) 
Representative example of a multicolour distal branch labelled with both luminal 
GFP and YFP clones and SMA co-staining. Z sections of the region with 
corresponding z-values are shown (inset). 
 
  




Figure 4.2.1.8 Examples of uni-colour labelled distal regions in mammary 
glands of 6 week old R26R-Confetti mice labelled in utero. 
(A) Representative example of single-colour labelling in terminal end buds distal 
branches (left and right, respectively) comprising YFP+ basal cells. (B) 
Representative example of single-colour distal branches and TEBs comprising 
RFP+ luminal cells. Z sections of the regions with corresponding z-values are 
shown (inset). (C) Graphs showing the percentage of single- and multi-coloured 
nipple regions (i) and distal branches (ii). Data are mean±s.e.m. of 940 cells (from 
seven nipple regions, n=5 mice) and 4439 cells (from 85 distal branches, n=7 mice) 
from randomly-selected 3D images.  
 





Figure 4.2.1.9 Labelled distal regions in mammary glands of 6 week old 
R26R-Confetti mice labelled in utero. 
(A) Example of a rare distal branch containing interspersed RFP+ luminal and basal 
cells. Images show maximum-intensity z-projections and optical slices of a region of 
interest (boxed and enlarged in panels). Arrow and arrowhead show adjacent RFP+ 
basal and luminal cells. (B) Cell neighbour analysis nipple regions (i) and distal 
branches (ii), showing that the majority of labelled cells had a same-colour 
neighbour of the same lineage. Data are mean±s.e.m. of 940 cells (from seven 
nipple regions, n=5 mice) and 4439 cells (from 85 distal branches, n=7 mice) from 
randomly-selected 3D images. 
 
  




4.2.2 Tracing pubertal mammary stem cells  
We next wanted to examine the role of mammary stem and progenitor cells during pubertal 
development. Similarly to embryonic MaSCs, there are no definitive markers and as such, and 
to avoid bias, this again requires the use of neutral lineage tracing models. We therefore 
utilised the same models to study pubertal morphogenesis as to those used in embryonic 
tracing, and again combined with optical tissue clearing and 3D imaging.  
 
4.2.2.1 R26 [CA]30 SYNgblA 
The first model we utilised to study pubertal mammary gland development was the R26[CA]30 
SYNbglA model. Use of the R26[CA]30 SYNbglA model enabled macroscopic clonal analysis by 
wholemount histochemistry. Labelling was examined in tissues from the mammary glands of 
mice 7 weeks of age, towards the end of puberty. Ducts containing variable numbers of 
SYNbglA+ cells interspersed with unlabelled cells could be visualised in situ, with ductal 
structures visualised using methyl green counter staining and CUBIC optical clearing, as 
outlined in the previous chapter (Figure 4.2.2.1a).  
 
In order to determine the slippage frequency in the pubertal mammary epithelium, clone 
abundance, size and distribution were examined when functionally active MaSCs are presumed 
to drive ductal elongation and branching morphogenesis. The amount of small (approximately 
2-5 cells), moderate (approximately 5-50 cells) and large (> 50 cells) SYNbglA+ regions were 
quantified per gland (from n=9 mice, examples shown in Figure 4.2.2.1a). The majority of 
observed clonal regions were small to moderate, containing less than 50 cells (Figure 4.2.2.1b), 
presumably having arisen from proliferation-limited progenitors or terminally differentiated 
cells. On the other hand, large clones were much rarer, occurring at a rate of approximately 
0.03 ± 0.06 per mammary gland. Based on the clone sizes, which sometimes was upwards of 
several hundred cells, and the number of branches that these regions occupied, it is likely that 
these arise from a single MaSC. Considering all regions, overall strand slippage was extremely 
rare with approximately 1.49 ± 0.92 events observed per gland – a similar figure to that seen 
in the intestine (Kozar et al., 2013) (Figure 4.2.2.1b). Consequently, the likelihood of clone 
convergence under these parameters is exceedingly low, and therefore provides confidence 
of true single cell lineage tracing using the R26[CA]30 model.  
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In order to find more of these rarer slippage eve1nts we then analysed a further 240 mammary 
glands from 30 mice. To gather more information about the potential MaSC characteristics, 
we quantified the length and the number branches that the clones occupied, in addition to the 
length from the nipple as an inference of the time that slippage occurred (see above, 
summarised in Figure 4.2.2.2). In total, we observed a further 8 large clonal regions, spanning 
up to 9mm in length and contributing to 20 major branches (representative examples shown 
in Figure 4.2.2.3). Interestingly, a similar labelling pattern to that seen in the embryonic tracing 
was observed, with SYNbglA+ cells seen to be intermixed with unlabelled cells. This was likely 
due to the dilution of marked daughter cells with the progeny of unmarked MaSCs/progenitors 
during ductal expansion in puberty.  
 
  




Figure 4.2.2.1 Calculating the rate of strand slippage in lineage tracing of 
R26[CA]30 SYNbglA pubertal animals. 
The event rate in the mammary gland was determined using R26[CA]30 SYNbglA 
mice, as this model is conducive to macroscopic analysis of all labelling events. (A) 
Example of different sizes of SYNbglA clones in mammary glands of R26[CA]30 
SYNbglA mice observed at 7 weeks of age. Examples of small (approximately 2-5 
cells), moderate (approximately 5-50 cells) and large (> 50 cells) labelled SYNbglA 
regions are shown, marked with arrow heads. (B) Quantification of labelling from of 
each of these bins, and the total rate of strand slippage, reflecting the chance of 
observing any labelling event. Note, due to the stochastic nature of labelling, it was 








Figure 4.2.2.2 Examples of large clonal regions in R26 [CA]30 SYNbglA 
pubertal animals. 
(A) and (B) Representative examples of SYNbglA labelling, with length of clonal 
regions denoted and distance from nipple (marked with an asterisk). Magnified 
views are shown inset. (C) Summary of the eight large clonally marked regions 
(likely to have arisen from the labelling of a MaSC/progenitor) observed from the 
analysis of 30 R26[CA]30 SYNbglA mice.  





Figure 4.2.2.3 Further examples of large clonal regions in R26 [CA]30 
SYNbglA pubertal animals. 
(A), (B) and (C) Representative examples of SYNbglA labelling in mammary galnds 
from different mice co-stained with Methyl Green epithelial counter stain. The length 
of clonal regions is denoted, with distance from nipple (marked with an asterisk). 
Magnified views are shown inset.  




4.2.2.2 R26[CA]30 YFP 
The R26[CA]30 SYNbglA model allowed for wholemount imaging and the identification of 
macroscopic clonal structures in situ, which is suitable for observing the entire gland in order 
to quantify labelling and observe patterns. However, for a more definitive determination of 
lineage on the basis of slippage co-localisation with markers of specific mammary gland cellular 
populations, a supplementary model is required. Consequently, the R26[CA]30 YFP model was 
used. As with the R26[CA]30 SYNbglA model, the reporter gene (in this case, YFP) becomes 
randomly expressed during cell replication (Figure 4.2.2.4a). If slippage occurs in a mammary 
stem or progenitor cell, this will then allow tracing of its progeny. 
 
For examining mammary stem and progenitor cell involvement in pubertal development we 
again investigated labelling at 7 weeks of age in mice hemizygous for R26[CA]30 YFP. SeeDB-
based optical tissue clearing was used for 3D visualisation of the ductal network, combined 
with immunolabelling for markers of basal (SMA) and luminal (K8) cell lineages. Accordingly, 
the progeny arising from a single fluorescently-marked cell could then be visualised using 
confocal imaging and characterised in situ with single cell resolution. Clonal expansion of YFP+ 
cells produced a distinctive mosaic labelling pattern, with both luminal and basal clonal regions 
detected (Figure 4.2.2.4b, left and right respectively). Importantly, these matched patterns 
observed in the R26[CA]30SYNbglA model. Together, these data strongly support the hypothesis 
that more than one MaSC/progenitor also contributes to the elongation of each major duct 
during puberty.  
 
In order to further characterise mammary stem or progenitor cell involvement in pubertal 
ductal expansion we analysed a further 504 mammary glands from a total of 63 mice. Similar 
to what was seen in the R26[CA]30 SYNbglA model, clones differed in size with the majority 
containing only a few cells. Despite the vast number of mammary glands examined, only three 
large clonal regions were observed (assumed to be arisen from a true MaSC due to the large 
number of cells involved) (summarised in Figure 4.2.2.4c). These appeared to all be of single 
lineage, but we next sought to further confirm this and characterise these clones in terms of 
composition and contribution to ducts. Since the timing of the slippage event cannot be 
determined in the R26[CA]30 model, it was again assumed that if clones were observed 1 mm 
proximally from the nipple region then slippage had occurred postnatally (Paine et al., 2016). 
Glands were imaged using stereomicroscopy to allow clones to be visualised in the context of 
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the entire ductal network. Higher resolution 3D confocal images of the clonal regions, which 
allow for single cell resolution, were then mapped back onto these stereomicroscopy images.  
 
The first large clonal region examined spanned over 7 mm in length and was comprised of 
over 10 major branches. Importantly, it occurred more than 2 mm past the nipple region 
(Figure 4.2.2.5a, marked with an asterisk), suggesting labelled cells were the progeny of a 
postnatally slipped cell. Upon 3D visualisation of the YFP+ cells, the lineage of all labelled cells, 
as determined by cell location in the duct and co-localisation with lineage markers, was luminal 
(Figure 4.2.2.5b), demonstrating that the cells are the progeny of a lineage restricted stem cell. 
 
We next observed a clone which spanned an even more vast region of the gland, spanning 
over 8 mm in length and occupying more than 20 branches when visualised using 
stereomicroscopy (Figure 4.2.2.6a and Figure 4.2.2.7a).  Upon closer inspection of this clone 
with confocal microscopy (Figure 4.2.2.6b), labelled cells were seen on both major branches 
(for example Figure 4.2.2.6a,iii and Figure 4.2.2.6c,i,iv) and in terminal end ducts and side 
branches (Figure 4.2.2.6b,i and c,vi). By morphology and co-localisation with K8, slipped cells 
all appeared to be of the luminal lineage. However, due to the vast nature of this clone 
supplementary confirmation was required. 
 
Consequently, to further investigate the adult MaSCs/progenitors and quantify their 
contribution to ductal morphogenesis, we adopted the use of imaging algorithms in 
collaboration with Dr Leila Muresan (see methods for detailed procedure). Briefly, Gaussian 
filtering was used on the entire 3D stacks to exclude noise and as such identify YFP+ cells 
within the ductal structures only. Labelled cells were then segmented and classified as either 
luminal or basal depending on the intensity values of the voxels in either the K8 or SMA 
channel; if the number of K8 voxels exceeded the number of SMA voxels then that cell would 
be classified as luminal and vice versa.  
 
By 3D volumetric segmentation, all cells analysed using this method expressed K8. For further 
confirmation, the gland was sectioned over its entire depth and traditional histochemical 
analysis carried out using fluorescent co-staining with YFP (Figure 4.2.2.9b). Lineage restriction 
was confirmed over the 300µm depth, with all YFP+ cells co-localising with K8 (Figure 
4.2.2.9c). These data support the observations with the R26[CA]30 SYNbglA mice, providing 
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further evidence that unipotent MaSCs/progenitors contribute extensively to ductal 
morphogenesis. 
 
Of note, whilst analysing the vast number of glands we noticed the differential expression of 
K8 in luminal cells, identifying what appeared to be two distinct populations comprising of K8lo 
and K8hi cells (Figure 4.2.2.9a). In order to characterise these further we therefore investigated 
the co-expression of hormone receptors of these cells (Figure 4.2.2.10a). Co-staining with 
progesterone receptor (PR) displayed K8hi cells co-express PR, whereas K8lo cells generally 
do not (Figure 4.2.2.10b). Interestingly, both populations of these cells appear to be present 
in a similar proportion to one another in the virgin mammary gland.  
 
In a number of cases, labelled cells appeared to encompass both these populations of luminal 
cells (for example in Figure 4.2.2.9a, arrow heads). Therefore, a custom computational 
algorithm was developed to determine whether a single marked luminal mammary 
stem/progenitor cell contributed equally to both K8hi/PR+ and K8lo/PR populations. In each of 
the four cases analysed within a single clonal region, this revealed that the K8 signal inside the 
YFP+ cells were significantly higher than the total luminal population, with a modest but 
significant overrepresentation of the YFP label in K8hi cells; thus the null hypothesis of equality 
of the two distributions was rejected (Figure 4.2.2.10c, Kolmogorov-Smirnov test at p < 0.05). 
 
We next developed another computational algorithm to determine the potential contribution 
of an active MaSC/progenitor to each duct.  To do so, a volumetric ratio of YFP+ cells relative 
to the total cellular volume of the ductal structure was computed (Figure 4.2.2.11a). This 
calculated that YFP+ cells comprised on average 4.7 ± 1.7% of the total cellular volume in this 
region, demonstrating the contribution of a single parent MaSC (Figure 4.2.2.11b). Assuming 
that other unlabelled MaSCs have similar proliferative and competitive capacities, these data 
suggests that there may be at least 20 lineage-restricted luminal MaSCs within each major duct 
that produce the luminal cells and drive ductal morphogenesis during puberty. 
 
Interestingly, only one large YFP+ basal clone was observed out of the 63 animals examined. 
This clone was slightly smaller than the luminal clones identified, comprising of approximately 
4mm of the pubertal gland and occupying 9 branches (Figure 4.2.2.12a). Following examination 
of the clone using 3D confocal imaging, labelled cells followed the same non-contiguous 
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pattern as the luminal clones (Figure 4.2.2.12b). To confirm the lineage restriction of this clone, 
we carried out similar computational analysis, with minor alterations. 
 
The different morphology of basal cells compared with luminal cells, together with the 
increased noise due to the depth of the clone, necessitated adaption of the algorithm: firstly, 
a denoising and deblurring step was applied to increase the signal-to-noise ratio of the images. 
Following this, a seeded watershed was used whereby the ductal structures were inverted and 
segmented to allow clear visualisation of the bi-layer, in addition to better co-localisation. As 
expected, this computed that all 53 cells examined co-localised with SMA and as such were of 
the basal lineage (Figure 4.2.2.12d). A similar volumetric analysis was also carried out 
suggesting that, on average, clonal regions occupied 5.8 ± 3.2% of the ducal regions analysed 
(Figure 4.2.2.12c). Assuming other basal stem and progenitors cells possess a similar capacity, 
this suggests that there could be at least 15 MaSCs that contributed to the basal lineage in this 
region – slightly lower than the luminal prediction, but this could be attributed to the reduced 
total number of basal cells in comparison to luminal cells in the mouse mammary gland (Rios 
et al., 2016).  
 
  




Figure 4.2.2.4 Overview of the R26[CA]30 YFP mouse model for pubertal 
lineage tracing 
(A) Schematic representation of the R26[CA]30 YFP construct. (B) Representative 
examples of luminal and basal (left and right panels, respectively) YFP+ clonal 
regions from mice, representing over 25 label-positive regions. Z sections of the 
regions with corresponding z-values are shown (inset), scale bars, 50 mm. (C) 
Summary table of the three clonally marked regions seen in pubertal R26[CA]30 YFP 
mammary glands, presumed to have arisen from the labelling of a 
MaSC/progenitor, from the analysis of 504 mammary glands from 63 R26[CA]30 YFP 
mice. 




Figure 4.2.2.5 Example of clonal labelling in R26 [CA]30 YFP mouse model 
during pubertal lineage tracing 
(A) Wholemount stereomicroscopic images of K8 immunofluorescence, showing 
the mammary ductal network of a 7 week R26[CA]30 YFP mouse, demarcating the 
linear length of the clone and regions that were imaged at high cellular resolution 
by confocal microscopy shown in (B), magnified views i–v. Asterisk shows the 
location of the nipple. 
 
  




Figure 4.2.2.6 Further example of clonal labelling in R26 [CA]30 YFP mouse 
model during pubertal lineage tracing 
(A) Wholemount stereomicroscopic images of K8 immunofluorescence, showing 
the mammary ductal network of a 7 week R26[CA]30 YFP mouse, demarcating the 
linear length of the clone and regions that were imaged at high cellular resolution 
by confocal microscopy shown in (B), magnified views i–v. Asterisk shows the 
location of the nipple. Scale bar, 1mm (wholemount) and 50µm (confocal). 
 
  




Figure 4.2.2.7 Further views of labelling in R26 [CA]30 YFP mouse mammary 
gland shown in Figure 4.2.1.6  
(A) Wholemount stereomicroscopic images of K8 immunofluorescence, showing the 
mammary ductal network of a 7 week R26[CA]30 YFP mouse, demarcating the region 
shown in Figure 4.2.1.6 and magnified regions shown in (B) with further regions of 
interest that were imaged at high cellular resolution by confocal microscopy shown in (c), 
magnified views i–vi.  





Figure 4.2.2.8. Computational analysis of clonal labelling in pubertal 
R26[CA]30 YFP mammary gland shown in Figure 4.2.1.6& 7 
(A) Images of a clonally marked region that was analysed by 3D image analysis, 
from fluorescent stereomicroscopy (left) and high-resolution 3D confocal 
microscopy. Scale bars, 1 mm (wholemount) and 100 µm (confocal). (B) and (C) 
Digital segmentation of YFP cells within the luminal (K8-expressing) and basal 
(SMA-expressing) compartments (left and right, respectively). BV, blood vessel. 
Algorithms developed in collaboration with Dr Leila Muresen. 





Figure 4.2.2.9 Analysis of differential K8 expression in luminal cells in 
R26[CA]30 YFP mice 
(A) Example of K8hi (arrow heads) and K8lo cells seen in pubertal mammary glands, 
showing that progeny from a single luminal MaSC/progenitor encompass both K8hi 
(arrowhead) and K8lo luminal cell populations. (B) Fluorescent 2D immunohistochemical 
staining of a clonal region for lineage confirmation (C) Tabulated results of this lineage 
analysis using 2D and 3D analyses (left and right, respectively), confirming all YFP+ were 
luminal. For 3D analysis, all segmented ductal YFP cells were classified as luminal based 
on the proportion of K8 versus SMA signal (n=227 cells from 4 image sequences). For 
2D analysis, cells were classified by manual scoring of histological sections (n=281 cells 
from 10 sections spanning 300m depth).  
  




Figure 4.2. 2.10 Further analysis of differential K8 expression in luminal 
cells in R26[CA]30 YFP mice 
(A) Representative 3D confocal images showing non-uniform expression of K8 in luminal 
cells, with K8hi cells co-staining with nuclear progesterone receptor (PR). (B) Tabulated 
results, showing the proportion of PR positive cells scored as K8hi in virgin pubertal 
mammary glands. (C) Results from analysis to determine whether YFP labelled cells 
encompassed both K8 populations. A Kolmogorov-Smirnov test revealed that the K8 
signal inside the YFP+ cells was significantly higher than the total luminal population. 
Data representative of the quantification of 6 images from 3 mice, with 1831 cells scored 
in total. 





Figure 4.2.2.11. Volumetric computational analysis of clonal labelling in 
pubertal R26[CA]30 YFP mammary gland shown in Figure 4.2.1.6&7 
(A) Images were segmented and the volumetric contribution of the clone to the total 
ductal volume was computed, tubulated results shown in (B). Analysis on four 
randomly selected regions.  
 
  




Figure 4.2.2.12. Basal clonal labelling in pubertal R26 [CA]30 YFP mammary 
gland  
(A) Wholemount stereomicroscopic images of K8 immunofluorescence, showing the 
mammary ductal network of a 7 week R26[CA]30 YFP mouse, demarcating the linear length 
of the clone and asterisk showing the location of the nipple. Magnified area shows where 
the clone was detected (bottom panel) with areas (i-vi) that were imaged at high cellular 
resolution by confocal microscopy shown in (B). (C) Tabulated results of the computed 
volumetric ratio of YFP cells, with respect to total basal cellular volume for each of the 
three regions analysed. (D) Tabulated results of the 3D lineage analysis, confirming the 
basal lineage of the clone (n=453 cells from 3 image sequences).  




Although the R26[CA]30 models provided important insights into the contribution of a single 
functional stem or progenitor cell to mammary gland development, we sought to confirm our 
observations with a second neutral approach that also allows the timing of the labelling event 
to be controlled and is also not dependent on a cell being in cycle at the time of labelling. We 
therefore used the R26-Confetti system again, this time in pubertal morphogenesis.  
 
To achieve this, mice that were hemizygous for both R26-Confetti (Livet et al., 2007) and R26-
CreERT2 (Ventura et al., 2007) were generated. To achieve the expression of the multicolour 
Confetti reporter, administration of tamoxifen is required for Cre-mediated recombination, 
which is achieved in a dose responsive manner (Livet et al., 2007; Ventura et al., 2007). As 
such, selection of the correct dose of tamoxifen is vital to accurately and confidently label 
single cells, whilst balancing this with a sufficient level of labelling. A titration of doses was 
carried out in order to select for optimal dose for single cell tracing. For this, a single dose of 
either 0.25mg, 0.5mg or 1mg of tamoxifen per mouse was injected via I.P injection at 4 weeks 
of age (Figure 4.2.2.13a). SeeDB- and CUBIC R1a-based clearing and 3D confocal imaging was 
utilised to visualise the clones and the amount of labelling was measured. To identify luminal 
and basal cells, wholemount immunostaining was performed using either K8 or SMA, 
respectively, and tissues were counterstained with DAPI to localise the mammary epithelium. 
Importantly, no labelling was observed in the vehicle injected control (Figure 4.2.2.13b) 
 
All doses examined resulted in relatively low-density multicolour labelling in the mammary 
epithelium, allowing individual clones to be distinguished. Using this approach, we were able 
to visualise luminal and basal lineage-restricted GFP+, YFP+ and RFP+ clones, with the amount 
of labelling increasing in a dose responsive manner. CFP-expressing clones were rare and 
under-represented and were therefore not analysed (Figure 4.2.2.14); the reason for this is 
not entirely clear but may relate to the poor penetration of short wavelength light through 
thick specimens and the fine membranous localisation of the CFP reporter protein, which may 
be particularly sensitive to the optical clearing process. Alternatively, it may simply be a 
characteristic of the model, with differential expression of the confetti colours being previously 
identified in the mammary gland, prostate and pancreas (Wuidart et al., 2016; Sznurkowska et 
al., 2018). 
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To examine initial labelling, we examined glands 2 days following induction of lineage tracing 
with tamoxifen. Small regions of labelled cells were identified, mostly comprised of single cells 
(Figure 4.2.2.13c). Next, we examined glands following a 3 week chase to trace the progeny 
of cells labelled at the onset of puberty. In doing so, multiple clonal regions were observed. 
Importantly, labelling in the confetti mice was similar to that in the R26[CA]30 models, in terms 
of both patterning and single clonal lineages, thus validating both approaches. However, a 
number of regions contained multiple clones of different colours (Figure 4.2.2.15a). In order 
to ensure confidence in tracing of single cells and labelling at a lower density to prevent clone 
convergence we proceeded to focus further analyses using 0.5mg per mouse (∼35 μg/g body 
weight) of tamoxifen for low density lineage tracing.  
 
At this dose, mammary branches labelled with single colours were observed (Figure 4.2.2.16a), 
in addition to branches with more than one colour (Figure 4.2.2.16b). To quantify labelling, 
the number of single- and multi-colour branches was calculated, which showed a chance of at 
least 50% clone convergence even at this low dose (Figure 4.2.2.16c).  To characterise the 
lineages of the clones, cell neighbour analysis was carried out (as in the embryonic tracing, 
summarised in Figure 4.2.2.17a). This revealed that the majority of labelled cells had a same-
colour labelled neighbour that was of the same lineage (Figure 4.2.2.17b, n=1419 cells 
distributed across 130 branches from 5 mice). Despite the higher chance of clone 
convergence, this supports the previous conclusions from the R26[CA]30 models – namely that 
the mammary stem and progenitor cells involved in ductal morphogenesis are unipotent.  
 
  




Figure 4.2.2.13. Overview of the use of the R26R-Confetti model for lineage 
tracing during branching morphogenesis 
(A) Schematic of lineage tracing using the R26R-Confetti model during branching 
morphogenesis. Tamoxifen was administered at the beginning of puberty (4 weeks) and tissue 
harvested 3 weeks later (at 7 weeks). (B) showing the absence of labelling in control mice 
injected with oil (vehicle) (Ci,ii) Representative example maximum-intensity z-projections 
showing labelling following a short (2 day) chase. 
  




Figure 4.2.2.14. Example of rare CFP labelling in R26R-Confetti mammary 
glands.  
(A) i and ii show maximum-intensity z-projection (single colour and overlay) and 
optical slices of a demarcated magnified region, inset.  
 
  




Figure 4.2.2.15. Labelling in R26R-Confetti mammary glands during 
branching morphogenesis after 1mg tamoxifen induction  
(A), (B) and (C) show representative images of maximum-intensity z-projections and 
optical slices of higher density labelling following induction of lineage tracing with 1mg 
of tamoxifen at 4 weeks of age, and imaged 3 weeks later. (A) shows a region containing 
YFP luminal cells and RFP basal cells (arrowhead) populating three branches, 
interspersed with unlabelled cells. (B) shows a region containing GFP, YFP and RFP 
luminal cells in a single branch. Scale bars, 100µm (overview) and 50µm (inset). Images 
are representative of three mice. 
 




Figure 4.2.2.16. Labelling in R26R-Confetti mammary glands during 
branching morphogenesis after 0.5mg tamoxifen induction  
(A) Example of single-colour branches and multicoloured branches (B). Images show 
maximum-intensity z-projections and optical slices of a region of interest (boxed and 
enlarged in panels below). (C) Quantification of labelling, showing the percentage of 
single- and multicolour branches in pubertal mice. 
  




Figure 4.2.2.17. Lineage analysis in R26R-Confetti mammary glands 
during branching morphogenesis after 0.5mg tamoxifen induction  
(A) Schematic outlining method of cell neighbour analysis carried out on R26-Confetti 
mice. (B) Results of nearest cell neighbour analysis, which revealed that the majority 
of labelled cells had a same colour labelled neighbour of the same lineage. Box 
extends from the 25th to 75th percentiles and whiskers indicate minimum to 
maximum values. Data from 1419 cells distributed across 130 branches from 
randomly selected 3D images (n=5 mice).  
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4.2.3 Mammary stem cell tracing beyond pubertal morphogenesis 
The mammary gland is traditionally thought to maintain a relatively quiescent state when not 
undergoing the morphogenic events during pubertal or alveolar development. However, the 
gland in fact undergoes small cyclical changes with oestrous cycling, and as such small changes 
can occur. Consequently, we wanted to investigate the fate of mammary stem or progenitor 
cells into adulthood. To do so, we utilised the R26-Confetti model whereby timing can be 
accurately applied. Lineage tracing was induced in virgin mice at 10 weeks of age, well beyond 
pubertal development when all TEBs will have regressed, to ensure tracing of stem or 
progenitor cells responsible for adult homeostasis. The mammary glands were then examined 
one year later.  
 
Initially, glands were optically cleared using the SeeDB protocol, and co-stained with DAPI and 
SMA or K8. However, due to the vast increase in size of the mammary glands at one year of 
age compared with the pubertal mammary gland, and the consequential increase in adipose 
tissue, imaging depth was severely affected, making lineage identification difficult (Figure 
4.2.3.1a). However, this still allowed visualisation of a number of small clones, with some 
multicolour regions detected (Figure 4.2.3.1b). However, the majority of labelled regions 
contained single colour clones (Figure 4.2.3.1c,i and ii). 
 
Consequently, we opted to use the CUBIC protocol which provides superior imaging depth 
due to the use of detergents. Accordingly, this provided better resolution of the adult gland 
(Figure 4.2.3.2a). Interestingly, despite the better depth achieved, only small clones were 
detected still. Some of the regions observed were of single colour (Figure 4.2.3.2b), but a 
number of regions were seen with more than two colours (Figure 4.2.3.2c,d). Through co-
localisation, these clones all appeared to be lineage restricted, with mostly luminal clones seen 
(data from 12 mammary glands from 3 mice).  
 
Overall, this suggests that the mammary stem or progenitor cells involved in homeostasis of 
the adult gland and oestrous cycling do not have a large capacity. One preliminary hypothesis 
may be that in fact the turnover of the gland during oestrous cycling means that progeny of 
MaSCs are constantly being replaced. However, the reduced imaging depth may mean other 
labelling events may have not been detected. Moreover, more mammary glands would need 
to be examined, as rare events would not be detected by this method.  
 




Figure 4.2.3.1 Lineage tracing in R26R-Confetti mammary glands during 
adult homeostasis, imaged with SeeDB optical clearing  
(A) Size difference in inguinal (4th) mammary glands from a 7 week virgin (left) and 
1 year virgin (right) (B) Representative maximum-intensity z-projections and optical 
slices of multi-coloured labelled region and (C) i and ii regions with labelling of only 
single colour (YFP and RFP, top and bottom panel respectively)  
  




Figure 4.2.3.2 Lineage tracing in R26R-Confetti mammary glands during 
adult homeostasis, imaged with SeeDB optical clearing  
(A) Maximum-intensity z-projection showing an example of superior imaging of 1 year 
old mammary gland staining with SMA and cleared using CUBIC optical clearing. (B) 
Representative maximum-intensity z-projections and optical slices of single coloured 
region, with RFP cells seen on side branches. (C) and (D) Regions with labelling 
multi-colour labelling. Data from 12 mammary glands from 3 mice. 
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4.2.4 Tracing alveolar mammary stem cells 
The other main morphogenic event of the mammary gland is pregnancy and lactation, whereby 
the established adult ductal tree undergoes enormous amounts of proliferation and tertiary 
branching and the milk-producing alveoli are formed at the branch tips, fulfilling the 
evolutionary purpose of the mammary gland. Like the pubertal mammary gland, the identity 
of the stem and progenitor cells involved in fulfilling this morphogenesis are still under much 
debate (Lloyd-Lewis et al., 2017). As such we opted to use the neutral lineage tracing 
approaches, combined with 3D imaging, to characterise the MaSC and/or progenitors involved 
in this vital process. 
 
4.2.4.1 R26[CA]30 YFP 
The first model utilised to study mammary alveologenesis was the R26[CA]30 YFP model. 
Mammary glands were harvested between lactation days 2 and 4 and SeeDB optical clearing 
utilised for 3D imaging with confocal microscopy. Labelling was observed throughout the 
lactating gland, with both luminal and basal clones detected (Figure 4.2.4.1a, left and right 
panels respectively). Variable sizes of clones were observed (Figure 4.2.4.1b), with the smaller 
ones reflecting either more recent slippages or stem or progenitors with limited potential.  
 
Of note, slippage was observed to be more frequent in the lactating glands when compared 
to the pubertal mammary gland – which is not unexpected given the increased number of cells 
and extensive proliferation during gestation to produce the expansion of the ductal tree and 
alveoli. A pattern of stochastic labelling was again observed, in a similar manner to the pubertal 
gland, whereby labelled cells were intermixed with the progeny of unlabelled stem or 
progenitor cells. This suggests that multiple stem or progenitor cells are also involved in 
alveologenesis of the mammary gland. Moreover, YFP+ cells were distributed with differential 
labelling patterns: the majority of alveoli were partially YFP+ (Figure 4.2.4.2a,i), but alveoli that 
were where almost entirely labelled were also seen (Figure 4.2.4.2a,ii). Interestingly, a third 
labelling pattern was detected, with only a single YFP+ cell per alveolus (Figure 4.2.4.2a,iii).  
 
In total, 4 large clonal regions were detected from the 80 mammary glands examined (n=10 
mice). Although low, this highlights the rare nature of the slippage and as such ensures 
confidence in single cell labelling. It may also suggest that MaSCs with such a large capacity are 
infrequent, with the majority of cells contributing to smaller portions of the alveolar units. The 
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capacity of these MaSCs were evaluated by quantifying the area of the gland that the clones 
occupied, and the potency by assessing the lineage of the cells (summarised in Figure 4.2.4.2b). 
 
75% of the large clonal regions detected contained entirely cells of the luminal lineage. In one 
particularly vast clonal region, the progeny of the lineage restricted MaSCs comprised up to 
more than 169 individual alveolar units (Figure 4.2.4.3a). The other two luminal clones were 
slightly smaller, occupying more than 68 individual alveolar units (Figure 4.2.4.3b and c). 
Interestingly, the differential expression of K8 in luminal cells, as was seen in pubertal ducts, 
was also seen in lactational alveoli (Figure 4.2.4.4a). However, rather than being present in 
similar proportions as in the pubertal gland, the majority of luminal cells were K8lo, with only 
single rare K8hi cells present on each alveolus. Given these K8hi cells also co-stained with PR, 
they may comprise a similar hormone sensing lineage of luminal cells as was seen in pubertal 
ducts (Figure 4.2.4.4a, arrow heads). Furthermore, luminal YFP clones comprised both of these 
populations of K8+ luminal cells (Figure 4.2.4.4b), suggesting that lineage restricted luminal 
MaSCs contribute to both the K8lo and K8hi luminal subtypes.  
 
Interestingly, out of the 80 mammary glands examined only one large basal clone was seen, 
identified by co-staining with SMA. Similar to the luminal clones seen, the progeny of this 
lineage restricted MaSC occupied a vast number of alveolar units, comprising over 100 
individual alveoli, some of which were entirely labelled by YFP+ cells (Figure 4.2.5.5i and ii). In 
order to assess the distribution of clonal patterns further, the number of alveoli that were 
fully populated by YFP+ cells of a single lineage (full) or populated by both YFP+ and unlabelled 
cells of a single lineage was calculated in the four large clones (Figure 4.2.4.5b). This 
demonstrated that the majority of alveoli were only partially labelled - in both luminal and 
basal clones – suggesting that most alveoli are polyclonal, comprised of the progeny of multiple 
lineage restricted MaSCs. 
 
 




Figure 4.2.4.1 Overview of labelling in the R26 [CA]30 YFP mouse model for 
lineage tracing during lactation  
(A) Representative maximum-intensity z-projection images, revealing extensive 
labelling in the lobuloalveolar network of a luminal (left) and basal (right) clonal region 
in independent lactating mammary glands. Labelled alveoli were populated by both 
lineage-restricted YFP and unlabelled cells (arrow), with occasional alveoli observed 
that were fully populated by YFP cells of a single lineage (arrowhead). Scale bar, 100 
mm (overview) and 40 mm (inset). (B) Representative maximum-intensity z-
projection, showing examples of labelled regions of increasing sizes observed. 
 




Figure 4.2.4.2 Examples of different labelling patterns in the R26 [CA]30 YFP 
mouse model for during lactation  
(A) Representative maximum-intensity z-projection showing the different labelling 
patterns: i) shows uneven contribution of a single labelled ductal cell to different 
lobuloalveolar structures; arrow indicates the presumptive YFP cell of origin at the 
ductal branch point. (ii) shows a rare instance of progeny from a single luminal YFP cell 
contributing almost entirely to the luminal lineage of 2–4 alveoli within a single lobule 
and (iii) shows an example of a single labelled YFP luminal cell that contributed one 
luminal daughter cell to multiple alveoli in a lobule. Scale bars, 100µm. (B) Tabulated 
summary of the four large clonally marked regions observed from the analysis of 80 
mammary glands from 10 R26[CA]30 YFP mice during lactation. 
 
  




Figure 4.2.4.3 Luminal clonal regions in the R26[CA]30 YFP mouse model 
for during lactation  
(A), (B) and (C) Maximum-intensity z-projections showing the extent of the three 
independent luminal clonal regions detected from analysis of 80 mammary glands 
from 10 R26[CA]30 YFP mice during lactation.  




Figure 4.2.4.4 Differential K8 expression seen in luminal cells of lactating 
R26[CA]30 YFP mice 
(A) Maximum-intensity z-projections showing Rare K8hi / PR+ luminal alveolar cells 
are observed in lactating mammary tissue. (B) Maximum-intensity z-projections 
showing that lineage restricted luminal MaSCs can contribute to both K8hi and K8lo 
populations. i) shows the YFP labelled region SMA co-staining with magnified view, 
and ii) shows K8 co-staining, with K8hi cells (arrows). Scale bars, 150µm and 50µm 
(inset).  
  




Figure 4.2.4.5 Basal clonal regions in the R26 [CA]30 YFP mouse model for 
during lactation  
(A) i and ii show maximum-intensity z-projections showing the extent the single basal clonal 
region detected from analysis of 80 mammary glands from 10 R26[CA]30 YFP mice during 
lactation. (B) Quantification of the number of alveoli that were fully populated by YFP cells 
of a single lineage (full) or populated by both labelled and unlabelled cells of a single lineage 
(partial). Lu, luminal; Ba, basal.  
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4.2.4.2 R26-Confetti lineage tracing in the lactational mammary gland 
To confirm the findings seen with the R26[CA]30 YFP model and to ensure accurate timing we 
next employed the R26-confetti model to study the role of adult MaSCs in alveologenesis. 
Adult virgin R26CreERT2;R26-Confetti mice (approximately 12 weeks of age) were injected 
with low-dose tamoxifen (1 mg per mouse, equivalent to roughly 40-50 μg/g body weight) and 
mated two weeks later. Following littering, mammary glands were harvested during lactation 
days 4 to 5 (Figure 4.2.4.6a). Importantly, no labelling was observed in glands taken from 
vehicle injected control mice (Figure 4.2.4.6b,I and ii). Reporter expression in the mammary 
glands was observed after a short chase period of 2 days to examine initial labelling events 
(Figure 4.2.4.7). Small regions of mostly individual cells were identified.  
 
Glands taken during early lactation were then examined for labelling events. Similar to the 
pattern seen in the R26[CA]30 YFP model, large clonal regions were observed, occupying 
multiple alveolar units. Some multicolour alveoli were observed (Figure 4.2.4.8a), however the 
majority of alveoli contained cells labelled with a single colour (Figure 4.2.4.8b,c). This was 
confirmed by subsequent quantification of alveoli, with on average 96.6% of alveoli containing 
single-coloured labelling, providing confidence in the clonal labelling method (Figure 4.2.4.9a,i). 
 
In order to analyse potential potency of the mammary stem or progenitor cells labelled we 
next analysed the lineage of these single colour labelled alveoli; strikingly, this revealed that 
only 0.1% contained both luminal and basal cells of the same colour (Figure 4.2.4.9a,ii). 
Together, these data support the data from the R26[CA]30 YFP data, in that the MaSCs involved 
in forming the milk-producing alveoli in lactation are also lineage restricted, similar to the 
morphogenesis events in embryogenesis and pubertal mammary gland development. 
 
The final aspect we sought to investigate was the clonality of singular alveolar units, as was 
shown in the R26[CA]30 YFP model. Therefore, the proportion of full versus partially labelled 
alveoli was quantified. Similar to the R26[CA]30 YFP model, this showed, in both basal and luminal 
clones, that the vast majority of alveoli were partially labelled. Only 2.3% of luminal and 0.5% 
of basal clones occupied entire alveolar units, out of 793 and 173 units examined, respectively 
(Figure 4.2.4.9b, i and ii).  




Figure 4.2.4.6 Overview of lineage tracing in R26R-Confetti mammary 
glands during lactation  
(A) Schematic of lineage tracing schedule: 1mg of tamoxifen was administered in adult 
virgins, at approximately 12 weeks of age, and mice were mated 2 weeks later (at 
approximately 14 weeks of age). Mammary gland tissue was harvested during lactation 
days 4 – 5. (B) i and ii) Images showing maximum intensity z-projections, 
demonstrating the absence of labelling in control mice injected with oil (vehicle). 
Arrowheads show non-specific background fluorescence. 
 
  




Figure 4.2.4.7 Lineage tracing in R26R-Confetti mammary glands during 
lactation  
Maximum intensity z-projection images of mammary glands from approximately 12 week 
old R26-Confetti mammary glands, showing the level of labelling following a short (2 day) 
chase. (BV=blood vessels). 
 
  




Figure 4.2.4.8 Example of clonal regions seen in lineage tracing of R26R-
Confetti mammary glands during lactation  
(A) Representative maximum intensity z-projection, showing single-colour luminal 
YFP+ and RFP+ adjacent alveoli within a larger lobuloalveolar structure. (B) 
Representative maximum intensity z-projection, showing single coloured alveoli, with 
YFP+ cells throughout a lobuloalveolar unit. (C) Example of a multi-colour basal 
GFP+ and YFP+ alveoli. Images show maximum- intensity z-projections and optical 
slices of a region of interest (boxed and enlarged in the right-hand panels). 
 




Figure 4.2.4.9 Quantification of lineage tracing in R26R-Confetti 
mammary glands during lactation  
(A) Quantification of R26R-Confetti labelling during lactation: i) graph showing the 
percentage of single- and multi-coloured alveoli and ii) graph showing the percentage 
of labelled alveoli in which the same colour cells were the same lineage (i.e. all 
luminal or all basal), or where same-colour cells were mixed lineage (both luminal 
and basal). Data are mean±s.e.m. (B) Fraction of alveoli that were fully populated by 
single-colour labelled cells of a single lineage (full) versus those populated by both 
single- or multi-coloured labelled cells and/or unlabelled cells of a single lineage 
(partial) in both luminal (i) and basal (ii) clones. Data represent 1016 alveoli from 
randomly selected 3D images (n=3 mice).  
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4.2.4.3 R26[CA]30 SYNbglA 
Finally, we utilised the R26[CA]30 SYNbglA model to analyse MaSC presence after multiple 
pregnancies. For this, adult virgin mice that were hemizygous for R26[CA]30 SYNbglA were 
mated and underwent full lactation for an average of 3 weeks, followed by natural weaning. 
Mating was repeated a further two times (Figure 4.2.4.10a), resulting in R26[CA]30 SYNbgl mice 
that had undergone three full gestation, lactation and involution cycles. This allowed us to 
examine the presence of clonal regions that were still present following multiple involutions.  
 
We first identified labelling during the first lactation to validate the use of this model, with 
multiple, small regions seen (Figure 4.2.4.10b). Following this, we observed staining in the 
multiparous mice. Despite the multiple pregnancies and consequently multiple expansions of 
the gland, only small labelled regions were observed (Figure 4.2.4.11). This is potentially due 
to remodelling of the gland involved in the process of involution. However, this may also 
support the notion that some cells remain following multiple involutions. While these may 
represent the progeny of a long-lived MaSC, since this is a continuous clonal labelling model, 
the originating cell may have been labelled at any stage of the study (which totalled 
approximately 8 months). 
  




Figure 4.2.4.10. Use of R26[CA]30 SYNbglA mice to study MaSCs involved in 
multiple gestation / lactation / involution cycles  
(A) Schematic showing the experimental protocol for obtaining lactating multiparous 
mammary tissue: mice of reproductive age were mated and lactating tissue harvested from 
some mice on lactation day 4. A cohort of mice were taken through three pregnancies each 
followed by a full natural wean (approximately 20 days). Mammary tissue was harvested 8-9 
weeks after the final wean. n=3 mice for each time-point. (B) Representative images showing 
initial SYNbglA labelling after 4 days of first lactation. Scale bar shows 500 µm.  
 
  




Figure 4.2.4.11 Representative labelling in R26[CA]30 SYNbglA mice after 
involved in multiple gestation / lactation / involution cycles  
Representative stereomicroscopy images of mammary glands following three full 
gestation / lactation / involution cycles. These SYNbglA cells (purple, arrowhead) may 
represent the progeny of a long-lived MaSC – however since this is a continuous clonal 
labelling model, the originating cell may have been labelled at any stage of the study. 
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4.3 Discussion  
4.3.1 Summary  
The identity of MaSCs has been a long debated topic since their existence was first 
demonstrated nearly 60 years ago (DeOme et al., 1959). Consequently, despite research into 
the subject having spanned a number of decades by a number of groups, considerable 
uncertainties and disparities between results remain. Recently, the molecular identity and 
potency of MaSCs in particular has come under scrutiny. Prime amongst the debate is the fate 
of adult MaSCs; a number of groups have shown data to support either side of the potency 
argument, demonstrating MaSCs being either unipotent or bipotent (Van Keymeulen et al., 
2011; van Amerongen et al., 2012; Rios et al., 2014; Wang et al., 2015; Wuidart et al., 2016; 
Scheele et al., 2017).  
 
One proposed reason for these inconsistencies is due to the experimental approaches used; 
previous lineage tracing has relied on presumed lineage-restricted promoters to drive 
reporter gene expression in a significant proportion of MaSCs for population-based fate-
tracking. In using this approach, the probability of two or more clones arising in the same 
region is high, leading to the potential convergence of clones which can result in incorrect 
interpretation of the data. In this case, labelling and subsequent expansion of two single lineage-
restricted MaSC could resemble clonal expansion of a single bipotent MaSC.  
 
Furthermore, recent work has highlighted that various markers presumed to be lineage 
restricted may not be so specific (Koren et al., 2015; Wuidart et al., 2016). Indeed, this chapter 
has demonstrated differential expression of K8, whereby differential expression is seen in 
luminal cells throughout the pubertal and adult gland. Consequently, use of K8 would lead to 
disparate labelling of luminal cell populations in fate mapping studies.  
 
Additionally, recent work from our laboratory has also highlighted that K14, a marker of basal 
cells, can be detected in rare luminal cells within the rabbit mammary epithelium (Hughes and 
Watson, 2018). Although murine and rabbit mammary glands have slight differences in 
embryonic development and ductal morphology (Propper et al., 2013), they share a number 
of similarities, such as marker expression. Consequently, this would need to be investigated 
further in the murine gland. However K14 expression in luminal cells has been previously 
demonstrated in the pre-pubertal mouse mammary gland (Sun et al., 2010; Boras-Granic et 
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al., 2014). Accordingly, use of these as promoters to drive tracing in mammary cells may in 
fact not result in entirely specific recombination and thus lineage tracing with these promoters 
is not definitive for the assessment of potency. 
 
4.3.2 Overview of main findings  
Accordingly, this means that investigating the role of mammary stem and progenitor cells 
requires the use of novel methods, and multiple models to validate conclusions. Here, we have 
developed techniques to support the use of neutral lineage tracing in both the R26[CA]30 and 
R26R-Confetti models in an attempt to identify the nature of these cells in the mammary gland 
without pre-determined bias. Moreover, the use of 3D imaging has provided an unprecedented 
view of mammary stem and progenitor cell progeny. 
 
Using these methods, we have investigated the main aims of this chapter - namely to 
characterise the fate of mammary stem and progenitor cells. However, the use these novel 
approaches outlined here have also resulted in a number of other unanticipated observations 
and valuable insights. The first, as discussed above, is the differential expression of K8 in luminal 
cells, with two populations of K8hi and K8lo being identified. Interestingly, these cells are found 
in similar proportions within virgin ducts, but during lactation the majority of cells in the alveoli 
express very low levels of K8, and K8hi cells were extremely sparse. Moreover, both 
populations were seen to be produced from a single luminal stem cell. 
 
Previous work has demonstrated an association between high K8/18 expression and a 
functionally distinct hormone sensing population of luminal cells expressing CD24hi/prominin-
1+/Sca1+ (Sleeman et al., 2007). Moreover, lineage tracing studies using K8-CreERT2 mice have 
demonstrated preferential genetic labelling of CD24hi/Sca1+ luminal cells (Koren et al., 2015). 
Indeed, this raises a number of questions: are the K8lo cells seen in lactational alveoli new cells 
that arise with the proliferation of the gland during gestation, or are they in fact ductal cells 
that downregulate K8 expression? If so, at what point during gestation or lactation does this 
process occur, and how are they affected in the remodelling during involution?  
 
Another noteworthy observation is the intra-ductal stochastic distribution of labelled cells, 
hypothesised to be a result of the admixing of cells with progeny from an unlabelled stem cell. 
This demonstrates the presence of multiple stem or progenitor cells within a duct, exhibiting 
the polyclonal nature of ducts (at least during the timepoints examined). This differs from 
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other epithelial structures such as the intestinal crypts, which overtime drift to monoclonality 
(Snippert et al., 2010; Kozar et al., 2013; Nicholson et al., 2018), or the pancreatic ductal tree, 
whereby the majority of branches are formed from a single stem cell (Sznurkowska et al., 
2018).   
 
Conversely, another reason for this pattern may be due to the movement of cells after being 
laid down during ductal expansion. Indeed, this has been demonstrated using intravital 
microscopy, during which cells were seen to be highly dynamic and migratory within TEBs, 
although not within the ducts (Scheele et al., 2017). However, TEBs are especially large 
structures and it may be that imaging deeper into the fat pad is more challenging and as such 
more difficult to image the ductal network and detect labelled cells.  
 
Likewise, the inter-ductal dissemination of labelled cells is of interest. Tracing of a single cell 
during pubertal development demonstrated the random distribution of progeny to multiple 
ducts. Interestingly, some regions contained a number of labelled cells, while other branches 
had a much lower density. As well as providing further evidence for the presence of multiple 
lineage-restricted stem cells, this also leads to intriguing insights into morphogenesis of 
epithelial organs. Likewise, it raises questions surrounding the differential proliferative and 
competitive behaviours of stem and progenitor cells, which may be responsible for 
determining this interesting pattern. 
 
Using 3D imaging algorithms, we performed a volumetric analysis on clonal regions identified 
to estimate the possible number of mammary stem and progenitor cells. Assuming that all cells 
have a similar capacity to contribute to the ductal tree, this estimated that at least 20 luminal 
and 15 basal mammary stem and progenitors contribute to the growth of a major duct. By 
extrapolation for the entire ductal tree, this would mean that there may be as many as a few 
hundred unipotent luminal and basal MaSCs/progenitors in the entire gland, which are 
responsible for driving ductal morphogenesis during puberty.  
 
The exact reason for this multiplicity is still unclear, but given the evolutionary importance of 
the mammary gland, the presence of multiple MaSCs cells would provide a level of redundancy 
to guarantee complete development of the ductal tree in puberty and subsequent 
alveologenesis. This would ensure the production of milk and consequent nourishment of the 
young. Moreover, it may provide a safeguarding mechanism to protect against oncogenic 
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transformation. In epithelial tissues which contain fewer stem cells, the effect of oncogenic 
hits on these rarer cells is much more detrimental (Kozar et al., 2013).  
 
In utilising these agnostic approaches, we have aimed to avoid any aforementioned issues that 
may have caused previous disparities. However, no model is without caveats and as such it is 
important to recognise the limitations of the systems used. The R26[CA]30 system utilises a 
continuous clonal labelling approach which allows for random labelling during DNA replication 
in proliferating cells. Although this model is neutral, in that it utilises the ubiquitous R26 
promoter, the inherent nature of the labelling system means that it is biased towards 
proliferative stem or progenitor cells. Consequently, any MaSC which is quiescent will not be 
labelled with this model. Indeed, this feature may explain the fact that less basal cell clones 
were detected, given the reduced proliferation that has been shown compared to the luminal 
compartment (Giraddi et al., 2015; Shehata et al., 2018). Therefore, this approach would not 
label possible bipotent embryonic MaSCs that may persist after birth and remain quiescent 
during the time periods examined (Boras-Granic et al., 2014). 
 
Another restriction of the R26[CA]30 model is the inability to time tracing events. Accordingly, 
the R26R-Confetti model was used to supplement this and allow tracking of cells within a 
known time period. This requires the use of tamoxifen for Cre-mediated recombination and 
subsequent expression of the confetti reporter, which can be problematic when studying 
mammary gland development (Rios et al., 2014). The use of high doses of tamoxifen (above 
5mg / per 25mg body weight) has been shown to increase proliferation in the short term, and 
caspase-3-mediated apoptotic cell death in the medium term (Shehata et al., 2014). However, 
this was shown to not affect pubertal development in the long run. Moreover, low, single 
doses of tamoxifen were utilised here, which was shown not to affect ductal or alveolar 
development in wholemounts. However, the development of more doxycycline-induced Cre 
expression mouse models may reduce any potential concerns in the future (although these 
are not without their drawbacks).  
 
Finally, the failure to detect a cell type in lineage tracing does not necessarily mean that this 
cell type does not exist. Rather, it may be a reflection of the models used, such as the 
specific Cre driver or quantification method employed (Rios et al., 2016). Consequently, it 
may be that MaSCs with a bipotent capacity are involved in another process of mammary gland 
that was beyond the scope of this work. Nonetheless, these data have highlighted, in multiple 
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settings, the lineage restriction of the functional stem and progenitor cells that actually 
contribute to the main morphogenic events in the mammary gland.  
 
4.3.3 Conclusions 
We posit that the MaSCs/progenitors that generate the ductal network during puberty are 
distinct unipotent cells that are distributed throughout the gland during pubertal 
morphogenesis. Initially found within the TEBs, they proliferate and move towards the 
subtending duct as it elongates. These unipotent MaSCs/progenitors may then be deposited 
throughout the ductal network for later recruitment in response to pregnancy hormones to 
generate alveoli in the lactating gland. Furthermore, embryonic MaSCs also display lineage 





Chapter 5   
Proliferation in the mammary gland 




5.1 Introduction  
As discussed in previous chapters, the mammary gland is rare among its epithelial counterparts 
in that the majority of its development occurs postnatally, with only a minor rudiment 
developing during embryogenesis. After birth, the rudiment expands isometrically from the 
initial ducts. The major expansion of the mammary gland then occurs with the onset of 
puberty, with the surge in ovarian hormones signalling for ductal elongation and branching.  
After this transformation during puberty, the gland also expands with the onset of pregnancy, 
with the formation of lobuloalveolar units and side branching during gestation and subsequent 
functional differentiation during early lactation. With post-lactational regression, known as 
involution, the gland then returns to a near-nulliparous state. This amazing ability for expansion 
and contraction can happen multiple times over a lifetime, with bursts of expansion and 
proliferation followed by subsequent regression and death. Cyclical changes in ovarian 
hormones during oestrous cycling also results in cyclical side branching and subsequent 
regression as the gland prepares for pregnancy with each oestrous cycle (Hodson et al., 2013).   
 
Proliferation in the mammary gland has been previously studied by others to try and 
understand this incredible capacity. Indeed, the TEBs during pubertal development have long 
be known to be highly proliferative, with tissue sections showing them to be a structure with 
a high percentage of proliferative cells, particularly in the cap cell region (Paine and Lewis, 
2017). Consequently, TEBs have been the proposed as the location of stem cells in the 
developing gland. However, after pubertal development the gland does not return to 
quiescence and instead remains dynamic with oestrous cycling. During this period, cyclical 
increases in progesterone and oestrogen result in secondary and tertiary branching and a 
process akin to alveolar budding occurs with the gland preparing for pregnancy (Zeps et al., 
1999). These then regresses with the drop in progesterone levels at the latter end of the 
oestrous cycle if a pregnancy this does not occur (Zeps et al., 1999). In the mouse, this cycle 
takes approximately four to five days, highlighting the ability of the gland to turnover in a short 
period of time. Consequently, this shows an additional requirement of the presumptive MaSC 
in gland homeostasis, outside of pubertal and alveolar morphogenesis. Furthermore, identifying 
regions where proliferation occurs may provide utility in identifying plausible locations / niches 
for the MaSC in the pubertal and post-pubertal gland. 
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However, traditionally examination of proliferation in the gland has been carried out in 2D 
using tissue sections. This both means that investigation of the entire mammary gland is time 
consuming, but also identifying patterns of proliferation is challenging. Hence, the 3D imaging 
methods, discussed in chapter 3, provide an approach that allows for a more accurate 
visualisation of proliferation throughout the entire ductal network, not previously possible 
through tissue sectioning. Another important consideration is the heterogeneous nature of 
the gland during different oestrous stages, due to the changes in both morphology and 
proliferation previously described. Consequently, in order to properly examine the changes 
in proliferation in the gland at different developmental stages all mice must be normalised for 
oestrous stage. 
 
 Importance  
In the previous chapters it was demonstrated that multiple unipotent functional stem cells are 
responsible for building the ducts in puberty and alveoli in gestation and lactation. However, 
lineage tracing only demonstrates the fate of these clones. As such, another important 
characteristic to examine is to ascertain proliferation levels in the mammary gland to 
appreciate the requirements of these mammary stem and progenitor cells. Similarly, with 
sustenance of proliferation being one of the original hallmarks of cancer (Hanahan et al., 2011), 
understanding the proliferation capacity of the mammary gland has important implications for 
cancer transformation.  
 
 Aims 
The work described in this chapter aims to define the proliferation levels of mammary 
epithelial cells during different developmental stages. There are a number of methods that can 
be utilised to do so, including DNA intercalators that are analogues of DNA and as such can 
become incorporated into DNA during the S-phase of the cell cycle. After a defined chase 
period, cells that were proliferating at the time of the pulse (and that have not divided multiple 
times the since the label) can subsequently be detected (Kee et al., 2002; Zeng et al., 2010). 
Traditionally, BrdU has been used. However, in recent years its use has been gradually 
declining as EdU is utilised more frequently. Both molecules are thymidine analogues, however 
BrdU requires antibody-based detection, which requires use of various harsh chemicals so 
that the antibody is able to bind to the BrdU which is tightly held within the DNA double 
helix. EdU on the other hand, can be detected fluorescently using a simple copper-based 
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chemical “Click” reaction (Zeng et al., 2010). As such, EdU presents as a more useful tool that 
allows for more co-stains as a consequence of not needing the harsh chemicals.  
   
Accordingly, here both Ki67 staining and EdU incorporation-based examination of 
proliferation will be used and combined with 3D imaging using optical tissue clearing 
wholemount confocal microscopy - allowing for an accurate appreciation of the proliferative 
regions in the gland. Visualisation of proliferating cells will be examined in pre-pubertal, 
pubertal, young adult and older adult animals 




 Oestrous staging optimisation  
As discussed above, proliferation in the gland varies with cyclical ovarian hormone changes during 
the oestrous cycle. Therefore, in order to remove any stage-specific bias mice were oestrous 
stage-matched. There are several ways to assess oestrous stage in mice that have been described, 
including monitoring serum hormone levels. However, this is particularly invasive and not feasible 
to carry out on a routine daily basis. Another technique is to asses cervical cell phenotypes. A 
number of methods have been developed to do this, such as swabbing of the vaginal entrance, 
however this can be invasive and risk either inducing pseudopregnancy (Adler et al., 1970; Yang 
et al., 2009) (which may affect mammary gland biology) or inflammation of the cervical canal 
(which would confound cytological assessment).  
 
Therefore, we sought to utilise a method that was minimally invasive which would both allow 
oestrous staging to be carried out on a daily basis and would not have the risk of inducing 
pseudopregnancy or inflammatory events. This was carried out using small amounts 
(approximately 50L) of PBS and a plastic bulb combined with a pipette tip (McLean et al., 2012). 
The PBS can then be flushed in and out of the vagina via aspiration, collecting exfoliated cells, 
meaning no insertion into the vaginal canal is needed. Lavage samples are then placed onto 
histology slides, dried and subsequently stained using a simple toluidine blue dye. Slides can be 
immediately assessed without the need for fixation or mounting and so consequently this process 
is very time efficient. 
 
Oestrous stage is assessed based on the relative ratios of three different cell types in the vaginal 
cytology samples: nucleated epithelial cells, cornified squamous epithelial cells, and leukocytes 
(Figure 5.2.1a). This reflects changes in cervical topology that occurs with the different endocrine 
environments during the different phases of the oestrous cycle. During proestrous, cells are 
mostly clusters of round, well-formed nucleated epithelial cells (Figure 5.2.1b,i). Next, during 
oestrus, cells are predominantly cornified squamous epithelial cells (Figure 5.2.1b,ii). During 
metoestrous, small leukocytes are detected mixed with both cornified squamous and nucleated 
epithelial cells (Figure 5.2.1b,iii). Finally, during dioestrous rare cornified squamous epithelial cells 
may still be present, however mostly leukocytes are detected (Figure 5.2.1b,iv). 
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Consequently, all mice were oestrous staged at the same time each day, 7 days prior to being 
assessed for proliferation. The reason for this is two-fold: firstly, all experiments were carried 
out when the mice were in dioestrous, when proliferation is at its highest due to increased 
progesterone levels (Giraddi et al., 2015; Shehata et al., 2018). Secondly, this allowed for 
identification of mice which had incorrect cycling – those that did not correctly cycle were 
therefore not used for this study. A normal oestrous cycle was defined as following these defined 
stages over 4 – 5 days. 
 
To assess the proliferation of the mammary gland at different developmental stages four different 
time points were examined: 4 weeks for pre/peri puberty, 7 weeks for late puberty, 12 weeks 
for young adult and 24 weeks for older adult. CUBIC optical clearing (the supplementary R1a 
protocol) was utilised in order to gain better visualisation due to superior depths that can be 
achieved with the protocol, which is particularly relevant when analysing older, larger glands.  
 
  




Figure 5.2.1 Outline of method for determining oestrous stage in mice using 
vaginal lavage 
(A) Schematic outlining the differing cellular compositions of vaginal lavages during the 
four different oestrous stages, based on the relative amounts of leukocytes (L), nucleated 
epithelial cells (N) and cornified epithelial cells (C). Diagram based on (Cora et al., 2015). 
(B) Light microscopy images showing representative vaginal cytologies obtained during 
i) proestrous, ii) oestrous, iii) metoestrous and iv) dioestrous. Nucleated epithelial cells 
highlighted by arrow heads and cornified epithelial cells highlighted by asterisks.   
 
  




Proliferation can be visualised in a number of ways, with Ki67 staining widely used as one of the 
easiest ways to detect cycling cells that are in any stage of the cell cycle, excluding G0 (Scholzen 
and Gerdes, 2000). Ki67 staining in the mammary gland has been previously investigated using 
2D tissue sections (Zeps et al., 1999; Fernandez-Gonzalez et al., 2009), and therefore it was 
decided to use Ki67 as an initial investigation of proliferative regions that can be examined in the 
mammary gland of optical cleared tissue. Accordingly, mammary glands were staining for Ki67 
and cleared using CUBIC-based optical clearing. Small intestine samples were taken as a 
proliferative control (Figure 5.2.2a), in addition to no-primary control staining to identify non-
specific or background staining (Figure 5.2.2b) 
 
At 4 weeks, the gland is composed of a basic ductal structure with approximately 5 main 
branches. The general consensus is that puberty begins in a mouse at approximately 3 – 4 weeks 
of age; however like humans, this number can vary from mouse to mouse based on several 
factors. Consequently, this age encompasses mice in either pre-puberty or early puberty, 
depending on whether they have been exposed to the pubertal hormones that instruct that gland 
to expand (Hinck and Silberstein, 2005).  
 
As expected, proliferation was seen concentrated in the cells of the TEBs in 4 week mammary 
glands. Largely this was seen in the outer layers of body cells and within the SMA+ cap cells 
(Figure 5.2.2a). However, in some cases SMA+ cap cells could be detected within the body of 
the TEB, some of which co-stained with Ki67 (Figure 5.2.2b, arrow head). Previously, it was 
hypothesised that cap cells represent a population of bipotent stem cells that are able to produce 
cells of both epithelial lineages, and they do so by entering the TEB body and laying down the 
cells in the subtending duct. Conversely, excess cap cells have been said to enter the TEB body 
to undergo programmed cell death (Paine et al., 2016) (see chapter 1 for discussion of these 
hypotheses). 
 
Furthermore, Ki67 staining was also observed in the subtending ducts leading up to the TEBs, 
both at branch points (Figure 5.2.4a) and further away from the TEB (Figure 5.2.4b, arrow head). 
Traditionally, proliferation during puberty is thought to be led by the TEBs. These areas in the 
duct have been reported to remain quiescence once laid down by the expanding TEB, until 
required to form lobuloalveolar expansion during pregnancy, and to a lesser degree with 
oestrous cycling.  




Similar observations were also seen in the mammary glands of 7 week mice. The majority of Ki67 
labelled cells were seen in the TEBs of the mammary gland (Figure 5.2.5a,b) but again Ki67 staining 
was detected also further down the ductal network  (Figure 5.2.6a,b). Moreover, stromal cells 
around the ducts also expressed Ki67 (Figure 5.2.6b, arrow heads). Definitive identification of 
these cells would require further investigation but given the role of stromal cells in pubertal gland 
development (discussed in introduction) this result is not surprising.  
 
Within post-pubertal mammary glands, Ki67 staining was much more infrequent. Indeed, 
uncommon rare cells could be detected, but the majority of staining was seen in the stromal 
compartment both at 12 weeks (Figure 5.2.7 and Figure 5.2.8) and at 24 weeks (Figure 5.2.9 and 
Figure 5.2.10). This reduction in proliferation in the post-pubertal mammary gland is expected 
given the fact that ductal morphogenesis is complete. However, given proliferation is still 
required for expansion in oestrous, small amounts of proliferation are still expected. 
 
  




Figure 5.2.2 Ki67 staining controls in the murine intestine and mammary 
gland 
(A) Sections of the small intestine were used as proliferation controls to ensure staining 
was compatible with optical clearing (B) Representative images of no primary control 
staining, with tissue only labelled with K8 primary antibody, followed by K8 and Ki67 
secondary antibodies and DAPI used for the nuclear stain. Images show maximum-
intensity z-projections of individual channels, merge and optical slices of a regions of 
interest (boxed and enlarged). 
 
  




Figure 5.2.3 Ki67 staining in 4 week mammary glands 
4 week mammary gland tissues were stained with K8 and Ki67, with DAPI used for 
nuclear staining. Ki67 staining was seen in both larger and smaller TEBs demonstrating 
that they were highly proliferative. (A) and (B) show representative images showing 
SMA+ cap cells in the body of the TEB co-staining with Ki67. (B) Asterisk marks CUBIC-
related autofluorescence (see chapter 3 for details). Images show maximum-intensity 
z-projections of individual channels, merge and optical slices of a regions of interest 
(boxed and enlarged). 
  




Figure 5.2.4 Ki67 staining seen in ductal regions of 4 week old mammary 
glands  
(A) Proliferation seen by Ki67 staining in multiple regions within a trifurcated TEB, 
including further down the subtending duct. Note the on/off nature of Ki67 staining, with 
the middle TEB staining less than the others. (B) Representative image showing more 
sparse proliferation in cells further down the ductal region. Images show maximum-
intensity z-projections of individual channels, merge and optical slices of a regions of 
interest (boxed and enlarged). 
 
  




Figure 5.2.5 Ki67 staining in terminal end ducts of 7 week mammary glands  
(A) and (B) show representative images of proliferation shown by Ki67 staining in 
bifurcating TEBs of 7 week mammary gland. (B) Asterisk marks CUBIC-related 
autofluorescence (see chapter 3 for details). Images show maximum-intensity z-
projections of individual channels, merge and optical slices of a regions of interest 
(boxed and enlarged). 
 
  




Figure 5.2.6 Ki67 staining in 7 week mammary glands  
Representative images showing that not all areas are proliferative in 7 week mammary 
glands. (A) shows a ductal region with proliferation in two areas. (B) representative images 
showing Ki67 staining in stromal cells surrounding terminal end ducts (arrow head). 
Images show maximum-intensity z-projections of individual channels, merge and optical 








Figure 5.2.7 Ki67 staining in 12 week mammary glands  
Representative images showing rare proliferative cells in 12 week mammary glands. 
(A) Example of budding region at a terminal end bud (B) Ki67+ proliferating cells in both 
ductal and stromal cell types. Images show maximum-intensity z-projections of 








Figure 5.2.8 Ki67 staining examples in 12 week mammary glands  
Further examples of Ki67 staining in ductal (A) and stromal (B) regions of 12 week 
mammary glands. Images show maximum-intensity z-projections of individual 
channels, merge and optical slices of a regions of interest (boxed and enlarged). 
 
  




Figure 5.2.9 Ki67 staining in 24 week mammary glands  
Representative images showing Ki67 staining in terminal ducts of adult 24 week mammary 
glands. (A) and (B) show Ki67+ proliferating cells in both ductal and stromal cell types. 
Images show maximum-intensity z-projections of individual channels, merge and optical 








Figure 5.2.10 Ki67 staining in 24 week mammary glands  
Representative images showing Ki67 staining in ductal regions of adult 24 week mammary 
glands. (A) and (B) show Ki67+ proliferating cells in both ductal and stromal cells. Images 
show maximum-intensity z-projections of individual channels, merge and optical slices of 
a regions of interest (boxed and enlarged). 
 
  





Ki67 staining to examine proliferation allows identification of cells within any stage of the cell 
cycle. However, use of DNA intercalators allows for a more precise measurement of active cell 
division in the mammary gland throughout development. Indeed, EdU incorporation only occurs 
during the S-phase of the cell cycle, as opposed to all the stages that are labelled with Ki67. As 
such, this allows for detection of cells that have actively proliferated within the chase period. 
Here, a 4-hour pulse chase period was used as an optimal amount of time to specifically mark 
actively proliferating cells (for example rather than investigating label retention). Following this, 
tissues were stained with basal and luminal cell markers and cleared using either SeeDB or 
CUBIC optical tissue clearing, with non-injected control and intestine samples for injection and 
staining controls (Figure 5.2.11). 
 
5.1.1.1 Pre-pubertal EdU proliferation 
Similar to tissues examined with Ki67 staining, expanding ductal trees with TEBs could be 
visualised in some mice. As expected based on both previous work in the field (Kenney et al., 
2001; Fernandez-Gonzalez et al., 2009; Paine et al., 2016) and data from Ki67 staining, high levels 
of EdU incorporation was seen in TEBs. This was observed in both large bifurcating TEBs, and 
smaller structures (Figure 5.2.12, a and b respectively). When analysing the composition of 
proliferation in the TEBs, both cap and body cells could be seen to have incorporated EdU.  
 
Proliferative SMA+ cells, which were presumably cap cells, could again be detected within the 
body of the TEB in a number of cases, as was seen with Ki67 staining. (Figure 5.2.12c, 
arrowheads). These cells have been described to be undergoing programmed cell death, but 
previous reports have also postulated a role for these cells in formation of the ductal lumen 
(Kenney et al., 2001). Further staining with a marker of cell death marker, such as CC3, would 
provide more insights into the role of these cells within the TEB. Interestingly, EdU incorporation 
seemed to be binary - in that TEBs were either “on” or “off”, with either most cells proliferating 
or none. This phenomenon also occurred within bifurcated TEBs (Figure 5.2.13). Indeed, this has 
been seen using other methods of wholemount imaging (Scheele et al., 2017), and has been 
suggested to be a mechanism to ensure the fat pad is evenly filled and to prevent ductal clashing.  
 
Furthermore, EdU proliferation could also observed within the main duct proximal to the nipple 
opening of some mammary glands (Figure 5.2.14). This is interesting considering this area 
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develops and expands during embryonic development and to a lesser degree after birth. 
However, given the significantly larger diameter of this duct in comparison with others, it may 
be that these proliferating cells are responsible for expanding the duct latitudinally, providing a 
strong and reinforced duct around the nipple for milk expulsion. Indeed, this could be seen by 
the multiple layers of K8+ luminal cells rather than a single layer (Figure 5.2.14a, inset). 3D 
imaging also revealed proliferation in stromal cells surrounding this area, including a vast network 
of SMA+ mesenchymal cells surrounding the nipple opening (Figure 5.2.14a). Further staining of 
this structure would need to be done to further identify these cells, but these may be either 
smooth muscle cells or blood vessels, both of which would be marked by SMA.  
 
Use of optical tissue clearing allowed wholemount imaging of the mammary glands which meant 
visualisation of entire regions of the ductal tree could be achieved. This revealed that proliferation 
was not always confined to the TEBs, in contrast to what has been previously shown. Confirming 
the observation seen with Ki67 staining, proliferation could also be seen in zones throughout the 
ducts, in both the basal and luminal cells (Figure 5.2.15a,b). In some of these regions there 
appeared to be a slight distention of the duct (Figure 5.2.15b, inset) - this may potentially suggest 
that these are regions where secondary lateral branches will form, but this is not possible to 
confirm without intravital imaging. However, this still shows for the first time that the ducts can 
remain proliferative, possibly to facilitate side branching or ductal elongation. Indeed, buds on 
the side of branches were also seen to be highly proliferative (Figure 5.2.16).  
 
Another interested morphological finding was detected. Within a number of ducts, small K8 
labelled cells could be detected. These were significantly smaller than normal luminal cells and 
appeared within the lumen (Figure 5.2.17b, arrowhead). The morphology and location of these 
cells is reminiscent of a population of Notch expressing cells that were identified using Notch 
reporter mice, termed “S” cells. These cells were seen to be arranged in “strings” surrounding 
a population of larger, Notch-expressing cells, termed “L” cells. Indeed, measurement of the 
smaller population of cells identified here showed they were on average 3.02 µm ± 0.49 in 
diameter – similar in size to the previous described population (2.80 μm ± 0.25) (Šale et al., 
2013). Further work involving staining for Notch activity, and most importantly functional studies 
would be required to validate this definitively.  
  




Figure 5.2.11 EdU proliferation seen in small intestine control tissues  
25mg/kg EdU was injected into 4, 7, 12 and 24 week-old-mice in dioestrous followed by a 
4-hour chase. Representative images show proliferative region of the small intestine, 
representing both EdU injection and staining reaction control.  
  




Figure 5.2.12 EdU proliferation in 4 week mammary glands terminal end buds 
High levels of proliferation can be seen in the TEBs of early pubertal mammary 
glands. (A) shows representative image of EdU incorporation in a bifurcating TEB, 
with proliferation seen in both cap and body cells. (B) Representative image showing 
a smaller TEB with EdU incorporation, including in SMA positive cells within the body 
of the TEB, with magnified z-section of boxed area shown in (C). Arrow head shows 
SMA+ EdU+ cells.  




Figure 5.2.13 EdU incorportation in a bifucated TEB of 4 week mammary gland 
Representative image of a birfucated TEB with binary proliferation seen in only one half of 
the TEB. Images show maximum-intensity z-projections of individual channels, merge and 
optical slices of a regions of interest (boxed and enlarged). 
 
  




Figure 5.2.14 EdU incorporation proximal to the nipple in 4 week mammary 
glands 
(A) Proliferation is seen in the nipple opening region in the initiating duct in a 4 week 
mammary gland. SMA+ mesenchyme is also shown with EdU incorporation. (B) 
Proliferation seen in regions further into the ductal network, which is not consistently the 
case (C). 
  




Figure 5.2.15 EdU incorporation seen in the ductal network of 4 week 
mammary glands.  
(A) and (B) show representative examples of EdU incorporation seen in ductal regions 
during early puberty, in both basal and luminal cells. Images show maximum-intensity z-
projections of individual channels, merge and optical slices of a region of interest (boxed 
and enlarged). 
  




Figure 5.2.16 EdU incorporation seen in the side buds of 4 week mammary 
glands.  
Representative example of EdU incorporation seen in side buds during early puberty, in 
both basal and luminal cells. Images show maximum-intensity z-projections of individual 
channels, merge and optical slices of a region of interest (boxed and enlarged). 
  




Figure 5.2.17 Population of  K8 cells seen in 4 week pubertal mammary 
glands  
(A) Representative images of ductal proliferation seen in both basal and luminal cells 
of 4 week mammary glands. (B) Magnified region of (A), showing a population of small 
K8+ cells surrounding a larger EdU+ cell. 
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5.2.1.1 Pubertal proliferation  
Mammary glands from 7 week old mice where next examined to investigate proliferation in the 
latter phase of pubertal development. At this stage, some TEBs remain at the tips of ducts that 
have not reached the extremities of the fat pad, which is yet to be completely filled. 
Consequently, proliferation could still be seen in some remaining TEBs (Figure 5.2.18a,b,c). 
Examination of cell types demonstrated EdU incorporation in both cap and body cells of the 
TEBs. However, proliferation was much more heterogenous, with overall less proliferation than 
the younger time point examined. The binary nature seen in 4 week mammary glands was seen 
again at this age, with not all TEBs and terminal ducts showing high levels of proliferation – indeed, 
a number of terminal end ducts and side branches has little to no EdU incorporation (Figure 
5.2.19a,b)  
 
Interestingly, at this age high levels of proliferation were also seen in the stromal cells surrounding 
TEBs (Figure 5.2.20a,b,c). The importance of stromal cells in providing both signalling cues and 
structural support has been previously reported, as discussed in the introduction (Williams and 
Daniel, 1983; Gouon-Evans et al., 2000; Lilla and Werb, 2010). Further staining would be required 
to definitively identify which stromal cells these may be, but cells including macrophages, mast 
cells and fibroblasts have been implicated in supporting ductal growth. It is not fully understood 
if these cells proliferate in situ or home from elsewhere, so this finding suggests that cues within 
the mammary stroma may induce expansion of these stromal cells.  
 
Similar to early puberty, ductal proliferation was also seen in some areas of 7 week mammary 
glands (Figure 5.2.21a)., although not to the same extent as that seen in earlier pubertal stages. 
Indeed, at this age proliferation appeared to be much more heterogenous, with some areas 
containing no EdU labelling – even within TEBs (Figure 5.2.21b), and expectedly in mid-ductal 
regions (Figure 5.2.22). Presumably this may be due to the fact that the fat pad is much more 
filled at this age and as such not as much proliferation is required to expand the ductal network.  
 
  




Figure 5.2.18 EdU proliferation seen in TEBs of 7 week mammary glands  
Proliferation seen in TEBs as measured by EdU incorporation in 7 week-old-mice. 
Proliferation can be seen in both cap and body cells, and also in the subtending ducts. 
Representative images from mammary glands of n=10 mice, showing maximum-intensity 
z-projections of individual channels, merge and optical slices of a region of interest (boxed 
and enlarged). 




Figure 5.2.19 Absence of proliferation in 7 week mammary glands  
Representative images of regions in later pubertal mammary glands, showing that not all 
regions remain proliferative. These include both terminal end ducts (A) and side branches 
(B). Representative images from mammary glands of n=10 mice, showing maximum-
intensity z-projections of individual channels, merge and optical slices of  regions of interest 
(boxed and enlarged). 
  




Figure 5.2.20 Proliferation seen in stromal cells in 7 week mammary glands  
Images show examples of proliferation seen in stromal cells surrounding TEBs during the 
latter phase of pubertal development. This is both in TEBs (A,B) and in bifurcating regions 
(C) Representative images from mammary glands of n=10 mice, showing maximum-
intensity z-projections of individual channels, merge and optical slices of a region of interest 
(boxed and enlarged). 




Figure 5.2.21 Proliferation in ductal regions of 7 week mammary glands seen 
by EdU incorporation  
(A) Representative image showing EdU incorporation in both TEBs, and in the subtending 
ducts (B) Representative image demonstrating absence of proliferation in both TEBs and 
ducts. Data from mammary glands of n=10 mice, showing maximum-intensity z-projections 
of individual channels, merge and optical slices of a region of interest (boxed and 
enlarged). 
  




Figure 5.2.22 Absence of proliferation in ductal regions of 7  week mammary 
glands  
Representative image demonstrating absence of proliferation, shown by no EdU signal, in a 
developed ductal region in 7 week mammary gland. Data representative from mammary glands of 
n=10 mice, showing maximum-intensity z-projections of individual channels, merge and optical 
slices of a region of interest (boxed and enlarged). 
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5.3.1.1 Post-pubertal EdU proliferation  
After pubertal morphogenesis has finished, proliferation in the gland returns to a much lower 
level, fulfilling only expansion during oestrous cycling. At 12 weeks, pubertal hormones will have 
diminished and the gland will have undergone a number of rounds of cyclical proliferation and 
regression with oestrous cycling. This could be seen with increased side branching of the ducts 
in 12 week-old animals. However, despite this proliferation levels were very low with only sparse 
EdU+ cells identified, both at the terminus of ducts (Figure 5.2.23a) and to a lesser extent within 
the ductal network (Figure 5.2.23b).  
 
In a similar vein, the mammary glands of 24 week animals were much more complex, with both 
increased side branching and vasculature (Figure 5.2.24a). EdU incorporation at this stage was 
also low, with the majority of ducts showing no proliferative activity (Figure 5.2.24b). A few, 
sparse labelling events could be detected, which were largely found within the secondary side 
buds and branches (Figure 5.2.25a,b). These presumably represented cells which have 
proliferated on hormonal stimulation with oestrous cycling. This reduction in proliferation 
compared with younger mice is to be expected due to the diminished requirement for such 
spectacular epithelial expansion and ductal elongation.  
 
  




Figure 5.2.23 Proliferation in 12 week adult mammary glands seen by EdU 
incorporation 
Examples of EdU incorporation seen in 12 week mammary glands. (A) Representative 
image showing sparse labelling in terminal end duct. (B) Example of a rare EdU+ cell seen 
within the ductal region. Images are from mammary glands of n=10 mice, showing 
maximum-intensity z-projections of individual channels, merge and optical slices of a 
regions of interest (boxed and enlarged). 
 
  




Figure 5.2.24 EdU incorporation investiageted in mammary glands of 24  
week mice  
(A) Representative image demonstrating the increased complexity in both the ductal 
and vascular network of older adult mammary glands. (B) Representative image 
showing the absence of EdU incorporation. Maximum-intensity z-projections of 
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individual channels, merge and optical slices of a regions of interest (boxed and 
enlarged) from mammary glands of n=10 mice. 
 
 
Figure 5.2.25 Proliferation in 24 week mammary glands using EdU 
incorporation  
Examples of EdU incorporation seen in mammary glands of 24 week mice, seen in 
side branches and buds. (A) and (B) show representative images from mammary 
glands of n=10 mice, showing maximum-intensity z-projections of individual channels, 
merge and optical slices of a regions of interest (boxed and enlarged). 
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 Use of the Fucci2a system to study mammary gland proliferation 
Genetically engineered transgenic mouse models have also been developed to allow visualisation 
of the cell cycle without the need for DNA intercalators, which also provide a higher resolution 
of cell cycle stage. Indeed, one such model, the Fluorescence Ubiquitin Cell Cycle Indicator 2a 
(Fucci2a) mouse, allows for a more distinct separation of the cell cycle stage by utilising mCherry 
tagged Cdt1 and mVenus tagged geminin (Mort et al., 2014). These proteins are expressed at 
distinct phases of the cell cycle and are then rapidly degraded. The expression of these reporters 
thus results in the ability to visualise cells in different stages of the cell cycle: cells in G1/0 express 
just Cdt1 as therefore mCherry alone, cells in G1/S transition express both Cdt1-mCherry and 
geminin-mVenus so can be seen as yellow, and those cells in late S/G2/M will be green due to 
geminin-mVenus expression. Furthermore, cells that have recently divided and so have not yet 
accumulated enough Cdt1-mCherry will show no reporter expression and can be distinguished 
as such (Figure 5.2.26a). Importantly, this is driven by the ubiquitous R26 promoter and so the 
construct should be expressed in all cells. 
 
Accordingly, to validate the results seen with EdU and Ki67, the mammary glands from 12 week 
virgin mice (n=12 mammary glands from 3 mice) were investigated for cell cycle stage. Tissues 
were stained with the luminal cell marker K8 and optically cleared using SeeDB optical clearing 
to ensure the reporter fluorescent integrity was not affected. In consensus with the data from 
EdU incorporation, the majority of cells visualised showed expression of Cdt1-mCherry, 
suggesting that the cells were in either G1 or G0 (Figure 5.2.26b). Given these mice were virgins, 
it is likely that the majority of Cdt1 expression in these cells is associated with the G0 stage of 
the cell cycle.  
 
However, a number of cells also showed no reporter expression – suggesting a recent cell 
division (Figure 5.2.26b, arrow heads). However, it may also be that this is a consequence of the 
3D imaging meaning reporter detection is affected, given the mature gland sizes. Furthermore, 
issues with transgene infidelity have been reported resulting in lack of expression in some cells 
(Mort et al., 2014). This is highlighted here, shown by the surrounding stromal cells, in which no 
expression of either reporter was seen in any cells (Figure 5.2.26b,c) – again, a phenomenon that 
has been reported in other systems.  
 
There were also rare instances of cells co-expressing both mVenus and mCherry, suggesting 
these cells were in G1/S transition. These cells were seen both in the tips of ducts (Figure 
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5.2.27a), in addition to further down the ductal tree (Figure 5.2.27b). It is tempting to speculate 
that these cells may represent those that are proliferating upon hormonal stimulation with 
oestrous cycling. Rare cells in the S/G2/M phases of the cell cycle, indicated by mVenus-Geminin 
expression, were also detected, again largely at the tips of ductal regions (Figure 5.2.28a,b,c).  
 
Together, these data highlight the utility of the Fucci2a system in the mammary gland to study 
proliferation, combined with 3D imaging. Further work examining this at different ages, utilising 
FACS to measure mVenus and mCherry expression would provide valuable quantification of cell 
cycle states, as has been recently shown in different oestrous cycle stages (Shehata et al., 2018). 
Importantly, these data corroborate that seen with both EdU incorporation studies and Ki67 
staining, in that post-pubertal mammary glands have greatly reduced proliferation in comparison 
to younger animals 
  




Figure 5.2.26 Use of Fucci2a systm to study cell cycle in 12 week mammary 
glands  
(A) Schematic of the Fucci2a system, which uses mCherry tagged Cdt1 and mVenus 
tagged Geminin to visualise cell cycle stages. Cells in G1/G0 will be mCherry+ (red), whilst 
cells in G1/S transition will be mCherry+ and mVenus+ (yellow) due to co-expression of 
both reporters. Cells in S/G2/M will be mVenus+ (green), with cells just divided having no 
reporter expression (B) Examples of Fucci2a transgenic mammary glands from 12 week-
old mice co-stained with K8 for luminal cells. The majority of cells express mCherry 
indicating G1/G0 phase, however some cells were also seen to have no reporter expression 
(arrow heads), suggesting they have just divided. Images are representative from mammary 
glands of n=3 mice, showing maximum-intensity z-projections of individual channels, merge 
and optical slices of a region of interest (boxed and enlarged). 





Figure 5.2.27 Fucci2a system in 12 week mammary glands shows cells in G1/S 
transition 
Examples of Fucci2a transgenic mammary glands from 12 week-old mice co-stained 
with K8 for luminal cells and DAPI. (A) and (B) show representative images of rare 
yellow cells, expressing both reporters mVenus-Geminin and mCherry-Cdt1, 
suggesting these cells are in G1/S transition (arrowhead). Images are representative 
from mammary glands of n=3 mice, showing maximum-intensity z-projections of 
individual channels, merge and optical slices of a region of interest (boxed and 
enlarged). 
  




Figure 5.2.28 Fucci2a system in 12 week mammary glands shows cells in 
S/G2/M transition 
Examples of Fucci2a transgenic mammary glands from 12 week-old mice co-stained with K8 
for luminal cells and DAPI. Representative images of rare green cells with mVenus-Geminin 
expression, suggesting these cells are in S/G2/M phase of the cell cycle. Images are 
representative from mammary glands of n=3 mice, showing maximum-intensity z-projections 
of individual channels, merge and optical slices of a region of interest (boxed and enlarged. 
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5.3 Discussion  
By examining proliferation in a variety of ways, combined with optical tissue clearing and 3D 
imaging, these data have provided fascinating insights into the development and homeostasis of 
the mammary gland. Using wholemount imaging, we have also shown where the proliferative 
regions in the mammary gland are located, and that levels dramatically reduce with age. By 
combining EdU incorporation, Ki67 staining and the Fucci2a system, these data have provided a 
useful tool to assess proliferation and the cycling nature of functional, proliferative 
progenitor/MaSCs when overlaid with the lineage tracing models.  
 
 Overview of main findings  
One of the most interesting aspects of these data relates to the finding that proliferation within 
the pubertal mammary gland is not restricted to the TEB. Indeed, the result that proliferation 
could be detected in the duct is an unexpected result that has not been previously described; 
proliferation and growth in the developing mammary gland is usually reported to be mediated by 
the TEBs (Kenney et al., 2001; Hinck and Silberstein, 2005). However, this information is 
generally obtained from 2D sections, and as such this can be difficult to infer how that data fits 
with the 3D topology of the gland. Here, 3D imaging has allowed areas to be imaged in the 
context of the entire ductal network. This was first seen with Ki67 staining but given this marks 
cells in any stage of the cell cycle, combined with the rapid growth of the gland during pubertal 
development, this does not provide definitive information. However, the subsequent use of EdU 
incorporation and a relatively short chase period demonstrates that these cells detected in the 
ducts are in fact actively proliferating. 
 
Several recent studies have reinforced the traditional view that the TEB is responsible for ductal 
elongation, even when using 3D or intravital imaging  (Scheele et al., 2017). This highlights the 
potential limitations of these imaging methods (outlined in chapter 3) – or in the case of intravital 
imaging, the challenges associated with imaging at a high enough resolution. Given the notion that 
stem cells and progenitors are found throughout the ductal network, supported by both early 
transplantation studies and fate mapping work carried out the previous chapter of this thesis, it 
is logical that stem/progenitor cells that are deposited by the travelling TEB are able to contribute 
to the elongation of the gland, in addition to secondary branching of the duct. 
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It may also be that these ductal regions represent areas where functional stem or progenitor 
cells are found, which could represent a “transit-amplifying” population, acting as an intermediate 
population able to support the regenerative capacity of the gland. Indeed, this has been 
established in other epithelial tissues, including both relatively more quiescent systems such as 
the hair follicle (Hsu et al., 2014) and highly regenerative tissues such as the crypts of the intestine 
(Snippert et al., 2010). However, this raises important questions surrounding the signals involved 
in this. Whether this proliferation is cell-intrinsic or in fact these cells have been called to 
proliferation by stromal or niche signals – and whether these signals may be hormonal (for 
example oestrogen or progesterone) or rather signalling factors released by local stromal cells 
such as macrophages remains to be determined.  
 
Traditionally, it has been suggested that MaSCs reside in the basal population, and as such it 
would be expected that it would be these cells that proliferate during ductal morphogenesis 
(Plaks et al., 2013; Rios et al., 2014; Wang et al., 2015). However here, proliferation was detected 
in both the luminal and basal lineages during this time. Further in-depth quantitative analysis 
would be useful to illuminate definitively the proportion of luminal and basal EdU+ cells at 
different stages of development and within different regions of the ductal system. However, this 
finding also aligns with the conclusions of the previous chapter, in that two different lineage 
restricted stem/progenitor cell populations produce cells of the luminal and basal lineages. 
 
As discussed in the introduction, the cycling nature of MaSCs is not yet fully understood. 
Consequently, it is important to appreciate that the approaches utilised here would not detect 
the existence of quiescent stem or progenitor cells within the mammary gland. Indeed, these 
cells would not be labelled by EdU or Ki67, nor can they be distinguished from cells in G1 with 
the Fucci2a system. For this, long term label retention studies would be required using either 
EdU or H2B-GFP to detect cells which have remained over time. These have been previously 
used (Smith, 2005; Boras-Granic et al., 2014), but combining them with 3D imaging would provide 
further resolution of the nature of these cells. Alternatively, newer Fucci models have been 
developed, including one system (termed FUCCI4) which allows for the distinction between all 
phases of the cell cycle by utilising four different fluorescent indicators, as opposed the two used 
in the Fucci2a system here (Bajar et al., 2016). 
 
Using both Ki67 staining and EdU incorporation, high levels of stromal cell proliferation were 
detected. Unfortunately, spectral limitations prevented co-staining of stromal cell markers in 
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addition to DAPI, EdU and labelling of basal and luminal cells. However, it would be interesting 
to determine the identity of these proliferating stromal cells seen both in early and later puberty. 
Indeed, a number of immune cells (including mast cells, eosinophils and macrophages) have been 
implicated in supporting ductal elongation in puberty, but the degree to which these cells 
proliferate and expand in situ within the gland, or home from elsewhere has yet to be determined.  
 
Further, the degree to which the lymph nodes, which are found in close proximity to the 
mammary glands, may provide this stromal support is a matter that requires further investigation. 
This is a particularly interesting aspect, given the frequency with which lymph nodes are the 
primary sites of metastasis in breast cancer (Li et al., 2014). Moreover, there is increasing 
understanding of the relevance of the immune system in a number of malignancies, including 
breast cancer (Azizi et al., 2018), and so understanding the normal immune environment is vital.  
 
 Oestrous cycling relevance  
An important consideration when studying proliferation in the postnatal mammary gland is 
normalising for the oestrous stage of the mice. Indeed, particular attention to this aspect was 
paid here given the heterogeneity that has been reported. Indeed, this is highlighted by previous 
work which showed that the numbers of basal and MaSCs (indicated by mammary repopulating 
units, MRU) can fluctuate 4 and 14-fold respectively in FVB mice, depending on the stage of 
oestrous (Giraddi et al., 2015). By using MRUs as a measurement of stem cell activity, it has also 
been previously observed that the number of stem/progenitor cells are at a maximum during 
dioestrous (Joshi et al., 2010).  
 
Furthermore, in C57BL/6J mice it has been suggested that basal cells increase 3-fold in dioestrous 
compared with other oestrus stages, in addition to an up to 7-fold increase in MRUs. Finally, it 
has also been shown that cells in dioestrous are especially sensitive to the S-phase cytotoxin 5FU, 
with a 75% reduction in MRU number upon exposure (Giraddi et al., 2015). Together, these data 
provided the impetus to examine mice in dioestrous, under the assumption that this is the most 
active stage of the oestrous cycle.  
 
However, more recent work has highlighted the heterogeneity even within this stage of the 
oestrous cycle. Utilising the Fucci2 mouse model together with sequential administration of DNA 
intercalators, these authors further highlighted the heterogeneity in both the cell cycle lengths 
of mammary epithelial cells, and the length of oestrous stages. As has been previously suggested, 
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they also demonstrated that there appears to be two distinct states of dioestrous, whereby cells 
are either highly proliferative or not. Furthermore, the inter-cycle heterogeneity was shown 
using CFSE labelling, which demonstrated that the proliferative expansion associated with 
dioestrous does not necessarily occur each cycle (Shehata et al., 2018). Here, we attempted to 
control confounding factors such as this by oestrous staging the mice and both injecting and 
culling at the same time every day. Furthermore, mice were examined for correct cycling for 7 
days prior. However, despite controlling for these factors, evidently it is not possible to be 
entirely certain when the mice cycle through the different stages, or to ensure that they do so 
at the same rate.  
 
 Importance and implications  
Identification of proliferative cells and regions in the mammary gland has implications for breast 
cancer. If cell populations are able to survive multiple cycles of proliferation and death throughout 
both oestrus cycles and multiple pregnancies, it raises the possibility that with the addition of 
oncogenic hits or pro-survival signalling from the niche then these could be the cells of origin, or 
at least contribute, to the development and maintenance of breast cancer.  
 
Previous work by others using gene expression profiling has shown that the genetic profiles of 
subpopulations of luminal cells in both mice and humans resemble that of two subtypes of breast 
cancer, luminal A and luminal B (Lim et al., 2010; Shehata et al., 2012), which account for 50% of 
breast cancers. Moreover, Ki67 has been implicated multiple times as a prognostic marker in 
breast cancer (Inwald et al., 2013), demonstrating the importance of understanding proliferation 
in the normal mammary gland 
 
 Overall conclusions  
Overall, the results presented in the chapter highlight the vast proliferative capacity of the 
pubertal mammary gland, and highlights the importance of using multiple methods combined with 
3D imaging. Moreover, the finding of ductal proliferation during pubertal development provides 





Chapter 6   
Assessment of an ex vivo organoid model 
to study mammary gland development  
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6.1 Introduction  
The work presented in this thesis has thus far have aimed to examine aspects of mammary gland 
development using agnostic and unbiased methodologies in vivo. Through the use of such 
techniques, we have highlighted a number of novel insights into mammary gland and stem cell 
biology. In this chapter, we sought to determine whether our observations were recapitulated 
in an ex vivo organoid culture model. Although potentially less faithful to true biological processes 
than their in vivo counterparts, ex vivo culture systems offer numerous opportunities for rapid 
and complex perturbation studies, for example CRISPR/Cas9 gene editing or small molecule drug 
treatment, which can aid in a holistic understanding of mammary gland development in health 
and disease. 
 
6.1.1 Background of 3D culture models in the mammary gland 
Although in vivo models are generally thought to have higher fidelity to processes of human health 
and disease, ex vivo culture systems have specific utility in perturbation and high throughput 
studies. For example, a recent study by Bruna et al., established a biobank of more than 80 patient 
derived xenograft (PDX) models of breast cancer (Bruna et al., 2016). The authors found that 
although the models were more representative of their originating samples when expanded in 
vivo, it was only when ex vivo culture systems were established that high throughput drug screens 
were possible.  
 
Over the last five decades, in vitro and ex vivo culture methodologies for human mammary cells 
have become more complex, drawing on our increasing understanding of the complexity of 
signalling in the tissue niche. Indeed, it has been demonstrated that a number of cell signalling 
networks are significantly altered when cells are in 2D rather than 3D – highlighted by the fact 
that drug screening outcomes often are not replicated when taken into an in vivo setting. Even 
when controlling for a lack of cellular diversity, factors often overlooked in in vitro culture systems 
such as cellular tension and surface nanotopography can have profound effects on cellular 
behaviour (Cassidy, 2014). Traditionally, in vitro cultures of mammary cells (for example 
MCF10As) have largely comprised monolayers cultured on tissue culture plastic.  The first 3D 
culture model of the mammary gland was described in 1977, utilising floating collagen membranes 
in a medium containing insulin, hydrocortisone and prolactin. This system was composed of a 
continuous “pavement” of mammary epithelial cells with some alveolus-like structures that could 
be maintained for one month in culture (Emerman and Pitelka, 1977). Since this time, more 
complex collagen-based cultures have been developed, utilising both scaffolds (Campbell et al., 
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2017; Hume et al., 2018b) and gels to study aspects of mammary biology, including branching 
morphogenesis and migration of mammary cancer cells. 
 
Recently, the development of ECM-based gels has led to an explosion in protocols for so-called 
“organoid” systems, largely pioneered by culture of single Lgr5+ intestinal stem cells into mini 
crypt-villus structures (Sato et al., 2009). Since then, a number of other organoid culture systems 
have been developed for other epithelial tissues, including the liver (Huch et al., 2014), stomach 
(Barker et al., 2010), and pancreas (Huch et al., 2013a). This has led to confusion in the 
nomenclature, with the term organoid having different definitions depending on the tissue of 
origin. Largely, organoids can be defined as in vitro or ex vivo cultures of 3D cellular clusters that 
have been derived from primary tissue, embryonic stem cells, or induced pluripotent stem cells, 
which are capable of self-renewal and self-organisation, and  can exhibit similar organ functionality 
as the tissue of origin (Fatehullah et al., 2016).  
 
Given the uncertainty of the identity of the stem cells within the mammary gland, the term largely 
refers to primary explants of epithelial ducts into 3D ECM gels, as opposed to clonal cultures 
derived from single cells (Shamir and Ewald, 2014). A number of ECM gels have been developed 
for this, but Matrigel is the most widely used, having been originally described in 1977. It is derived 
from the secretions from tumours of the Engelbreth-Holm-Swarm (EHS) mouse sarcoma cell 
line (Orkin et al., 1977), with its major constituents being collagen IV, laminin and fibronectin, in 
addition to a number of growth factors including TGFβ and EGF – all of which are components 
of the basement membrane in the mammary gland  
 
Consequently, a number of organoid culture systems for the murine mammary gland have 
recently been described which have contributed significantly to our understanding of the biology 
of the mammary gland, providing insights into aspects such as differentiation, hormonal 
regulation, paracrine signalling and cell-cell interactions (Mroue and Bissell, 2013; Shamir and 
Ewald, 2014). Some of these methods have shown that cultures can be derived from single, FACS 
sorted mammary epithelial cells (Jamieson et al., 2017). However, the process of dissociation the 
mammary gland into single cells for this process has been shown to disrupt the normal biology. 
Moreover, this prevents inclusion of the mammary mesenchyme, including stromal cells, which 
have been shown to be vital in supporting mammary gland development and homeostasis.  
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A protocol that does not require dissociation into single cells for downstream FACS and allows 
for long term culture that recapitulates the normal mammary gland was chosen. This method 
utilises a medium containing growth factors which have been shown to be important for 
mammary gland development and maintenance including Neuregulin1 (Nrg1) and R-spondin 1 
(Rspo1) (Cai et al., 2014). Importantly, vital aspects of mammary gland biology are maintained, 
including luminal/basal cellular organisation and hormone receptor expression in luminal cells 
(Jardé et al., 2016). Indeed, organoids were even seen to express milk protein when stimulated 
with prolactin to induce differentiation, demonstrating that they retain this important 
functionality.  
 
6.1.2 Importance  
The utility of ex vivo models which recapitulate the tissues of origin have far reaching uses. Indeed, 
well characterised organoid culture systems have been developed for a number of other epithelial 
tissues as mentioned above, which have been used in the study of both homeostasis and 
carcinogenesis. For example, a biobank of 20 human colorectal carcinoma (CRC) organoids has 
recently been described that largely recapitulates molecular features of the originating tumour 
sample (van de Wetering et al., 2015). Through exome-sequencing and RNA expression analysis, 
the authors were able to show that the CRC organoid biobank captures most of the mutational 
and expression landscapes observed in large CRC studies. Furthermore, screening of these 
cultures was carried out using an 83-compound library to identify molecular signatures associated 
with drug responses, highlighting the utility of in vitro 3D cultures in the drug discovery process.  
 
The development of an organoid culture system in the mammary gland would provide a model 
to study developmental mechanisms and tease out specific pathways of interest, in addition to 
showing translational benefit in breast cancer drug screening studies. In order to develop such a 
culture methodology, we sought to qualitatively assess the fidelity of organoid culture protocols 
for maintaining features of mammary gland biology, and mammary stem cell behaviour, elucidated 
and described earlier in this thesis.   
 
6.1.3 Aims 
This chapter aims to assess the use of 3D organoid culture to study aspects of mammary gland 
development that have been explored in this thesis, mainly assessed through the use of the three 
techniques described in the previous chapters: 3D imaging using optical clearing, lineage tracing 
using the R26[CA]30 model and examining proliferation with EdU incorporation. 




6.2.1 Assessment of organoid biology 
As discussed, a number of methods have been developed for 3D ex vivo culture of the mammary 
gland. In the system used here, mammary epithelial cells are derived from the glands of adult 
virgin mice. Briefly, tissues were mechanically minced then enzymatically digested before a brief 
fibroblast depletion step to remove the bulk of the fibroblasts. After this, cells were re-suspended 
in Matrigel, plated and maintained in culture with organoid media for up to four months. After 
only a day in culture, small spherical organoids could be observed (Figure 6.2.1,i), which were 
seen to begin to branch in under a week (Figure 6.2.1,v). We next sought to investigate the 
organoids in more detail, focussing on how well they recapitulated the biology of the normal 
mammary gland. As such, we moved to higher resolution imaging using confocal microscopy.  
 
Due to the 3D nature of the organoids, it is important to be able to observe them in multiple 
focal planes to fully appreciate their morphology, similar to the in vivo mammary gland. Some of 
the older cultures were seen to be particularly large, at times reaching up to 1mm in diameter, 
and as such we also investigated if optical clearing could be used to achieve increased imaging 
depths, and so turned to CUBIC optical clearing. As the cultures lack adipocytes, they do not 
have the same imaging limitations as the in vivo gland, and so our clearing protocol was adapted 
to be limited to a short incubation with CUBIC R2, rather than sequential incubations in R1 
which contains high concentrations of detergents. Using confocal microscopy, imaging depths up 
to 300µm could be achieved, which was considerably greater than that possible with uncleared 
organoids (typically 100µm). Using this high depth imaging methodology, we noted considerable 
heterogeneity in organoid morphologies. Organoids could be broadly divided into three 
morphological types: cystic spheres, branched structures, and budding structures. Interestingly, 
similar phenotypes have been described in both normal mouse mammary (Jamieson et al., 2017) 
and human breast cancer organoids (Sachs et al., 2018). 
 
To further profile our organoid cultures, we next assayed expression of normal lineage markers 
by immunocytochemistry (staining controls for each channel shown in Figure 6.2.1). Basal cells 
markers in the normal mammary gland include smooth muscle actin protein SMA, the 
transcription factor p63 and the keratin K5. In the organoids, p63 was seen to be uniformly 
expressed in the outer cell layers (Figure 6.2.3). SMA was less consistently expressed in both 
uncleared and cleared organoids, indeed some organoids did not stain well for SMA despite 
having good p63 expression (Figure 6.2.4a). Given its purpose, SMA could be considered as more 
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of a functional marker of basal cells while p63 may mark less differentiated cells of the basal 
lineage. Alternatively, it may be that the process of dissociation and regeneration in an abnormal 
environment led to SMA expression either being disrupted or not being required, although other 
studies using the same protocol have found organoids had normal SMA expression (Jardé et al., 
2016). Indeed, K5 staining was uniform, although the morphology of some cells was slightly less 
elongated when compared with that seen in wholemount mammary glands (Figure 6.2.4b). Thus, 
basal cells are thought to exist in our organoid cultures, despite a lack of SMA expression being 
seen.  
 
We next examined the expression of luminal lineage markers, E-cad and K8. E-cad expression 
could be seen uniformly in all luminal cells; however, this was not the case with K8. A number 
of E-cad+ luminal cells have either very low or no expression of K8. In some organoids, the 
pattern was particularly interesting – the more budding cultures seemed to have only rare K8+ 
cells (Figure 6.2.5a). On the other hand, some organoids had K8 expression only in certain 
regions (Figure 6.2.5b). This is interesting given the variable K8 expression that was seen in the 
in vivo gland (see Chapter 4.2.2.2). The more budded cultures did seem to have a morphology 
reminiscent of lobuloalveolar structures seen during lactation. Further work examining protein 
expression would be useful to explore this further, in particular, markers such as -casein could 
enable us to investigate the process of lobuloalveologenesis and milk production.  
 
A vital function of the luminal lineage is its response to endogenous hormones and endocrine 
cues, and as such, expression of hormone receptors is seen as a hallmark of the luminal lineage. 
Therefore, expression of PR was assessed in the organoids. PR expression was seen in a number 
of luminal cells (Figure 6.2.6a and b). Together, this suggests that despite aberrant K8 expression 
in some cells, the luminal lineage is maintained in these cultures. Again this observation reflects 
that observed in vivo where a subset of luminal cells express PR. 
 
To explore stem cell enrichment by our culture conditions, organoids were also cultured in basic 
media, without the main growth factors that have been shown to be required for mammary gland 
organoid growth (Nrg1, noggin and Rpso1) (Jardé et al., 2016; Jamieson et al., 2017). Cells 
cultured under these conditions did grow as small 3D spheres, but at a much slower rate 
compared to those grown in complete media. After a week, most cultures were mainly 
composed of stromal cells and fibroblasts. The organoids were examined using confocal 
microscopy for lineage markers, and although both SMA+ basal cells and K8+ luminal cells were 
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present, the overall morphology was disrupted, with discontinuous cell layers seen. Moreover, 
these cultures did not re-grow on passage, suggesting the growth factors used are required for 
organoid maintenance.  
 
Organoids established from other tissues do not necessarily perfectly reflect the in vivo 
morphology seen in their originating tissues. For example, liver organoids are composed of a 
single layer epithelium in a cystic sphere, as opposed to a branching structure as seen in the in 
vivo ducts (Huch et al., 2013b). Organoids in our study displayed a branching pattern reminiscent 
of the in vivo mammary gland, although they did not always have a single bi-layer of basal and 
luminal cells. As such, lumen presence was assessed using the tight junction scaffolding protein, 
zona occludens 1 (ZO1). In the in vivo mammary gland, ZO1 is expressed on the apical membrane 
of luminal cells, where it is essential for tight junction formation (Stull et al., 2007). In our 
organoids, ZO1 expression could be seen in multiple areas within the centre of the cultures 
(Figure 6.2.8). However, there did not appear to be continuous expression around a central 
lumen, suggesting tight junctions and lumen formation within the organoid is not identical to the 
in vivo mammary gland. Interestingly, in 3D mammary cultures grown in ECM gel, ZO1 expression 
is continuous on the apical surface of organoids (Jechlinger et al., 2009). This further reinforces 
the importance of recapitulation of the in vivo ECM in these cultures.  




Figure 6.2.1 Time course showing the initial growth of mammary gland 
organoids  
Organoids were cultured in Matrigel and imaged using brightfield microscopy from day of 
culture (Day 0, (i). By the end of the first day, small spheres had formed which expanded in 
size (ii-iv). By day 7 (v), organoids began displaying a branched morphology which became 








Figure 6.2.2 Staining controls for confocal microscopy of organoids 
Organoids were prepared for staining using the normal protocol (see methods), excluding 
the primary antibody staining step. Images show maximum intensity projections of 
secondary antibody only controls in: (A) wholemount uncleared organoids and (B) cleared 








Figure 6.2.3 Basal lineage marker staining in mammary gland organoids: 
p63 
(A) and (B) show representative images of p63 expression in basal cells of mammary gland 
organoids, also stained with DAPI, K8 and E-cad. Images are maximum-intensity z-
projections of individual channels, merge and magnified optical slices of a region of interest 








Figure 6.2.4 Basal lineage marker staining in mammary gland organoids: 
SMA and K5 
(A) Representative image showing incomplete SMA expression in basal cells of mammary 
gland organoids, also stained with DAPI and K8. (B) Representative image showing normal 
K5 expression in basal cells, also stained with DAPI. Images are maximum-intensity z-
projections of individual channels, merge and magnified optical slices of a region of interest 
(boxed and enlarged). 
 
  




Figure 6.2.5 Luminal lineage marker staining in mammary gland organoids: 
K8 and E-cad 
(A) Representative image showing sparse K8 labelling in luminal cells of mammary gland 
organoids, also stained with DAPI, K8 and E-cad. (B) Representative image of K8 expression 
in luminal cells only in the centre of an organoid, also stained with DAPI and p63. Images 
are maximum-intensity z-projections of individual channels, merge and magnified optical 
slices of a region of interest (boxed and enlarged, right). 
 
  




Figure 6.2.6 Luminal lineage marker staining in mammary gland organoids: 
hormone receptors  
Representative images showing PR expression in luminal cells of mammary gland organoids, 
also stained with DAPI and K8. (A) and (B) show an inner layer of K8+PR+ luminal cells. 
Images are maximum-intensity z-projections of individual channels, merge and magnified 
optical slices of a region of interest (boxed and enlarged, right). 
 
  




Figure 6.2.7 Mammary gland organoid formation in basal media  
(A) Representative brightfield images showing growth of mammary gland organoids after 1 
week in culture in basal media, without growth factors. (Bi,ii) Representative confocal 
images showing SMA+ basal and K8+ luminal cells in basal cultures conditions, with 
discontinuous cell layers seen. Images are maximum-intensity z-projections of individual 








Figure 6.2.8 Lumen formation in mammary gland organoids using ZO1 
Representative images showing ZO1 expression in mammary gland organoids, also stained 
with p63 and E-cad (for basal and luminal cells, respectively). (A) and (B) show an inner 
layer of a large organoid. Images are maximum-intensity z-projections of individual channels, 
merge and magnified optical slices of a region of interest (boxed and enlarged, right). 
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6.2.2 Investigating stromal cell presence in organoid cultures  
As previously discussed, stromal cells play an important part in mammary gland development 
and homeostasis (See Chapter 1.1). CD45 staining in optically cleared tissue has shown an 
abundance of immune cells both in the mammary stroma, and in close proximity to the ductal 
network (Dr Jessica Hitchcock, unpublished, Figure 6.2.9). CD45 is a pan-immune cell marker, 
selected to detect the presence of any of the several immune cell subtypes shown to be 
present in the mammary gland (see introduction). The organoid culture method used in this 
study was selected in part to maintain any native stromal cells by avoiding specific depletion 
steps.  
 
Indeed, although the growth factors included in this culture are specific for mammary epithelial 
growth, brightfield images of the cultures showed a number of what appeared to be stromal 
cells growing, in addition to the mammary organoids, and often in close proximity (Figure 
6.2.10). Immunocytochemistry confirmed the presence of multiple CD45+ cells in our 
organoid cultures, with a number also seen in tight association with the epithelial cells, in a 
similar manner to that seen in vivo (Figure 6.2.11). Further examination of the morphology of 
these cells suggested that several different immune cell subtypes may be present, although 
further staining would be required to accurately identify which immune cell types these are. 
Indeed, some small, rounded cells with an appearance similar to T-cell morphology (Figure 
6.2.12a, arrowhead), whereas other larger cells were reminiscent of monocytes such as 
macrophages (Figure 6.2.12b, arrowhead). The purpose of these cells in the organoid cultures 
is not clear – whether they support organoid development or rather are passively remaining 
from mammary gland dissociation is yet to be seen - functional studies or investigation into 
the cytokine environment of these cultures would certainly be of value.  
 
  




Figure 6.2.9 Example of immune cells in the in vivo mammary gland using 
CD45 
Maximum-intensity z-projection of CD45-expressing immune cells in an adult virgin 
mammary gland with SMA co-staining, imaged in 3D using CUBIC optical tissue clearing and 
confocal microscopy. Image courtesy of Dr Jessica Hitchcock (unpublished).  
 
  




Figure 6.2.10 Brightfield images of stromal cells in mammary organoid 
cultures    
Representative images showing examples of murine mammary gland organoid cultures 
containing stromal-like cells in close contact with the epithelial structures.  
 
  




Figure 6.2.11 CD45 cells in mammary gland organoid cultures  
Representative images showing examples of CD45+ immune cells in mammary organoid 
cultures. Cells of different morphologies could be observed with small, T-cell like cells (A) 
seen. Larger cells with a more monocyte-like morphology were also seen (B). Both were 
in close proximity to the epithelial organoids. Images are maximum-intensity z-projections 








Figure 6.2.12 CD45 cells in mammary gland organoid cultures  
Further representative images showing examples of CD45+ immune cells in mammary 
organoid cultures. Cells of different morphologies could be observed with small, more T-
cell like cells (A) seen. Larger cells with more of a monocyte-like morphology was also seen 
(B). Both were in close proximity to the epithelial organoids. Images are maximum-intensity 
z-projections of individual channels, merge and magnified optical slices of a region of interest 
(boxed and enlarged, right). 
 
  
Chapter 6 - Results 
228 
 
6.2.3 Investigating proliferation in organoid cultures  
In the previous chapter, the proliferation in the mammary gland was investigated using Ki67 
staining and EdU incorporation (see Chapter 5.2.2). By examining the mammary gland in 
multiple focal planes, we uncovered interesting patterns of proliferation not often described 
in the literature, such as proliferation in the duct during pubertal morphogenesis. As such, we 
next investigated proliferation in our organoid models to elucidate whether these proliferative 
patterns were recapitulated ex vivo. In particular, we sought to answer whether expansion of 
the branched organoids can occur through proliferation throughout the organoids - in a similar 
manner to the in vivo gland - or whether expansion occurs due to tip-dependent growth. This 
was first examined using Ki67 staining, labelling cells in G1/S/G2/M phase of the cell cycle. 
Ki67+ cells were generally found throughout the organoids, in both basal and luminal epithelial 
cells (Figure 6.2.13 a,b) suggesting proliferation throughout.  
 
Next EdU incorporation in the organoids was used as a more specific marker of cells 
undergoing DNA replication. In a previous chapter (Chapter 5.2.1), slight differences were 
seen in Ki67 staining and EdU incorporation in the mammary gland in vivo, potentially due to 
the differences in cell cycle phases they mark. We selected a pulse-chase of two hours in our 
organoid cultures - slightly shorter to that used in vivo in an attempt to account for differences 
in EdU diffusion through the ECM as opposed to I.P. injection in mice. Cultures were then 
stained for EdU and lineage markers, including an EdU staining control (Figure 6.2.14), and 
imaged using confocal microscopy. 
 
Generally, EdU incorporation was seen to occur in a similar pattern to Ki67 staining, with 
specific differences seen depending on the type of organoid morphology. In budding organoids, 
which had shorter protrusions, EdU+ cells were seen throughout the organoid (Figure 6.2.15). 
In more branched cultures, the majority of EdU+ cells appeared to be found on the tips of the 
branches (Figure 6.2.16). EdU incorporation occurred in both luminal and basal cells within 
the organoids (Figure 6.2.17). Ongoing work should focus on quantification of proliferative 








Figure 6.2.13 Examination of proliferation in mammary organoids using 
Ki67 staining  
Representative images showing examples of Ki67 staining showing proliferation in 
mammary gland organoids co-stained with DAPI, p63 (basal) and K8 (luminal) lineage 
markers. Images are maximum-intensity z-projections of individual channels and merge. 
 
  




Figure 6.2.14 EdU staining control in mammary organoids 
Representative images showing background EdU staining in organoids not treated with EdU, 
and stained with the EdU staining protocol and DAPI, K8 and K5 lineage markers. Images 








Figure 6.2.15 Examination of proliferation in mammary organoids using EdU 
incorporation  
Representative images showing proliferation in organoids by EdU incorporation, co-stained 
with DAPI, K8 and K5 lineage markers. Images are maximum-intensity z-projections of 








Figure 6.2.16 Examination of proliferation in mammary organoids using EdU 
incorporation  
Representative images showing proliferation in branched tips of organoids by EdU 
incorporation, co-stained with DAPI and K8 luminal lineage marker. Images are maximum-
intensity z-projections of individual channels and merged. 
 
  




Figure 6.2.17 Examination of proliferation in mammary organoids using EdU 
incorporation  
Representative images showing proliferation in organoids by EdU incorporation, co-stained 
with DAPI, K8 and K5 lineage markers. Images are maximum-intensity z-projections of 
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6.2.4 Lineage tracing  
A key area of study in mammary gland biology is defining the specific potency of stem and 
progenitor cells. Using neutral lineage tracing models, in Chapter 4 we demonstrated that the 
stem cells involved in the morphogenic events of the mammary gland are lineage restricted. 
We sought to ascertain whether this conclusion was supported by MaSC growth in our 
organoid system. To do this, organoids were derived from the mammary gland of mice 
hemizygous for R26[CA]30 YFP and tracing examined at different time points.  
 
Interestingly, despite high amounts of proliferation required for organoid formation, slippage 
was still relatively infrequent. The [CA]30 slippage rate in murine embryonic fibroblasts in 
culture (with 95% confidence interval) has been reported as 1.06 ± 0.38 ×104 per mitosis  
(Kozar et al., 2013), and although quantification in our organoid system would be needed to 
confirm this observation, it appears slippage events are rare enough in our model to ensure 
clonal labelling. 
 
Previously, dissociation of the mammary gland, especially to single cells for FACS, has been 
shown to significantly disrupt its normal biology – potentially putting it under a “regenerative 
state” (Shehata et al., 2012). As such, we next investigated if this is the case for this organoid 
system by examining the potency of clones, characterised by co-expression of lineage markers 
(SMA, K5 or p63 for basal, and K8, E-cad or EpCam for luminal). All smaller clones examined, 
comprised of less than 10 cells, were of a single lineage – that is either consisting of only 
luminal (Figure 6.2.18a,i and ii) or only basal labelled cells (Figure 6.2.18b). Given that [CA]30 
slippage in this model is continuous, it may be that these cells represent the progeny of a 
recently labelled cell, or a progenitor with limited differentiation capacity. This was also the 
case for medium-sized clonal regions, classed as those with 10 – 50 labelled cells (Figure 
6.2.19). 
 
However, a number of larger clones (comprising of more than 50 cells) had labelled cells of 
both luminal and basal lineages (examples seen in Figure 6.2.20 and Figure 6.2.21). Given both 
the artificial system, and the regenerative state that may be induced, it is not surprising that 
mammary stem or progenitor cells involved in organ formation may not be lineage restricted, 
and in fact be bipotent. Alternatively, it cannot be ruled out that these larger clones represent 
the progeny from two (or more) lineage restricted stem cells. Whether these cells are the 
same cells that are involved in ductal elongation and alveologenesis, or whether they are an 
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entirely different population of stem/progenitor cells that is activated upon culture remains to 
be determined.  
 
Of note, there was a striking similarity in labelling patterns seen in the organoids to that seen 
in the in vivo mammary gland. Specifically, labelled cells were seen to be intermixed with 
unlabelled cells. This suggests that these organoids are formed from multiple stem and 
progenitor cells, in a similar manner to that demonstrated in the in vivo gland in Chapter 4. 
Alternatively, [CA]30 slippage may have occurred in the stem/progenitor cell at a later stage 
of organoid growth.  
 
  




Figure 6.2.18 Examples of small clonal regions in R26[CA]30 YFP mammary 
organoids  
Representative organoids showing small clonal labelled regions in R26[CA]30 YFP mammary gland 
organoids, comprised of less than 10 YFP+ cells. (Ai,ii) shows lineage restricted luminal clones. 
(B) shows lineage restricted basal clone. Images are maximum-intensity z-projections of 
individual channels, merge and magnified optical slices of a region of interest (boxed and 
enlarged, right). 





Figure 6.2.19 Examples of medium-sized clonal regions in R26[CA]30 YFP 
mammary organoids 
Representative organoids showing medium-sized clonal labelled regions in R26[CA]30 YFP 
mammary gland organoids, comprised of 10-50 YFP+ cells. (A) and (B) show lineage 
restricted luminal clones. Images are maximum-intensity z-projections of individual 








Figure 6.2.20 Example of a large clonal region in R26[CA]30 YFP mammary 
organoids 
Representative image of a R26[CA]30 YFP mammary gland organoid with a large (50+) labelled 
clonal region. (A) Shows maximum-intensity z-projections of individual channels and merge. 
(B) Magnified optical slices of a region of interest boxed in (A). Labelled cells are both 
luminal (arrowhead) and basal (arrow). 
 
  




Figure 6.2.21 Example of a large clonal region in R26[CA]30 YFP mammary 
organoids 
Representative image of a R26[CA]30 YFP mammary gland organoid with a large (50+) labelled 
clonal region. (A) Shows maximum-intensity z-projections of individual channels and merge. 
(B) Magnified optical slices of a region of interest boxed in (A). Labelled cells are both 
luminal (arrowhead) and basal (arrow). 
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6.3 Discussion  
 
6.3.1 Overview  
Traditional 2D culture systems have multiple drawbacks, specifically in recapitulating the complex 
milieu of growth factors, cytokines and physical signalling cues found in vivo. Although potentially 
more faithful to the underlying biology, in vivo models have specific limitations in their lack of 
amenability to high throughput screening and ease of perturbation studies. Complex, 3D, culture 
methodologies are increasingly being developed to bridge the gap between tractability of in vitro 
systems and biological relevance of in vivo models. In mammary gland and stem cell biology, the 
specific utility of such 3D ex vivo tissue models are being increasingly understood. However, it is 
important to understand how well they recapitulate the normal mammary gland biology, together 
with their specific limitations. The focus of this thesis has been mammary gland development and 
associated stem cells. In this chapter we aimed to characterise an ex vivo culture methodology, 
specifically focussing on the degree to which our prior findings could be recapitulated in this 
model.  
 
Our organoid culture protocol was adapted from a methodology first described by Jardé et al. In 
this study, the authors reported that organoids could be maintained in culture for up to two and 
a half months whist retaining normal morphology and chromosomal stability.  In our study, 
chromosomal number was not specifically investigated, but disruption in the normal cell layers 
was seen in organoids cultured for up to four months, Interestingly,   we noted lack of K8 and 
SMA expression in some organoids; the  exact reason for these differences are not clear, but 
batch to batch variations can be particularly significant in Matrigel and growth factors. One reason 
for the absence of SMA may be due to the lack of appropriate basement membrane. Although 
Matrigel expresses many of the proteins also seen in basement membranes, it cannot fully 
recapitulate both the molecular and physical characteristics. Given that basal cells, by definition, 
line the basement membrane, it may be that they are especially sensitive to changes in this.  
 
Matrigel was utilised for culturing of organoids. However, a number of limitations of Matrigel 
have been highlighted in recent years, largely due to its origin. Matrigel is derived from the 
secretions from tumours of the Engelbreth-Holm-Swarm (EHS) mouse sarcoma cell line. This 
means the synthesis is not tightly controlled resulting in significant batch-to-batch variations in 
exact constitution and protein and growth factor content. Here, the growth factor reduced 
variant has been utilised, however even this has been shown to vary up to 50% in protein content 
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among different suppliers (Hughes et al., 2010). This uncertainty of exact composition may result 
in experimental variations which can lead to reduced reproducibly. Consequently, using Matrigel-
based organoid systems such as the one described herein may not be appropriate in experiments 
which require knowledge of exact protein constituents and concentrations. Here, we have tried 
to control for these aspects by ensuring experiments used similar batches. However, 
development of models utilising known ECM substitutes would be valuable. 
 
We sought to determine whether our organoid models recapitulated observations in specific 
patterns of proliferation seen in vivo. Ki67 staining and EdU incorporation studies demonstrated 
that proliferation largely occurs in the expanding tips of branches within organoids, in a manner 
reminiscent of TEBs in the pubertal gland (Paine and Lewis, 2017). Indeed, organoid branches 
could be seen to have bifurcated, highlighting the similarities to the in vivo gland. However, Ki67 
staining and EdU incorporation only allow investigation of proliferation at a fixed timepoint and 
in fixed samples. An interesting future study could derive organoids from transgenic FUCCI mice, 
as shown in Chapter 5, to further investigate proliferation in organoid models. Similar studies 
have been completed in organoids derived from both the taste buds (Aihara et al., 2015) and 
intestine (Carroll et al., 2018), which allowed more accurate resolution of cell cycle stage. 
Further, FUCCI-organoids could be imaged live for real-time assessment of cell cycle stages, 
giving us an even greater understanding of specific kinetics of proliferation within the growing 
organoids.  
 
Live imaging could also be utilised to examine lineage tracing in situ within the organoids as it 
happens, which would also allow for definitive examination of potency. Indeed, this was 
attempted with the R26[CA]30 YFP system to examine live slippage and reporter expression. 
However, unfortunately the fluorescent intensity of the YFP reporter of this model is not strong 
enough, and imaging required an antibody to amplify the signal. An interesting future investigation 
could include the use of a reporter with strong enough signal to allow for live imaging. One such 
system could be the R26-Confetti system, used in Chapter 4. Indeed, the use of this has been 
demonstrated in organoid systems of both the mammary gland (Jamieson et al., 2017) and taste 
bud (Aihara et al., 2015). It also has the added benefit of allowing timing of tracing, and multiple 
colours for better separation of clones. 
 
As discussed, the one of the greatest limitations of organoid systems is that they generally lack a 
functional microenvironment and the associated signalling that this provides. Attempts to reduce 
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these limitations, for example by using more biologically relevant ECM-matrices with control of 
physical signalling cues, have shown promising results (Sokol et al., 2016; Miller et al., 2018). 
However, one of the aspects that is more challenging to recapitulate is soluble cues, which are 
particularly important for mammary gland biology - such as ovarian hormone signalling, which is 
a key driver in the morphogenesis of the mammary gland both during development and 
homeostasis (Ruan et al., 2005; Rajaram et al., 2015). 
 
Here, PR expression was maintained in the luminal cells suggesting hormone sensing is still 
possible. Previously, hormones associated with lactation, such as prolactin, have been shown to 
induce milk protein expression, again highlighting that organoids maintain hormone sensing 
capabilities (Jardé et al., 2016; Jamieson et al., 2017). Since oestrous cycling is another important 
aspect of mammary gland biology, it would be interesting to investigate if exogenous application 
of progesterone and oestrogen, to mimic the different endocrine environments of the different 
oestrous stages, would affect mammary organoid morphology in a similar manner to that seen in 
vivo. 
 
6.3.2 Importance and implications  
Development of better in vitro systems for tissue culture is vital for not only increasing 
understanding of normal biology, but also for providing a system for high throughput screening 
in drug development – an area which has been severely affected by the lack of appropriate models 
(Cassidy et al., 2016). Moreover, the use of 3D models is a particularly attractive aspect for 
studying human breast development, given the difficulties and associated differences between 
woman and mouse. A number of these models have been investigated using different substrates, 
including a particularly elegant system using floating collagen gels which facilitate the development 
of structures resembling human terminal ductal-lobular units (Linnemann et al., 2015). Further 
characterisation of the role of stem and progenitor cells in the development of these models will 




Chapter 7   
Discussion  




7.1 Context  
Aside from gaining a greater understanding of normal tissue development, study of the stem and 
progenitor cells within an epithelial tissue structure can offer great insight into the processes of 
disease, notably including neoplastic transformation. The link between stem cell biology and 
cancer has been demonstrated in epithelial systems such as the intestine (Kozar et al., 2013) and 
stomach (Barker et al., 2010), in addition to haematopoietic stem cell involvement in blood 
malignancies (Prick et al., 2014). Within the mammary gland, the stem cell hierarchy is less well 
understood. Consequently, the involvement of MaSCs in malignant transformation is not entirely 
clear, but a number of studies have demonstrated a potential role (Koren et al., 2015; Lawson et 
al., 2015; Van Keymeulen et al., 2015).  
 
Indeed, the intrinsic subtypes of breast cancer (Luminal A, Luminal B, HER2-enriched and Basal-
like) have each been linked to neoplastic transformation of different cells in the MaSC 
developmental hierarchy, with relatively low concordance amongst the literature (Sorlie et al., 
2003; Prat and Perou, 2011). For example, it has been variably suggested that the cell of origin 
of both sporadic and BRCA1-mutated Basal-like breast cancers is a luminal progenitor cell, but 
also that an unknown MaSC (not a luminal progenitor) is the cell of origin of all Basal-like tumours 
(Prat and Perou, 2011). Clearly, further study is required to elucidate the MaSC hierarchy and 
how malignant transformation at different developmental stages can lead to breast cancer of 
distinct clinicopathological subtypes.  
 
Breast cancer is the most common cancer, with an estimated 2.4 million new diagnoses in 2015; 
indeed, one in 8 women and one in 603 men will develop breast cancer between birth and age 
79 years. In England alone, breast cancer accounted for 44,000 new cancer registrations in 2016 
and was the most commonly diagnosed cancer (Wang et al., 2016). These observations reinforce 
the global burden due to breast cancer, and the need for improved outcomes through the 
development of new clinical strategies which will become increasingly important over the next 
several decades. This can be achieved through a better understanding of breast cancer biology 
coupled with advances in prevention, detection and treatment. This includes characterisation of 
the origins and development of breast cancer, which first requires an understanding of the normal 
biology of the mammary gland (Wansbury et al., 2011). 
 
Chapter 7 - Discussion 
245 
 
Using a low-density, neutral, genetic labelling strategy, combined with a method of imaging that 
is free of proteolytic digestion, we have provided corroborating evidence of the lineage 
restriction of proliferative stem/progenitor cells at the three major stages of mammary 
development: in the late embryo, during puberty and in reproduction. These findings also confirm 
that remarkable heterogeneity exists within the adult mammary stem and progenitor cell 
compartment and suggests similar multiplicity within their embryonic precursors. However, 
whether these adult stem cells work cooperatively or competitively to achieve the required 
developmental and morphogenetic outcomes in the mammary gland is a particularly interesting 
aspect that remains unclear.  
 
Importantly, this work has also revealed the remarkable capacity of a single embryonic MaSC to 
contribute to ductal development, providing unprecedented insights that could only be disclosed 
by this single-cell approach. It is increasingly hypothesised that certain cancers may arise from 
reactivation of embryonic developmental programmes in postnatal tissues (Howard and 
Veltmaat, 2013; Wahl and Spike, 2017). Thus, an elucidation of the full spectrum of 
stem/progenitor cell populations in both the pre- and postnatal mammary gland is paramount for 
defining the cellular origin of heterogeneous breast tumours (Sreekumar et al., 2015). 
 
The origin of luminal and basal cell lineages in the mammary gland has been the subject of intense 
investigation and debate. Work shown in Chapter 4, in addition to recent saturation lineage 
tracing, single-cell lineage tracing and promoter driven lineage tracing studies have provided 
support for lineage restriction of MaSCs from late embryogenesis (Lilja et al., 2018; Lloyd-Lewis 
et al., 2018; Wuidart et al., 2018) into adulthood (Van Keymeulen et al., 2011; Davis et al., 2016; 
Wuidart et al., 2016; Scheele et al., 2017). The work shown here has also  demonstrated the 
capacity of these unipotent stem cells to contribute to the development of the adult mammary 
epithelium, while at the same time revealing significant redundancy in the construction of each 
major duct in puberty (Figure 7.1a) and lobuloalveolar structure in lactation (Figure 7.1b) (Davis 
et al., 2016; Wuidart et al., 2016; Scheele et al., 2017). However, studies attributing postnatal 
mammary gland development to bipotent stem cells  are still being published. Consequently, this 
raises the question - what level of evidence will be required to achieve a unifying definition of 
physiological MaSC potency? 
 
Finally, it is important to emphasise that the lack of evidence for the presence of multilineage 
clones does not unequivocally show that bi/multipotent stem cells do not exist (Visvader and 
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Stingl, 2014; Rios et al., 2016). Indeed, although the small number of cells initially labelled in the 
models shown here permits the indisputable analysis of clonal progeny, it also limits the power 
to detect and characterise the full spectrum of stem and progenitor cells that are present in the 
mammary epithelium. For example, quiescent bi/multipotent MaSCs, if they exist, would not be 
detected by this approach. Thus, it is imperative that the epithelial hierarchy in the mammary 
gland is rigorously assessed at various developmental stages, using a range of methods, models 
and systems of analyses.  
 
 
Figure 7.1 Schematic for proposed model of mammary stem cells  
Diagram outlines the common labelling pattern arising from the genetic labelling of a single lineage-
restricted MaSC/progenitor to (A) ductal morphogenesis and (B) alveologenesis, identified 
in R26[CA]30 mice and confirmed using the R26-Confetti model 
 
7.2 Defining a transcriptional profile of MaSCs 
In order to better understand the role of MaSC(s) in health and disease, we must define a possible 
molecular portrait of the cell. This has been achieved in other adult stem cell systems using single-
cell RNA-Seq, which allows whole-transcriptome profiling of individual cells (Bach et al., 2017; 
Kumar et al., 2017). This can then be combined with methods to either label single cells and all 
of their progeny (for example from single-cell lineage-tracing) or incrementally mark cells (for 
example using CRISPR-generated barcoding). This then creates a molecular profile of all cells 
within a single clone, which may then reveal a transcription profile of the cell of origin.  
 
Significant work has already been done in this regard, but there is still much disagreement in the 
field and disparities in findings between groups (Lim et al., 2010; Spike et al., 2012; dos Santos et 
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al., 2013; Bach et al., 2017). Moreover, a definitive marker of MaSCs has yet to be identified by 
these studies. Indeed, one recent study isolated cells from developing TEBs and found significant 
transcriptional heterogeneity in both luminal and basal cell populations. This highlights that it may 
not be possible to link behaviour and identity of stem cells in the mammary gland to a single 
molecular profile or specific markers (Scheele et al., 2017). Whether this heterogeneity is a 
function of varied positional location of MaSCs, or a reflection of the multiple states of potential 
MaSCs is as yet unclear.  
 
Stem cells are defined by their functional abilities, that is: proliferation, self-renewal, the 
production of a large number of differentiated progeny, tissue regeneration/repair, and flexibility 
within these states (Potten and Loeffler, 1990). The challenge in the mammary gland thus far has 
been how to study the functionality of a cell without inadvertently altering its function. Further 
refinement of lineage-tracing approaches and the application of other novel experimental models 
and methods for marking, visualising, and profiling individual cells will continue to provide 
important insights in this field (Clevers and Watt, 2018).  
 
7.2.1 Tracing of embryonic mammary stem cells  
A number of studies have previously revealed the bipotent nature of embryonic MaSCs, using 
both transplantation and lineage tracing studies (Van Keymeulen et al., 2011; Boras-Granic et al., 
2014). Here, lineage restriction in embryonic MaSCs from E17.5 was demonstrated using neutral 
fate mapping models from embryonic mammary development, to pubertal morphogenesis of the 
gland. This is corroborated by other reports using Notch lineage tracing models (Lilja et al., 2018; 
Wuidart et al., 2018). The signals involved in this switch from multipotency to unipotency is 
unclear and questions remain regarding the mechanisms, whether they be intrinsic – through 
transcriptional control - or extrinsic – for example via microenvironmental signalling. Exploration 
to further define the normal biology of the gland combined with delineating the exact time point 
and a molecular understanding for this temporal switch will be useful.  
 
 
7.2.2 Examination of proliferation. 
Using wholemount imaging, we have also shown where the proliferative regions lie in the 
mammary gland, and that proliferation levels dramatically reduce with age. The finding that EdU 
incorporation could be detected in the duct was unexpected, having not been previously 
described. Proliferation and growth in the developing mammary gland is usually reported to be 
Chapter 7 - Discussion 
248 
 
mediated by the TEBs (Kenney et al., 2001; Hinck and Silberstein, 2005). This supports the 
hypothesis that MaSCs may be laid down along the duct from the TEBs as the gland develops. 
Moreover, traditionally it has been suggested that MaSCs reside in the basal population (Plaks et 
al., 2013; Rios et al., 2014; Wang et al., 2015). Here, we have shown that at least during puberty, 
proliferation is found in both the luminal and basal lineages, in addition to the cap and body cells 
in the TEBs.  
 
In the post pubertal gland, oestrous cycling in the mammary gland provides a fascinating model 
of postnatal epithelial proliferation, degradation and regeneration on a short time scale. Here, 
proliferation was examined during dioestrous using 3D imaging, but further examination of 
different oestrous stages using these methods, in addition to examination of programmed cell 
death (for example using cleaved caspase 3 staining) will further elucidate the mechanisms 
involved in this turnover.  
 
7.3 Overall conclusions  
We posit that the MaSCs/progenitors that generate the ductal network during puberty are 
distinct unipotent cells that are distributed throughout the gland during ductal morphogenesis. 
These lineage restricted cells emerge from late embryonic development, demonstrated by 
marking cells during embryogenesis and tracking their fate into puberty (Figure 7.2). These data 
are consistent with previously reported work showing unipotent MaSCs being primarily present 
in the TEBs during puberty, where they proliferate and move towards the subtending duct as it 
elongates. This is supported by data shown herein, demonstrating that ductal cells also remain 
proliferative during ductal development. After completion of pubertal morphogenesis, these 
slow-cycling unipotent MaSCs/progenitors may then be deposited throughout the ductal network 
for later recruitment in response to pregnancy hormones to generate alveoli in the lactating 
gland, and even to a lesser extent with oestrous cycling.  
 




Figure 7.2 Working model of the mammary epithelial cell hierarchy  
Multipotent MaSCs are present in the embryo, but some also become lineage restricted during 
embryonic development. Postnatal mammary gland development (i.e. ductal and alveolar 
morphogenesis) is principally driven by unipotent luminal and basal mammary stem cells (MaSCs). 
Luminal stem cells give rise to ductal and alveolar cells that can be ER-positive or -negative. The 
extent of sub-lineage diversity in the basal compartment, and whether there are distinct ductal 
and alveolar basal cells, is not yet clear. In addition to the cells responsible for building mammary 
ducts and alveoli under physiological conditions (left panel), various studies indicate that 
quiescent and potential stem cells may also reside within the adult mammary gland (right panel). 
Quiescent bi/multipotent MaSCs (not detected by quantitative or single-cell lineage-tracing 
approaches) may remain in the mammary gland after embryonic development. In addition, a 
plastic, intermediate cell type with properties similar to the basal cell lineage may be capable of 
reverting to a multipotent state under regenerative conditions. 
 
Responsible for building ducts and alveoli 
during normal development and homeostasis 
Unknown / limited contribution during 
normal development and homeostasis 
































Genotyping protocols  
Confetti genotyping  
 
 x1 (µL) 
10x buffer 2 
DNTPs (10 µm) 0.5 
Forward primer 1 







Common reverse: 5’-CCAGATGACTACCTATCCTC  
Rosa26 forward: 5’-AAAGTCGCTCTGAGTTGTTAT 
Confetti mutant forward: 5’-GAATTAATTCCGGTATAACTTCG 
Cre forward: 5’-GCGGTCTGGCAGTAAAAACTATC 




94 C 3 min  
94 C 30 sec 
X 35 60 C 30 sec 
72 C 1 min 
72 C 5 min  













Component x1 (µL) 
10x buffer 2 
DNTPs 0.5 
Forward primer 1 







Rosa26 forward: ACAGAGGAGCCATAACTGCA 
Rosa26 reverse: TGGCAGGAAGGAGGCTTTAA 
CA30YFP reverse: GAACTTCAGGGTCAGCTTGC 




95 C 3 min  
95 C 30 sec 
X 35 59 C 1 min 
72 C 2 min 
72 C 5 min  






CUBIC reagent recipes  
Reagent 1(A) 
 
Ingredient Sigma cat # R1 %w/v R1a %w/v for 500ml R1a 
Urea U5378 25 10 50g 
N,N,N’,N’-
tetrakis  
122262 25 5 25g 
Triton x 100 BP151 15 10 50g 
5M NaCl - - 1:200 2.5mL 




Ingredient SIGMA CAT # ORIGINAL VOL. FOR 18G 
Sucrose  - 50% w/v 8 
Urea U5378 25% w/v 4 
Triethanolamine 90279 
 
10% w/v 1.6 
Triton x 100 BP151 0.1% w/v 180uL of 10% 


















Ingredient Supplier Final conc. In 1ML   
Stock medium  N/A N/A 980 
Neuregulin R&D, 5898-NR-050 10uL/mL 10 (of 1/10 diluted stock) 
Noggin Peprotech, 250-38 10uL/mL 10 (of 1/20 diluted stock) 
R-spondin-1 R&D, 3474-RS-050 100ng/mL 1 
  
Stock Ingredient Supplier 50 ML 
DMEM/F12  - 47 
Glutamax (x100) Invitrogen, 35050-038 0.5 
Hepes (1m) Invitrogen 15630-056 0.5 
Pen/strep (x100) Invitrogen, 15140122 0.5 
N2 supplement Gibco, 17502 0.5 
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Single-cell lineage tracing in the mammary
gland reveals stochastic clonal dispersion of
stem/progenitor cell progeny
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The mammary gland undergoes cycles of growth and regeneration throughout reproductive
life, a process that requires mammary stem cells (MaSCs). Whilst recent genetic
fate-mapping studies using lineage-specific promoters have provided valuable insights into
the mammary epithelial hierarchy, the true differentiation potential of adult MaSCs remains
unclear. To address this, herein we utilize a stochastic genetic-labelling strategy to indelibly
mark a single cell and its progeny in situ, combined with tissue clearing and 3D imaging.
Using this approach, clones arising from a single parent cell could be visualized in their
entirety. We reveal that clonal progeny contribute exclusively to either luminal or basal
lineages and are distributed sporadically to branching ducts or alveoli. Quantitative analyses
suggest that pools of unipotent stem/progenitor cells contribute to adult mammary gland
development. Our results highlight the utility of tracing a single cell and reveal that progeny of
a single proliferative MaSC/progenitor are dispersed throughout the epithelium.
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T
he mammary epithelium is comprised of a highly
branched, bilayered ductal tree with an inner layer of
cytokeratin (K)8/18-expressing luminal cells and a
surrounding layer of basal cells that typically express K5/14
and the contractile protein alpha-smooth muscle actin (SMA)1.
As presumptive targets for transformation in breast cancer, the
identity of adult mammary stem cells (MaSCs) and the origin of
luminal and basal cell lineages have been the subject of intense
investigation and debate2. Whilst results from transplantation
assays in the mouse mammary gland point to the existence of
bi/multipotent MaSCs that reside in the basal compartment3–5,
early genetic fate-mapping studies using lineage-specific
promoters demonstrated that distinct unipotent MaSCs
maintain the luminal and basal lineages postnatally under
physiological conditions6. Subsequent lineage-tracing studies
have provided further evidence in support of each model7–10.
However, transplantation assays have been suggested to
re-programme cells6,8,10, and conventional lineage-tracing
approaches have relied on prior assumptions regarding the
specificity and consistency of expression of lineage markers.
Moreover, these studies have induced labelling at levels
significantly higher than clonal density, thus confounding
analysis of daughter cells and their contribution to different
lineages. Consequently, we have sought to resolve these
complexities and determine unequivocally the potential of
adult MaSCs, during puberty and pregnancy, by combining the
use of mouse models that enable labelling of a single random cell
and all of its progeny in situ with confocal three-dimensional
(3D) imaging.
Results
Optical clearing and 3D imaging of the intact mammary gland.
To accurately determine the capacity of a single marked stem or
progenitor cell and its progeny to contribute to the development
of the branching mammary epithelial network in vivo, the entire
ductal tree needs to be visualized at high spatial resolution. The
utility of 3D imaging for fate-mapping studies has previously
been demonstrated in stroma-divested mammary glands7,9.
In this study we developed and refined methods for 3D
imaging in the mammary gland, using techniques for optical
tissue clearing to enable visualization of the mammary epithelium
at single-cell resolution, without the need for enzymatic digestion
or mechanical dissection.
Tissue clearing methods that have been developed are based on
mitigating light scattering caused by cellular and extracellular
structures with different refractive indices11. However, the utility of
these protocols in the mammary gland remains largely unexplored.
We determined that the SeeDB12 and the CUBIC13 tissue-clearing
protocols provide superior optical clarity in mammary tissue
(Fig. 1a). Moreover, by combining optical tissue clearing with
wholemount immunostaining (Supplementary Fig. 1a) and
algorithms to improve the signal-to-noise ratio of 3D image
sequences14 (Supplementary Fig. 1b), we were able to visualize the
epithelial ductal tree to depths exceeding 400mm, identifying
K5-expressing basal cells and K8-expressing luminal cells at single-
cell resolution (Fig. 1b, Supplementary Fig. 2 and Supplementary
Movies 1 and 2). We could also image lactating mammary glands
in 3D, highlighting the organization of basal cells by SMA
immunostaining and luminal cells by their expression of
E-cadherin and K8 (Fig. 1c and Supplementary Movie 3).
We noted that K8 is non-uniformly expressed in luminal cells
(Fig. 1b,c and Supplementary Movie 2) and identified two distinct
subpopulations comprising K8lo and K8hi cells in situ, the latter
co-staining with nuclear progesterone receptor (PR) (Fig. 1d and
Supplementary Fig. 3). While these K8 subpopulations are present
in similar proportions in virgin ducts, K8hi cells are extremely
sparse in lactational alveoli (Fig. 1c and Supplementary Fig. 3c). An
association between high K8/18 expression and the functionally
distinct CD24hi/prominin-1þ /Sca1þ hormone-sensing luminal
population has previously been observed15. Moreover, lineage-
tracing studies using K8-CreERT2/Tomato-reporter mice have
demonstrated preferential genetic labelling of CD24hi/Sca1þ
luminal cells16. Collectively, these observations question the
utility of the promoters of keratins and other presumed
lineage-specific genes as suitable drivers of reporter proteins for
lineage-tracing studies.
A stochastic labelling strategy for single-cell lineage tracing.
To avoid prior assumptions regarding the expression profile
of MaSCs and to track the fate of a single marked cell
in the mammary epithelium, we utilized R26[CA]30 reporter
mice, which have previously been used to infer stem cell
dynamics in the intestinal epithelium17. This model encompasses
a dinucleotide repeat tract, [CA]30, positioned downstream of the
translational start site of an out-of-frame reporter gene (enhanced
yellow fluorescent protein (EYFP) or modified b-glucosidase
(SYNbglA)) inserted in the constitutively expressed Rosa26 locus
(Fig. 2a). The inherent instability of microsatellite repeats can
lead to spontaneous, random frame-shift mutations during DNA
replication, which may place the reporter gene in-frame, thereby
resulting in its expression. The advantages of this labelling
approach are twofold: first, replication slippage is equally likely to
occur in all cycling cells; and second, strand slippage is extremely
rare17, thus allowing all of the progeny of a single labelled cell to
be identified with confidence.
Clonal labelling patterns in the mouse mammary gland. To
determine the suitability of this model for single-cell lineage
tracing in the mammary epithelium we examined clone
abundance, size and distribution in R26[CA]30SYNbglA mice during
pubertal development, when functionally active MaSCs are
presumed to drive ductal elongation and branching
morphogenesis18,19. These mice contain a modified b-glucosidase
gene, which is thermostable and resistant to epigenetic silencing,
downstream of the [CA]30 tract (Fig. 2a), enabling macroscopic
clonal analysis by wholemount histochemistry. Using this model,
combined with CUBIC-based tissue clearing, regions of ducts
containing variable numbers of b-glucosidaseþ cells interspersed
with unlabelled cells could be visualized in situ (Fig. 2b–d
and Supplementary Figs 4 and 5). As in the intestine, strand
slippage was extremely rare in the mammary epithelium, with
B1.49±0.92 total labelling events observed per gland
(Supplementary Fig. 4) and, as such, the likelihood of clone
convergence in this model is exceedingly low. We observed large
contiguous clonal regions containing several hundred
label-positive cells that spanned numerous branching ducts
(Fig. 2b,c and Supplementary Fig. 5). These were considered to
have arisen from a single MaSC or progenitor. Isolated regions
that contained limited numbers of label-positive cells were also
observed (Supplementary Fig. 4), most likely the result of strand
slippage in more differentiated cells or in progenitors with
restricted replicative potential (for example, Elf5-expressing
luminal progenitors7). However, given the continual, albeit rare,
genesis of labelled cells in this model, the possibility of recent
strand slippage in a MaSC or highly proliferative progenitor could
not be excluded. Label-positive regions were also detected after
multiple pregnancy/involution cycles (Supplementary Fig. 6),
indicating that some progeny may be long-lived.
Whilst strand slippage in a germ cell resulted in complete and
uniform genetic labelling of ducts (Supplementary Fig. 7), clonal
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expansion from a single MaSC/progenitor produced a stochastic
labelling pattern, with b-glucosidaseþ cells intermixed randomly
with unlabelled cells in branching ducts spanning over 8 mm in
length (Fig. 2b–d and Supplementary Fig. 5). These clonal
labelling patterns strongly suggest that a pool of active mammary
stem/progenitor cells reside within each terminal end bud
(TEB), the presumptive origin of MaSCs20, and contribute to
the development of each major duct during puberty. The unequal
distribution of labelled progeny between branching ducts (for
example, Fig. 2b) is most likely due to the dilution of marked
daughter cells with the progeny of unmarked MaSCs/progenitors
during TEB bifurcation or secondary branching.
Labelled progeny arising from the expansion of a single
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Figure 1 | Optical tissue clearing and 3D imaging of the mammary gland. (a) Transmission images of an entire virgin mammary gland before (left panels)
and after (middle panels) tissue clearing using CUBIC or SeeDB, and a CUBIC-cleared mammary gland counterstained with methyl green to visualize the
complete ductal network (right panel). Representative images from three mice. Grid width: 2 mm. (b) 3D imaging of K5 and K8 immunostaining of
SeeDB-cleared virgin mammary tissue within its native stroma. K5 overview shows 1.18 mm (xy) of mammary gland (z¼ 114mm imaging stack depth);
K8 overview shows 834mm (xy) (z¼ 114mm). The depth (z) is relative to the first image in the image sequence, reached after passing through the
mammary fat pad (B350mm). Scale bars, 50mm. (c) Immunostaining for SMA (xy¼ 579mm; z¼ 53mm), E-cadherin (xy¼467mm; z¼ 36mm) and K8
(xy¼ 399mm; z¼ 32mm) in mammary glands from lactating mice. Scale bars, 50mm. (d) Immunostaining shows populations of K8hi and K8lo luminal cells,
with the K8hi cells costaining with nuclear PR (arrowhead) (representative images from three mice); scale bars, 50mm.
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Supplementary Fig. 5) in the majority of label-positive regions.
Regions with basal-like b-glucosidaseþ cells were observed but
were less common, possibly reflecting a smaller proportion of
proliferating cells in this cellular compartment21,22. On one
occasion we observed ducts that appeared, on the basis of
morphology, to be comprised exclusively of b-glucosidaseþ
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Figure 2 | Single-cell lineage tracing in the virgin mammary gland. (a) Schematic representation of the R26[CA]30 mouse model. (b,c) Examples of two
large clonally marked regions (BP.8 and BP.7) in mammary glands from R26[CA]30SYNbglA mice that were likely to have arisen from the labelling of a
MaSC/progenitor (based on linear length and number of label-positive branches) (d). Dark purple staining is b-glucosidaseþ cells; mammary tissue
was counterstained with methyl green. Annotations show the linear length of the clones and their distance from the nipple region (asterisk). Clone BP.7
originated in the nipple region and is likely to have been labelled very early in development. Scale bars, 2 mm (overview) and 0.5 mm (inset).
(d) A summary of the eight clonally marked regions likely to have arisen from the labelling of a MaSC/progenitor, observed from the analysis of 30
R26[CA]30SYNbglA mice. (e) Examples of luminal (top panel) and basal (bottom panel) EYFPþ cells from R26[CA]30EYFP mice representing over 25
label-positive regions. Scale bars, 50mm. (f) A large clonally marked region containing many EYFPþ cells. Labelled progeny spanned multiple ducts and
exhibited a sporadic labelling pattern, intermixed with unlabelled cells. Scale bars, 100 mm. (g) A summary of three clonally marked regions presumed to
have arisen from the labelling of a MaSC/progenitor, observed from the analysis of 63 R26[CA]30EYFP mice. Lu, luminal; Ba, basal.
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luminal cells connected to ducts comprised exclusively of
b-glucosidaseþ basal cells (Fig. 2c(i) and (iii) versus (ii)).
The proximity of these diverging ducts suggests that labelled
cells arose from a single, bipotent parent cell that gave rise to one
luminal and one basal daughter. Given the expansive nature
of this exceptional clone (BP.7, 49 mm in length), and the
presence of labelled cells in the nipple region, it is likely that a
bipotent MaSC was genetically marked very early in development
of the gland, possibly during embryogenesis6,23, and later gave
rise to lineage-restricted progeny in the postnatal gland.
This juxtaposition of presumptive luminal and basal ductal
clones provides intriguing new insights into the likely fate of
progeny of a bipotent embryonic MaSC that could only be
revealed by single-cell labelling.
Unipotent cells contribute extensively to ductal morphogenesis.
To examine more closely the clonal labelling patterns arising
from adult MaSCs/progenitors, and to more definitively deter-
mine lineage on the basis of appropriate markers, we utilized the
R26[CA]30EYFP mouse model, combined with SeeDB-based optical
tissue clearing. Using this approach we were able to visualize and
characterize progeny arising from a single fluorescently marked
cell in situ with single-cell resolution (Fig. 2e,f). We note that
despite the high degree of optical clarity achieved using this
method, some regions deep within the mammary fat pad could
not be visualized at single-cell resolution by confocal microscopy
and thus a larger number of mice were required for analysis in
this model. Immunolabelling for markers of basal (SMA) and
luminal (K8) lineages confirmed that the majority of labelled
clones were luminal, with few basal clones observed (Fig. 2e).
Only one large EYFPþ basal clone, spanning over nine branches,
which could have arisen from a stem cell, was observed (Fig. 2g).
Clonal expansion of a single EYFPþ luminal cell produced a
mosaic labelling pattern identical to those observed in the
R26[CA]30SYNbglA model (Fig. 2f), confirming that more than one
luminal MaSC/progenitor contributes to the elongation of each
major duct during puberty. Since the timing of the slippage event
cannot be determined, we measured both the length of each clone
and the distance from the nipple region where labelled cells are
first observed (Fig. 2g and Supplementary Fig. 8, clone YP.2). If
the labelled cell of origin is more than 1 mm from the nipple
region, our assumption is that slippage has occurred in a stem or
progenitor cell postnatally20. All such large clonal regions were
lineage-restricted and we did not detect luminal and basal
EYFPþ cells intermingled within the same duct (Fig. 2g). These
data support our observations with the R26[CA]30SYNbglA mice and
provide further compelling evidence that unipotent MaSCs/
progenitors contribute extensively to ductal morphogenesis6.
However, due to the requirement for proliferation to label and
trace stem and progenitor cells and the aforementioned issues
associated with deep imaging, we cannot rule out the possibility
that rare quiescent bipotent MaSCs, not detected in the
R26[CA]30EYFP model, may exist.
To confirm the lineage restriction of adult MaSCs/progenitors,
and quantify their contribution to ductal morphogenesis, we
analysed a large clonal region (Fig. 3a–e and Supplementary
Fig. 9) using imaging algorithms for the volumetric segmentation
of mammary ducts and the subsequent characterization of all
ductal EYFPþ cells (Methods and Fig. 3c). This clonal region was
more than 8 mm in length and comprised over 20 branching
ducts (Figs 2g and 3a and Supplementary Fig. 9). Since the clone
originated more than 2 mm from the nipple region, this suggests
that strand slippage most likely occurred postnatally. All EYFPþ
cells examined by 3D analysis expressed the luminal marker K8
(Fig. 3b), and encompassed both K8hi and K8lo subpopulations
(Fig. 3c and Supplementary Movie 4), with a modest but
significant overrepresentation of the EYFP label in K8hi cells
(Kolmogorov–Smirnov test at Po0.05) (Supplementary Fig. 10a).
The lineage restriction of this clone was also confirmed by
histological analysis of sectioned tissue over depths of 300mm
(Fig. 3d and Supplementary Fig. 10b). To determine the potential
contribution of an active MaSC/progenitor to each duct, a
volumetric ratio of EYFPþ cells with respect to the total cellular
volume was computed, revealing that the parent cell contributed
on average 4.7±1.7% of the total cellular volume in this region
of the clone (Fig. 3e). A similar analysis was performed for a
basal clone (Fig. 4a–c), where it was determined that the parent
basal MaSC/progenitor contributed on average 5.8±3.2% of
the total cellular volume (Fig. 4d). Whilst these numbers may
reflect the differential proliferative and competitive behaviours of
stem/progenitor cells and their progeny, in addition to their
random distribution with branching, these data indicate that
there may be at least 20 luminal and 15 basal lineage-restricted
stem/progenitor cells in each major duct driving mammary gland
morphogenesis during puberty.
Neutral lineage tracing using a multicolour reporter. Although
the R26[CA]30SYNbglA and R26[CA]30EYFP models have provided
unprecedented insights into the contribution of a single
stem/progenitor cell to mammary gland development, we sought
to confirm the labelling pattern during pubertal development
with a different neutral approach that also allows the timing of
the labelling event to be controlled and is not dependent on a cell
being in cycle at the time of labelling. To achieve this, we utilized
the Confetti multicolour reporter mouse24, combined with
wholemount immunostaining and 3D imaging. We generated
mice that were hemizygous for both R26-Confetti (ref. 24) and
R26-CreERT2 (ref. 25; Fig. 5a) and administered a single
low-dose of tamoxifen to 4-week-old mice followed by a 3-week
chase to trace the progeny of cells labelled at the onset of puberty
(Supplementary Fig. 11a). This resulted in low-frequency26
multicolour labelling in the mammary epithelium, allowing us
to distinguish individual clones. To identify luminal and basal
cells, wholemount immunostaining was performed using a
lineage-specific marker (either K8 or SMA, respectively) and
tissues were counterstained with 40,6-diamidino-2-phenylindole
(DAPI) to localize the mammary epithelium. Cyan fluorescent
protein (CFP)-expressing clones were under-represented and
were therefore not analysed. The explanation for this is not
entirely clear but may relate to the poor penetration of short-
wavelength light through thick specimens and the fine
membranous localization of the CFP reporter protein. Using
this approach, we were able to visualize luminal and basal lineage-
restricted GFPþ , YFPþ and RFPþ clones (Fig. 5b,c and
Supplementary Fig. 11b,c). Notably, labelling patterns in the
confetti mice were similar to those in the R26CA30 models,
validating the latter approach.
Unipotent cells contribute extensively to alveologenesis. Finally,
to investigate the contribution of a single adult MaSC/progenitor
to the formation of lobuloalveolar structures during pregnancy,
we analysed clonal labelling patterns in lactating R26[CA]30EYFP
mice (Fig. 6 and Supplementary Figs 12 and 13). We noted an
increased number of clonal regions in tissue from lactating mice
compared with puberty (probably as a consequence of the higher
levels of proliferation), and a striking variety of patterns. The
unequal distribution of EYFPþ cells between lobuloalveolar units
could suggest that an alveolar stem cell niche is situated close to
the branch point of the subtending ducts (Fig. 6a). Competition
for niche occupancy may dictate the dispersal of labelled and
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unlabelled daughter cells between adjacent lobules, with further
competitive interactions between their respective progeny possi-
bly determining labelling outcomes within each alveolus27.
Indeed, alveoli that were comprised almost entirely of label-
positive luminal cells were occasionally observed (Fig. 6b),
implying that the descendants of any unmarked luminal stem/
progenitor cell had been outcompeted. We also observed an
interesting pattern where many alveoli within a lobule contained
only a single EYFPþ cell (Fig. 6c) suggesting the possibility that
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minor, although possibly important, component of each alveolus.
This has not been observed before and the identity and function
of these cells is unclear. Similar to the pubertal epithelium, all
large clonally marked regions were lineage-restricted, with
separate luminal and basal clones observed during lactation
(Fig. 6d and Supplementary Fig. 13). Of note, luminal cells
contributed to both the K8hi hormone-sensing lineage, as well as
the more abundant K8lo alveolar lineage (Supplementary Fig. 13,
clone YL.1). In all cases, EYFPþ progeny was intermixed with
unlabelled cells in a polyclonal pattern that spanned numerous
lobuloalveolar structures (Fig. 6d). Quantification of labelling
patterns in these large clonally marked regions, some comprising
over 100 alveoli (Fig. 6e), revealed that the majority of alveoli
were comprised of both EYFPþ cells and unlabelled cells of a
single lineage (Fig. 6f), demonstrating that most alveoli are
derived from at least two lineage-restricted stem/progenitor cells.
These data contrast with previous studies suggesting that alveoli
can be comprised of the progeny of a single cell7,8. The reason for
this discrepancy is not clear but possibly reflects the uncertainties
in analysing progeny of co-incident clones. Alternatively,
stochastic stem cell fate could result in neutral drift and
elimination of other stem cells and their progeny28. These
insights into alveolar stem cell biology reflect the power of in vivo
lineage tracing at clonal density.
Discussion
The existence of MaSCs was demonstrated over 50 years ago29.
More recently, the identity and potential of these cells has come
under intense scrutiny, yet a number of uncertainties remain.
Prime amongst these is whether MaSCs in the adult are unipotent
or bipotent6–9. Although this may appear to be a relatively
straightforward question to address, current experimental
approaches have not provided an unequivocal answer. This is
primarily a consequence of their dependence on presumed
lineage-restricted promoters to drive reporter gene expression in
a significant proportion of MaSCs for population-based fate
tracking. Using this approach the probability of two or more
clones arising in the same region is high, confounding their
analysis. Thus, promiscuous labelling and subsequent expansion
of even a single lineage-restricted MaSC could resemble clonal
expansion of a bipotent MaSC26. In this context it is important to
note that the expression of K14 and K18 is differentially regulated
in the pre-pubertal mammary gland with some luminal cells
unexpectedly expressing K14 (refs 30,31). Similar difficulties
arise with the K8 promoter that is expressed at low levels in a
subset of cells, leading to the disparate labelling of luminal cell
populations in fate-mapping studies16. Thus, lineage tracing
with these promoters is not definitive for the assessment of
potency. We therefore adopted two agnostic fate-mapping
strategies to avoid these confounding issues and this has
resulted in a number of unanticipated observations and
valuable insights that could only have been revealed by this
stochastic single-cell-labelling approach.
Our first intriguing observation was the random distribution of
labelled progeny of a single cell to multiple ducts (depicted
schematically in Fig. 7a). Some regions had a high density of
labelled cells while others had a much lower density, indicating
the presence of multiple lineage-restricted stem cells and the
admixing of their progeny. Imaging of entire mammary glands
also revealed that all labelled ducts were connected, suggesting
bifurcation and branching from a TEB in which the labelled cell
presumably arose during puberty. We investigated the nature of
cells within large clones using 3D imaging algorithms, and
revealed that all labelled cells within these regions were lineage
restricted. Furthermore, based on a volumetric analysis and the
assumption that all MaSCs/progenitors have the same capacity to
contribute to ductal outgrowth, we estimate that at least 20
luminal and 15 basal MaSCs/progenitors contribute to the growth
of a major duct. By extension, this would equate to a few hundred
unipotent luminal and basal MaSCs/progenitors per gland, which
drive ductal morphogenesis during puberty. Our lactation data
reveal the unexpected presence of different subpopulations of
alveolar cells, including one type that contributes only a single
cell to most alveoli in a lobuloalveolar cluster. We suggest that,
as alveolar expansion during pregnancy is critically important,
and may occur several times in a lifetime, a pool of alveolar
stem or committed progenitor cells is required. The variable
contribution of cells to individual alveoli (depicted schematically
in Fig. 7b), with 100% contribution being rare, could reflect
prior commitment to specific lineages or competition for the
stem/progenitor cell niche32,33.
We posit that the MaSCs/progenitors that generate the ductal
network during puberty are distinct from those that have a more
homeostatic function in the adult, the latter possibly arising from
bipotent embryonic MaSCs that may persist after birth and
remain quiescent30. Indeed, these cells would not have been
labelled by our approach. Nevertheless, our data are consistent
with unipotent mammary stem/progenitor cells being primarily
present in the TEBs during puberty, where they proliferate
and move towards the subtending duct as it elongates. These
TEB-resident MaSCs/progenitors would be lost when the TEBs
regress at the completion of puberty. However, slow-cycling
unipotent MaSCs/progenitors may be deposited throughout the
ductal network34,35 and could later be recruited in response to
pregnancy hormones to generate alveoli.
Our work has illuminated the capacity of a single cell in the
adult mammary gland to contribute to mammary gland
development. A complete resolution of the mammary
stem cell hierarchy controversy will require the ability to label a
single cell at a defined moment and follow its fate over time.
Although fraught with difficulties, prospective isolation and
transcriptome analysis of single MaSCs will be an aim for the
future.
Figure 3 | 3D analysis of a clone arising from a single labelled luminal presumptive MaSC. (a) Wholemount fluorescence images
(K8 immunofluorescence) of the mammary ductal network demarcating the linear length of the clone and one region (magnified views, i–v) that was
imaged at high cellular resolution by confocal microscopy in b. Further regions from this clone are shown in Supplementary Fig. 9. Asterisk shows the
location of the nipple. Scale bar, 1 mm (wholemount) and 50mm (confocal). (c) Images of a clonally marked region that was analysed by 3D image analysis.
Digital segmentation of EYFPþ cells within the luminal (K8-expressing) and basal (SMA-expressing) compartments is shown. Original 3D images show
that progeny from a single luminal MaSC/progenitor included both K8hi (arrow) and K8lo (arrowhead) cells. BV, blood vessel. Scale bars, 1 mm
(wholemount) and 100mm (confocal). (d) Tabulated results of 3D and two-dimensional (2D) clonal analyses. For 3D analysis, all segmented ductal EYFPþ
cells were classified as luminal based on the proportion of K8 versus SMA signal (n¼ 227 cells from 4 image sequences). For 2D analysis, cells were
classified by manual scoring of histological sections (n¼ 281 cells from 10 sections spanning 300 mm depth). This clone (YP.1) is one of three clones likely
to have arisen from the labelling of a MaSC (based on linear length and number of label-positive branches), identified from the analysis of over 500
mammary glands from 63 hemizygous R26[CA]30EYFP pubertal mice. (e) Tabulated results of the computed volumetric ratio of EYFPþ cells with respect to
cellular volume for each of the four regions analysed.
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Methods
Animal models. R26[CA]30SYNbglA and R26[CA]30EYFP mice (on a C57Bl/6J
background)17 were provided by Prof. Douglas Winton (Cancer Research UK
Cambridge Institute). Female virgin mice were killed by dislocation of the
neck or terminal anaesthesia at 7 weeks of age for all studies in puberty. For
single-cell lineage tracing in lactating mice, female R26[CA]30 mice were mated with
C57Bl/6J male studs and tissue was collected between lactation days 2–4. For
analysis of multi-parous mice, female R26[CA30]SYNbglA mice were mated with
C57Bl/6J male studs (for 3 pregnancy/involution cycles), and allowed to naturally
litter and wean their pups. The final wean was followed by an 8- to 9-week interval
before mammary tissue was collected. All quantitative analyses were performed on
mice that were hemizygous for R26[CA]30SYNbglA or R26[CA]30EYFP. Mice that were
hemizygous for both R26-Confetti (ref. 24) and R26-CreERT2 (ref. 25)
(R26-Confetti;R26-CreERT2) were generated by mating homozygous mice. These
mice can theoretically produce cells that express either membrane-bound cyan,
nuclear green, cytoplasmic yellow or cytoplasmic red fluorescent proteins following
tamoxifen administration. Eight mammary glands (excluding the first (cervical)
pair) were dissected and analysed for each mouse. Mammary glands were excised
and fixed in 10% neutral buffered formalin (NBF) for 9 h at room temperature.
Animals were housed in individually ventilated cages under a 12:12 h light–dark
cycle, with water and food available ad libitum. All animal experimentation was
carried out in accordance with the Animal (Scientific Procedures) Act 1986, the
European Union Directive 86/609 and with local ethics committee approval. No
statistical method was used to predetermine sample size.
Induction of lineage tracing. Lineage tracing was induced at 28 days for studies in
puberty in R26-Confetti;R26-CreERT2 mice. A single intraperitoneal injection of
tamoxifen (1 mg) in sunflower oil was administered and tissues were collected
after a 2-day chase to determine initial labelling or after 3 weeks for pubertal
lineage-tracing studies.
Reagents. The following reagents were purchased from Sigma Aldrich: NBF; urea;
N,N,N0 ,N0-tetrakis(2-hydroxypropyl)ethylenediamine; 2,20 ,200-nitrilotriethanol;
fructose; a-thioglycerol; DAPI dilactate; 3,30-diaminobenzidine tetrahydrochloride
(DAB); and tamoxifen. Sucrose was purchased from Fisher Scientific. Triton X-100
was purchased from VWR International. The following primary antibodies were
used for immunostaining: rabbit anti-K5 (Covance, PRB160P, 1:100); rat anti-K8
(Developmental Studies Hybridoma Bank, TROMA-I, 1:50); rabbit anti-SMA
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Figure 4 | 3D analysis of a clone arising from a single labelled basal presumptive MaSC. (a) Wholemount fluorescence images (K8 immuno-
fluorescence) of the mammary ductal network, mapping regions (i–vi) that were imaged using a confocal microscope in b. All EYFPþ cells in this clone
(YP.3) were basal. A distinct clone (separated by 41 mm) was identified in this tissue piece and contained only luminal cells (shown in Supplementary
Fig. 8). Luminal and basal EYFPþ cells were not imaged in the same branches and clones were never intermixed. Asterisk shows the nipple and origin of
the ductal network. Scale bar, 1 mm (wholemount) and 100 mm (confocal, overview) or 30 mm (confocal, magnified view). (c) Tabulated results of the 3D
lineage analysis (n¼ 53 cells from 3 image sequences). (d) Tabulated results of the computed volumetric ratio of EYFPþ cells with respect to total basal
cellular volume for each of the three regions analysed.
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anti-E-cadherin (Cell Signaling, 3,195, 1:50); rabbit anti-PR (DAKO, A0098, 1:50);
and chicken anti-GFP (Abcam, ab13970, 1:2,000). The following Alexa
Fluor-conjugated secondary antibodies were purchased from Life Technologies and
used 1:500: goat anti-mouse 488 (A11001); goat anti-mouse 647 (A21237); goat
anti-rat Cy3 (A10522); goat anti-rat 488 (A11006); goat anti-rabbit 488
(A11008); goat anti-rabbit 647 (A21245); goat anti-chicken 488 (A11039); and goat
anti-chicken 568 (A11041).
Optical tissue clearing and wholemount immunostaining. Mammary tissue was
dissected and cut into large pieces (B15 15 2 mm) for immunostaining and
clearing. CUBIC-based tissue clearing was performed13, with minor modifications,
for visualization of clones from R26[CA]30SYNbglA mice. CUBIC Reagent 1 was
prepared as a mixture of urea (25% w/w), N,N,N0 ,N0-tetrakis(2-hydroxypropyl)
ethylenediamine (25% w/w) and Triton X-100 (15% w/w) in distilled water. CUBIC
Reagent 2 was prepared using sucrose (44% w/w), urea (22% w/w), 2,20 ,
200-nitrilotriethanol (9% w/w) and Triton X-100 (0.1% w/w) in distilled water.
Tissues were immersed in CUBIC Reagent 1 at 37 C for 3 days. Mammary glands
were counterstained for 1.5 h in methyl green (0.5%), washed and de-stained in
acid alcohol. Tissues were immersed in CUBIC Reagent 2 at 37 C for 1–2 days
until transparent and imaged using a Leica MZ75 dissecting microscope.
SeeDB-based tissue clearing12 was combined with wholemount
immunolabelling for visualization of fluorescent clones from R26[CA]30EYFP and
R26-Confetti;R26-CreERT2 mice. Mammary tissue was blocked and permeabilized
overnight at 4 C in PBS with Triton X-100 (1%) and bovine serum albumin
(10%). Primary antibodies were diluted in blocking buffer and incubated at 4 C for
4 days with gentle rocking. Tissue was washed and incubated with secondary
antibodies for 2 days at 4 C before further washing and incubation with DAPI
(10 mM) for 1–2 h. Samples were serially incubated for 8–16 h at room temperature
in 2–3 ml of 20, 40, 60 and 80% (w/v) fructose in distilled water, and subsequently
transferred to 100% (w/v) fructose solution (24 h) and 115% (w/v) fructose solution
for 24 h or until imaged. All fructose solutions contained a-thioglycerol (0.5%) to
inhibit the Maillard reaction12 and incubations were performed with gentle
agitation.
Detection of b-glucosidase expression. For detection of modified b-glucosidase
expression36,37, mammary glands were excised and fixed for 4 h at room
temperature in 10% NBF. Endogenous b-glucosidase activity was heat inactivated
for 15 min at 65 C in phosphate-buffered saline (PBS). Wholemount mammary
glands were incubated for 48 h at 50 C in a solution containing 1 part Solution
A (5-bromo-6-chloro-3-indolyl-b-D-glucopyranoside (1%) in dimethyl sulfoxide)
and 25 parts Solution B (magnesium chloride (0.02% w/v), potassium ferricyanide
(0.096% w/v) and potassium ferrocyanide (0.13% w/v) in PBS), with substrate
replenishment after 24 h. Mammary glands were post-fixed in 10% NBF overnight
at 4 C. Tissue clearing was performed using the CUBIC clearing protocol. For all
animals,B5 cm of the small intestine distal from the stomach was excised and used
as a reaction control for the detection of b-glucosidase expression.
Histology and two-dimensional immunostaining. For histological analysis of
tissue from R26[CA]30EYFP mice, SeeDB-based optical tissue clearing was reversed
by overnight incubation in PBS at 4 C. Standard protocols for paraffin processing
and embedding using alcohol and xylene were used. Paraffin-embedded sections
(6 mm) were de-waxed in xylene, and antigen retrieval was performed by boiling in
tri-sodium citrate buffer (10 mM, pH 6.0), for 11 min. Sections were blocked in
goat serum (5%) in PBS supplemented with 0.05% Triton X-100 PBS for 1 h at
room temperature. Sections were incubated with primary antibodies overnight at
4 C. Primary antibodies used were as follows: rat anti-K8 (1:200); chicken
c
ba
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YFP/RFP/SMA GFP/YFP/RFP/SMA
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X
Figure 5 | Clonal labelling patterns observed in R26-Confetti;R26-CreERT2 pubertal mice. (a) Schematic representation of the R26-Confetti;R26-CreERT2
mouse model. (b) Initial labelling level observed 2 days after the administration of a single, low-dose of tamoxifen (1 mg intraperitoneal (i.p.)) to 4-week-old
mice. Scale bar, 100mm. (c) Labelling patterns observed in R26-Confetti;R26-CreERT2 pubertal mice confirm the results from the R26[CA]30 model. Labelling
was induced by the administration of a single, low-dose of tamoxifen (1 mg i.p.) to 4-week-old mice and mammary glands were collected after a 3-week
chase. Left panel shows a region containing YFPþ luminal cells and RFPþ basal cells (arrowhead) populating three branches, interspersed with unlabelled
cells. Right panel shows a region containing GFPþ , YFPþ and RFPþ luminal cells in a single branch. Scale bar, 100mm (overview) and 50mm (inset).
Images are representative of three mice. Additional images are shown in Supplementary Fig. 11.
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Total no. 10 mice (80 mammary glands)
MaSC clone ID YL.1 YL.2 YL.3 YL.4
Linear length (mm) >2 >1 >1 >2
No. alveoli >169 >68 >69 >100
Composition Lu Lu Lu Ba
Shown in (Fig ref.) 6, S13 S13 S13 6, S13
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+
Figure 6 | Contribution of a single MaSC/progenitor to alveologenesis. (a) An image showing the uneven contribution of a single labelled ductal cell to
different lobuloalveolar structures; arrow indicates the presumptive EYFPþ cell of origin at the ductal branch point. Scale bar, 50mm. (b) A rare instance of
progeny from a single luminal EYFPþ cell contributing almost entirely to the luminal lineage of 2–4 alveoli within a single lobule. Scale bar, 50mm.
(c) An example of a single labelled EYFPþ luminal cell that contributed one EYFPþ luminal daughter cell to multiple alveoli in a lobule. Scale bar, 100mm.
(d) 3D images revealing the extensive contribution of a single luminal (left, clone YL.1) and basal (right, clone YL.4) EYFPþ cell to the lobuloalveolar
network in independent lactating mammary glands. Labelled alveoli were mostly populated by both lineage-restricted EYFPþ and unlabelled cells (arrow),
with occasional alveoli observed that were fully populated by EYFPþ cells of a single lineage (arrowhead). Scale bar, 100mm (overview) and 40mm
(inset). (e) A summary of the four large clonally marked regions observed from the analysis of 10 R26[CA]30EYFP mice during lactation. (f) The number of
alveoli that were fully populated by EYFPþ cells of a single lineage (full) or populated by both EYFPþ and unlabelled cells of a single lineage (partial).
Lu, luminal; Ba, basal.
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anti-GFP (1:2,000); and rabbit anti-SMA (1:200). Secondary antibodies were
diluted 1:500. Nuclei were counterstained with DAPI (5 mM).
Confocal microscopy and image analysis. Images of wholemount mammary
glands were acquired using a Leica TCS SP8 inverted confocal microscope with
10 /0.4 or 20 /0.75 HC PL APO objective lenses. Laser power, line averaging
and step increment were adjusted manually to give optimal fluorescence intensity
for each fluorophore with minimal photobleaching. Imaging depths were recorded
from the top of the epithelial structure being imaged. However, an actual imaging
depth of B350 mm through the native fat pad was typically required before
reaching the mammary ductal tree. Thus, imaging depths were routinely
350–500 mm through the tissue. An XZ projection illustrating the lower axial
resolution versus the lateral resolution is shown in Supplementary Fig. 14a. The
reduced resolution had little effect on the 3D image analyses, with EYFPþ cells
able to be discriminated on the anterior and posterior surfaces of most ducts.
CFP-expressing clones were rarely observed in R26-Confetti;R26-CreERT2 mice,
possibly related to the brightness of the fluorescent protein, poor penetration of
short-wavelength light through the lipid-rich mammary fat pad, the fine
membranous localization of the CFP reporter protein, as well as the available laser
lines on the confocal microscope. Image reconstructions were generated using
Imaris image management software (v8.0, Bitplane). Denoizing of 3D image
sequences was performed in MATLAB14.
Analyses of 3D image stacks, selected on the basis of their resolution
and compatibility with 3D image analysis, aimed to identify ducts within the intact
mammary stroma and to subsequently recognize all ductal EYFPþ cells.
Ductal EYFPþ cells were classified as luminal or basal based on the proportion
of K8 versus SMA fluorescence signal. For a volumetric analysis, the volume ratio
of EYFPþ cells within each duct was computed with respect to the entire
ductal (cellular) volume, and the intensity of K8 in EYFPþ cells was also compared
with the overall K8 intensity level within the duct. For computational efficiency, a
multi-resolution transform38 was used for the K8 channel; a coarse scale was used
to detect the duct and the full detail scale was used to identify voxels significantly
different from the background. The coarse scale was segmented with a robust
threshold, obtained as the median of the intensity values in the transformed
stack plus three times the median absolute deviation of these values. The
up-sampled structure represents an approximation of the duct (Supplementary
Fig. 14b) and the sum of all its voxels was a measure of the volume of the
duct. Within the duct, significant voxels (excluding intercellular spaces and nuclei)
were detected plane-wise from the fine detail levels of the wavelet coefficients of the
two-dimensional wavelet transformed image by applying a false discovery
rate-based thresholding39. Independently, EYFPþ cells were identified after a
difference of Gaussian filtering suited to the noise level of the image; as the filter
was applied on the full-resolution 3D stack, a recursive filter implementation in
CImg (Deriche, CImg) was used for time efficiency. The threshold was computed
as above, as the robustly estimated 99% quantile of the Gaussian distribution of
filtered intensity values: the median plus three times the median absolute deviation
of these intensities (Supplementary Fig. 14c). Subsequently, only EYFPþ cells
inside the detected duct were taken into account. These cells were classified as
luminal or basal based on the comparison of intensity values in the K8 and
SMA channels of the voxels belonging to each segmented cell; for a chosen
threshold, the voxels exceeding this threshold in the K8 and SMA channels,
respectively, were counted. If the number of K8 voxels exceeded the SMA, the
cell was classified as luminal, otherwise it was classified as basal (Supplementary
Fig. 14d). Note that a perfect exclusion of one colour cannot be expected due
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Figure 7 | Schematic model. Schematic model of the most common labelling pattern arising from the genetic labelling of a single lineage-restricted MaSC/
progenitor to (a) ductal morphogenesis and (b) alveologenesis, identified in R26[CA]30 mice and confirmed using the R26-Confetti;R26-CreERT2 model
(puberty).
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the choice of the intensity threshold, the classification was performed using a
multi-threshold approach, with levels 100, 300, 500, up to 1,500 and the
majority vote for all thresholds gave the final classification of the cell. Finally, a
Kolmogorov–Smirnov test was performed to determine if the significant voxels of
the duct in K8 channel were differentially distributed compared with the significant
voxels inside the segmented EYFPþ cell.
Some particularities of the basal EYFPþ co-localization images (related
to clone YP.3) such as the poorer signal-to-noise ratio of these images (due
to the depth of this clone within the mammary fat pad) and the elongated shape
of the EYFPþ cells, made a few modifications of the described analysis
necessary. To improve the quality of the images, a denoizing step was applied
followed by a fast deblurring step (Dr Jerome Boulanger, Medical Research
Council—Laboratory of Molecular Biology, private communication). The
segmentations are performed in 3D for all channels, however, to separate
elongated and overlapping EYFPþ cells, a seeded watershed was used (the seeds
are thresholded distance images of the inverted segmented EYFPþ image, where
the threshold is manually selected). The classification of the EYFPþ cells is
performed as before: if the number of K8 voxels exceeded the SMA, the cell was
classified as luminal, otherwise it was classified as basal. Using this analysis, two
cells were excluded from the classification due to their localization in regions where
the SMA signal was undetectable and thus the double/nested tubular structure
could not be observed.
Quantification of PRþ and K8hi cells (Supplementary Fig. 3b) was performed
on maximum intensity projections of 3D image stacks using the Cell Counter
plugin in Image J (v1.50a, National Institutes of Health). Maximum intensity
projections of PR and K8 channels were scored independently. At least 200 cells
were counted per image, with six images analysed from three independent mice
(total cells counted: 1,831). Manual counting of EYFPþ cells (Fig. 3d and
Supplementary Fig. 10b) was performed on 10 histological sections cut 425 mm
apart, and spanning B300 mm. K8 was used to mark the luminal lineage and SMA
was used to mark basal cells.
The number of alveoli that were fully or partially populated by EYFPþ cells of a
single lineage were manually counted in Image J.
Statistics. The Kolmogorov–Smirnov test (Supplementary Fig. 10a) was
performed in MATLAB (R2014a, The MathWorks Inc., Natick, Massachusetts).
All values are shown as mean±s.d.
Data availability. The data supporting the findings of this study are available
within the article and its Supplementary Information files. All other relevant source
data are available from the authors on request.
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Imaging the mammary gland and
mammary tumours in 3D: optical tissue
clearing and immunofluorescence methods
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Abstract
Background: High-resolution 3D imaging of intact tissue facilitates cellular and subcellular analyses of complex
structures within their native environment. However, difficulties associated with immunolabelling and imaging
fluorescent proteins deep within whole organs have restricted their applications to thin sections or processed tissue
preparations, precluding comprehensive and rapid 3D visualisation. Several tissue clearing methods have been
established to circumvent issues associated with depth of imaging in opaque specimens. The application of these
techniques to study the elaborate architecture of the mouse mammary gland has yet to be investigated.
Methods: Multiple tissue clearing methods were applied to intact virgin and lactating mammary glands, namely 3D
imaging of solvent-cleared organs, see deep brain (seeDB), clear unobstructed brain imaging cocktails (CUBIC) and
passive clarity technique. Using confocal, two-photon and light sheet microscopy, their compatibility with whole-
mount immunofluorescent labelling and 3D imaging of mammary tissue was examined. In addition, their suitability
for the analysis of mouse mammary tumours was also assessed.
Results: Varying degrees of optical transparency, tissue preservation and fluorescent signal conservation were
observed between the different clearing methods. SeeDB and CUBIC protocols were considered superior for volumetric
fluorescence imaging and whole-mount histochemical staining, respectively. Techniques were compatible with 3D
imaging on a variety of platforms, enabling visualisation of mammary ductal and lobulo-alveolar structures at vastly
improved depths in cleared tissue.
Conclusions: The utility of whole-organ tissue clearing protocols was assessed in the mouse mammary gland. Most
methods utilised affordable and widely available reagents, and were compatible with standard confocal microscopy.
These techniques enable high-resolution, 3D imaging and phenotyping of mammary cells and tumours in situ, and will
significantly enhance our understanding of both normal and pathological mammary gland development.
Keywords: Mammary gland, Lactation, Breast cancer, Tissue clearing, 3D imaging, Fluorescence microscopy, Light
sheet fluorescence microscopy, Two-photon microscopy
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Background
The mammary gland is composed of a branching epithe-
lial ductal network deeply embedded within a vascu-
larised stromal matrix made up of adipocytes, fibroblasts
and immune cells [1]. Due to its capacity for rapid
growth and regeneration, the mouse mammary gland is
a powerful model in which to study a range of develop-
mental processes associated with tissue morphogenesis
and remodelling, and provides important insights into
the perturbations that give rise to breast cancer [1].
However, visualisation of the complex cellular networks
within the intact mammary epithelium is greatly im-
peded by the lipid-rich and optically opaque nature of
this organ. As a result, immunolabelling and fluores-
cence imaging of mammary tissue has traditionally been
performed using thin tissue sections with assumptions
about the architectural context and uniformity of a par-
ticular 2D plane. Whilst 3D imaging has recently been
used to investigate mammary stem cell dynamics [2–4]
and binucleated cells in lactational alveoli [5], these
studies have relied on tissue microdissection [2, 5]
or enzymatic digestion [3]. Consequently, visualisation of
the mammary epithelial tree at single-cell resolution
within its native stroma remains a fundamental challenge
in mammary gland research.
The utility of rendering tissue optically transparent has
been appreciated for over a century [6]. However, recent
advances in fluorescence microscopy have heralded the
development of numerous whole-organ tissue clearing
methods aimed at improving optical access and depth of
imaging in intact specimens (reviewed in [7]). These
methods are primarily based on mitigating light scatter-
ing caused by heterogeneous cellular components with
different refractive indices (RIs). Techniques broadly rely
either on organic solvent-based or hydrophilic reagent-
based clearing solutions to homogenise RIs within tis-
sue, and may also include prior hydrogel embedding
to stabilise cellular structures. Whilst many protocols
were originally optimised for the central nervous sys-
tem and whole embryos, recent refinements in tissue
clearing techniques have facilitated exceptional optical
access to many other mammalian tissues. However,
the application of these techniques to the mammary
gland is yet to be explored.
Here, we describe the application of four leading tissue
clearing protocols, namely three-dimensional imaging
of solvent-cleared organs (3DISCO) [8], see deep brain
(SeeDB) [9], clear unobstructed brain imaging cocktails
(CUBIC) [10] and passive clarity technique (PACT) [11],
to virgin and lactating mammary glands. Whilst the
underlying principles for achieving tissue transparency
are fundamentally different in each of these methods,
the majority utilise simple and affordable reagents, and
can be completed within two weeks.
3DISCO [8] is based on earlier clearing methods that
use high-index organic solvents such as benzyl alcohol
benzyl benzoate (BABB) [12, 13], and can be combined
with optimised whole-mount immunolabelling proce-
dures (termed iDISCO) [14]. To date, 3DISCO remains
the only method previously applied to mammary tissue,
albeit superficially [8]. PACT [11] relies on hydrogel em-
bedding to stabilise cellular structures prior to tissue
delipidation using ionic detergents. Due to the need for
custom electrophoresis equipment, CLARITY [15] is diffi-
cult to implement and can lead to heat-induced tissue
damage and epitope loss [11]. The PACT protocol cir-
cumvents these issues, relying instead on passive diffusion.
Furthermore, PACT utilises more economical RI match-
ing solutions (RIMS and sRIMS), an additional benefit
over CLARITY. CUBIC [10] is a urea-based clearing re-
agent that includes aminoalcohols and detergents to re-
move lipids and homogenise RIs within tissue. In addition,
CUBIC reagents decolourise blood by eluting the heme
chromophore, further enhancing optical transparency by
minimising light absorption [16]. Finally, SeeDB [9] is a
water-based optical clearing agent that utilises saturated
solutions of fructose and alpha-thioglycerol (which limits
autofluorescence) for RI matching.
We compared these four protocols for optical transpar-
ency and tissue preservation in the intact mammary gland,
in addition to their compatibility with immunofluorescent
labelling and 3D imaging of mammary epithelial cells.
Their suitability for the analysis of mammary tumours was
also investigated. Using standard confocal and advanced
imaging techniques, ductal and lobulo-alveolar structures
could be readily visualised in cleared tissue, with varying
degrees of fluorescent signal preservation between the dif-
ferent methods. Overall, our results placed SeeDB and
CUBIC as methods of choice for high-resolution fluores-
cence imaging and whole-mount histochemical staining of
mammary glands. The ability to visualise the mammary
epithelial tree at single cell resolution within its native
stroma will provide invaluable insight into mammary
gland development and tumourigenesis.
Methods
Reagents and antibodies
The following reagents were purchased from Sigma
Aldrich: neutral buffered formalin (NBF), dimethyl
sulfoxide (DMSO), tetrahydrofuran (THF), dichloro-
methane (DCM), dibenzyl ether (DBE), benzyl alcohol,
benzyl benzoate, urea, N,N,N’,N’-tetrakis(2-hydroxy-
propyl)ethylenediamine, 2,2′,2″-nitrilotriethanol, fruc-
tose, α-thioglycerol, D-sorbitol and 4′,6-diamidino-2-
phenylindole (DAPI) dilactate. RapiClear-CLARITY
Specific (RC-CS) Solution and Mounting Medium and
iSpacer imaging chambers were purchased from the
SunJin Lab: 2,2′-Azobis[2-(2-imidazolin-2-yl)propane]
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dihydrochloride was purchased from Wako Pure Chem-
ical Industries. Imaging dishes were purchased from Ibidi
(81158). Acrylamide (40%) was purchased from Bio-Rad
Laboratories. Sodium dodecyl sulphate (SDS) was
purchased from Melford Laboratories. Triton-X100 was
purchased from VWR International. The following pri-
mary antibodies were used for immunostaining: rabbit
anti-α-smooth muscle actin (SMA) (Abcam, ab5694;
1:200-1:300 for 2D and 3D studies), rabbit anti-keratin 5
(BioLegend, 905501; 1:100 (3D)), rat anti-cytokeratin 8
(Developmental Studies Hybridoma Bank, TROMA-I;
1:50 (3D) or 1:150-200 (2D)), rabbit anti-E-cadherin
(Cell Signaling, 3195; 1:50 (3D) or 1:200 (2D)), mouse
anti-E-cadherin (BD Transduction Laboratories,
610182; 1:300 (2D)), rabbit anti-cleaved caspase 3 (Cell
Signaling, 9661S; 1:200 (2D)) and rabbit anti-human epi-
dermal growth factor receptor 2 (HER2) (DAKO, A0485;
1:300 (3D) or 1:500 (2D)). The following Alexa Fluor con-
jugated secondary antibodies were purchased from Life
Technologies and diluted 1:500 (2D and 3D studies) in
blocking buffer: goat anti-rat Cy3 (A10522), goat anti-
rabbit 647 (A21245) and chicken anti-rabbit 647
(A21443). Anti-rabbit horseradish peroxidase (HRP)-con-
jugated secondary antibody was purchased from DAKO
(P0448; 1:500).
Mice
Mice (C57BL/6 and BALB/c) were housed in indi-
vidually ventilated cages under a 12:12 h light-dark
cycle, with water and food available ad libitum. Mice
were euthanized by dislocation of the neck or ter-
minal anaesthesia. All tissue from virgin mice was
harvested during puberty (5–8 weeks). For studies
during lactation, mice were mated with studs, allowed
to litter and tissue was harvested between lactation days
2 to 10. Mammary glands (excluding the cervical (first)
pair) were excised and immediately spread and fixed on
card (Tetra Pak) in 10% NBF for 9 h at room temperature,
unless otherwise specified. A 9-h fix provided optimal
staining for all antibodies used in this study; however,
SMA and K8 also performed well with overnight fixation
(4 °C). Fixed tissue was stored at 4 °C in phosphate-
buffered saline (PBS) containing sodium azide (0.05% (w/
v)) for up to 8 weeks.
Syngeneic mammary tumours were established by
orthotopically implanting 5 × 103 TUBO cells [17], into
the abdominal (fourth) mammary gland. This cloned cell
line was established from a mammary carcinoma that
spontaneously arose in a BALB-neuT mouse and there-
fore carries the Her-2/neu oncogene driven by the
MMTV promoter. Mice were monitored regularly and
tumours were harvested before exceeding humane end-
points (approx. 4–5 weeks).
3DISCO-based clearing and immunohistochemical
analysis (IHC)
3DISCO was performed as previously described [8].
Solvent immersion times were adjusted for mammary
tissue pieces (approx. 10 × 10 × 1 mm) as follows: 50%
(v/v) THF in H2O (40 min), 70% (v/v) THF in H2O
(40 minutes), 80% (v/v) THF in H2O (40 minutes),
100% (v/v) THF (3 × 40 minutes), and DCM (15 mi-
nutes). All solvent immersion steps were performed
in glass vials. Although DBE is reported to be a su-
perior optical clearing agent vs. BABB [8], this solvent
requires specialised imaging chambers and solvent-
resistant adhesive (e.g. dental cement), and can se-
verely damage objectives if the chamber fails. Thus,
we used BABB as the final clearing agent for trans-
mission and confocal imaging in this study. BABB
was prepared as a mixture of benzyl alcohol and ben-
zyl benzoate (1:2). Immunostaining was performed as
per the iDISCO protocol [14], with a methanol pre-
treatment. Following the iDISCO immunolabelling
protocol, samples were washed in PBS and incubated
with DAPI (10 μM) for 2–3 h, cleared using the
3DISCO protocol and imaged the same day.
PACT-based clearing and IHC
The A4P0 hydrogel formulation was selected for PACT-
based clearing of the mouse mammary gland [11]. A4P0
was prepared to contain acrylamide (4% (v/v)), 2,2′-Azo-
bis[2-(2-imidazolin-2-yl)propane] dihydrochloride (0.25%
(w/v)) in PBS. PACT-clearing solution consisted of SDS
(8% (w/v)) in distilled water, pH 7.5. Mammary tissue
pieces (approx. 10 × 10 × 1 mm) were incubated in A4P0
hydrogel monomer for 4 days at 4 °C and heated to 37 °C
in a water bath for 4–6 h. Excess gel was carefully re-
moved from the tissue and samples were immersed in
PACT clearing solution for 24 h at room temperature.
Samples were immersed in fresh clearing solution, incu-
bated at 37 °C for 4 days (with replenishment every sec-
ond day), and finally washed with PBS containing triton-
X100 (0.1% (w/v)) for 24 h. For immunostaining, samples
were blocked in PBS containing triton-X100 (0.5% (w/v))
with goat serum (10% (v/v)) overnight at 4 °C. Primary
antibodies were diluted in blocking buffer at 4 °C for 4 days
with agitation, tissue was washed (3 × 1 h) in PBS and in-
cubated with Alexa Fluor conjugated secondary antibodies
for 2 days. Samples were washed in PBS and incubated
with DAPI (10 μM) for 2–3 h. PACT-sRIMS samples were
incubated in sRIMS for 4 days or until imaging. sRIMS
was prepared by combining sorbitol (70% (w/v)) in 0.02 M
phosphate buffer [11, 18]. PACT-RC samples were incu-
bated in Rapiclear CS for 4 h and mounted between two
coverslips using RC-CS Mounting Medium and iSpacers
for image acquisition and long-term storage.
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CUBIC-based clearing and IHC
CUBIC-based tissue clearing was performed as previously
described [10], with minor modifications. CUBIC Reagent
1 was prepared as a mixture of urea (25% (w/w)),
N,N,N’,N’-tetrakis(2-hydroxypropyl)ethylenediamine (25%
(w/w)), triton-X100 (15% (w/w)) in distilled water. CUBIC
Reagent 2 was prepared using sucrose (44% (w/w)), urea
(22% (w/w)), 2,2′,2″-nitrilotriethanol (9% (w/w)), triton-
X100 (0.1% (w/w)) in distilled water. CUBIC Reagent 1A
was prepared using urea (10% (w/w))), N,N,N’,N’-tetra-
kis(2-hydroxypropyl)ethylenediamine (5% (w/w)), triton-
X100 (10% (w/w)) and NaCl (25 mM) in distilled water
(unpublished, protocol available at http://cubic.riken.jp/).
Tissue pieces (approx. 10 × 10 × 1 mm) were immersed in
CUBIC Reagent 1 or 1A at 37 °C for 2–3 days, depending
on the size of the tissue piece. For immunostaining
samples were washed and subsequently blocked in PBS
containing triton-X100 (0.5% (w/v)) and goat serum (10%
(v/v)) overnight at 4 °C. Primary antibodies were diluted in
blocking buffer at 4 °C for 4 days with gentle rocking.
Tissue was washed (3 × 1 h) and incubated with Alexa
Fluor conjugated secondary antibodies for 2 days, washed
in PBS and incubated with DAPI (10 μM) for 2–3 h. Sam-
ples were transferred to CUBIC Reagent 2 at 37 °C for at
least 1 day for refractive index matching. Samples were
immersed in CUBIC Reagent 2 for imaging and were im-
aged within 1 week. Diffuse, non-specific fluorescence was
observed using the CUBIC protocol in the absence of the
primary antibodies (Additional file 1: Figure S1, top panel).
Whole-mount histochemical and IHC analysis combined
with CUBIC-based tissue clearing
Excised and fixed mammary glands were immersed in re-
agent 1 for 2–3 days. Glands were removed and stained
with methyl green (0.5% (w/v)), Harris haematoxylin (10%)
or carmine for 1.5–2 h at room temperature with gentle
agitation. After staining, tissues were rinsed twice in tap
water and once in distilled water before de-staining with
acid alcohol (50% ethanol with hydrochloric acid (25 mM))
for 20 minutes and immersion in reagent 2. For detection
of β-glucosidase expression (magenta histochemical stain)
[19], mammary glands were excised and fixed for 4 h at
room temperature. Endogenous β-glucosidase activity was
heat inactivated at 65 °C for 15 minutes in PBS. Whole
mammary glands were incubated for 48 h at 50 °C in a so-
lution containing 1 part Solution A (5-Bromo-6-chloro-3-
indolyl- β-D-glucopyranoside (1% (w/v)) in DMSO) and 25
parts solution B (magnesium chloride (0.02% (w/v)), potas-
sium ferricyanide (0.096% (w/v)) and potassium ferrocyan-
ide (0.13% (w/v)) in PBS). Mammary glands were post-
fixed in 10% NBF overnight at 4 °C and cleared using the
standard CUBIC-clearing protocol.
For whole-mount immunohistochemical analysis, sam-
ples were dehydrated by a methanol series and incubated
overnight in methanol containing DMSO (20%) and
H2O2 (3%) to quench endogenous peroxidase activity
[20]. Samples were rehydrated by methanol series and
blocked and permeabilised in PBS containing BSA (10%
(w/v)) and triton-X100 (1% (w/v)). Samples were incu-
bated with rabbit anti-SMA antibody (1:200) for 4 days
at 4 °C with gentle agitation. After washing, samples
were incubated with anti-rabbit HRP-conjugated second-
ary antibody (1:500) for a further 2 days, before immersion
in reagent 2. Alternatively, quenching, blocking and anti-
body steps can be performed after immersion in reagent 1
with a similar outcome.
SeeDB-based clearing and IHC
SeeDB-based clearing was performed as previously de-
scribed [9], with minor modifications. Briefly, mammary
tissue pieces (approx. 10 × 10 × 1 mm) were blocked and
permeabilised overnight at 4 °C in PBS with triton-X100
(1% (w/v)) and BSA (10% (w/v)). Primary antibodies were
diluted in blocking buffer at 4 °C for 4 days with gentle
rocking. Tissue was washed (3 × 1 h) and incubated with
secondary antibodies for 2 days before further washing
in PBS and incubation with DAPI (10 μM) for 2–3 h.
Samples were serially incubated for 8–16 h (twice daily
changes) in 2–3 mL of 20%, 40%, 60% and 80% (w/v)
fructose in distilled water, and subsequently transferred
to 100% (w/v) fructose solution (24 h) and 115% (w/v)
fructose solution for 24 h or until imaging. All fructose
solutions contained α-thioglycerol (0.5% (v/v)) to in-
hibit the Maillard reaction [9, 21] and incubations were
performed with gentle agitation. For optimal perform-
ance, samples were imaged within 2 weeks of clearing;
however, staining was still observed up to 6 months
after clearing. Diffuse, non-specific fluorescence was
observed using the SeeDB protocol in the absence of
the primary antibodies (Additional file 1: Figure S1,
bottom panel).
Two-dimensional IHC on CUBIC-recovered and SeeDB-
recovered tissue, and formalin-fixed paraffin-embedded
(FFPE) tumour sections
Samples were immersed in PBS for approx. 3 days for
passive rehydration and removal of the clearing agent
[9]. Standard protocols for paraffin processing and em-
bedding using alcohol and xylene were employed.
Paraffin-embedded sections (4–6 μm) were de-waxed in
xylene and antigen retrieval was performed by boiling in
a pressure cooker in tri-sodium citrate buffer (10 mM,
pH 6.0), for 11 minutes [22]. Sections were blocked in
goat serum (5% (v/v)) in PBS supplemented with triton-
X100 (0.05% (w/v)) for 1 h in a humidified chamber at
room temperature. Sections were incubated with pri-
mary antibodies overnight at 4 °C. Primary antibodies
used were: rat anti-K8, rabbit anti-SMA, rabbit anti-E-
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cadherin, mouse anti-E-cadherin and rabbit anti-cleaved
caspase 3. Alexa Fluor conjugated secondary antibodies
were diluted 1:500. Nuclei were counterstained with
DAPI (1–5 μM).
Optical clearing and measurement of sample size changes
Mammary tissue pieces were processed using 3DISCO,
PACT-RC, PACT-sRIMS, CUBIC or SeeDB-based tissue
clearing protocols, and images were acquired on a dissect-
ing microscope (Leica MZ75) with constant exposure,
gain and magnification. For quantification of sample size
changes, image thresholding was performed using ImageJ
(v1.49p, National Institutes of Health) and the pixel area
was measured [9]. Volume changes were calculated as the
ratio of the pixel area before and after tissue clearing.
Confocal microscopy
Tissues cleared by 3DISCO, PACT-sRIMS, CUBIC and
SeeDB were imaged in their respective RI matching solu-
tions in Ibidi μ-Dishes. PACT-RC-cleared tissues were
mounted using iSpacer chambers in RC-CS Mounting
Medium. Images were acquired using a Leica TCS SP8
inverted confocal microscope with 10×/0.4 or 20×/0.75
HC PL APO objective lenses. Laser power and gain were
adjusted manually to give optimal fluorescence intensity
for each fluorophore with minimal photobleaching. Step
size and line averaging were kept constant for all main
figures (line averaging, 16; step size 1–2), excluding
CUBIC and SeeDB depth cueing examples. Imaging
depths were recorded from the top of the epithelial
structure being imaged (typically 350 μm through the
native fat pad for the CUBIC and SeeDB protocols).
Image reconstructions were generated using Imaris
image management software (v8.0, Bitplane) or ImageJ
(v1.50c, National Institutes of Health) [23, 24]. Depth
coding was performed using the Temporal Colour Code
plugin with the spectrum LUT. De-noising of 3D image
sequences was performed in MATLAB (R2014a, The
Mathworks Inc.) [25].
Two-photon and light sheet fluorescence microscopy (LSFM)
Two-photon imaging was performed on a LaVision
BioTec TriM Scope II with a 25×/1.05 water dipping
lens and an insight DeepSee dual-line laser (tuneable
710–1010 nm and fixed 1040 nm lines), with 810 nm
wavelength used to excite DAPI and HER2-AF647. Tiled
images, having a 20% overlap, were stitched together using
the Grid Collection/Stitching plugin in ImageJ [26].
For LSFM, samples were immunostained and cleared
according to the CUBIC protocol [10]. After clearing,
samples were embedded within an agarose (1% (w/v) in
H2O) tube, prepared by aspirating agarose (37–38 °C)
into a pre-warmed 1-mL syringe in which the syringe
neck had been cut off. Mammary tissue strips were
quickly placed within the agarose tube using forceps and
centred by rolling the syringe between the palms. After
setting, the plunger was removed and the entire syringe
was submerged in CUBIC reagent 2. Samples were im-
aged in reagent 2 or glycerol in H2O (34% (w/w)).
The light sheet system was a home-built modified ver-
sion of the OpenSPIM system [27]. The microscope was
built and operated in the T-SPIM layout, whereby illu-
mination happens from two sides simultaneously by
overlapping two individual sheets to allow a more even
illumination and to reduce artefacts, such as striping.
We used two Olympus 5×/0.15 air lenses to generate the
light sheet. The higher refractive indices, long working
distance (20 mm) and the fact that the lenses were on
threaded mounts allowed us to adjust the point of focus
accordingly. The imaging light path was equipped with a
Nikon 16×/0.8 water dipping lens. We imaged onto an
Andor Neo 5.5 (ANDOR) or a Hamamatsu ORCA-
Flash4 V2 (Hamamatsu) with 6.5 um pixels. For excita-
tion a home-built laser combiner was used, bundling
405 nm, 488 nm, 561 nm and 640 (Coherent Cube 405
and 640, Coherent Sapphire 488 and 561) into a single-
mode fibre. Channels were acquired sequentially and
emission was filtered by suitable band-pass or long-pass
filters (DAPI: 447/60; AF647: 705/72; both AHF Analy-
sentechnik). The sample was mounted in a 4D (xyzθ)
stage (Picard Industries) allowing optimal positioning of
the sample in the light sheet. During imaging the sample
was moved through the light sheet with a step size of
1.5 μm and the light sheet thickness was adjusted to be
ca. 6 μm to warrant an even thickness of the sheet
across the entire sample width. Exposure times were be-
tween 15 and 150 ms.
Results
Optical transparency in the mammary gland
We evaluated four passive whole-organ tissue clearing
protocols for optical clarity and morphology preservation
during two distinct phases of mammary gland develop-
ment, puberty and lactation. The PACT protocol was eval-
uated using two RI matching solutions: the commercially
available aqueous-based solution RapiClear CS® (RI = 1.45)
and a more-economical sorbitol-based solution, sRIMS
(RI = 1.46) [18]. Of the four methods tested, PACT-based
protocols [11] were the most time-intensive and labour-
intensive, taking between 10 and 13 days for completion
(Fig. 1a). In contrast, the simple, immersion-based tissue
clearing protocols CUBIC [10] and SeeDB [9] required
only 5 days (Fig. 1a), and resulted in superior optical clar-
ity in both virgin and lactating tissue (Fig. 1b). CUBIC
clearing provided the highest degree of transparency in
mammary tissue and was also highly effective in decolour-
ising blood vessels (Fig. 1b) [16]. To determine whether
these methods altered the structural integrity of mammary
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Fig. 1 Optical clearing of mammary tissue. a Experimental procedure and timelines for optical clearing of mouse mammary tissue. Black arrows
show the stage at which (optional) immunostaining may be performed. The experimental timeline can be altered depending on the size and
nature of the tissue, and the degree of transparency required. b Transmission images of whole abdominal (fourth) mammary glands (virgin and
lactating) before and after clearing using the passive clarity technique (PACT) with rapiclear (RC) or sorbitol refractive index matching solution
(sRIMS), clear unobstructed brain imaging cocktails (CUBIC) or the see deep brain (SeeDB) clearing protocols. c Volume changes resulting from
optical clearing of virgin and lactating mammary tissue. Values are representative of measurements from three tissue pieces from each clearing
protocol at each developmental time point. See additional file 18 for a high resolution version of these PDFs and http://rdcu.be/lT3Z for
additional high resolution examples of these imaging techniques [38]
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tissue, as has been reported for other clearing protocols
[12, 28], we measured the sample volume of fixed mam-
mary tissue before and after tissue clearing protocols were
applied (Fig. 1c). PACT-RC and CUBIC were associated
with a moderate degree of tissue expansion, which was
more prominent during lactation. A small reduction in
sample volume was observed with SeeDB (Fig. 1c).
We also tested the solvent-based tissue clearing proto-
col 3DISCO (Additional file 2: Figure S2a), a method
previously employed for tissue clearing in the mammary
gland [8]. Using 3DISCO, we observed shrinkage of both
virgin and lactating mammary tissue samples, which was
associated with significant structural deformations to ducts
and lactational alveoli (Additional file 2: Figure S2b-d). Al-
though this protocol was extremely rapid to implement
(Additional file 2: Figure S2a), achieved a high degree of
optical clarity (Additional file 2: Figure S2b) and may be
useful in other organ systems [8], its application to the
mammary gland, which was left brittle and damaged from
the clearing process, is extremely limited. Additionally, the
solvents used in this protocol pose significant laboratory
safety risks and require specialised imaging chambers [8].
For these reasons we did not pursue 3DISCO further for
optical clearing of mammary tissue.
PACT-based tissue clearing and 3D imaging of the
unsectioned mouse mammary gland
We assessed PACT-based clearing approaches for the visu-
alisation of mammary epithelial cells in virgin and lactating
mammary glands in situ. When combined with whole-
mount immunostaining, these protocols required 17
(PACT-RC) to 20 (PACT-sRIMS) days preparation prior to
imaging (Additional file 3: Figure S3a and Fig. 2a) [11].
Samples prepared using the PACT-RC protocol are not
stable in the RI matching solution, and thus require
mounting in a specialised mounting medium (SunJin
Labs). Whilst this approach is conducive to long-term sam-
ple storage, the limited working distances of standard con-
focal microscope objectives makes imaging of PACT-RC-
mounted samples problematic, as samples cannot be re-
orientated against the coverglass for optimal sample illu-
mination (Additional file 3: Figure S3b-c). Consequently,
we chose to pursue PACT-sRIMS for whole-mount immu-
nostaining and 3D imaging in this study. However, we note
that this is purely a hardware issue, and PACT-RC may be
useful with more specialised imaging objectives [18].
PACT-sRIMS permitted imaging of surface structures
(Fig. 2b) at marginally improved depths over uncleared
tissue (Additional file 4: Figure S4). Using PACT-sRIMS
combined with 3D de-noising algorithms (Additional file 5:
Figure S5) [25], we were able to visualise surface epithelial
structures in 3D at high cellular resolution (Fig. 2b, c and
Additional file 6: Figure S6). Figure legends provide a
link to higher resolution files. Lactating tissue was
particularly amenable to 3D imaging, due to the lower
content of adipocytes and the increased surface epithe-
lial mass (Fig. 2c). Using this approach, we were able to
observe K5-expressing and SMA-expressing basal cells
and K8-expressing and E-cadherin-expressing luminal
cells, with confidence.
CUBIC tissue clearing and 3D imaging of the unsectioned
mouse mammary gland
Like PACT-sRIMS, CUBIC clearing allowed visualisation
of the virgin and lactating mammary epithelia at high
cellular resolution (Fig. 3, Additional file 7: Movie 1 and
Additional file 8: Figure S7). Additionally, due to the
high degree of optical transparency achieved by CUBIC
clearing, deeper structures could be readily visualised
and imaged using this method (Fig. 3). Whilst we ob-
served strong immunostaining with K5 and SMA anti-
bodies using the CUBIC method, K8 and E-cadherin
were not readily and uniformly observed in these condi-
tions. This could be due to sub-optimal fixation or a re-
sult of differential protein loss caused by exposure to
high levels of detergent without prior sub-cellular stabil-
isation using a hydrogel monomer. However, using a re-
cent modification to the CUBIC Reagent 1 formulation
(Reagent 1A, see “Methods”), we observed improved im-
munostaining of K8 and E-cadherin (Additional file 9:
Figure S8), suggesting that epitope availability is better
preserved with this new reagent. The stability of various
genetically encoded fluorescent proteins (FPs), including
GFP, YFP and RFP, was also assessed and found to be
adequately preserved through CUBIC processing
(Additional file 10: Figure S9a, b).
We determined that CUBIC-cleared samples were
amenable to rehydration, paraffin embedding and immu-
nohistochemical staining following whole-mount imaging
(Additional file 10: Figure S9c), facilitating the subse-
quent 2D cellular analysis of whole-mount-imaged mam-
mary structures. On account of the high level of optical
clarity achieved using CUBIC-based tissue clearing and
its compatibility with subsequent 2D imaging, we also
evaluated its utility for whole-mount histochemical ana-
lysis (Fig. 4). Currently, carmine is the most prevalent
histochemical stain for assessing mammary gland mor-
phogenesis in whole mount. This pigment stains the
mammary epithelia an intense pink/red colour and relies
on the solvent xylene or methyl salicylate for subsequent
optical transparency [29, 30]. Here, we developed and
optimised an alternative histochemical stain for the
mammary gland, using the cationic dye methyl green
and CUBIC tissue clearing. Using this approach we were
able to achieve delicate green/blue staining of epithelial
structures in the mammary gland of virgin and
lactating mice (Fig. 4a). This new staining approach
offers improved colour palette flexibility for dual-
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Fig. 2 Passive clarity technique (PACT)-sorbitol refractive index matching solution (sRIMS) clearing and 3D imaging of virgin and lactating mouse
mammary tissue. a PACT-sRIMS tissue clearing and immunostaining protocol and timeline. Three-dimensional confocal imaging of PACT-sRIMS-
cleared virgin (b) and lactating (c) mammary glands immunostained with basal cell markers (K5 and smooth muscle actin (SMA)) and luminal cell
markers (K8 and E-cadherin (E-CAD)). Main image shows the maximum intensity projection of the entire image sequence, with thin optical slices
(1 μm) and their depth (z value) relative to the first image in the image sequence. These images are representative of images from at least two
mice; further examples of PACT-sRIMS-cleared tissue are shown in Additional file 6: Figure S6). DAPI 4′,6-diamidino-2-phenylindole. See additional
file 18 for a high resolution version of these PDFs and http://rdcu.be/lT3Z for additional high resolution examples of these imaging techniques
[38]
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colour staining, for example with the novel magenta
β-glucosidase (SYNbglA) reporter [19] (Fig. 4b). CUBIC
clearing was also semi-compatible with the more trad-
itional whole-mount histochemical stains carmine and
haematoxylin (Additional file 11: Figure S10), although
these were not the focus of this study and staining may be
improved with further optimisation. Importantly, CUBIC
clearing was compatible with whole-mount DAB immu-
nohistochemical analysis (Fig. 4c), which has not previ-
ously been achieved in the mammary gland.
SeeDB tissue clearing for 3D imaging of the unsectioned
mouse mammary gland
Similar to CUBIC clearing, mammary ducts and
alveoli could be imaged at high cellular resolution
and at considerable depths using SeeDB clearing (Fig. 5,
Additional file 12: Movie 2 and Additional file 13:
Figure S11). SeeDB-cleared mammary tissue was highly
compatible with all antibodies (Fig. 5) and endogenous
fluorochromes tested (Additional file 14: Figure S12a, b),
with structural morphology well preserved by this simple
CUBIC Reagent #1Fix Reagent #2
Block Primary Antibody Secondary Antibody& DAPI = 12 days 
Day 0 1 2 3 4 5 6 7 8 9 10 11 12 13
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K5 DAPI
z = 7 µm
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30 µm
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Fig. 3 Clear unobstructed brain imaging cocktails (CUBIC) clearing and 3D imaging of virgin and lactating mouse mammary tissue. a CUBIC tissue
clearing and immunostaining protocol and timeline. Three-dimensional confocal imaging of CUBIC-cleared virgin (b) and lactating (c) mammary
glands immunostained with basal cell markers (K5 and smooth muscle actin (SMA)) and luminal cell markers (K8 and E-cadherin (E-CAD)). Main image
(green) shows the maximum intensity projection of the entire image sequence, with thin optical slices (1 μm) and their depth (z value) relative to the
first image in the image sequence. Right panel shows depth-coding of SMA-expressing cells; images in an image stack are assigned a colour
based on their relative depth. These images are representative of images from more than three mice; further examples of CUBIC-cleared tissue
are shown in Additional file 8: Figure S7 and a modified (Reagent 1A) CUBIC protocol in Additional file 9: Figure S8). BV blood vessel (SMA-expressing).
DAPI 4′,6-diamidino-2-phenylindole. See additional file 18 for a high resolution version of these PDFs and http://rdcu.be/lT3Z for additional high
resolution examples of these imaging techniques [38]
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fructose-based clearing technique. Additionally, SeeDB-
cleared samples were also highly compatible with rehydra-
tion and additional whole-mount immunostaining or with
paraffin embedding, sectioning and 2D immunostaining
(Additional file 14: Figure S12c). Collectively, these prop-
erties of optical transparency, morphology preservation,
quality of whole-mount immunostaining and suitability
for rehydration and 2D analyses, made SeeDB our pre-
ferred method for 3D fluorescence imaging of the mam-
mary gland.
Three-dimensional imaging of mammary tumours
We also tested the performance of PACT-sRIMS,
CUBIC and SeeDB clearing protocols on mouse mam-
mary tumours derived from the syngeneic TUBO cell
line [17]. All clearing protocols permitted high reso-
lution imaging of HER2-expressing cells in mammary
tumours at enhanced depths (Fig. 6 and Additional file
15: Movie 3). Similar to virgin and lactating tissue, K8
immunostaining was less intense in CUBIC-cleared
mammary tumours (Fig. 6b), but may be improved by
the second generation formulation (Reagent 1A). We ob-
served that HER2, K8 and DAPI fluorescence intensity
was reduced with increasing imaging depth in all proto-
cols (Fig. 6). Whilst this may in part be attributable to a
technical artefact, e.g. sub-optimal fixation or inadequate
antibody penetration, it may also be a reflection of the in-
herent biology and heterogeneity of these tumour samples.
Indeed, 2D immunohistochemical analysis revealed that
the centre of many tumour lobules contained cleaved
caspase-3-positive cells within areas of low E-cadherin
staining (Additional file 16: Figure S13), highlighting
the value of performing 2D analyses and 3D imaging in
parallel when characterising complex and heteroge-
neous specimens.
Finally, we utilised two-photon excitation microscopy
(TPEM) and light sheet fluorescence microscopy (LSFM)
for rapid, large-scale imaging of normal and tumouri-
genic mammary tissue at improved depths and speeds
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Fig. 4 Clear unobstructed brain imaging cocktails (CUBIC) clearing
for whole-mount transmission imaging of the mouse mammary
gland. a Virgin and lactating mammary glands stained with methyl
green and cleared with CUBIC for whole-mount morphometric
analysis. These images are representative of images from more
than three mice. b Methyl green counterstaining, showing the
compatibility of this light green counterstain with magenta-glu
detection of β-glucosidase+ cells; β-glucosidase+ cells are interspersed
with unlabelled cells in this R26[CA]30SYNbglA mouse model. c Compatibility
of CUBIC clearing with smooth muscle actin (SMA)-immunostaining
and horseradish peroxidase-3,3-diaminobenzidine detection.
Immunostaining steps can be performed before CUBIC clearing
(top panel) or after CUBIC clearing (bottom panel). See additional file
18 for a high resolution version of these PDFs and http://rdcu.be/lT3Z
for additional high resolution examples of these imaging techniques
[38]
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(Fig. 7 and Additional file 17: Figure S14). TPEM uses
longer wavelengths, thus allowing deeper penetration,
less scattering of light and reduced out-of-focus photo-
bleaching than laser scanning confocal microscopy [31].
Using this technique, we were able to image approx.
1.2 × 1.2 × 0.1 mm of SeeDB-cleared tumour tissue in
less than 15 minutes per individual channel at high cel-
lular resolution (Fig. 7). Deeper imaging was achievable
(Fig. 7, orthogonal projections); however, as seen with
confocal microscopy, HER2 immunostaining declined
with increasing depth (Fig. 7, optical slices). Furthermore,
using a home-built LSFM [27], with dual side illumination,
we were able to image a volume of 0.8 × 0.8 × 1.5 mm in
normal mammary tissue with CUBIC clearing in less
than 5 min per individual channel (Additional file 17:
Figure S14). These data demonstrate that SeeDB-cleared
and CUBIC-cleared mammary tissue are also compatible
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Fig. 5 See deep brain (SeeDB)-clearing and 3D imaging of virgin and lactating mouse mammary tissue. a SeeDB tissue clearing and immunostaining
protocol and timeline. Three-dimensional confocal imaging of SeeDB-cleared virgin (b) and lactating (c) mammary glands immunostained with basal
cell markers (K5 and smooth muscle actin (SMA)) and luminal cell markers (K8 and E-cadherin (E-CAD)). Main image (green) shows the
maximum intensity projection of the entire image sequence, with thin optical slices (1 μm) and their depth (z value) relative to the first
image in the image sequence. Right panel shows depth-coding of SMA-expressing cells; images in an image stack are assigned a colour
based on their relative depth. These images are representative of images from more than three mice; further examples of SeeDB-cleared
tissue are shown in Additional file 13: Figure S11). BV blood vessel (SMA-expressing). DAPI 4′,6-diamidino-2-phenylindole. See additional file
18 for a high resolution version of these PDFs and http://rdcu.be/lT3Z for additional high resolution examples of these imaging tech-
niques [38]
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Discussion
Recent developments and refinements in whole-organ
tissue clearing and 3D imaging techniques, such as LSFM,
optical projection tomography (OPT) and X-ray tomog-
raphy, have provided unprecedented optical access to in-
tact mammalian tissues [32]. These protocols have been
utilised for a range of biological applications, including
neuronal circuit reconstruction [8–11, 15, 28, 33], charac-
terisation of arterial wall structure [34] and single-cell
lineage tracing in the embryonic heart [35]. In this
technical report, we compared leading tissue clearing pro-
tocols for optical transparency, structural preservation
and 3D fluorescent imaging in the intact mammary gland.
This is the first study to employ tissue clearing protocols
to examine mammary epithelial cells at single-cell reso-
lution within their native stroma.
We first assessed these protocols for their ability to
render opaque mammary tissue transparent. SeeDB and
CUBIC clearing techniques achieved the highest degree
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Fig. 6 Three-dimensional confocal imaging of mouse mammary tumours cleared with the passive clarity technique (PACT)-sorbitol refractive
index matching solution (sRIMS), clear unobstructed brain imaging cocktails (CUBIC) and see deep brain (SeeDB) methods. PACT-sRIMS cleared
tumour tissue (a), CUBIC-cleared tumour tissue (b) and SeeDB-cleared tumour tissue (c). Images show maximum intensity projections of
4′,6-diamidino-2-phenylindole (DAPI) nuclear staining and human epidermal growth factor receptor 2 (HER2) and K8 immunostaining, with
thin optical slices (1 μm) and their depth (z value) relative to the first image in the image sequence. These images are representative of
at least two regions acquired. See additional file 18 for a high resolution version of these PDFs and http://rdcu.be/lT3Z for additional high
resolution examples of these imaging techniques [38]
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the exceptional clarity achieved using the CUBIC proto-
col, we also investigated its suitability as an alternative
to xylene delipidation for macroscopic imaging of mouse
mammary gland whole mounts. CUBIC clearing com-
bined with methyl green staining resulted in uniform,
single-colour staining of mammary epithelial ducts and
alveoli, and improved-contrast counterstaining for multi-
colour histochemical analysis. Importantly, CUBIC clear-
ing was also compatible with whole-mount chromogenic
immunostaining using HRP-DAB detection. Additionally,
whole-mount-imaged tissue could be easily recovered
and sectioned for subsequent 2D immunohistochemical
SeeDB cleared mammary tumour imaged on 2-photon microscope
z = 16 µm z = 28 µm z = 40 µm z = 52 µm z = 64 µm z = 76 µm z = 88 µm z = 94 µm





Fig. 7 Imaging of see deep brain (SeeDB)-cleared mammary tumours using 2-photon excitation microscopy. Two-photon imaging of SeeDB-
cleared human epidermal growth factor receptor 2 (HER2)-positive mammary tumours immunostained with HER2 (green) and 4′,6-diamidino-2-
phenylindole (DAPI) nuclear staining (blue) and magnified view (inset). Orthagonal views show XZ (purple line and box) and YZ (red line and box)
planes. Thin optical slices (2 μm) and their depth (z value) relative to the first image in the image sequence are also shown. See additional file 18 for a high
resolution version of these PDFs and http://rdcu.be/lT3Z for additional high resolution examples of these imaging techniques [38]
Table 1 A comparison of selected clearing methods in the mammary gland
Method Method overview RI Clearing
capability








Uncleared No clearing protocol
applied
− − 1 day Preserved Preserved Compatible No Possiblef −
3DISCO Organic solvent-based 1.56 Strong 2 days Compromised Rapid loss Difficultc No Not possible [8]
PACT-RC Aqueous solution-based
(hydrogel embedding)
1.45 Weak 10 days Preserved,
mild expansion
Preserved Compatible Yes Not possible [11]
PACT-sRIMS Aqueous solution-based
(hydrogel embedding)
1.46 Weak 13 days Preserved Preserved Compatible No Possiblef [11]
CUBIC Aqueous solution-based
(simple immersion)







1.49 Moderate 5 days Preserved,
mild shrinkage
Preserved Compatible Noe Confirmed [9]
aDuration from the time of tissue harvest (includes fixation time typically 6–16 h for mammary tissue). bAs previously reported [10, 39] and the observed
requirement for slightly higher laser power for confocal imaging. This may be improved by using the second generation protocol (using Reagent 1A). cUsing the
three-dimensional imaging of solvent-cleared organs combined with optimised whole-mount immunolabelling procedures iDISCO/three-dimensional imaging of
solvent-cleared organs (3DISCO) method. The fluorescence signal is rapidly quenched using benzyl alcohol benzyl benzoate (BABB) and a specialised imaging
chamber is required for dibenzyl ether (DBE). dSome antibodies (i.e. E-cadherin, K8 and human epidermal growth factor receptor 2) do not perform as well as in
other clearing protocols. eOptimally imaged within 2 weeks but may be stored for several months. fLikely to be compatible, but not tested in this study. RI refractive
index, FP fluorescent protein, IHC immunohistochemical analysis, PACT-RC passive clarity technique-Rapiclear, sRIMS sorbitol refractive index matching solution, CUBIC
clear unobstructed brain imaging cocktails, SeeDB see deep brain
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analysis. For these reasons, we propose CUBIC clear-
ing as a novel, superior clearing agent for mammary
gland whole mounts.
A major limitation of early tissue-clearing techniques
is pronounced sample volume changes, leading to cellular
deformations [12, 28]. Here, we found that mammary tis-
sue cleared with PACT-RC and CUBIC was associated
with a moderate degree of sample expansion, as previously
observed in brain tissue cleared using these techniques
[10, 11]. Conversely, SeeDB was associated with minor
shrinkage of mammary tissue (Table 1), while PACT-
sRIMS had no effect on sample volume. Importantly,
morphological deformations were not observed by con-
focal microscopy for any of the four main tissue clear-
ing protocols assessed in this study. Thus, these small,
predictable changes in linear sample volume are not
likely to pose a major problem for the majority of stud-
ies in the mammary gland, provided the control/com-
parator mammary gland is also subjected to the same
clearing protocol. Additionally, in contrast to mechan-
ical dissection or enzymatic digestion, most optical tis-
sue clearing protocols preserve both tissue and matrix
architecture, and thus facilitate 3D imaging and analysis
of epithelial-stromal interactions.
Whilst important biological information can be gar-
nered from 3D imaging of near-surface structures in un-
cleared tissue [36, 37], the advantages presented by
tissue clearing for the visualisation of expansive areas of
mammary tissue are considerable, e.g. for comprehensive
clonal analysis in lineage tracing studies [38] or mapping
the cellular circuitry driving mammary gland develop-
ment. Using tissue clearing protocols we were able to
image genetically encoded fluorescent proteins and a
range of immunolabelled lineage markers at vastly im-
proved depths and at high cellular resolution in virgin,
lactating and tumour tissue. Adoption of these protocols
combined with volumetric imaging and published de-
noising algorithms will greatly enhance our understand-
ing of the structural organisation and development of
the normal mammary gland, and how these processes
are subverted in cancer. An evaluation of the perform-
ance of these protocols for diagnostic and experimental
studies using clinical tumour biopsies is an aim for the
future.
Although not evaluated in this study, it is expected
that other antibodies, with appropriate optimisation,
would be compatible with whole-mount immunostain-
ing, tissue clearing and 3D imaging in the mammary
gland. Thus, this technique has widespread applications
in the broader fields of mammary gland biology and
pathology. In particular, appropriate optimisation of the
tissue fixation time is paramount for whole-mount im-
munostaining, which is not compatible with heat-
induced epitope retrieval. Reduced performance of some
antibodies was observed with CUBIC clearing in the
mammary gland. This method relies on high concentra-
tions of detergent (15% triton-X100) for clearing and,
unlike the PACT protocol, does not entail prior hydrogel
embedding to stabilise cellular structures, raising concerns
that this protocol may be associated with some protein
loss (Table 1) [10]. Indeed, this may explain the compro-
mised fluorescence immunostaining of K8, E-cadherin
and HER2 observed with the CUBIC clearing protocol in
our study. To overcome this issue an updated CUBIC
protocol has recently been developed (unpublished, see
“Methods”) aimed at improving issues related to protein
loss [39]. Alternatively, samples could be gel-embedded
according to the CLARITY protocol [15] prior to CUBIC
clearing; however, this has not been rigorously assessed in
this or other [10] studies, and would require further opti-
misation for mammary tissue.
An assessment of the qualities of optical transparency,
structural preservation, imaging depth, immunostaining,
compatibility with downstream analyses, cost and safety
(Table 1), placed SeeDB as our method of choice for tis-
sue clearing and volumetric imaging of mammary tissue
using standard confocal and advanced fluorescence im-
aging techniques. The deep tissue imaging of normal
and pathological mammary tissue will greatly improve
our understanding of this architecturally complex and
heterogeneous organ.
Conclusions
This technical report compared the strengths and limita-
tions of a range of whole-organ tissue clearing protocols
for optical transparency and 3D imaging in the mouse
mammary gland. Notably, the methods examined here are
open source protocols, which utilise reagents that are both
widely available and affordable to most laboratories. Add-
itionally, whilst these protocols are compatible with ad-
vanced imaging techniques, they can also be paired with
standard confocal microscopy and open source analysis
platforms for universal use. We hope that this publication
sheds light on the methods available for optical tissue
clearing of the mouse mammary gland, and encourages
other researchers to perform their mammary tissue im-
aging in 3D, with all architectural information preserved.
Additional files
Additional file 1: Figure S1. No primary antibody controls of CUBIC
cleared tissue (top panel) and SeeDB cleared tissue (bottom panel).
See Additional file 18 for a high resolution version of these PDFs. (PDF 243 mb)
Additional file 2: Figure S2. 3DISCO clearing and 3D imaging of virgin
and lactating mouse mammary tissue. a 3DISCO tissue clearing and
immunostaining protocol and timeline. b Transmission images of 3DISCO
cleared tissue. c Volume changes caused by 3DISCO-based clearing
of virgin and lactating mammary tissue. Values are representative of
measurements from three tissue pieces at each developmental timepoint.
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d 3D confocal imaging of 3DISCO-cleared virgin and lactating mammary
glands immunostained with the basal cellb marker SMA. These images are
representative of images from more than two mice. See Additional file 18
for a high resolution version of these PDFs. (PDF 8 mb)
Additional file 3: Figure S3. PACT-RC clearing and 3D imaging of virgin
and lactating mouse mammary tissue. a PACT-RC tissue clearing and
immunostaining protocol and timeline. b The optimal (i) and PACT-RC (ii)
imaging configuration for confocal microscopy. For optimal illumination,
samples are squeezed between two glass coverslips and are easily flipped
or re-positioned for imaging. In contrast, for PACT-RC-cleared samples,
samples are mounted using an iSpacer chamber and are difficult
to adjust or reposition for optimal illumination, thus the working
distance becomes the limiting factor in image acquisition. To overcome
this, sample thickness must be closely matched to the thickness of the
iSpacer chamber, specialised imaging objectives need to be used or
different RI-matching solutions are needed. c 3D confocal imaging of
PACT-RC-cleared virgin and lactating mammary glands immunostained with
the basal cell marker SMA and stained with the nuclear stain DAPI. These
images are representative of images from at least two mice. See Additional
file 18 for a high resolution version of these PDFs. (PDF 124 mb)
Additional file 4: Figure S4. 3D imaging of uncleared virgin and
lactating mouse mammary tissue. a Immunostaining protocol and
timeline, without a tissue clearing step. 3D confocal imaging of uncleared
virgin (b) and lactating (c) mammary glands immunostained with basal
cell marker SMA and the luminal cell marker E-cadherin. Main image
shows the maximum intensity projection of the entire image sequence,
with thin optical slices (1 μm) and their depth (z value) relative to the first
image in the image sequence. Visible structures were located very close
to the surface of the tissue. See Additional file 18 for a high resolution
version of these PDFs. (PDF 176 mb)
Additional file 5: Figure S5. De-noising of 3D image sequences. DAPI
staining (top panel) and E-cadherin immunostaining (bottom panel) in lactating
mammary tissue before and after a de-noising algorithm was applied to
minimise Poisson-Gaussian noise in the 3D image stacks. De-noising does
not greatly alter the outward appearance of the image sequence, but rather
aids downstream computer-assisted analyses. See Additional file 18 for a
high resolution version of these PDFs. (PDF 4 mb)
Additional file 6: Figure S6. Additional 3D confocal images of PACT-
sRIMS-cleared mammary glands, related to Fig. 2. BV blood vessel (SMA-
expressing). See Additional file 18 for a high resolution version of these
PDFs. (PDF 13 mb)
Additional file 7: Movie 1. Three-dimensional rendering of SMA
immunostaining (red) and DAPI nuclear staining (blue) in CUBIC-cleared
lactating mammary tissue. Movie shows a layer of basket-like basal cells
surrounding each alveolus with single cell resolution. (AVI 20400 kb)
Additional file 8: Figure S7. Additional 3D confocal images of CUBIC-
cleared mammary glands, related to Fig. 3. Arrowhead shows non-specific
intraluminal staining occasionally observed with CUBIC clearing, which
may be improved with more rigorous washing following immersion in
Reagent 1. See Additional file 18 for a high resolution version of these
PDFs. (PDF 23 mb)
Additional file 9: Figure S8. Three-dimensional confocal images of
mammary glands cleared using a modified CUBIC clearing protocol
(Reagent 1A) to minimise protein loss. Images show the maximum intensity
projection of the entire image sequence. Bottom right panel shows
depth-coding of SMA-expressing myoepithelial cells in lactating mam-
mary tissue; images in an image stack are assigned a colour based on their
relative depth. Arrowhead shows non-specific intraluminal staining
occasionally observed with modified CUBIC clearing, which may be improved
with further washing. These images are representative of images from two
mice. BV blood vessel (SMA-expressing). See Additional file 18 for a high reso-
lution version of these PDFs. (PDF 12 mb)
Additional file 10: Figure S9. Compatibility of CUBIC clearing with
genetically encoded FPs and recovery for histological sections. a CUBIC
clearing of tissue from R26-Confetti mice with reporter expression (nuclear
GFP, cytosolic YFP and cytosolic RFP) induced at very low, sporadic levels.
Membranous CFP was not observed with any clearing protocol and may be
technical; however, this FP is also reportedly underrepresented in mammary
tissue from R26-Confetti mice. b Tissue from lactating R26-Tdtomato
mice induced at very high levels. c CUBIC-cleared tissue was rehydrated in
PBS prior to standard processing, paraffin embedding and sectioning.
Immunostaining for E-cadherin (luminal) and SMA (basal) markers
confirm the compatibility of CUBIC clearing with tissue recovery and
immunostaining. See Additional file 18 for a high resolution version
of these PDFs. (PDF 126 mb)
Additional file 11: Figure S10. Compatibility of CUBIC clearing with
carmine and haematoxylin whole-mount staining. Carmine staining (top)
shows light pink, non-uniform staining in virgin and lactating tissue.
Haematoxylin staining (bottom) was an intense blue colour in both ducts
and stroma. See Additional file 18 for a high resolution version of these
PDFs. (PDF 30 mb)
Additional file 12: Movie 2. Three-dimensional rendering of SMA
(green) and K8 (red) immunostaining in SeeDB-cleared virgin mammary
tissue. Movie shows luminal and basal cell layers with single cell resolution.
(AVI 32300 kb)
Additional file 13: Figure S11. Additional 3D confocal images of
SeeDB-cleared mammary glands, related to Fig. 5. See Additional file 18
for a high resolution version of these PDFs. (PDF 10 mb)
Additional file 14: Figure S12. Compatibility of SeeDB clearing with
genetically encoded FPs and recovery for histological sections. a SeeDB
clearing of tissue from virgin R26-Confetti mice with reporter expression
(nuclear GFP, cytosolic YFP and cytosolic RFP) induced at very low,
sporadic levels. Membranous CFP was not observed with any clearing
protocol and may be technical; however, this FP is also reportedly
underrepresented in mammary tissue from R26-Confetti mice. b Tissue from
lactating R26-Tdtomato mice induced at very high levels. c SeeDB-cleared
tissue was rehydrated in PBS prior to standard processing, paraffin
embedding and sectioning. Immunostaining for K8 (luminal) and SMA
(basal) markers confirm the compatibility of SeeDB clearing with tissue
recovery and immunostaining. See Additional file 18 for a high resolution
version of these PDFs. (PDF 154 mb)
Additional file 15: Movie 3. Three-dimensional rendering of HER2 (red)
and K8 (green) immunostaining with DAPI nuclear staining (blue) in
SeeDB-cleared mammary tumours. Movie shows optical slices and the
single cell resolution, allowing visualisation of the 3D structure of the
tumour tissue. (AVI 45300 kb)
Additional file 16: Figure S13. Two dimensional immunohistochemical
analysis of tumour fragments. K8 and HER2 (a) and E-cadherin and cleaved
caspase-3 (CC3) (b) immunostaining on formalin-fixed paraffin embedded
tissue sections from mouse mammary tumours. CC3-positive cells can be
observed close to the tumour boundary and in the centre of the tumour
fragment, and thus, are not simply an artefact of sub-optimal tissue fixation.
Dotted line in left panel shows the tissue boundary. DAPI nuclear staining
(blue). See Additional file 18 for a high resolution version of these PDFs.
(PDF 26 mb)
Additional file 17: Figure S14. LSFM imaging in the mammary gland.
SMA immunostaining and CUBIC clearing of mammary tissue from (a)
early gestation (total depth 800 μm) and (b) virgin (total depth 500 μm)
mammary tissue. BV blood vessel (SMA-expressing). See Additional file 18
for a high resolution version of these PDFs. (PDF 9 mb)
Additional file 18: All figures in high resolution. (ZIP 127 MB)
Acknowledgements
We thank the Department of Pathology Biological Services Unit for help with
animal work, H. Skelton for help with histology, and Peter Humphreys, Drs Leila
Muresan, Kevin O’Holleran and Martin Lenz for imaging support. All imaging
was performed at the Cambridge Advanced Imaging Centre, Cambridge Stem
Cell Institute and the Medical Research Council Laboratory for Molecular
Biology (MRC LMB). We thank Adam Fowle and Steve Scotcher from the MRC
LMB mechanical workshop for excellent support, and Dr Nick Barry from the
light microscopy facility of the MRC LMB for advice on modifications of the
light sheet system. We also thank Drs Ueda and Susaki (RIKEN Quantitative
Biology Center) for their assistance with CUBIC-based tissue clearing.
Lloyd-Lewis et al. Breast Cancer Research  (2016) 18:127 Page 15 of 17
Funding
This work was supported by a grant from the Medical Research Council
(MRC) programme grant number MR/J001023/1 (BL-L and CJW). FMD was
funded by a National Health and Medical Research Council CJ Martin
Biomedical Fellowship (GNT1071074). OBH was funded by a Wellcome Trust
PhD Studentship (105377/Z/14/Z). JRH was funded by an MRC research
grant number MR/K011014/1. FCL was funded by Cancer Research UK and
MP was funded by the MRC-LMB (MC_U105178788).
Availability of data and materials
The authors declare that all data supporting the findings of this study are
available in the manuscript and its supplementary information files, or are
available from the corresponding authors upon request.
Authors’ contributions
FMD and BL-L conceived and designed all experiments, performed the
optical clearing assays, confocal imaging and whole-mount histochemical
analysis and wrote the manuscript. OBH performed confocal imaging
and DAB-HRP whole-mount histochemical analysis and helped to revise
the manuscript. JRH generated all tumour tissue for confocal and TPEM
studies and helped to revise the manuscript. FCL helped design PACT
and CUBIC studies, assisted with PACT tissue clearing and helped to revise the
manuscript. MP developed and performed all LSFM studies and helped to
revise the manuscript. CJW conceived the experiments and helped to revise
the manuscript. All authors read and approved the final manuscript.
Authors’ information
Drs Felicity Davis, Bethan Lloyd-Lewis, Jessica Hitchcock and Filipe Lourenco
are Postdoctoral Fellows and Olivia Harris is a PhD Student at the University
of Cambridge. Dr Mathias Pasche is a Technical Support Officer at the Light
Microscopy Facility of the MRC Laboratory of Molecular Biology. Prof
Christine Watson is a Group Leader at the University of Cambridge and
Vice Principal of Newnham College.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
All animal experimentation was carried out in accordance with the Animal
(Scientific Procedures) Act 1986, the European Union Directive 86/609 and with
local ethics committee approval (University of Cambridge Animal Welfare
and Ethical Review Body (AWERB), UK Home Office and The University of
Queensland Animal Ethics Committee).
Author details
1Department of Pathology, University of Cambridge, Cambridge CB2 1QP,
UK. 2School of Pharmacy, The University of Queensland, Brisbane 4072,
Australia. 3Wellcome Trust-Medical Research Council Cambridge Stem Cell
Institute, University of Cambridge, Cambridge CB2 1QR, UK. 4Cancer Research
UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre,
Cambridge CB2 0RE, UK. 5Medical Research Council Laboratory for Molecular
Biology, Cambridge CB2 0QH, UK.
Received: 24 June 2016 Accepted: 18 August 2016
References
1. Macias H, Hinck L. Mammary gland development. Wiley Interdiscip Rev Dev
Biol. 2012;1:533–57.
2. Rios AC, Fu NY, Lindeman GJ, Visvader JE. In situ identification of bipotent
stem cells in the mammary gland. Nature. 2014;506:322–7.
3. Wuidart A, Ousset M, Rulands S, Simons B, Van Keymeulen A, Blanpain C.
Quantitative lineage tracing strategies to resolve multipotency in tissue-
specific stem cells. Genes Dev. 2016;30:1261–77.
4. Wang D, Cai C, Dong X, Yu QC, Zhang X-O, Yang L, et al. Identification of
multipotent mammary stem cells by protein C receptor expression. Nature.
2015;517:81–4.
5. Rios AC, Fu NY, Jamieson PR, Pal B, Whitehead L, Nicholas KR, et al. Essential
role for a novel population of binucleated mammary epithelial cells in
lactation. Nat Commun. 2016;7:11400.
6. Spalteholz W. Uber das Durchsichtigmachen von menschlichen und
tierischen Praparaten. Leipzig; 1914.
7. Tainaka K, Kuno A, Kubota S, Murakami T, Ueda H. Chemical principles in
tissue clearing and staining protocols for whole-body cell profiling. Annu
Rev Cell Dev Biol. 2016;32:1–29.
8. Erturk A, Becker K, Jahrling N, Mauch CP, Hojer CD, Egen JG, et al. Three-
dimensional imaging of solvent-cleared organs using 3DISCO. Nat Protoc.
2012;7:1983–95.
9. Ke M-T, Fujimoto S, Imai T. SeeDB: a simple and morphology-preserving
optical clearing agent for neuronal circuit reconstruction. Nat Neurosci.
2013;16:1154–61.
10. Susaki EA, Tainaka K, Perrin D, Kishino F, Tawara T, Watanabe TM, et al.
Whole-brain imaging with single-cell resolution using chemical cocktails
and computational analysis. Cell. 2014;157:726–39.
11. Yang B, Treweek JB, Kulkarni RP, Deverman BE, Chen CK, Lubeck E, et al.
Single-cell phenotyping within transparent intact tissue through whole-
body clearing. Cell. 2014;158:945–58.
12. Becker K, Jährling N, Saghafi S, Weiler R, Dodt HU. Chemical clearing and
dehydration of GFP expressing mouse brains. PLoS One. 2012;7:e33916.
13. Dodt H-U, Leischner U, Schierloh A, Jährling N, Mauch CP, Deininger K, et al.
Ultramicroscopy: three-dimensional visualization of neuronal networks in
the whole mouse brain. Nat Methods. 2007;4:331–6.
14. Renier N, Wu Z, Simon DJ, Yang J, Ariel P, Tessier-Lavigne M. iDISCO: a
simple, rapid method to immunolabel large tissue samples for volume
imaging. Cell. 2014;159:896–910.
15. Chung K, Deisseroth K. CLARITY for mapping the nervous system. Nat
Methods. 2013;10:508–13.
16. Tainaka K, Kubota SI, Suyama TQ, Susaki EA, Perrin D, Ukai-Tadenuma M, et al.
Whole-body imaging with single-cell resolution by tissue decolorization. Cell.
2014;159:911–24.
17. Rovero S, Amici A, Di Carlo E, Bei R, Nanni P, Quaglino E, et al. DNA
vaccination against rat her-2/Neu p185 more effectively inhibits
carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.
J Immunol. 2000;165:5133–42.
18. Marx V. Microscopy: seeing through tissue. Nat Methods. 2014;11:1209–14.
19. McCutcheon SC, Jones K, Cumming SA, Kemp R, Ireland-Zecchini H,
Saunders JC, et al. Characterization of a heat resistant beta-glucosidase as a
new reporter in cells and mice. BMC Biol. 2010;8:89.
20. Manousiouthakis E, Mendez M, Garner MC, Exertier P, Makita T. Venous
endothelin guides sympathetic innervation of the developing mouse heart.
Nat Commun. 2014;5:3918.
21. Dills WL. Protein fructosylation: fructose and the Maillard reaction. Am J Clin
Nutr. 1993;58:779S-87S.
22. Sargeant TJ, Lloyd-Lewis B, Resemann HK, Ramos-Montoya A, Skepper J,
Watson CJ. Stat3 controls cell death during mammary gland involution by
regulating uptake of milk fat globules and lysosomal membrane
permeabilization. Nat Cell Biol. 2014;16:1057–68.
23. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an
open source platform for biological image analysis. Nat Methods. 2012;9:676–82.
24. Linkert M, Rueden CT, Allan C, Burel JM, Moore W, Patterson A, et al. Metadata
matters: access to image data in the real world. J Cell Biol. 2010;189:777–82.
25. Boulanger J, Kervrann C, Bouthemy P, Elbau P, Sibarita J-B, Salamero J.
Patch-based nonlocal functional for denoising fluorescence microscopy
image sequences. IEEE Trans Med Imaging. 2010;29:442–54.
26. Preibisch S, Saalfeld S, Tomancak P. Globally optimal stitching of tiled 3D
microscopic image acquisitions. Bioinformatics. 2009;25:1463–5.
27. Pitrone P, Schindelin J, Stuyvenberg L, Preibisch S, Weber M, Eliceiri K, et al.
OpenSPIM: an open-access light-sheet microscopy platform. Nat Methods.
2013;10:598–9.
28. Hama H, Kurokawa H, Kawano H, Ando R, Shimogori T, Noda H, et al. Scale:
a chemical approach for fluorescence imaging and reconstruction of
transparent mouse brain. Nat Neurosci. 2011;14:1481–8.
29. Plante I, Stewart MKG, Laird DW. Evaluation of mammary gland
development and function in mouse models. J Vis Exp. 2011;53:2–6.
30. van Amerongen R. Lineage tracing in the mammary gland using Cre/lox
technology and fluorescent reporter alleles. Methods Mol Biol. 2015;1293:187-211.
31. Drobizhev M, Makarov NS, Tillo SE, Hughes TE, Rebane A. Two-photon
absorption properties of fluorescent proteins. Nat Methods. 2011;8:393–9.
Lloyd-Lewis et al. Breast Cancer Research  (2016) 18:127 Page 16 of 17
32. Shearer T, Bradley R, Hidalgo-Bastida A, Sherratt M, Cartmell S. Three-
dimensional visualisation of soft biological structures by X-ray computed
micro-tomography. J Cell Sci. 2016;129:2483–92.
33. Schmitt O, Modersitzki J, Heldmann S, Wirtz S, Fischer B. Image registration
of sectioned brains. Int J Comput Vis. 2007;73:5–39.
34. Walton LA, Bradley RS, Withers PJ, Newton VL, Watson REB, Austin C, et al.
Morphological characterisation of unstained and intact tissue micro-
architecture by x-ray computed micro- and nano-tomography. Sci Rep.
2015;5:10074.
35. Li J, Miao L, Shieh D, Spiotto E, Li J, Zhou B, et al. Single-cell lineage tracing
reveals that oriented cell division contributes to trabecular morphogenesis
and regional specification. Cell Rep. 2016;15:158–70.
36. Davis FM, Janoshazi A, Janardhan KS, Steinckwich N, D’Agostin DM, Petranka
JG, et al. Essential role of Orai1 store-operated calcium channels in lactation.
Proc Natl Acad Sci U S A. 2015;112:5827–32.
37. Raymond K, Cagnet S, Kreft M, Janssen H, Sonnenberg A, Glukhova MA.
Control of mammary myoepithelial cell contractile function by α3β1
integrin signalling. EMBO J. 2011;30:1896–906.
38. Davis, Lloyd-Lewis et al. Single-cell lineage tracing in the mammary gland
reveals stochastic clonal dispersion of stem/progenitor cell progeny. Nature
Communications. 2016. doi:10.1038/ncomms13053.
39. Susaki EA, Ueda HR. Whole-body and whole-organ clearing and imaging
techniques with single-cell resolution: toward organism-level systems
biology in mammals. Cell Chem Biol. 2016;23:137–57.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Lloyd-Lewis et al. Breast Cancer Research  (2016) 18:127 Page 17 of 17
Trends
The ability of stem cells to generate
and repeatedly regenerate the elabo-
rate mammary epithelium at any stage
during the female reproductive lifespan
reveals the extraordinary capacity and
longevity of stem cells in the adult
mammary gland (breast).
Some breast cancers may also be hier-
archically organized, containing can-
cer stem cells that propel and
sustain tumor growth and therapy-
resistant regrowth.
The adoption and refinement of novel
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Adult mammary stem cells (MaSCs) drive postnatal organogenesis and remod-
eling in the mammary gland, and their longevity and potential have important
implications for breast cancer. However, despite intense investigation the
identity, location, and differentiation potential of MaSCs remain subject to
deliberation. The application of genetic lineage-tracing models, combined with
quantitative 3D imaging and biophysical methods, has provided new insights
into the mammary epithelial hierarchy that challenge classical definitions of
MaSC potency and behaviors. We review here recent advances – discussing
fundamental unresolved properties of MaSC potency, dynamics, and plasticity
– and point to evolving technologies that promise to shed new light on this
intractable debate. Elucidation of the physiological mammary differentiation
hierarchy is paramount to understanding the complex heterogeneous breast
cancer landscape.and quantitative methodologies have
provided insights into the mammary
epithelial cell hierarchy that could not
have been achieved using conven-
tional approaches.
Evolving techniques to label, trace,
and profile individual cells, both in
the normal mammary gland and in
tumors, will offer further insights into
the capacity, multiplicity, and dynami-
city of mammary stem cells and their
malignant counterparts.
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Adult stem cells exist in diverse organs, such as the intestine, skin, and skeletal muscle [1,2]. In
these tissues their primary role is homeostatic, that is, to replenish cells lost to attrition or injury.
However, unlike many other organs, the mammary gland primarily develops postnatally [3,4]
(Figure 1), and thus stem cells in the adult mammary gland serve both developmental and
homeostatic functions.
Construction of the branching ductal epithelium during puberty is driven by hormones, growth
factors, and local signaling cues, and proceeds via proliferation of mammary stem cells
(MaSCs, see Glossary) and their progeny within bulbous distal structures known as terminal
end buds (TEBs) (Figure 1B) [5,6]. By the end of puberty, ductal morphogenesis is complete
and the TEBs have fully regressed (Figure 1C) [4]. Although it is generally accepted that stem
cells persist in the adult mammary gland following the demise of the TEBs – where they have
essential roles in the generation and regeneration of the alveolar (milk-producing) epithelium
during pregnancy and lactation (Figure 1C–F) – the location of these cells within the complex
ductal epithelium remains elusive [6,7]. In addition, despite intense investigation and debate,
the differentiation potential of adult MaSCs (i.e., their ability to generate one or both of the
mammary epithelial cell lineages) remains contentious [7–18]. The longevity and extensive self-
renewal properties of these cells, however, place them as probable candidates for oncogenic
transformation in some breast cancers [19,20]. Moreover, some breast cancers may be
hierarchically organized and contain a pool of cancer stem cells that drive their precipitous
long-term growth and regrowth [19–21]. Thus, a greater understanding of the identity, plastic-
ity, and differentiation potential of adult MaSCs, and the specific pathways that regulate their556 Trends in Cell Biology, August 2017, Vol. 27, No. 8 http://dx.doi.org/10.1016/j.tcb.2017.04.001
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f.davis@uq.edu.au (F.M. Davis).self-renewal and fate, may also provide important insights into the heterogeneity and treatment-
resistance of this intractable disease.
Recent studies, using single-cell lineage-tracing approaches, have revealed the immense
capacity of a single MaSC to contribute to the formation of the ductal epithelium during puberty
[16,18] and of the alveolar epithelium during pregnancy/lactation [16]. These studies also
highlight considerable redundancy within this system [16,18], positing that several hundred
lineage-restricted MaSCs actively and stochastically contribute to ductal and alveolar morpho-
genesis under physiological conditions. This is not entirely surprising, given that lactation is an
evolutionarily essential aspect of mammalian survival that demands functional stem cells. How-
ever, if MaSCs are the cell of origin in some breast cancers, then this superfluity brings with it a
heightened opportunity for oncogenic transformation. Regardless, the inextricable connections
between MaSCs and breast cancer warrants further investigation to achieve a unified and
enduring characterization of their potential, anatomical location, and molecular profile.
We discuss here recent insights into the mammary epithelial cell hierarchy, addressing
unanswered questions relating to MaSC potency, dynamics, and plasticity. We discuss the
unique challenges in elucidating the mammary epithelial cell hierarchy, and highlight evolving
technologies that promise to shed new light on these difficult issues.
The Epithelial Cell Hierarchy: An Evolving Paradigm
In 1959, a seminal study published in Cancer Research demonstrated that fragments of
mammary tissue could be transplanted into the epithelium-divested fat pad of a recipient(B) Puberty
Terminal end bud (TEB)
Presumed locaon of
MaSCs during puberty MaSCs may be distributed throughout
the ductal epithelium and be recruited
during estrus cycling and in pregnancy  











Figure 1. Postnatal Mammary Gland Development in Mice. (A) Mammals are born with only a rudimentary ductal structure (see [3,4] for a description of embryonic
mammary gland development) which begins to elongate and invade the empty fat pad at puberty (B). By the end of puberty (C), the ductal structures have reached the
boundaries of the mammary fat-pad and the terminal end buds (TEBs) have fully regressed. Mammary ducts are composed of two epithelial cell lineages arranged into
distinct cell layers; luminal cells line the lumen of each duct and are surrounded by an outer layer of basal cells (depicted inset). Whether MaSCs in the adult mammary
gland are lineage-restricted or can give rise to both luminal and basal cells is an area of contention. (C–E) Resident mammary stem cells (MaSCs) in the mature mammary
epithelium are responsible for the generation of milk-producing alveoli during pregnancy and lactation. (F) Stem cells are likely to survive post-lactational regression
(involution) to enable successive lactations. The mouse is an excellent model for studying processes regulating human mammary gland development and
tumorigenesis, however, key differences exist [83]. Notably, the human mammary gland is arranged in distinct lobes, each with a separate ductal structure and outlet.
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Glossary
Basal cell: one of the two main cell
lineages in the mammary gland;
basal cells surround the luminal cell
layer and typically express
cytokeratin-5, -14, and smooth
muscle actin.
Bi/multipotent: able to give rise to
more than one cell lineage, for
example a bipotent MaSC may be
able to give rise to both basal and
luminal progeny.
Clone: all of the progeny of a single
parent cell.
Label-retaining cell: a cell that is
able to retain a label (be it a lipophilic
dye, DNA precursor nucleoside, or
regulated expression of a
fluorescently tagged histone) over a
defined chase period. Cells that
remain in cycle dilute the label,
whereas slow-cycling or quiescent
cells remain labeled at the end of the
assay.
Lineage tracing: a technique to
identify the progeny of a single cell;
the phrase ‘population-basedmouse, successfully engraft, and generate an entire ductal epithelium anew [22]. What
followed was a divisive pursuit to identify and characterize the cells responsible for the
development, maintenance, and regeneration of the mammary epithelium (i.e., adult MaSCs)
that has lasted for more than 50 years (Figure 2). Transformative advances came on the back
of at least three key enabling methodologies: the isolation of cells with enhanced repopulating
and self-renewal properties upon transplantation; population-based genetic fate-mapping;
and stochastic, single-cell genetic lineage-tracing. The ability to image ducts and alveoli in 3D
[14–16,18,23,24] or 4D [18] (Box 1), combined with quantitative image analysis and biosta-
tistical modeling [5,15,18], has also provided important insights into clonal dynamics and
dispersion patterns that could not have been attained through the examination of thin tissue
sections [25]. We broadly examine these techniques, summarizing key findings with a
retrospective wisdom.
Transplantation
The observation that any fragment of mammary tissue has the potential to regenerate the entire
bilayered mammary epithelium upon serial transplantation provided strong evidence that
mammary repopulating cells (believed to be bona fide MaSCs) were distributed throughout
the length of the adult ductal epithelium [26–28]. Subsequent work using retroviral-tagged
mammary tissue fragments [29] and limiting dilutions of heterogeneous cell suspensions
confirmed these results [30,31], and these studies were in turn refined and expanded
by the identification and purification of a subset of cells with superior repopulating capacity
[8–10] (Figure 2). Collectively, these analyses supported the notion that adult MaSCs arelineage-tracing’ has been used here
to distinguish techniques that trace
the progeny of specific populations
of cells (e.g., cytokeratin-14-
expressing cells) generally at levels
higher than clonal density.
Luminal cell: one of the two main
cell lineages in the mammary gland;
luminal cells line the lumen of ducts
and alveoli, they typically express
cytokeratin-8, and may be hormone
receptor positive or negative.
Mammary epithelial cell
hierarchy: the organization of stem,
progenitor, and differentiated cells in
the mammary gland.
Mammary repopulating cells: cells
enriched for the ability to regenerate
the mammary epithelium upon serial
transplantation at limiting dilution into
the cleared fat pad of a recipient
mouse.
Mammary stem cells (MaSCs):
undifferentiated cells in the mammary
gland that are capable of giving rise
indefinitely to more stem cells (self-
renewal) as well as to more-
differentiated daughters through
symmetric and asymmetric divisions.
Uncertainties surrounding the
identity, differentiation potential, and
plasticity of these cells have
generated semantic debate, and
MaSCs are also referred to more
conservatively as ‘stem/progenitor
cells’.
Box 1. Emerging Technologies
Transplantation assays and population-based genetic lineage-tracing studies have largely guided our interrogation of
the mammary epithelial cell hierarchy. Now, techniques to label/barcode, visualize, and profile individual cells in real-time
in the mammary gland are offering fresh insights into the organization and plasticity of MaSCs and the pathways that
dictate their fate. An overview of some of these technologies, many of which have already been utilized by mammary
gland biologists and breast cancer researchers, is given below.
Tissue clearing. Tissue clearing techniques [e.g., CUBIC (clear, unobstructed brain imaging cocktail) and SeeDB (see
deep brain)] render whole organs transparent and are largely based on minimizing light scattering at oil–water interfaces
[73,74]. These techniques facilitate in situ 3D imaging of mammary epithelial cells at high cellular resolution [24].
3D and 4D Imaging. Platforms for rapid, multiscale imaging of cells, tissues, and organs include confocal, two-photon,
and light sheet microscopy [24]. Tissue clearing can be combined with 3D imaging for the visualization of fixed tissues.
Limited 4D imaging can be performed on ex vivo tissue [75]; however, these studies are confounded by various
artefacts, such as tissue hypoxia, and thus their use is generally restricted to short-term imaging. The surgical insertion
of an imaging window for intravital imaging overcomes these issues and allows long-term visualization of cells deep
within tissues of living mice [18,76,77].
Single-Cell RNA-Seq. This method allows whole-transcriptome profiling of individual cells [78]. This may be combined
with methods to either (i) label single cells and all of their progeny (e.g., single-cell lineage-tracing) [18] or (ii) incrementally
mark cells (e.g., CRISPR-generated barcoding), to create a molecular profile of all cells within a single clone.
CRISPR-Generated Barcoding. Genome editing using CRISPR facilitates the interrogation of lineage relationships by
creating cumulative genetic mutations (or ‘barcodes’) in cells without interfering with their normal development or
function. Genome editing of synthetic target arrays for lineage tracing (GESTALT) [79] and mammalian synthetic cellular
recorders integrating biological events (mSCRIBE) [80] are two such examples. Computational analysis of common
mutations allows the reconstruction of lineage relationships.
Ex Vivo Models. 3D culture systems, such as organoid culture [81], facilitate ex vivo modeling of epithelial tissue
morphogenesis. Using this technology, adult stem cells can be maintained long-term in culture, driving the formation of
highly ordered, multicellular structures that recapitulate the organization of their resident tissues. Mammary organoids
[82] facilitate the interrogation of epithelial cell–cell interactions, hormone regulation, and paracrine signaling in an
accessible, but normal, mammary epithelial cell environment.
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Potential stem cell: a more
differentiated cell that is able to
reacquire stem-like properties under
regenerative/wounding conditions;
also known as facultative stem cells.
Stem cell niche: the specialized
microenvironment in which a stem
cell resides that can regulate stem
cell self-renewal, differentiation, and
longevity.
Terminal end bud (TEB): bulbous
proliferative structures at the ends of
each main duct during puberty; the
presumptive location of pubertal
MaSCs.
Unipotent: able to give rise to one
main cell lineage; for example, a
unipotent luminal stem cell is able to
give rise only to luminal progeny, and
a unipotent basal stem cell is able to
give rise only to basal progeny.bi/multipotent. The demonstration that lineage-restricted cells could be forced to adopt a
multipotent fate under ‘regenerative conditions’ [11–13] challenged this dogma. It is now
widely accepted that mammary repopulating cells, identified by transplantation, are distinct
from stem cells that exist under physiological conditions. Nevertheless, this technique has
provided some important insights into the qualities of self-renewal and regeneration, with
enduring relevance.
Population-Based Genetic Fate-Mapping
The application of genetic lineage-tracing techniques to mammary tissue has enabled temporal
examination of lineage relationships under physiological conditions. These studies have utilized
tamoxifen- or doxycycline-responsive transgenic mouse models to induce the expression of
reporter genes in predefined cohorts of cells [11–15,17]. The genetic label, typically a fluo-
rescent or histochemical reporter, is permanently expressed by the original cell and is trans-
mitted to all of its progeny. An analysis of reporter expression through time can be used to
determine whether the original labeled population contained lineage-restricted stem cells or
cells with multi-lineage differentiation potential (Figure 2). In its original application in the
mammary gland [11], this approach was used to track the fate of luminal cells [e.g.,
cytokeratin (K)8-expressing] and basal cells (e.g., K14-expressing), demonstrating that line-
age-restricted MaSCs drive postnatal mammary gland development and maintenance. Sub-
sequent lineage-tracing studies have provided evidence in support of both unipotent and bi/
multipotent adult MaSCs [12–15,17,32] (Figure 2). Lineage-restricted cell populations have also
been shown to convert to multipotency in vivo by oncogenic PI3KCA signaling, suggesting that
there is scope for plastic transformation, thereby adding further complexity to this system
[33,34].
Inconsistencies in recent lineage-tracing studies in the normal mammary gland may be in part
attributable to the temporal expression of pathway-specific promoters [12,13] or the fidelity of
pan-lineage promoters. Given that a single mammary stem/progenitor cell is capable of
producing many hundred progeny [16], the promiscuous labeling of even a small number
of cells of the opposing lineage could significantly confound downstream lineage analysis in this
model [15,16]. A second limitation relates to the power of population-based labeling
approaches to accurately detect the expansion of a single clone, which is a function of both
the method of detection and the initial labeling density (Figure 3). To overcome this problem, as
well as potential tracing artefacts associated with the preferential labeling of specific (and
potentially non-representative) cell subpopulations, a recent study has mapped the fate of all
basal cells (a technique termed saturation lineage-tracing) [15]. If rare bipotent MaSCs do
reside in the basal compartment, and contribute even minimally to mammary gland morpho-
genesis and homeostasis [1], this could be detected by an increase in the number of
fluorescently labeled luminal cells observed using either fluorescence-activated cell sorting
or 3D image quantification. No population flux was detected using either method of analysis in
these studies, suggesting that basal MaSCs are indeed lineage-restricted [15]. A subsequent
report [35], however, demonstrated that enzymatic digestion before 3D imaging [15,18,36,37]
can deplete or structurally damage basal cells, postulating that rare bi-lineage clones are not
detected under these conditions [35]. Recently described methods for non-proteolytic 3D
imaging [16,24], together with quantitative platforms for image analysis which consider tissue
architecture, cell morphology, chimerism, and Cre-specificity [15,35], will undoubtedly aid
future lineage-tracing studies in the mammary gland.
Stochastic, Single-Cell Genetic Lineage-Tracing
Lineage-tracing has facilitated in situ examination of MaSC properties under conditions of
minimal interference. However, unlike transplantation assays, these studies have been unable
to map the fate of a single labeled cell [9]. Obstacles to single-cell genetic lineage-tracing have,Trends in Cell Biology, August 2017, Vol. 27, No. 8 559
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2013,  Intravital mulcolour
lineage-tracing of mouse
mammary tumours supports
a cancer stem cell model
with inherent plascity [77]  
2017, Lineage-tracing and
quantave analysis at clonal
density suggest that most cells
in the TEB funcon as unipotent,
heterogeneous MaSCs [18]
  
2006, Separaon of cells with
enhanced repopulang acvity
(CD29 and CD24). Luminal and
basal layers regenerated from a
single LinnegCD29hiCD24+cell [9] 
Expression of reporter in a random,
single cell and all of its progeny 
Figure 2. A Summary of the Key Discoveries in the Field and the Methodologies That Enabled These Advances. This timeline focuses on discoveries made within the
past decade using transplantation or genetic lineage-tracing assays (see [19,20,84] for more-detailed historical reviews). Schematic diagrams summarizing each in vivo
methodology are depicted at puberty; however, these techniques have also been utilized to assess cell fate at other developmental stages, and in some cases their use
has also been extended to investigate cellular dynamics in mammary tumorigenesis (also see [7–18,22,26,29,30,33,34,77]). Abbreviations: ER, estrogen receptor;
MaSC, mammary stem cell; TEB, terminal end bud.however, been mitigated in part by advances in whole-organ clearing [24] and high-resolution
3D imaging [14] (Box 1).
Recently, R26[CA]30 mice [38] have been used to achieve unbiased labeling of single proliferat-
ing cells in the mammary gland [16]. Genetic labeling in this model is exceedingly rare, and thus
it can be combined with 3D imaging to track the fate of a single labeled cell with confidence
(Figure 2). A similar approach to achieve low-density, unbiased labeling involves the use of mice
that express inducible Cre recombinase in all cells (R26CreERT2). Neutral, multicolor labeling is
achieved by crossing these mice with R26Confetti animals, and sparse reporter induction is
attained using low doses of tamoxifen [16,18]. Recent application of these models has provided
further evidence that unipotent MaSCs drive ductal morphogenesis during puberty [16,18] and
alveolar morphogenesis during gestation [16]. However, although the small number of cells
initially labeled in these models permits the indisputable analysis of clonal progeny, it also limits
their power to detect and characterize the full spectrum of stem and progenitor cells that are560 Trends in Cell Biology, August 2017, Vol. 27, No. 8
(A) Clonal dispersion paerns (determined by the labeling of a single cell)
Stochasc labeling paerns make it difficult
to determine the relaonships of marked cells
when labeled greater than clonal density
Progeny of a single cell
All cells (counterstain)
(B) Clone dispersion (schemac)
Progeny of a single labeled cell can be
dispersed throughout the epithelium
Figure 3. Limitations of Population-Based Lineage-Tracing Studies. (A) Clonal patterns arising from the genetic labeling of a single cell (purple). These studies
demonstrate that the progeny of a single marked cell can be distributed throughout the length of the ductal epithelium in a stochastic, interspersed labeling pattern.
These patterns are likely to be caused by the proliferation of both labeled and unlabeled terminal end bud (TEB)-resident stem cells, which deposit their progeny
throughout the epithelium during ductal elongation. Labeling patterns can extend more than 8 mm in linear length and comprise many side branches, highlighting the
importance of performing 3D imaging and/or macro clone analysis. Scale bar, 0.2 mm. Adapted, with permission, from Lloyd-Lewis et al. [24]. A schematic
representation of these labeling patterns in luminal and basal clones is shown in (B). The extensive and stochastic dispersion of stem cell progeny increases the
likelihood of clone convergence in studies where labeling is performed above clonal density. Clone convergence is particularly evident when using a multi-color reporter
gene. In the example here (bottom panel), it is difficult to distinguish whether luminal and basal blue cells came from a single bipotent precursor or whether they arose
from separate labeling events. Other technical limitations of population-based lineage-tracing approaches include periodic and promiscuous labeling by pathway-
specific or pan-lineage promoters.present in the mammary epithelium. For example, quiescent bi/multipotent MaSCs, if they exist,
would not be detected by this approach [16].
Single-cell lineage-tracing has unquestionably demonstrated the immense capacity of uni-
potent stem cells to contribute to the development of the adult mammary epithelium, while at
the same time revealing significant redundancy in the construction of each major duct [16,18]
and lobuloalveolar structure [16]. Whether adult stem cells work cooperatively or competitively
to achieve developmental and morphogenetic outcomes in the mammary gland is an area of
active investigation and is discussed in more detail later in this review.
Multiplicity in the Mammary Gland: Roles for Potential and Quiescent Stem
Cells
In addition to the cells that are responsible for the genesis and expansion of the mammary
epithelium (known as professional, functional, or bona fide stem cells), there may also exist a
population of cells in the adult breast with the capacity to behave as stem cells under
particular conditions (i.e., facultative or potential stem cells) [1,39]. This may include (i) a
subset of cells that remain quiescent during normal tissue development, and (ii) cells that are
recruited under regenerative conditions [9,11,40] or in cancer [33,34]. Support for a cellular
arrangement in the breast that departs from a unidirectional, top-down model is given by
transplantation studies. Although it is now generally accepted that mammary repopulating
cells are activated under non-homeostatic conditions [11–13], the underlying experimental
observation (i.e., that not all cells are capable of repopulating the empty fat-pad [8–10])
points to the existence of a population of cells that have an intermediate or plastic nature.
The physiological and pathological role of these cells, and their relationship to putative
populations of quiescent MaSCs, is not immediately apparent (Figure 4). However, the
notion that fate decisions within the hierarchy are not strictly unidirectional, and in some
conditions can be reversed, has wide-reaching implications for oncology and regenerative
medicine.Trends in Cell Biology, August 2017, Vol. 27, No. 8 561
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Figure 4. A Working Model of the Mammary Epithelial Cell Hierarchy. Multipotent MaSCs are present in the embryo.
Although the exact stage of lineage-specification is not clear, postnatal mammary gland development (i.e., ductal and
alveolar morphogenesis) is principally driven by unipotent luminal and basal mammary stem cells (MaSCs). Luminal stem
cells give rise to ductal and alveolar cells that can be estrogen receptor (ER)-positive or -negative. The extent of sublineage
diversity in the basal compartment, and whether there are distinct ductal and alveolar basal cells, is not yet clear. In addition
to the cells responsible for building mammary ducts and alveoli under physiological conditions (left panel), various studies
indicate that quiescent and potential stem cells may also reside within the adult mammary gland (right panel). Quiescent bi/
multipotent MaSCs (not detected by quantitative or single-cell lineage-tracing approaches) may remain in the mammary
gland after embryonic development. In addition, a plastic, intermediate cell type with properties similar to the basal cell
lineage may be capable of reverting to a multipotent state under regenerative conditions. Lineage-restricted luminal and
basal progenitors have also been shown to reacquire multipotency with oncogenic reprogramming. A holistic description
of the cellular differentiation hierarchy in the mammary gland may need to accommodate aspects of plasticity.A Putative Population of Quiescent MaSCs
A pool of quiescent stem cells, which have temporarily and reversibly exited the cell cycle, has
been observed in several self-renewing tissues including the skin [41–43] and intestine [44].
These cells may be able to re-enter the cell cycle when required, for example upon injury [45] or
homeostasis [46]. Quiescent stem cells are unlikely to be detected by conventional lineage-
tracing approaches which require proliferation for clone identification [47]. As such, label-
retention assays have been developed for the analysis of slow-cycling and quiescent cells [48].
DNA nucleoside analogs {e.g., bromodeoxyuridine (BrdU), 5-ethynyl-20-deoxyuridine (EdU),
and [3H]-thymidine} can be used to label cells that are in cycle at the time of the pulse [47].
Alternatively, a GFP-labeled histone H2B model can be used to label specific populations of
cells, with expression of H2B–GFP temporally moderated by administration of doxycycline
[43,48,49]. Cells that remain labeled after a predetermined chase, known as label-retaining
cells, are presumed to be slow-cycling/quiescent stem cells, but may also be long-lived
terminally-differentiated cells [48]. Application of the H2B–GFP model to the mammary gland
has identified a novel population of CD1d+ cells with enhanced repopulating ability upon
transplantation [49]. CD1d+ mammary repopulating cells are also enriched for Bcl11b expres-
sion, a C2H2 zinc finger transcription factor that has independently been shown to be
associated with physiological quiescence and superior repopulating activity under transplan-
tation conditions [50]. Interestingly, neither Cd1d nor Bcl11b mRNAs are enriched in the
recently-identified quiescent basal cell population defined by Lgr5 and Tspan8 expression
[51]. These Lgr5+Tspan8hi basal cells, located within the proximal ductal tree, were also
demonstrated to have enhanced repopulating activity in limiting dilution transplantation562 Trends in Cell Biology, August 2017, Vol. 27, No. 8
assays [51]. Thus, these data suggest significant multiplicity, even within the putative subset of
quiescent mammary repopulating cells.
Unanswered Questions: Organization, Function, and Recruitment
The proliferative demand on mammary stem and progenitor cells throughout reproductive life is
substantial (Figure 1) [3,4]. Thus, the relative importance of quiescent MaSCs in normal
development and homeostasis is unclear. How quiescent and potential stem cells may be
recruited by specific signals in the microenvironment and their hierarchical relationship to
functional stem cells is also shrouded in uncertainty. In light of the ongoing debate regarding the
identity and potency of MaSCs [11–18], the fundamental necessity for cell proliferation for clone
detection in lineage-tracing studies [47], and the idea that quiescent stem cells may reside at
the apex of tissue hierarchies [49], one could reasonably suggest that there may be a residual
population of quiescent bi/multipotent MaSCs that remain in the postnatal mammary gland
after embryonic development (Figure 4). In utero DNA labeling has provided some support for
this hypothesis, identifying long-lived label-retaining cells that are able to reversibly re-enter the
cell cycle and contribute to tissue development and maintenance [46]. More recent saturation
lineage-tracing, which has been able to label >95% of all cells within a single lineage, however,
indicates that quiescent MaSCs (if they exist and participate in any way to tissue development
and/or homeostasis), are lineage-restricted [15]. Analysis of cell division kinetics and telomere
lengths in mammary epithelial populations also suggests that that each lineage is maintained by
its own precursors throughout reproductive life [52].
Several important questions in this area remain unanswered. However, given the complex
cellular heterogeneity in breast cancer, a long-lived and highly plastic stem cell could serve as a
potential cell of origin for this disease. This highlights the importance of determining the full
landscape of MaSC populations and the factors regulating their recruitment.
The MaSC Niche: An Elusive Entity or Dynamic Force?
The ability of MaSCs to rapidly and faithfully respond to developmental and homeostatic
demands throughout reproductive life may be attributable to their intimate association with
a specific cellular microenvironment, known as the mammary stem cell niche. Stem cell
niches can embody discrete and highly specialized sites in particular tissues, for example the
crypt base of the small intestine and the hair follicle [2]. Other tissues, including the post-
pubescent mammary gland, prostate, and lung, lack an easily discernable niche, and stem cells
in these organs may instead respond to more ubiquitous tissue signals [2]. In any case,
reciprocal interactions between MaSCs and their mature epithelial progeny, neighboring
stromal cells, and the supporting extracellular matrix undoubtedly provide the autocrine,
juxtracrine, and paracrine signals that direct and adjust cell fate [19]. Extrinsic regulatory cues
may include diffusible molecules (e.g., growth factors and cytokines) as well as mechanical
forces (e.g., cell–cell and cell–matrix interactions) [53,54]. In this section we outline designs of
mammary stem and progenitor cell distribution in the pubescent, mature, and secretory
epithelium, discussing how the spatial arrangement of these cells may underpin the develop-
ment and integrity of this highly dynamic tissue.
Architectural Conceptions of a MaSC Niche
The absence of a definitive molecular portrait of MaSCs, combined with uncertainties regarding
their precise location within the post-pubescent mammary epithelium, has greatly impeded the
analysis of prospective MaSC niches. Cell-surface signatures that facilitate the isolation of
mammary repopulating cells also provide little insight into the tissue-positional cues that direct
cell behavior. Early transplantation and ultrastructural studies, however, did imply that mam-
mary repopulating cells were distributed throughout the ductal epithelium [26–28,55], positing
that MaSC niches may reside in a ‘suprabasal' location in the epithelial bilayer [27,56,57].Trends in Cell Biology, August 2017, Vol. 27, No. 8 563
Although the precise location of stem cells within the post-pubescent breast remains unclear
(Figure 1C), it is generally accepted that the TEBs of elongating ducts serve as a transient niche
during puberty (Figure 1B) [5,19]. Thus, a comprehensive examination of signaling events in
TEB-resident stem cells is expected to yield important insights into the pathways directing
MaSC activity and fate, which may also be relevant in the post-pubescent gland. TEBs consist
of an outer layer of cap cells that envelop multiple layers of inner body cells [3]. Cap and body
cells are generally considered to be the precursors of mature basal and luminal epithelial
lineages, respectively [19]. Cap cells have also long been hypothesized to represent an
enriched population of bi/multipotent MaSCs [27,58,59]. Indeed, the alternative promoter
(s-Ship) of the stem cell-associated phosphatase gene Ship1/INPP5D, in the mammary gland
is exclusively expressed in cap cells during puberty, correlates with enhanced mammary
repopulating capacity in limiting dilution transplantation assays [6]. In addition, s-Ship-express-
ing cap cells are strongly associated with the expression of Par3L, a protein related to the cell
polarity regulator Par3 which is required for MaSC maintenance and ductal morphogenesis
[60]. Recent mathematical modeling of mammary ductal elongation, however, suggests that
inwardly migrating cap cells do not contribute to the luminal epithelial lineage as previously
hypothesized [5]. Therefore, the precise contribution of these anatomically distinct cells to
ductal morphogenesis requires further investigation. The relationship between cap cells in the
TEB and unipotent MaSCs, identified by genetic lineage-tracing [11,15,16,18], is also unclear.
An answer to these important questions, and a potential unifying definition of physiological
MaSC potency, awaits future inducible fate-mapping studies using transgenic s-Ship and/or
Par3L reporter models.
In the post-pubescent mammary gland, where TEBs have fully regressed, the location of
MaSCs and their niche constituents is more ambiguous (Figure 1C). It is presumed that
MaSCs, left behind by elongating TEBs during pubertal growth, are dispersed throughout the
adult epithelial network, where hormonal cues stimulate further branching and the formation
of alveolar-like buds and lobuloalveoli during estrous cycling and in pregnancy, respectively
[61]. The notable absence of hormone receptors in mammary repopulating [62] and in MaSC-
enriched basal cell populations [63] implies that paracrine interactions between hormone
receptor-expressing cells and stem cells guide tissue development and homeostasis [64–68].
Multiple paracrine signaling pathways, including Wnt, EGFR, IGFR, and RANK signaling, are
reported to regulate MaSC function downstream of hormone action. In addition, FGF,
Hedgehog and Notch signaling pathways have also been implicated in modulating MaSC
fate during different stages of mammary gland development. How the local activities of these
pathways are controlled by systemic changes in hormone levels, however, remains unknown
[69,70]. Nevertheless, the widespread distribution of hormone receptor-positive cells
throughout the adult mammary epithelial tree [16,71] suggests that MaSCs would be able
to receive and integrate these paracrine signals at most architectural locations within the
ductal epithelium. Moreover, alterations in the abundance and distribution of hormone
receptor-positive cells with age [71] may reflect lifetime-dependent variations in a putative
MaSC niche.
MaSCs are thought to survive tissue remodeling during post-lactational involution, enabling
further cycles of expansion with each subsequent pregnancy (Figure 1C–F). It is therefore
tempting to speculate that MaSCs reside in the vicinity of epithelial branch points and are
poised to generate the lateral branches and lobuloalveolar structures required for lactation.
Fate-mapping studies using an alveolus-specific whey acidic protein (WAP)-driven Cre have
also identified a population of long-lived parity-induced mammary epithelial cells (PI-MECs) that
are sustained through multiple reproductive cycles [72]. These cells reside at ductal extremities
in the post-parous mammary gland and contribute exclusively to the hormone receptor-
negative luminal lineage in subsequent pregnancies [7,72]. Intriguingly, a recent single-cell564 Trends in Cell Biology, August 2017, Vol. 27, No. 8
Outstanding Questions
Is there a distinct and universal molec-
ular signature for adult MaSCs? Or do
stem cells reside along a wide and
dynamic spectrum of activities?
How do lineage-restricted cells reac-
quire a multipotent fate under regener-
ative conditions or in particular
cancers?
Is there a hierarchical relationship
between functional and putative quies-
cent mammary stem cell populations?
Do MaSCs reside within a stem cell
niche in the post-pubescent mammary
gland? Is their relationship within the
niche cooperative or competitive?
Do different niche environments exist
for quiescent and functional MaSC
populations, similar to those observed
in the intestine and hair follicle?
Do polyclonal ducts and alveoli drift
towards monoclonality with age?
What level of evidence will be required
to achieve a unifying definition of phys-
iological MaSC potency?lineage-tracing study has revealed an unequal distribution of MaSC progeny between lobu-
loalveolar units in lactating mammary tissue [16]. Thus, these striking observations also support
a model wherein an alveolar stem cell niche is positioned near bifurcation sites in the mature
ductal epithelium. Interestingly, increased MaSC activity during pregnancy correlates with the
re-expression of s-Ship specifically in basal cells at the tips of alveolar buds, suggesting the
emergence of a transient stem cell niche during lobuloalveologenesis [6].
MaSC Niche Dynamics
As described earlier in this review, distinct adult MaSCs are postulated to fulfill the proliferative
and homeostatic demands of the mammary gland (Figure 4) [19]. The degree to which the
heterogeneity in the MaSC compartment is intrinsic or a result of microenvironmental cues,
however, is not known. A recent single-cell lineage-tracing study, which employed quantitative
volumetric analysis to determine the contribution of a single labeled MaSC to ductal morpho-
genesis, estimated that at least 35 lineage-restricted MaSCs actively and stochastically
contribute to the development of each major duct during puberty [16]. A subsequent study,
also using quantitative lineage-tracing at clonal density, put this number at 260 lineage-
restricted MaSCs per TEB, leading to the suggestion that most TEB cells can function as
lineage-committed MaSCs [18]. Discrepancies between these two studies may reflect differing
functional definitions of MaSCs as well as the quantitative and mathematical platforms and
assumptions for analysis. Quantitative lineage-tracing studies also suggest that molecularly
heterogeneous populations of TEB-resident MaSCs function as single equipotent pools,
colonizing ductal branches through stochastic neutral drift dynamics [18]. Random segregation
during successive rounds of TEB bifurcation mediates the unequal distribution of MaSC
progeny between adjacent ductal structures, leading to clonal enrichment or extinction over
time [18], supporting previous observations of clonal labeling patterns [16]. Furthermore, single-
cell lineage-tracing has shown that most lactational alveoli comprise the progeny of more than a
single unipotent MaSC, indicating that a pool of lineage-restricted alveolar MaSCs also
contribute to alveolar morphogenesis during pregnancy and lactation [16]. These early appli-
cations of quantitative and single-cell lineage-tracing approaches in the mammary gland
[16,18] have provided unprecedented insights into clonal dynamics and stem/progenitor
heterogeneity and multiplicity, heralding a new era in our investigation and understanding of
normal and malignant stem cells in the breast.
Concluding Remarks
In this review we have examined the properties of potency, dynamics, and plasticity in adult
MaSCs and the respective technologies that have underpinned key experimental observations.
Although this area has received considerable attention over the past decade, many questions
remain unanswered (see Outstanding Questions). At the center of this enquiry is whether
MaSCs in the adult breast are unipotent, bipotent, or something less discordant.
Stem cells are defined by their functional abilities, that is: proliferation, self-maintenance, the
production of a large number of differentiated progeny, tissue regeneration/repair, and flexibility
within these states [39]. The challenge thus far has been how to study the functionality of a cell
without inadvertently altering its function. Lineage tracing has come a long way in this respect
[11–16,18]. The refinement of lineage-tracing approaches and the application of other novel
experimental models and methods for marking, visualizing, and profiling individual cells (Box 1)
will continue to provide important insights in this field. The question then becomes, what level of
evidence is required to achieve a consensus?
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ABSTRACT
Mammary gland development occurs over multiple phases, beginning
in themammalian embryo and continuing throughout reproductive life.
The remarkable morphogenetic capacity of the mammary gland at
each stage of development is attributed to the activities of distinct
populations of mammary stem cells (MaSCs) and progenitor cells.
However, the relationship between embryonic and adult MaSCs, and
their fate during different waves of mammary gland morphogenesis,
remains unclear. By employing a neutral, low-density genetic labelling
strategy, we characterised the contribution of proliferative stem/
progenitor cells to embryonic, pubertal and reproductive mammary
gland development. Our findings further support a model of lineage
restriction of MaSCs in the postnatal mammary gland, and highlight
extensive redundancy and heterogeneity within the adult stem/
progenitor cell pool. Furthermore, our data suggest extensive
multiplicity in their foetal precursors that give rise to the primordial
mammary epithelium before birth. In addition, using a single-cell
labelling approach, we revealed the extraordinary capacity of a single
embryonic MaSC to contribute to postnatal ductal development.
Together, these findings provide tantalising new insights into the
disparate and stage-specific contribution of distinct stem/progenitor
cells to mammary gland development.
KEY WORDS: Mammary gland development, Embryonic mammary
stem cells, Adult mammary stem cells, Lineage tracing
INTRODUCTION
Mammary gland development is a complex and multi-stage process
that begins in the embryo and continues throughout the reproductive
life of female mammals (Cowin and Wysolmerski, 2010; Gjorevski
and Nelson, 2011; Hinck and Silberstein, 2005). This process
commences with the formation of two milk lines from the overlying
ectoderm on embryonic day (E) 10.5 in mice, and the asynchronous
appearance of five pairs of placodes at specific and symmetric
locations between the fore- and hindlimbs by E11.5 (Hens and
Wysolmerski, 2005). These ectodermal placodes develop
asynchronously and invaginate to form the mammary bud by
E13.5, followed by the formation of an epithelial tubular sprout by
E15.5-16.5 that invades the underlying mammary fat pad precursor.
Contact with the developing fat pad initiates a phase of branching
morphogenesis, resulting in the formation of the primordial ductal
tree by E18.5, prior to birth (Veltmaat, 2017; Veltmaat et al., 2003;
Watson and Khaled, 2008).
In the weeks immediately after birth, growth of the ductal tree is
commensurate with body growth and it is not until puberty that
ductal structures begin to elongate rapidly and invade the empty fat
pad, driven by hormonal and growth factor signalling in the micro-
environment (Hinck and Silberstein, 2005). This process, known as
ductal morphogenesis, is orchestrated by proliferation of adult
mammary stem and progenitor cells within the distal terminal end
bud (TEB) structures (Bai and Rohrschneider, 2010; Paine et al.,
2016; Sreekumar et al., 2015). After pubertal growth is complete,
the mammary epithelium re-enters a phase of balanced proliferation,
with only minor growth and remodelling occurring with cyclical
ovarian hormone stimulation. However, rapid expansion of the
epithelium again occurs during pregnancy and lactation, when adult
MaSCs proliferate to form lobuloalveolar structures capable of
producing and expelling milk for neonatal nourishment (Davis
et al., 2016; Lloyd-Lewis et al., 2017; Sreekumar et al., 2015).
Despite their essential role in pre- and postnatal mammary gland
development, studies to determine the molecular identity and
differentiation potential of MaSCs have yielded conflicting results
(for recent reviews, see Sreekumar et al., 2015; Lloyd-Lewis et al.,
2017). Recently, both saturation and single-cell genetic lineage-
tracing studies have demonstrated that lineage-restricted MaSCs
appear to drive postnatal mammary development under
physiological conditions (Davis et al., 2016; Scheele et al., 2017;
Wuidart et al., 2016). However, these studies also demonstrated
significant redundancy and heterogeneity within the adult MaSC
compartment, and the differential and stage-specific contribution of
diverse stem/progenitor cells in the breast is still emerging (Bach
et al., 2017; Cai et al., 2017; Van Keymeulen et al., 2017; Wang
et al., 2017). In this study, we employed a low-density, neutral,
genetic labelling strategy to further investigate the extent and nature
of the contribution of proliferative stem/progenitor cells to
embryonic, pubertal and reproductive mammary development.
RESULTS AND DISCUSSION
A pool of lineage-biased adult stem/progenitor cells propel
ductal elongation during puberty
Recently, genetic lineage-tracing studies in the mouse mammary
gland have achieved in vivo indelible marking of specific
populations of cells (characterised by their expression of
nominated genes at specific developmental stages) and theReceived 3 February 2018; Accepted 19 June 2018
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subsequent analysis of the progeny of proliferative labelled cells
after an appropriate chase (Sale and Pavelic, 2015). Targeted cell
populations include those temporally or stably expressing: keratin
(K) 5 (Rios et al., 2014; Van Keymeulen et al., 2011), K14 (Rios
et al., 2014; Tao et al., 2014; Van Keymeulen et al., 2011; Wuidart
et al., 2016), K8 (Tao et al., 2014; Van Keymeulen et al., 2011;
Wuidart et al., 2016), K18 (Van Keymeulen et al., 2011), K19
(Wuidart et al., 2016), Elf5 (Rios et al., 2014), Lgr5 (de Visser et al.,
2012; Fu et al., 2017; Rios et al., 2014; Van Keymeulen et al., 2011;
Wuidart et al., 2016), Lgr6 (Blaas et al., 2016; Wuidart et al., 2016),
Sox9 (Wang et al., 2017; Wuidart et al., 2016), Axin2 (van
Amerongen et al., 2012), Notch1 (Rodilla et al., 2015), Notch2
(Šale et al., 2013), Notch3 (Lafkas et al., 2013), WAP (Chang et al.,
2014), Acta2 (Prater et al., 2014), p63 (Sreekumar et al., 2017),
Procr (Wang et al., 2015), prominin 1 (Wang et al., 2017) and ER
(Van Keymeulen et al., 2017). However, although providing
valuable information on mammary development and the epithelial
differentiation hierarchy, these models have relied on prior
assumptions regarding the specificity and consistency of the
expression of the chosen gene promoters, and have generated
conflicting results.
In this study, we have employed a neutral genetic labelling
strategy for lineage analysis in the mammary gland using
R26CreERT2;R26Confetti mice (Fig. 1A) (Davis et al., 2016; Li et al.,
2016; Scheele et al., 2017). Administration of a low dose of
tamoxifen induces the stochastic expression of up to four
fluorescent proteins (FPs) (Fig. 1A). Importantly, FP expression
can occur in any cell, overcoming issues pertaining to the requisite
high-level Cre specificity inherent to other models (discussed by
Wuidart et al., 2016; Davis et al., 2016 ; Lloyd-Lewis et al., 2017).
Fig. 1. Lineage tracing during branching
morphogenesis. (A) The R26CreERT2;R26Confetti
model. R26CreERT2 mice (expressing inducible
Cre-recombinase in all cells) were crossed to
R26Confetti mice (expressing a conditional
multicolour reporter in all cells) to generate double
hemizygous mice. Administration of low-dose
tamoxifen produced stochastic genetic labelling of
cells at relatively low density. Labelling outcomes
include membranous CFP (mCFP), nuclear GFP
(nGFP), cytosolic YFP (YFP) or cytosolic RFP
(RFP); however, CFP+ clones (Fig. S2) were
under-represented (Davis et al., 2016) and were
not analysed. (B) For lineage tracing during
branching morphogenesis, tamoxifen was
administered (4 weeks) and tissue harvested
(7 weeks). (C,D) Example of single-colour
branches (C) and multicoloured branches (D).
Images show maximum-intensity z-projections
and optical slices of a region of interest (boxed
and enlarged in the right-hand panels). (E) The
percentage of single- and multicolour branches in
pubertal mice. (F) Cell neighbour analysis
revealed that the majority of FP+ cells had a same-
colour FP+ neighbour that was the same lineage.
Box extends from the 25th to 75th percentiles and
whiskers indicate minimum to maximum values.
Data are from 1419 cells distributed across 130
branches from randomly selected 3D images
(five mice).
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Neutral labelling of proliferative cells at clonal density (where the
chance of clone convergence is extremely low) has previously been
described using the R26CreERT2;R26Confetti model (using an ‘ultra-
low’ dose of tamoxifen; 0.2 mg per 25 g body weight) (Scheele
et al., 2017) and the R26[CA]30 model (Davis et al., 2016). Using
these models combined with 3D imaging, all of the progeny of a
single labelled cell can be analysed with confidence. These studies
revealed that lineage-restricted stem/progenitor cells orchestrate
ductal (Davis et al., 2016; Scheele et al., 2017) and alveolar (Davis
et al., 2016) mammary morphogenesis. However, they also revealed
extraordinary multiplicity in the MaSC compartment and thus their
power to capture the full spectrum of mammary stem/progenitor
cells is limited.
In the current study, we injected pubertal R26CreERT2;R26Confetti
mice with 0.5 mg tamoxifen (∼35 µg/g) to achieve low-density
labelling in the mammary epithelium (Fig. 1B and Fig. S1A). This
dose is approximately fourfold higher than previous studies using
‘ultra-low’ tamoxifen dosing in puberty (Scheele et al., 2017).
Using this approach, we observed mammary branches that
contained labelled cells of a single colour (Fig. 1C) as well as
branches comprising two or more colours (Fig. 1D), as expected. No
labelling was observed in control vehicle-injected mice (Fig. S1B).
Quantification of the number of single- and multicoloured branches
indicated that, under these conditions, the likelihood of clone
convergence is at least 50% (Fig. 1E); this number may be even
higher, as distinct coincident labelling events of the same colour
cannot be distinguished.
Consistent with previous reports (Davis et al., 2016), we observed
stochastic dispersion of labelled cell progeny throughout the
developing ducts (Fig. 1C,D and Fig. S3). This labelling pattern
is likely to have arisen from the deposition of labelled progeny along
developing ducts by proliferative labelled cells in elongating TEBs
(Bai and Rohrschneider, 2010; Davis et al., 2016). As ductal
elongation and side branching occur as the result of cell proliferation
by stem/progenitor cells within both TEB and ductal structures and
the admixing of clonal progeny (Fu et al., 2017; Rios et al., 2014;
Wang et al., 2015), we employed a cell-neighbour analysis to assess
lineage potential (Fig. 1F; see supplementary Materials and
Methods). A striking majority of same-colour cell neighbours
consisted of cells of the same lineage, providing further evidence of
physiological lineage bias in the postnatal mammary gland (Davis
et al., 2016; Scheele et al., 2017; Van Keymeulen et al., 2011; Wang
et al., 2017; Wuidart et al., 2016).
Alveolar morphogenesis is driven by a pool of lineage-biased
adult stem/progenitor cells
Low-density labelling using the R26CreERT2;R26Confetti model was
also used for lineage analysis during alveolar morphogenesis
(Fig. 2, Figs S4 and S5). R26CreERT2;R26Confetti mice were
injected with low-dose tamoxifen (1 mg per mouse; ∼40-50 µg/g)
(Fig. S5A), mated and tissue harvested during lactation (Fig. 2A).
Under these conditions, a large number of single-colour alveoli
were observed (Fig. 2B,C and Fig. S4) with fewer multicoloured
alveoli (Fig. 2D). No FP+ cells were observed in control mice
(Fig. S5B). Analysis of individual alveolar units revealed the vast
majority (96.6%) of alveoli were single-coloured (Fig. 2E). Of the
single-coloured alveoli, only 0.1% contained both luminal and basal
cells of the same colour (Fig. 2F). Thus, these data support previous
lineage-tracing studies using a different neutral model at single cell
density showing lineage restriction during alveolar morphogenesis
(Davis et al., 2016). Previous single cell lineage-tracing studies,
which quantified only very large labelled clones (containing
hundreds of labelled cells, with each clone presumably arising
from a single MaSC), demonstrated that most alveoli comprise the
progeny of a pool of lineage-restricted cells (Davis et al., 2016).
Analysis of the number of partially versus fully populated alveoli in
this low-density model revealed a seemingly higher rate of
polyclonality (Fig. 2G). This is likely due to the inclusion of
small, medium and large clones in the current study, representing
the wider spectrum of stem and progenitor cell divisions.
Neutral lineage tracing supports the presence of
lineage-biased embryonic stem/progenitor cells by
late embryogenesis
Although MaSCs appear to be lineage restricted postnatally,
numerous studies have suggested that their foetal precursors are
multipotent (Boras-Granic et al., 2014; Fu et al., 2017; Rodilla et al.,
2015; Spike et al., 2012; Trejo et al., 2017; Van Keymeulen et al.,
2011; Wang et al., 2015). Embryonic MaSCs display multipotential
activity in in vitro and transplantation assays, and increase
dramatically in number during this developmental window (Spike
et al., 2012). Moreover, in vivo population-based fate mapping has
shown that all mammary epithelial lineages derive from embryonic
K14-expressing stem/progenitor cells labelled at E17 (Van
Keymeulen et al., 2011), an observation reinforced by other
lineage-tracing studies using different gene promoters (Fu et al.,
2017; Rodilla et al., 2015; Trejo et al., 2017; Wang et al., 2015).
However, whether embryonic MaSCs are truly multipotent or
whether they consist of populations of distinct progenitors that are
already committed to give rise to different lineages after birth, has
remained subject to deliberation. In addition, it has remained
unclear when putative multipotent embryonic MaSCs become
lineage restricted. Recent studies using low-density lineage tracing
of embryonic cells have shed new light on this debate (Lilja et al.,
2018; Wuidart et al., 2018). Clonal labelling of K14-expressing
cells at E13 (when K14 appears to be universally expressed in
luminal and basal lineages) points to the existence of multipotent
stem cells at this stage of mammogenesis (Wuidart et al., 2018).
However, at birth, segregation of basal and luminal lineages appears
to be complete, with K5-expressing (Wuidart et al., 2018) and
Acta2-expressing (Lilja et al., 2018) cells exclusively giving rise to
basal progeny, and Notch1-expressing (Lilja et al., 2018) cells
exclusively giving rise to luminal progeny. As targeted promoters
may be differentially expressed in the neonatal and prenatal
mammary gland (Sun et al., 2010; Boras-Granic et al., 2014;
Trejo et al., 2017), definitive determination of the potential of
embryonic MaSCs and their perinatal lineage segregation requires a
neutral and inducible approach to labelling that is independent of
these promoters. In addition, it has been demonstrated (Rios et al.,
2016) that enzymatic digestion prior to 3D visualisation (Lilja et al.,
2018; Wuidart et al., 2018) can alter tissue architecture and cell
morphology, potentially confounding lineage-tracing outcomes.
Unequivocal lineage determination must therefore include studies
that employ methods of 3D visualisation that are void of proteolytic
digestion (Lloyd-Lewis et al., 2016). To address this, a single low-
dose of tamoxifen (33 µg per g maternal body weight) was
administered by oral gavage to pregnant transgenic mice to induce
incontrovertible neutral labelling in R26CreERT2;R26Confetti embryos
at E16.5-E17.5. This route of delivery, although subject to first-pass
metabolism, is reported to have less embryonic toxicity and more
uniform recombination by Cre (Park et al., 2008). Mammary glands
of offspring labelled in utero were subsequently visualised in 3D
(without prior proteolytic digestion) (Fig. 3A). Using this approach,
we observed large regions of labelled cells, some spanning from the
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nipple to the outer reaches of the fad pad (Fig. 3B-F, and Fig. S6).
3D imaging of areas proximal to the nipple revealed that these
regions always comprised cells of two or more colours (Fig. 3C).
Ductal branches in distal regions, however, more commonly
contained cells of a single colour (Fig. 3D-F versus Fig. S7).
Quantification of the number of single- and multicoloured branches
in nipple and distal regions confirmed this observation, and
indicated that the likelihood of clone convergence under these
conditions was high (Fig. 3G). Mixed-lineage cells of the same
colour were occasionally detected in both nipple (Fig. 3C) and distal
(Fig. 3F) ductal regions, supporting the notion that embryonic
MaSCs may possess multipotent capacity (Spike et al., 2012; Van
Keymeulen et al., 2011). However, a cell neighbour analysis
indicated that the majority of same-colour neighbours consisted of
cells of the same lineage (Fig. 3H), suggesting that embryonic stem/
progenitor cells are already lineage biased in the foetal mammary
gland. Indeed, a recent study, which was able to achieve multicolour
labelling at clonal density, has demonstrated that Notch1-expressing
cells display lineage restriction at E15.5 and E17.5 (Lilja et al.,
2018). It is important to note, however, that although the results of
this study at E16.5-E17.5 are consistent with previous analyses at
clonal density (Lilja et al., 2018; Wuidart et al., 2018), mammary
glands in our study are marked at levels higher than clonal density
and thus we cannot exclude the possibility that bipotent embryonic
MaSCs were initially labelled and gave rise to luminal and basal
progeny that expanded only after lineage specification occurred.
A single stem cell labelled in utero can contribute extensively
to both the basal and luminal lineages in the adult mammary
gland. Whereas the low-density and neutral R26CreERT2;R26Confetti
model provided important corroborating evidence into the fate of
primordial stem/progenitor cells to mammary development, we
sought to reinforce these observations using an alternative neutral
approach. To achieve this, we used the R26[CA]30 reporter mouse
model (Kozar et al., 2013) that was previously exploited to achieve
unbiased, single-cell labelling in the mammary gland (Davis et al.,
2016). This model encompasses a [CA]30 microsatellite repeat
positioned directly upstream of an out-of-frame modified
β-glucosidase (SYNbglA) reporter gene targeted to the Rosa26
locus (Fig. 4A). During DNA replication, spontaneous frame-shift
mutations in the inherently unstable dinucleotide repeat tract may
place the reporter gene in-frame, leading to its expression. This
‘strand slippage’ produces a permanent mark on the cell, which is
subsequently transmitted to all of its progeny. Importantly, genetic
labelling in this model is exceedingly rare, thereby allowing the
Fig. 2. Lineage tracing after alveolar
morphogenesis. (A) Tamoxifen was
administered (∼12 weeks), mice were
mated (∼14 weeks) and tissue
harvested during lactation.
(B-D) Example of single-colour luminal
YFP+ alveoli (B), single-colour luminal
YFP+ and RFP+ adjacent alveoli within
a larger lobuloalveolar structure
(arrowheads indicate different alveoli)
(C) and multicolour basal GFP+ and
YFP+ alveoli (D; red arrows show GFP+
and YFP+ cells within a single
alveolus). Images show maximum-
intensity z-projections and optical
slices of a region of interest (boxed and
enlarged in the right-hand panels).
(E) Graph (data are mean±s.e.m.)
showing the percentage of single- and
multicoloured alveoli; a lower rate of
clone convergence is observed in this
model following expansion during
gestation and lactation. (F) Graph
(data are mean±s.e.m.) showing the
percentage of FP+ alveoli in which the
same-colour cells were the same
lineage (i.e. all luminal or all basal) or
where same-colour cells were mixed
lineage (both luminal and basal).
(G) Fraction of alveoli that were fully
populated by single-colour FP+ cells
of a single lineage (full) versus those
populated by both single- or
multicoloured FP+ cells and/or
unlabelled cells of a single lineage
(partial). Data represent 1016 alveoli
from randomly selected 3D images
(three mice).
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fate of a single-labelled cell to be traced with a high degree
of confidence.
Using this model, we observed variable numbers of label-positive
cells randomly intermixed with unlabelled cells in developing ducts
(Fig. 4B), mirroring the stochastic labelling pattern observed in
pubertal R26CreERT2;R26Confetti mice (Fig. 1C,D). The majority of
labelled progeny arising from a single β-glucosidase+ cell expressed
markers of the luminal lineage (Fig. 4C), potentially reflecting the
higher proliferative capacity in this compartment compared to basal
cells (Giraddi et al., 2015). Isolated regions containing limited
numbers of label-positive cells were most-commonly observed
(Fig. 4B). These most likely arose from a recent frame-shift
mutation, or from strand slippage in replicative-restricted
progenitors or differentiated cells. Occasionally, large, contiguous
clonal regions spanning several ductal branches were also observed,
which were considered to have arisen from a single proliferative
MaSC/progenitor cell.
On one occasion, we observed ductal regions that comprised
exclusively β-glucosidase+ basal cells in close proximity to regions
comprising only β-glucosidase+ luminal cells (Fig. 4D,E). The
expansive size of this clone (>10 mm), in addition to its location at
the nipple region of the mammary gland, suggest that a bipotent
MaSC was labelled at some point during embryogenesis, giving rise
to a luminal and a basal daughter cell that later generated lineage-
Fig. 3. Lineage tracing following
embryonic labelling. (A) Tamoxifen
(33 µg/g maternal weight) was
administered by oral gavage (E16.5-
E17.5) and tissue harvested from
R26CreERT2;R26Confetti offspring.
(B) Analysis was divided into nipple
regions and distal branches. (C) Example
of a multicoloured nipple region. Arrow
and arrowhead indicate adjacent RFP+
basal and luminal cells, respectively.
(D) Example of single-colour distal
branches and terminal end buds (TEBs)
comprising YFP+ basal cells. i and ii are
two examples showing the same thing.
(E) Example of single-colour distal
branches and TEBs comprising RFP+
luminal cells. (F) Example of a rare distal
branch containing interspersed RFP+
luminal and basal cells. Images show
maximum-intensity z-projections and
optical slices of a region of interest (boxed
and enlarged in the right-hand panels).
Arrow and arrowhead in F show adjacent
RFP+ basal and luminal cells,
respectively. (G) Graphs (data are mean
±s.e.m.) showing the percentage of
single- and multicoloured nipple regions
and distal branches. (H) Cell neighbour
analysis showing that the majority of FP+
cells had a same-colour FP+ neighbour of
the same lineage [data are mean±s.e.m.
of 940 cells (seven nipple regions, n=5
mice) and 4439 cells (85 distal branches,
n=7 mice) from randomly-selected 3D
images].
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restricted progeny during postnatal development. Remarkably, we
also observed a clone that spanned the entire abdominal mammary
gland (Fig. 4F). This is in stark contrast to the contribution of cells
labelled during late embryogenesis in R26CreERT2;R26Confetti mice,
which appeared, overall, more limited in scope (Fig. 3). The vast
nature of this exceptional clone (and its origin at the nipple region)
might, therefore, suggest that a cell was marked very early in
development, likely before E12.5-E13.5, where clone size was
considerably and consistently smaller (Lilja et al., 2018; van
Amerongen et al., 2012; Wuidart et al., 2018). However, without
knowing the precise stage of labelling in the R26[CA]30SYNbglA
model, the differential contribution of these putative embryonic
cells to ductal morphogenesis in this model (Fig. 4D versus 4F)
could also point to heterogeneity and multiplicity within the
embryonic MaSC compartment. Histochemical analysis of this rare
clone (Fig. 4F) revealed that the majority of labelled cells were
luminal (Fig. 4G), further suggesting that some MaSCs might
exhibit a degree of lineage bias, even during early embryonic
development.
The origin of luminal and basal cell lineages in the mammary
gland has been the subject of intense investigation and debate.
Recent saturation lineage-tracing, single-cell lineage-tracing and
promoter-driven lineage-tracing studies have provided support for
lineage restriction of MaSCs from late embryogenesis into
Fig. 4. Single-cell genetic labelling using the
R26[CA]30SYNbglA model. (A) Schematic
representation of the R26[CA]30 model.
(B,C) Dispersion of β-glucosidase+ cells (purple)
throughout the ductal epithelium (green) (B) and
lineage analysis of β-glucosidase+ cells with
immunohistochemistry (C). (D,E) Example of a
β-glucosidase+ clone that originated at the nipple
region (asterisk) (D) and consisted of regions
containing β-glucosidase+ luminal cells adjacent to
regions containing β-glucosidase+ basal cells (E).
Arrows and arrowheads show cells with a basal and
luminal morphology, respectively. (F) A rare clone
spanning the entire abdominal mammary gland.
Asterisk indicates the nipple region. (G) Lineage
analysis of β-glucosidase+ cells with
immunohistochemistry. Black arrows indicate β-
glucosidase+ basal cells among β-glucosidase+
luminal cells. Scale bars: 20 µm. Clones shown in D
and F represent two out of three putative embryonic
labelling events observed from the analysis of 30
mice.
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adulthood (Davis et al., 2016; Li et al., 2016; Lilja et al., 2018;
Van Keymeulen et al., 2011; Wuidart et al., 2016, 2018). However,
the lack of evidence for the presence of multilineage clones does not
unequivocally show that bi/multipotent stem cells do not exist (Rios
et al., 2016; Visvader and Stingl, 2014). Thus, it is imperative that
the epithelial hierarchy in the mammary gland is rigorously assessed
at various developmental stages, using a range of methods, models
and systems of analyses. Using a low-density, neutral, genetic
labelling strategy and method of imaging that is free of proteolytic
digestion, we have provided corroborating evidence of the lineage
restriction of proliferative stem/progenitor cells to the three major
stages of mammary development: in the late embryo, during puberty
and in reproduction. Our findings also confirm that remarkable
heterogeneity exists within the adult mammary stem and progenitor
cell compartment, and suggest similar multiplicity within their
embryonic precursors. Importantly, we have revealed the
remarkable capacity of a single embryonic MaSC to contribute to
ductal development, providing unprecedented insights that could
only be disclosed by this single-cell approach. It is increasingly
hypothesised that certain cancers may arise from reactivation of
embryonic developmental programs in postnatal tissues (Howard
and Veltmaat, 2013; Wahl and Spike, 2017). Thus, an elucidation of
the full spectrum of stem/progenitor cell populations in the pre- and
postnatal mammary gland is paramount for defining the cellular
origin of heterogeneous breast tumours.
MATERIALS AND METHODS
Antibodies and reagents
Antibodies used in these studies include: rabbit anti-SMA (Abcam,
ab5694, lot number GR248336-23, 1:200 and 1:300 for 2D and 3D
studies, respectively), rat anti-K8 (Developmental Studies Hybridoma
Bank, TROMA-I, 1:200 and 1:50 of supernatant for 2D and 3D studies,
respectively), rabbit anti-E-cadherin (Cell Signaling, 3195, lot number
10, 1:400), goat anti-rabbit AlexaFluor (AF) 647 (Thermo Fisher Scientific,
A21245, lot number 1805235, 1:500) and anti-rabbit horseradish
peroxidase (HRP) (DAKO, P0448, lot number 20023997, 1:500). See
supplementary Materials and Methods for further information and
Lloyd-Lewis et al. (2016) for optimisation and validation studies.
Animal models
All animal experimentation was carried out in accordance with the Animal
(Scientific Procedures) Act 1986, the European Union Directive 86/609,
and with local ethics committee approval. Mouse (Mus musculus) strains
R26[CA]30 (Kozar et al., 2013) (a kind gift from Prof. D. Winton, Cancer
Research UK Cambridge Institute), R26Confetti (Livet et al., 2007) and
R26CreERT2 (Ventura et al., 2007) have previously been described. R26[CA]30
experimental mice were hemi- or homozygous for R26[CA]30SYNbglA. Mice
were analysed for β-glucosidase expression during adulthood (7-22-weeks).
Multi-colour lineage-tracing studies were performed on mice that were
hemizygous for both R26Confetti and R26CreERT2 (R26Confetti;R26CreERT2
mice). See supplementary Materials and Methods for further information.
Induction of lineage tracing in R26Confetti;R26CreERT2 mice
Tamoxifenwas prepared in sunfloweroil containing 10%ethanol. For lineage
tracing during puberty in R26Confetti;R26CreERT2 mice, labelling was induced
at the onset of puberty (4weeks of age) by a single intraperitoneal injection of
tamoxifen (0.5 mg per mouse, ∼35 μg/g) and tissue was harvested from 7-
week-old mice. Using this dose, mammary gland development appeared to
progress unabated, as previously reported (Rios et al., 2014). For lineage-
tracing in lactating R26Confetti;R26CreERT2 mice, labelling was induced after
puberty (12-14 weeks old) by a single intraperitoneal injection of tamoxifen
(1 mg per mouse, ∼40-50 μg/g), which did not grossly affect alveolar
development, as previously reported (Rios et al., 2014). After 10 days, female
mice were mated with C57BL/6J male studs and lactating tissue was
harvested between lactation days 4 and 5. For embryonic labelling,
homozygous R26Confetti mice were mated with homozygous R26CreERT2
mice. A single dose of tamoxifen (33 μg per g maternal body weight)
containing progesterone (13 µg per g maternal body weight) was
administered to pregnant mice via oral gavage at E16.5-17.5 (Li et al.,
2016; Park et al., 2008). Using this dose, terminal end buds (TEBs) appeared
morphologically normal and branching morphogenesis appeared normal via
stereomicroscopy (Fig. S6). Mice were allowed to litter and tissue was
collected from R26Confetti;R26CreERT2 offspring 6 weeks after birth.
Optical tissue clearing and whole-mount immunostaining
Fixed mammary tissue was cut into large pieces (∼15×15×2 mm) for
immunostaining and tissue clearing, without any mechanical or enzymatic
manipulation or microdissection. Optical tissue clearing was performed
using either SeeDB (Ke et al., 2013) or a modified CUBIC (Reagent 1A)
protocol (Susaki and Ueda, 2016), as previously described in detail (Lloyd-
Lewis et al., 2016). Whole-mount immunostaining was performed prior
to tissue clearing (SeeDB) or following immersion in CUBIC Reagent 1A,
as previously described. See supplementary Materials and Methods for
further information.
Confocal microscopy
Optically clear tissues were imaged in their respective refractive index
matching solutions in 35 mm glass-bottom MatTek dishes. Images were
acquired using a Leica TCS SP8 inverted confocal microscope with 10×/0.4
or 20×/0.75 HC PL APO objective lenses. All colours (GFP, YFP, RFP and
far red) were imaged for consistency and quantification. CFP-expressing
clones were under-represented and were not routinely imaged (see Fig. S2).
See supplementary Materials and Methods for further information.
Whole-mount histochemistry
Detection of modified β-glucosidase expression in the mammary gland was
performed as previously described (Davis et al., 2016). Briefly, excised
mammary glands were fixed at room temperature for 4 h in NBF (10%).
Tissue was heated to 65°C for 15 min in phosphate-buffered saline for
endogenous β-glucosidase inactivation. Whole-mount mammary glands
were incubated for 24 h at 50°C in a solution containing one part solution A
[5-bromo-6-chloro-3-indolyl-β-D-glucopyranoside (1%) in dimethyl
sulfoxide] and 25 parts solution B [magnesium chloride (0.02% w/v),
potassium ferricyanide (0.096% w/v) and potassium ferrocyanide (0.13%
w/v) in PBS]. After 24 h, the substrate was replenished and tissue incubated
for an additional 24 h. Mammary glands were post-fixed in 10% NBF
overnight at 4°C. Tissue clearing was performed using the CUBIC clearing
protocol (Susaki et al., 2014), with methyl green counterstaining, as
previously described (Davis et al., 2016; Lloyd-Lewis et al., 2016).
Histology
For histological analysis of tissue from R26[CA]30SYNbglA mice, CUBIC-
based tissue clearing was reversed by overnight incubation in PBS at 4°C.
Paraffin processing was performed using a butanol clearing protocol, to
maintain the histochemical magenta staining. Briefly, tissue was placed in a
cassette and immersed in 70% ethanol (2 h), 96% ethanol (2 h), 100%
ethanol (2 h) and finally transferred to n-butanol for 2 h before paraffin wax
embedding. Paraffin wax-embedded sections (4-6 µm) were de-waxed in
xylene (3×2 min washes) and processed as described above. Primary
antibodies used for immunohistochemistry on paraffin slides were: rabbit
anti-SMA (Abcam, ab5694, 1:200) and rabbit anti-E-cadherin (Cell
Signaling, 3195, 1:50). Goat anti-rabbit HRP-conjugated secondary
antibody (Jackson ImmunoResearch) was used at a dilution of 1:250.
Clonal analysis method
A cell neighbour analysis was used to analyse labelling outcomes in this
study and is described in detail in the supplementaryMaterials andMethods.
Briefly, we created z-projections of randomly selected 3D image stacks
containing label-positive cells. For all cells within each region, the lineage
of the closest same-colour neighbour was recorded as either ‘same’ or
‘different’ by manual scoring. GFP, YFP, RFP and far red channels were
imaged for each image sequence.
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